0001104659-15-056946.txt : 20150806 0001104659-15-056946.hdr.sgml : 20150806 20150806114924 ACCESSION NUMBER: 0001104659-15-056946 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150806 DATE AS OF CHANGE: 20150806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLUG POWER INC CENTRAL INDEX KEY: 0001093691 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRICAL INDUSTRIAL APPARATUS [3620] IRS NUMBER: 223672377 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34392 FILM NUMBER: 151031875 BUSINESS ADDRESS: STREET 1: 968 ALBANY-SHAKER ROAD CITY: LATHAM STATE: NY ZIP: 12110 BUSINESS PHONE: 5187827700 MAIL ADDRESS: STREET 1: 968 ALBANY-SHAKER ROAD CITY: LATHAM STATE: NY ZIP: 12110 10-Q 1 a15-12551_110q.htm 10-Q

Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

x                 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2015

 

OR

 

o                    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM              TO                

 

Commission File Number: 1-34392

 

PLUG POWER INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

22-3672377

(State or Other Jurisdiction of
Incorporation or Organization)

 

(I.R.S. Employer
Identification Number)

 

968 ALBANY SHAKER ROAD, LATHAM, NEW YORK 12110

(Address of Principal Executive Offices, including Zip Code)

 

(518) 782-7700

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  x  No  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer  x

 

Accelerated filer  o

 

 

 

Non-accelerated filer  o

 

Smaller reporting company  o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b 2 of the Exchange Act).  Yes  o  No  x

 

The number of shares of common stock, par value of $.01 per share, outstanding as of August 6, 2015 was 173,523,949.

 

 

 



Table of Contents

 

INDEX to FORM 10-Q

 

 

Page

 

 

PART I.   FINANCIAL INFORMATION

 

 

 

Item 1 — Interim Consolidated Financial Statements (Unaudited)

3

 

 

Consolidated Balance Sheets

3

 

 

Consolidated Statements of Operations

4

 

 

Consolidated Statements of Comprehensive Loss

5

 

 

Consolidated Statement of Stockholders’ Equity

6

 

 

Consolidated Statements of Cash Flows

7

 

 

Notes to Interim Consolidated Financial Statements

8

 

 

Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

 

 

Item 3 — Quantitative and Qualitative Disclosures About Market Risk

22

 

 

Item 4 — Controls and Procedures

22

 

 

PART II.   OTHER INFORMATION

 

 

 

Item 1 — Legal Proceedings

23

 

 

Item 1A — Risk Factors

23

 

 

Item 2 — Unregistered Sales of Equity Securities and Use of Proceeds

23

 

 

Item 3 — Defaults Upon Senior Securities

23

 

 

Item 4 — Mine Safety Disclosures

23

 

 

Item 5 — Other Information

23

 

 

Item 6 — Exhibits

24

 

 

Signatures

25

 

2



Table of Contents

 

PART 1.   FINANCIAL INFORMATION

 

Item 1 — Interim Financial Statements (Unaudited)

 

Plug Power Inc. and Subsidiaries

Consolidated Balance Sheets

(In thousands, except share and per share amounts)

(Unaudited)

 

 

 

June 30,

 

December 31,

 

 

 

2015

 

2014

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

109,139

 

$

146,205

 

Accounts receivable

 

12,524

 

16,095

 

Inventory

 

32,889

 

24,736

 

Prepaid expenses and other current assets

 

5,950

 

5,710

 

Total current assets

 

160,502

 

192,746

 

 

 

 

 

 

 

Restricted cash

 

11,634

 

500

 

Property, plant, and equipment, net of accumulated depreciation of $27,218 and $26,539, respectively

 

5,989

 

5,312

 

Leased property under capital lease, net of accumulated depreciation of $1,420 and $1,162, respectively

 

1,679

 

1,937

 

Note receivable

 

415

 

447

 

Intangible assets, net

 

768

 

1,490

 

Other assets

 

1,967

 

1,719

 

Total assets

 

$

182,954

 

$

204,151

 

 

 

 

 

 

 

Liabilities, Redeemable Preferred Stock, and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

12,188

 

$

10,185

 

Accrued expenses

 

5,655

 

8,750

 

Product warranty reserve

 

1,006

 

1,311

 

Deferred revenue

 

3,494

 

3,319

 

Obligations under capital lease

 

200

 

587

 

Other current liabilities

 

2,199

 

1,555

 

Total current liabilities

 

24,742

 

25,707

 

Deferred revenue

 

6,114

 

6,772

 

Common stock warrant liability

 

6,982

 

9,418

 

Finance obligation

 

2,391

 

2,426

 

Other liabilities

 

 

392

 

Total liabilities

 

40,229

 

44,715

 

Redeemable preferred stock

 

 

 

 

 

Series C redeemable convertible preferred stock, $0.01 par value per share (aggregate involuntary liquidation preference $16,664) 10,431 shares authorized; Issued and outstanding: 5,231 at June 30, 2015 and December 31, 2014

 

1,153

 

1,153

 

Stockholders’ equity:

 

 

 

 

 

Common stock, $0.01 par value per share; 450,000,000 shares authorized; Issued (including shares in treasury): 173,827,314 at June 30, 2015 and 173,644,532 at December 31, 2014

 

1,738

 

1,736

 

Additional paid-in capital

 

1,100,009

 

1,096,392

 

Accumulated other comprehensive income

 

898

 

898

 

Accumulated deficit

 

(958,411

)

(938,081

)

Less common stock in treasury:

 

 

 

 

 

378,116 at June 30, 2015 and at December 31, 2014

 

(2,662

)

(2,662

)

Total stockholders’ equity

 

141,572

 

158,283

 

Total liabilities, redeemable preferred stock, and stockholders’ equity

 

$

182,954

 

$

204,151

 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

3



Table of Contents

 

Plug Power Inc. and Subsidiaries

Consolidated Statements of Operations

(In thousands, except share and per share amounts)
(Unaudited)

 

 

 

Three months ended

 

Six months ended

 

 

 

June 30,

 

June 30,

 

 

 

2015

 

2014

 

2015

 

2014

 

Product revenue

 

$

15,324

 

$

12,579

 

$

19,391

 

$

15,741

 

Service revenue

 

8,428

 

4,415

 

13,731

 

6,481

 

Research and development contract revenue

 

257

 

327

 

303

 

674

 

 

 

 

 

 

 

 

 

 

 

Total revenue

 

24,009

 

17,321

 

33,425

 

22,896

 

 

 

 

 

 

 

 

 

 

 

Cost of product revenue

 

11,653

 

10,448

 

15,491

 

13,892

 

Cost of service revenue

 

10,483

 

5,908

 

18,121

 

9,926

 

Cost of research and development contract revenue

 

311

 

770

 

362

 

1,188

 

Research and development expense

 

3,425

 

1,398

 

6,326

 

2,652

 

Selling, general and administrative expenses

 

8,002

 

5,439

 

15,751

 

9,258

 

 

 

 

 

 

 

 

 

 

 

Operating loss

 

(9,865

)

(6,642

)

(22,626

)

(14,020

)

 

 

 

 

 

 

 

 

 

 

Interest and other income

 

32

 

49

 

63

 

94

 

Gain on bargain purchase

 

 

1,014

 

 

1,014

 

Change in fair value of common stock warrant liability

 

667

 

9,577

 

2,436

 

(58,856

)

Interest and other expense

 

(60

)

(121

)

(150

)

(212

)

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to the Company

 

$

(9,226

)

$

3,877

 

$

(20,277

)

$

(71,980

)

 

 

 

 

 

 

 

 

 

 

Preferred stock dividends declared

 

(27

)

(52

)

(53

)

(104

)

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to common shareholders

 

$

(9,253

)

$

3,825

 

$

(20,330

)

$

(72,084

)

 

 

 

 

 

 

 

 

 

 

Net (loss) income per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.05

)

$

0.02

 

$

(0.12

)

$

(0.49

)

Diluted

 

$

(0.05

)

$

0.02

 

$

(0.12

)

$

(0.49

)

 

 

 

 

 

 

 

 

 

 

Basic weighted average number of common shares outstanding

 

173,439,391

 

159,916,449

 

173,402,611

 

146,905,767

 

Diluted weighted average number of common shares outstanding

 

173,439,391

 

176,157,179

 

173,402,611

 

146,905,767

 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

4



Table of Contents

 

Plug Power Inc. and Subsidiaries

Consolidated Statements of Comprehensive Loss

(In thousands)

(Unaudited)

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30,

 

June 30,

 

 

 

2015

 

2014

 

2015

 

2014

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to the Company

 

$

(9,226

)

$

3,877

 

$

(20,277

)

$

(71,980

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive (Loss) Income

 

$

(9,226

)

$

3,877

 

$

(20,277

)

$

(71,980

)

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

5



Table of Contents

 

Plug Power Inc. and Subsidiaries
Consolidated Statement of Stockholders’ Equity

(In thousands, except share amounts)
(Unaudited)

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

Total

 

 

 

Common Stock

 

Additional Paid-

 

Comprehensive

 

Treasury Stock

 

Accumulated

 

Stockholders’

 

 

 

Shares

 

Amount

 

in-Capital

 

Income

 

Shares

 

Amount

 

Deficit

 

Equity

 

December 31, 2014

 

173,644,532

 

$

1,736

 

1,096,392

 

$

898

 

378,116

 

$

(2,662

)

$

(938,081

)

$

158,283

 

Net loss attributable to the Company

 

 

 

 

 

 

 

(20,277

)

(20,277

)

Stock based compensation

 

47,337

 

1

 

3,434

 

 

 

 

 

3,435

 

Stock option exercises

 

116,667

 

1

 

130

 

 

 

 

 

131

 

Stock dividend

 

18,778

 

 

53

 

 

 

 

(53

)

 

June 30, 2015

 

173,827,314

 

$

1,738

 

$

1,100,009

 

$

898

 

378,116

 

$

(2,662

)

$

(958,411

)

$

141,572

 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements

 

6



Table of Contents

 

Plug Power Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(In thousands)
(Unaudited)

 

 

 

Six months ended

 

 

 

June 30,

 

 

 

2015

 

2014

 

Cash Flows From Operating Activities:

 

 

 

 

 

Net loss attributable to the Company

 

$

(20,277

)

$

(71,980

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

Depreciation of property, plant and equipment, and investment in leased property

 

969

 

939

 

Amortization of intangible assets

 

722

 

1,174

 

Stock-based compensation

 

3,435

 

1,255

 

Gain on bargain purchase

 

 

(1,014

)

Gain on disposal of property, plant and equipment

 

(2

)

(27

)

Change in fair value of common stock warrant liability

 

(2,436

)

58,856

 

Changes in operating assets and liabilities that provide (use) cash, net of effects of acquisition:

 

 

 

 

 

Accounts receivable

 

3,571

 

(9,716

)

Inventory

 

(8,153

)

(4,195

)

Prepaid expenses and other assets

 

(488

)

(3,170

)

Note receivable

 

32

 

31

 

Accounts payable, accrued expenses, product warranty reserve and other liabilities

 

(1,145

)

4,188

 

Deferred revenue

 

(483

)

3,725

 

Net cash used in operating activities

 

(24,255

)

(19,934

)

 

 

 

 

 

 

Cash Flows From Investing Activities:

 

 

 

 

 

Purchases of property, plant and equipment

 

(1,388

)

(524

)

Purchase of ReliOn, net of cash acquired

 

 

414

 

Proceeds from disposal of property, plant and equipment

 

2

 

27

 

Net cash used in investing activities

 

(1,386

)

(83

)

 

 

 

 

 

 

Cash Flows From Financing Activities:

 

 

 

 

 

Change in restricted cash

 

(11,134

)

 

Proceeds from exercise of warrants

 

 

18,317

 

Purchase of treasury stock

 

 

(64

)

Proceeds from issuance of common stock and warrants

 

 

176,700

 

Stock issuance costs

 

 

(10,977

)

Proceeds from exercise of stock options

 

131

 

 

Principal payments on obligations under capital lease and finance obligation

 

(422

)

(379

)

Net cash (used in) provided by financing activities

 

(11,425

)

183,597

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

2

 

(Decrease) increase in cash and cash equivalents

 

(37,066

)

163,582

 

Cash and cash equivalents, beginning of period

 

146,205

 

5,027

 

Cash and cash equivalents, end of period

 

$

109,139

 

$

168,609

 

 

 

 

 

 

 

Cash paid for interest

 

$

176

 

$

221

 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

7



Table of Contents

 

Notes to Interim Consolidated Financial Statements (Unaudited)

 

1.  Nature of Operations

 

Description of Business

 

Plug Power Inc., (the “Company” or “Plug Power”), is a leading provider of alternative energy technology focused on the design, development, commercialization and manufacture of hydrogen fuel cell systems used primarily for the material handling and stationary power market.

 

We are focused on proton exchange membrane, or PEM, fuel cell and fuel processing technologies, fuel cell/battery hybrid technologies, and associated hydrogen storage and dispensing infrastructure from which multiple products are available. A fuel cell is an electrochemical device that combines hydrogen and oxygen to produce electricity and heat without combustion. Hydrogen is derived from hydrocarbon fuels such as liquid petroleum gas, or LPG, natural gas, propane, methanol, ethanol, gasoline or biofuels. Hydrogen can also be obtained from the electrolysis of water, or produced on-site at consumer locations through a process known as reformation. Plug Power develops complete hydrogen delivery, storage and refueling solutions for customer locations.

 

We sell and continue to develop fuel cell product solutions to replace lead-acid batteries in material handling vehicles and industrial trucks for some of North America’s largest distribution and manufacturing businesses. We are focusing our efforts on material handling applications (forklifts) at multi-shift high volume manufacturing and high throughput distribution sites where our products and services provide a unique combination of productivity, flexibility and environmental benefits. Our current product line includes: GenDrive, our hydrogen fueled PEM fuel cell system providing power to material handling vehicles; GenFuel, our hydrogen fueling delivery system; GenCare, our ongoing maintenance program for both the GenDrive fuel cells and GenFuel products; ReliOn, our stationary fuel cell solution providing scalable, modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors; and GenKey, our turn-key solution coupling together GenDrive or ReliOn, GenFuel and GenCare, offering complete simplicity to customers transitioning to fuel cell power.

 

We sell our products worldwide, with a primary focus on North America, through our direct product sales force, leveraging relationships with original equipment manufacturers, or OEMs, and their dealer networks. We are party to a joint venture based in France with Axane, S.A. (Axane), a subsidiary of Air Liquide, under the name HyPulsion, to develop and sell hydrogen fuel cell systems for the European material handling market.  See note 9 regarding our agreement to acquire the remaining ownership of HyPulsion.  Also, we sell to businesses and government agencies.

 

We were organized in the State of Delaware on June 27, 1997.

 

Unless the context indicates otherwise, the terms “Company,” “Plug Power,” “we,” “our” or “us” as used herein refers to Plug Power Inc. and its subsidiaries.

 

Liquidity

 

Our cash requirements relate primarily to working capital needed to operate and grow our business, including funding operating expenses, growth in inventory to support both shipments of new units and servicing the installed base, funding the growth in our GenKey “turn-key” solution which also includes the installation of our customer’s hydrogen infrastructure as well as delivery of the hydrogen molecule, and continued development and expansion of our products. Our ability to achieve profitability and meet future liquidity needs and capital requirements will depend upon numerous factors, including the timing and quantity of product orders and shipments; attaining positive gross margins; the timing and amount of our operating expenses; the timing and costs of working capital needs; the timing and costs of building a sales base; the ability of our customers to obtain financing to support commercial transactions; our ability to obtain financing arrangements to support the sale or leasing of our products and services to customers; the timing and costs of developing marketing and distribution channels; the timing and costs of product service requirements; the timing and costs of hiring and training product staff; the extent to which our products gain market acceptance; the timing and costs of product development and introductions; the extent of our ongoing and new research and development programs; and changes in our strategy or our planned activities. If we are unable to fund our operations with positive cash flows and cannot obtain external financing, we may not be able to sustain future operations.  As a result, we may be required to delay, reduce and/or cease our operations and/or seek bankruptcy protection.

 

8



Table of Contents

 

We have experienced and continue to experience negative cash flows from operations and net losses.  The Company incurred net losses attributable to common shareholders of $9.3 million and $20.3 million for the three and six months ended June 30, 2015, respectively, and $88.6 million, $62.8 million and $31.9 million for the years ended December 31, 2014, 2013 and 2012, respectively, and has an accumulated deficit of $958.4 million at June 30, 2015.

 

Net cash used in operating activities for the six months ended June 30, 2015 was $24.3 million. Additionally, on June 30, 2015, we had cash and cash equivalents of $109.1 million and net working capital of $135.8 million. By comparison, net working capital at December 31, 2014 was $167.0 million.

 

During 2015, we had an increase in restricted cash of $11.1 million primarily related to sale/leaseback transactions, as described in note 8.  During 2014, we received gross proceeds of $176.7 million from three underwritten public offerings.  Net proceeds after underwriting discounts and commissions and other estimated fees and expenses were $165.7 million.  In addition, during 2014 we received $18.3 million from the exercise of previously issued common stock warrants.

 

To date, we have funded our operations primarily through public and private offerings of common and preferred stock, a sale-leaseback of our building, and our previous line of credit. The Company believes that its current cash, cash equivalents, cash anticipated to be generated from future sales and, to the extent exercised, cash generated from the exercise of outstanding warrants will provide sufficient liquidity to fund operations for at least the next twelve months. This projection is based on our current expectations regarding product sales, cost structure, cash burn rate and other operating assumptions.

 

2. Summary of Significant Accounting Policies

 

Principles of Consolidation

 

The accompanying unaudited interim consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Interim Financial Statements

 

The accompanying unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). In the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly, in accordance with U.S. generally accepted accounting principles (GAAP), the financial position, results of operations and cash flows for all periods presented, have been made. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the full year.

 

Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. These unaudited interim consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K, filed for the fiscal year ended December 31, 2014.

 

The information presented in the accompanying consolidated balance sheet as of December 31, 2014 has been derived from the Company’s December 31, 2014 audited consolidated financial statements.  All other information has been derived from the unaudited interim consolidated financial statements of the Company.

 

Cash Equivalents

 

Cash equivalents consist of money market accounts with an initial term of less than three months. For purposes of the unaudited consolidated statements of cash flows, the Company considers all highly-liquid debt instruments

 

9



Table of Contents

 

with original maturities of three months or less to be cash equivalents.  The Company’s cash and cash equivalents are deposited with financial institutions located in the U.S. and may at times exceed insured limits.

 

Revenue Recognition

 

The Company recognizes revenue under arrangements for products and services, which may include the sale of products and related services, including revenue from installation, service and maintenance, spare parts, hydrogen fueling services (which may include hydrogen supply as well as hydrogen fueling infrastructure) and leased units. The Company also recognizes revenue under research and development contracts, which are primarily cost reimbursement contracts associated with the development of PEM fuel cell technology.

 

Products and Services

 

The Company enters into revenue arrangements that may contain a combination of fuel cell systems and equipment, installation, service, maintenance, spare parts, hydrogen fueling and other support services. Revenue arrangements containing fuel cell systems and equipment may be sold, or under a limited number of arrangements, leased to customers. For the above multiple deliverable arrangements, the Company accounts for each separate deliverable as a separate unit of accounting if the delivered item or items have value to the customer on a standalone basis. The Company considers a deliverable to have standalone value if the item is sold separately by us or another entity or if the item could be resold by the customer. The Company allocates revenue to each separate deliverable based on its relative selling price. For a majority of our deliverables, the Company determines relative selling prices using its best estimate of the selling price as vendor-specific objective evidence and third-party evidence is generally not available for the deliverables involved in its revenue arrangements due to a lack of a competitive environment in selling fuel cell technology. When determining estimated selling prices, the Company may consider the cost to produce the deliverable, the anticipated margin on that deliverable, the selling price and profit margin for similar products and services, the Company’s ongoing pricing strategy and policies, the value of any enhancements that have been built into the deliverable and the characteristics of the varying markets in which the deliverable is sold, as applicable. The Company determines estimated selling prices for deliverables in its arrangements based on the specific facts and circumstances of each arrangement and analyzes the estimated selling prices used for its allocation of consideration of each arrangement.

 

Once relative selling prices are determined, the Company proportionately allocates the sale consideration to each element of the arrangement. The allocated sales consideration related to fuel cell systems and equipment, spare parts, and hydrogen infrastructure is recognized as revenue at shipment if title and risk of loss have passed to the customer, there is persuasive evidence of an arrangement, the sales price is fixed or determinable, collection of the related receivable is reasonably assured, and customer acceptance criteria, if any, have been successfully demonstrated. The allocated sales consideration related to installation, service, maintenance, and hydrogen molecule delivery is generally recognized as revenue when completed or on a straight-line basis over the term of the contract, as appropriate.

 

The Company does not include a right of return on its products other than rights related to standard warranty provisions that permit repair or replacement of defective goods. The Company accrues for anticipated standard warranty costs at the same time that revenue is recognized for the related product.

 

The Company has also sold extended warranty contracts that generally provide for a five to ten year warranty from the date of product installation. These types of contracts are accounted for as a separate deliverable, and accordingly, revenue generated from these transactions is deferred and recognized in income over the warranty period, generally on a straight-line basis. Additionally, the Company may enter into annual service and maintenance contracts that are billed monthly. Revenue generated from these transactions is recognized in income on a straight-line basis over the term of the contract. Costs are recognized as incurred over the term of the contract.

 

Research and Development Contracts

 

Contract accounting is used for research and development contract revenue. The Company generally shares in the cost of these programs with cost sharing percentages ranging from 30% to 50% of total project costs. Revenue

 

10



Table of Contents

 

from time and material contracts is recognized on the basis of labor hours expended plus other reimbursable contract costs incurred during the period. All allowable work performed through the end of each calendar quarter is billed, subject to limitations in the respective contracts. We expect to continue research and development contract work that is directly related to our current product development efforts. At June 30, 2015 and December 31, 2014, the Company had unbilled amounts from research and development contract revenue in the amount of approximately $0.5 million and $1.0 million, respectively, which is included in other current assets in the accompanying unaudited consolidated balance sheets. Unbilled amounts are expected to be billed during the following quarter.

 

Common Stock Warrant Accounting

 

The Company accounts for common stock warrants in accordance with applicable accounting guidance provided in Accounting Standards Codification (ASC) Subtopic 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity, as either derivative liabilities or as equity instruments depending on the specific terms of the warrant agreement. In compliance with applicable securities law, registered common stock warrants that require the issuance of registered shares upon exercise and do not sufficiently preclude an implied right to cash settlement are accounted for as derivative liabilities. We currently classify these derivative warrant liabilities on the accompanying unaudited consolidated balance sheets as a long-term liability, which is revalued at each balance sheet date subsequent to the initial issuance using the Black-Scholes pricing model. The Black-Scholes pricing model, which is based, in part, upon unobservable inputs for which there is little or no market data, requires the Company to develop its own assumptions. Changes in the fair value of the warrants are reflected in the accompanying unaudited consolidated statements of operations as change in fair value of common stock warrant liability.

 

Joint Venture

 

We are party to a joint venture with Axane, under the name HyPulsion (the JV). The principal purpose of the JV is to develop and sell hydrogen fuel cell systems for the European material handling market. In exchange for initial ownership of the JV, Axane contributed cash and we contributed the right to use our technology, including design and technology know-how on GenDrive systems. We are not obligated to contribute any cash.

 

We currently own 20% and Axane owns 80% of the JV. We have the right to purchase an additional 60% of the JV from Axane at any time between January 4, 2018 and January 29, 2018 at a market-based price. If we exercise our purchase right, Axane will have the right, at any time between February 1, 2018 and December 31, 2021, to require the Company to buy the remaining 20% interest at a market-based price.  See note 9 regarding our agreement to acquire the remaining ownership of HyPulsion.

 

In accordance with the equity method of accounting, we will increase our investment in the JV by our share of any earnings, and decrease our investment in the JV by our share of any losses. Losses in excess of the investment are not recognized and must be restored from future profits before our proportionate share of profits can be recognized. As of June 30, 2015, we had a zero basis for our investment in the JV.

 

Use of Estimates

 

The unaudited interim consolidated financial statements have been prepared in conformity with GAAP, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

11



Table of Contents

 

Reclassifications

 

Reclassifications are made, whenever necessary, to prior period financial statements to conform to the current period presentation.  These reclassifications did not impact the results of operations or net cash flows in the periods presented.

 

Recent Accounting Pronouncements

 

In August 2014, an accounting update was issued relating to how management assesses conditions and events that could raise substantial doubt about an entity’s ability to continue as a going concern. This accounting update is effective for reporting periods beginning after December 31, 2016. We do not expect the adoption of this update to have a significant effect on our consolidated financial statements.

 

In June 2014, an accounting update was issued that replaces the existing revenue recognition framework regarding contracts with customers. In July 2015, the Financial Accounting Standards Board (FASB) announced a one year delay in the required adoption date from January 1, 2017 to January 1, 2018.  We are evaluating the effect this update will have on our consolidated financial statements and have not yet selected a transition method.

 

3. Acquisition of ReliOn, Inc.

 

On April 2, 2014, the Company completed the acquisition of ReliOn, Inc. (“ReliOn”) for an aggregate purchase price of $4.0 million. The Company acquired substantially all of the assets of ReliOn, including patents, technology and other intangible assets, equipment and other tangible assets. ReliOn is a developer of hydrogen fuel cell stack technology based in Spokane, Washington. As consideration, the Company issued 530,504 shares of common stock, and assumed certain specified liabilities of ReliOn. The total purchase price is based on the issuance of 530,504 shares of Plug Power common stock at the closing price of the Company’s stock on April 1, 2014 of $7.54. Results of operations of ReliOn have been consolidated since acquisition.  The fair value of the acquired net assets of approximately $5.0 million exceeded the purchase consideration, and therefore a gain on bargain purchase of $1.0 million was recognized during the six months ended June 30, 2014.

 

4. Earnings Per Share

 

The following table provides the components of the calculations of basic and diluted earnings per share (in thousands, except share amounts):

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 2015

 

June 30, 2014

 

June 30, 2015

 

June 30, 2014

 

Numerator:

 

 

 

 

 

 

 

 

 

Net loss attributable to common shareholders

 

$

(9,253

)

$

3,825

 

$

(20,330

)

$

(72,084

)

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding - basic

 

173,439,391

 

159,916,449

 

173,402,611

 

146,905,767

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

Options and restricted stock awards

 

 

4,120,364

 

 

 

Common stock warrants

 

 

1,054,486

 

 

 

Preferred stock

 

 

11,065,880

 

 

 

Weighted average number of common shares outstanding - diluted

 

173,439,391

 

176,157,179

 

173,402,611

 

146,905,767

 

 

When the Company is in a net loss position, all common stock equivalents would be considered to be anti-dilutive and are, therefore, not included in the determination of diluted earnings per share.

 

12



Table of Contents

 

The potential dilutive common shares are summarized as follows:

 

 

 

At June 30,

 

 

 

2015

 

2014

 

Stock options outstanding (1)

 

8,576,278

 

5,200,768

 

Restricted stock outstanding

 

395,558

 

650,002

 

Common stock warrants (2)

 

4,219,442

 

4,244,442

 

Preferred stock (3)

 

5,554,594

 

11,076,271

 

Number of dilutive potential common shares

 

18,745,872

 

21,171,483

 

 


(1)

 

During the three months ended June 30, 2015 and 2014, the Company granted 440,000 and 435,500 stock options, respectively. During the six months ended June 30, 2015 and 2014, the Company granted 650,000 and 686,000 stock options, respectively.

(2)

 

In May 2011, the Company issued 7,128,563 warrants as part of an underwritten public offering. As a result of additional public offerings, and pursuant to the effect of the anti-dilution provisions of these warrants, the number of warrants increased to 22,995,365. Of these warrants, 219,342 and 244,342 were unexercised as of June 30, 2015 and 2014, respectively. In February 2013, the Company issued 23,637,500 warrants as part of an underwritten public offering. Of these warrants, 100 were unexercised as of June 30, 2015 and 2014. In January 2014, the Company issued 4,000,000 warrants as part of an underwritten public offering. Of these warrants, all are unexercised as of June 30, 2015 and 2014. As of June 30, 2015, the remaining warrants have a weighted average exercise price of $3.84.

(3)

 

The preferred stock amount represents the dilutive potential common shares of the Series C redeemable convertible preferred stock issued on May 16, 2013 based on the conversion price of the preferred stock as of June 30, 2015. Of the 10,431 preferred shares issued in May 2013, 5,200 had been converted to common stock as of June 30, 2015.

 

5.  Inventory

 

Inventory as of June 30, 2015 and December 31, 2014 consisted of the following (in thousands):

 

 

 

June 30, 2015

 

December 31, 2014

 

Raw materials and supplies

 

$

23,299

 

$

18,502

 

Work-in-process

 

2,764

 

237

 

Finished goods

 

6,826

 

5,997

 

 

 

$

32,889

 

$

24,736

 

 

6. Income Taxes

 

Under Internal Revenue Code (IRC) Section 382, the use of loss carryforwards may be limited if a change in ownership of a company occurs. If it is determined that, due to transactions involving the Company’s shares owned by its 5 percent or greater shareholders, a change of ownership has occurred under the provisions of IRC Section 382, the Company’s federal and state net operating loss carryforwards could be subject to significant IRC Section 382 limitations.

 

Based upon recent IRC Section 382 studies, Section 382 ownership changes occurred that resulted in all but $54 million of the Company’s federal and state net operating loss carryforwards generated through June 30, 2015 to be subject to IRC Section 382 limitations. Of the net operating loss carryforwards subject to IRC Section 382 limitations, $13 million will not expire prior to utilization and are reflected in the Company’s gross deferred tax asset at June 30, 2015.

 

The ownership changes also resulted in net unrealized built in losses per IRS Notice 2003-65 which should result in recognized built in losses during the five year recognition period. These recognized built in losses will translate into unfavorable book to tax add backs in the Company’s 2015 to 2018 U.S. corporate income tax returns of

 

13



Table of Contents

 

approximately $17.7 million that resulted in a gross deferred tax liability of $6.8 million at June 30, 2015 with a corresponding reduction to the valuation allowance. This gross deferred tax liability will offset certain existing gross deferred tax assets (i.e. capitalized research expense). This has no impact on the Company’s current financial position, results of operations, or cash flows because of the full valuation allowance.

 

The Company’s remaining deferred tax assets have been offset by a full valuation allowance because it is more likely than not that the tax benefits of the net operating loss carryforwards and other tax assets may not be realized.

 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense. The Company had $0.4 million of interest and penalties accrued at June 30, 2015 and December 31, 2014, respectively.

 

7. Fair Value Measurements

 

The following table summarizes the financial instruments measured at fair value on a recurring basis in the consolidated balance sheets (in thousands):

 

Balance at June 30, 2015

 

Total

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

 

 

 

 

 

 

 

 

Common stock warrant liability

 

$

6,982

 

$

 

$

 

$

6,982

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock warrant liability

 

$

9,418

 

$

 

$

 

$

9,418

 

 

The common stock warrant liability is measured at fair value using Level 3 inputs.  Level 3 inputs are unobservable inputs and should be used to determine fair value only when observable inputs are not available. Unobservable inputs should be developed based on the best information available in the circumstances, which might include internally generated data and assumptions being used to price the asset or liability.  When possible, the Company looks to active and observable markets to price identical assets, however when identical assets are not traded in active markets, the Company looks to market observable data for similar assets. Nevertheless, certain assets are not actively traded in observable markets and the Company must use alternative valuation techniques to derive a fair value measurement.

 

For our common stock warrants, fair value is based on the Black-Scholes pricing model which is based, in part, upon unobservable inputs for which there is little or no market data, requiring the Company to develop its own assumptions. The Company used the following assumptions for its common stock warrants:

 

 

 

At June 30, 2015

 

At December 31, 2014

 

 

 

 

 

 

 

Risk-free interest rate

 

0.28%-1.375%

 

0.21%-1.35%

 

Volatility

 

52.92%-134.4%

 

119.16%-136.62%

 

Expected average term

 

0.92-3.55

 

1.42-4.04

 

 

There was no expected dividend yield for the warrants granted. If factors change and different assumptions are used, the warrant liability and the change in estimated fair value could be materially different. Generally, as the market price of our common stock increases, the fair value of the warrant increases, and conversely, as the market price of our common stock decreases, the fair value of the warrant decreases. Also, a significant increase in the volatility of the market price of the Company’s common stock, in isolation, would result in a significantly higher fair value measurement; and a significant decrease in volatility would result in a significantly lower fair value measurement.

 

14



Table of Contents

 

The following table shows reconciliations of the beginning and ending balances for financial instruments measured at fair value on a recurring basis using significant unobservable inputs (in thousands):

 

 

 

Fair Value

 

 

 

Measurement Using

 

 

 

Significant

 

 

 

Unobservable Inputs

 

 

 

Three months ended

 

Six months ended

 

Common stock warrant liability

 

June 30, 2015

 

June 30, 2014

 

June 30, 2015

 

June 30, 2014

 

 

 

 

 

 

 

 

 

 

 

Beginning of period

 

$

7,649

 

$

25,742

 

$

9,418

 

$

28,830

 

Change in fair value of common stock warrants

 

(667

)

(9,577

)

(2,436

)

58,856

 

Issuance of common stock warrants

 

 

 

 

11,773

 

Exercise of common stock warrants

 

 

(36

)

 

(83,330

)

End of period

 

$

6,982

 

$

16,129

 

$

6,982

 

$

16,129

 

 

8. Commitments and Contingencies

 

Litigation

 

Legal matters are defended and handled in the ordinary course of business.  We have established accruals for matters for which management considers a loss to be probable and reasonably estimable. It is the opinion of management that facts known at the present time do not indicate that such litigation, after taking into account insurance coverage and the aforementioned accruals, will have a material adverse impact on our results of operations, financial position, or cash flows.

 

Concentrations of credit risk

 

Concentrations of credit risk with respect to receivables exist due to the limited number of select customers with whom the Company has initial commercial sales arrangements. To mitigate credit risk, the Company performs appropriate evaluation of a prospective customer’s financial condition.

 

At June 30, 2015, two customers comprise approximately 42.6% of the total accounts receivable balance, with each customer individually representing 23.4% and 19.2% of total accounts receivable, respectively.  At December 31, 2014, four customers comprise approximately 69.9% of the total accounts receivable balance, with each customer individually representing 30.2%, 16.0%, 13.4% and 10.3% of total accounts receivable, respectively.

 

For the six months ended June 30, 2015, 95.1% of total consolidated revenues were associated with three customers, with each representing 68.8%, 16.1%, and 10.2% of total consolidated revenues, respectively.  For the six months ended June 30, 2014, 35.9% of total consolidated revenues were associated with two customers, with each representing 20.7% and 15.2% of total consolidated revenues, respectively.

 

Restricted Cash

 

The Company has entered into sales/leaseback agreements associated with its products and services.  In connection with these agreements, cash of $10.6 million is required to be held in escrow, which will be released over the lease term.

 

The Company also has letters of credit in the aggregate amount of $1.0 million associated with an agreement to provide hydrogen infrastructure and hydrogen to a customer at its distribution center and with a finance obligation from the sale/leaseback of its building.  Cash collateralizing these letters of credit is considered restricted cash.

 

9. Subsequent Event

 

On July 24, 2015, we entered into a Share Purchase Agreement with Axane, pursuant to which on July 31, 2015 we (through a wholly-owned subsidiary) acquired Axane’s 80% equity interest in HyPulsion for $11.5 million, payable in shares of our common stock. In connection with the agreement, we issued 4,781,250 shares of our common stock and agreed to the issuance of up to 3,105,348 additional shares of our common stock in certain circumstances. The purchase price is also subject to certain other post-closing adjustments payable in cash.

 

15



Table of Contents

 

Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion should be read in conjunction with our accompanying unaudited interim consolidated financial statements and notes thereto included within this report, and our audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K, filed for the fiscal year ended December 31, 2014.  In addition to historical information, this Form 10-Q and the following discussion contain statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements contain projections of our future results of operations or of our financial position or state other forward-looking information. In some cases you can identify these statements by forward-looking words such as “anticipate,” “believe,” “could,” “continue,” “estimate,” “expect,” “intend,” “may,” “should,” “will,” “would,” “plan,” “projected” or the negative of such words or other similar words or phrases. We believe that it is important to communicate our future expectations to our investors. However, there may be events in the future that we are not able to accurately predict or control and that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements. Investors are cautioned not to unduly rely on forward-looking statements because they involve risks and uncertainties, and actual results may differ materially from those discussed as a result of various factors, including, but not limited to: the risk that we continue to incur losses and might never achieve or maintain profitability; the risk that we will need to raise additional capital to fund our operations and such capital may not be available to us; the risk that our lack of extensive experience in manufacturing and marketing products may impact our ability to manufacture and market products on a profitable and large-scale commercial basis; the risk that unit orders will not ship, be installed and/or converted to revenue, in whole or in part; the risk that a loss of one or more of our major customers could result in a material adverse effect on our financial condition; the risk that a sale of a significant number of shares of stock could depress the market price of our common stock; the risk that negative publicity related to our business or stock could result in a negative impact on our stock value and profitability; the risk of potential losses related to any product liability claims or contract disputes; the risk of loss related to an inability to maintain an effective system of internal controls or key personnel; the risks related to the use of flammable fuels in our products; the risk that pending orders may not convert to purchase orders, in whole or in part; the cost and timing of developing, marketing and selling our products and our ability to raise the necessary capital to fund such costs; our ability to obtain financing arrangements to support the sale or leasing of our products and services to customers; the ability to achieve the forecasted gross margin on the sale of our products; the cost and availability of fuel and fueling infrastructures for our products; market acceptance of our products and services, including GenDrive systems; our ability to establish and maintain relationships with third parties with respect to product development, manufacturing, distribution and servicing and the supply of key product components; the cost and availability of components and parts for our products; our ability to develop commercially viable products; our ability to reduce product and manufacturing costs; our ability to successfully expand internationally; our ability to improve system reliability for our products; competitive factors, such as price competition and competition from other traditional and alternative energy companies; our ability to protect our intellectual property; the cost of complying with current and future federal, state and international governmental regulations; the risks associated with potential future acquisitions; the volatility of our stock price; and other risks and uncertainties discussed under Item IA—Risk Factors in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, as filed March 17, 2015. Readers should not place undue reliance on our forward-looking statements. These forward-looking statements speak only as of the date on which the statements were made and are not guarantees of future performance. Except as may be required by applicable law, we do not undertake or intend to update any forward-looking statements after the date of this Form 10-Q.

 

Overview

 

Plug Power Inc., or the Company, is a leading provider of alternative energy technology focused on the design, development, commercialization and manufacture of hydrogen fuel cell systems used primarily for the material handling and stationary power market.

 

We are focused on proton exchange membrane, or PEM, fuel cell and fuel processing technologies, fuel cell/battery hybrid technologies, and associated hydrogen storage and dispensing infrastructure from which multiple products are available. A fuel cell is an electrochemical device that combines hydrogen and oxygen to produce electricity and heat without combustion. Hydrogen is derived from hydrocarbon fuels such as liquid petroleum gas, or LPG, natural gas, propane, methanol, ethanol, gasoline or biofuels. Hydrogen can also be obtained from the electrolysis of water, or produced on-site at consumer locations through a process known as reformation. Plug Power develops complete hydrogen delivery, storage and refueling solutions for customer locations.

 

16



Table of Contents

 

We concentrate our efforts on developing, manufacturing and selling our hydrogen products and services on commercial terms for material handling applications, with a focus on multi-shift high volume manufacturing and high throughput distribution sites.

 

2015 Outlook

 

In 2015, we anticipate:

 

·                  greater than $200 million in bookings for the year.  During the second quarter of 2015, bookings exceeded $59 million, and through June 30, 2015, year to date, our bookings are more than $106 million;

 

·                  greater than $100 million in total revenue, comprised of sales of more than 3,300 GenDrive units and construction of at least 15 GenFuel hydrogen infrastructures; and

 

·                  continual progress on our gross margins.

 

We expect revenue for the third quarter of 2015 to exceed $30 million. To date, in the 3rd quarter, we have already recognized $10 million of revenue.

 

We achieved a 7% overall gross margin in the second quarter, with our longest-running product line, GenDrive, achieving a 26% gross margin.  In the last 24 months, gross margins have improved for our GenDrive product line from 4% to 26%.

 

Recent Developments

 

On July 24, 2015, we entered into a Share Purchase Agreement with Axane, pursuant to which on July 31, 2015 we (through a wholly-owned subsidiary) acquired Axane’s 80% equity interest in HyPulsion for $11.5 million, payable in shares of our common stock. In connection with the agreement, we issued 4,781,250 shares of our common stock and agreed to the issuance of up to 3,105,348 additional shares of our common stock in certain circumstances. The purchase price is also subject to certain other post-closing adjustments payable in cash.  The HyPulsion Share Purchase is described in greater detail in our Current Reports on Form 8-K filed on July 27, 2015 and July 31, 2015, which are incorporated herein by reference.

 

Results of Operations

 

Product revenue: Product revenue generally includes revenue from the sale of our GenDrive units, as well as revenue from ReliOn’s stationary backup power units.

 

Product revenue for the three months ended June 30, 2015 increased $2.7 million or 21.8%, to $15.3 million from $12.6 million for the three months ended June 30, 2014. The increase is due to 892 fuel cell systems in total that were recognized as revenue for the three months ended June 30, 2015, compared to 687 for the three months ended June 30, 2014, offset by product mix.  The revenue recognized included the effect of closing sales/leaseback transactions that involved 498 fuel cell systems for the three months ended June 30, 2015, as compared to 299 for the three months ended June 30, 2014.

 

Product revenue for the six months ended June 30, 2015 increased $3.7 million or 23.2%, to $19.4 million from $15.7 million for the six months ended June 30, 2014. The increase is due to 1,157 fuel cell systems in total that were recognized as revenue for the six months ended June 30, 2015, compared to 852 for the six months ended June 30, 2014, offset by product mix.  The revenue recognized included the effect of closing sales/leaseback transactions that involved 736 fuel cell systems for the six months ended June 30, 2015, as compared to 299 for the six months ended June 30, 2014.

 

17



Table of Contents

 

Service revenue: Service revenue generally includes revenue from installation of hydrogen infrastructure, our service and maintenance contracts, hydrogen delivery contracts, spare parts, and leased units.

 

Service revenue for the three months ended June 30, 2015 increased $4.0 million or 90.9%, to $8.4 million from $4.4 million for the three months ended June 30, 2014. The increase is primarily related to an increase in the number of units covered by GenCare service contracts over the last year, when the Company introduced GenKey, a turn-key solution.  GenKey has led to an increase in the installed base of GenDrive units, as well as incremental GenFuel contracts, as our customer base grows and requires additional hydrogen deliveries and uptime maintenance. Also, the Company recognized revenue for hydrogen installations at three sites during the three months ended June 30, 2015, as compared to one site during the three months ended June 30, 2014.

 

Service revenue for the six months ended June 30, 2015 increased $7.3 million or 111.9%, to $13.7 million from $6.5 million for the six months ended June 30, 2014. The increase is generally due to the same reasons as for the three month period commented on above. Also, the Company recognized revenue for hydrogen installations at four sites during the six months ended June 30, 2015, as compared to one site during the six months ended June 30, 2014.

 

Research and development contract revenue: Research and development contract revenue relates to both cost reimbursement and fixed price research and development contracts associated with the development of PEM fuel cell technology.  Revenue from time and material contracts is recognized on the basis of labor hours expended plus other reimbursable contract costs incurred during the period. Revenue from fixed fee contracts is recognized on the basis of percentage of completion. We expect to continue certain research and development contract work that is related to our current product development efforts.

 

Research and development contract revenue for the three months ended June 30, 2015 decreased $70 thousand, or 21.1%, to $257 thousand from $327 thousand for the three months ended June 30, 2014. The decrease is primarily related to a reduced effort on legacy funded projects that are complete or near completion.

 

Research and development contract revenue for the six months ended June 30, 2015 decreased $371 thousand, or 55.0%, to $303 thousand from $674 thousand for the six months ended June 30, 2014. The decrease is primarily related to a reduced effort on legacy funded projects that are complete or near completion.

 

Cost of product revenue: Cost of product revenue includes direct material and labor costs, warranty cost, and an allocation of overhead costs that relate to the manufacture of GenDrive products and ReliOn’s stationary backup power units.

 

Cost of product revenue for the three months ended June 30, 2015 increased 11.5%, or $1.2 million, compared to the three months ended June 30, 2014. The increase in cost is a result of the increase in the number of units shipped and recognized as revenue, however gross margin improved from 17% for the three months ended June 30, 2014 to 24% for the three months ended June 30, 2015.  This can be attributed to better leverage on the fixed cost base, supply chain and product design cost down programs, and manufacturing process improvements.

 

Cost of product revenue for the six months ended June 30, 2015 increased 11.5%, or $1.6 million, compared to the six months ended June 30, 2014. The increase in cost is a result of the increase in the number of units shipped and recognized as revenue, however gross margin improved from 12% for the six months ended June 30, 2014 to 20% for the six months ended June 30, 2015.  This can be attributed to the same initiatives as for the three month period above.

 

Cost of service revenue. Cost of service revenue includes the labor and material costs incurred for our hydrogen installations, our product service and hydrogen site maintenance contracts, our hydrogen delivery contracts, replacement parts, rental units (short term) and leased units. In addition, cost of service revenue also includes allocation of overhead costs that relate to the servicing of our products.

 

Cost of service revenue for the three months ended June 30, 2015 increased 77.4%, or $4.6 million, compared to the three months ended June 30, 2014.  The increase in the cost of service revenue was primarily

 

18



Table of Contents

 

related to the increase in the number of hydrogen sites installed and serviced (which we did not have until June 2014), and a higher number of GenFuel and GenCare service contracts, as noted in the service revenue section above.  Gross margin improved from (34)% for the three months ended June 30, 2014 compared to (24)% for the three months ended June 30, 2015.  The improvement in the margin can be attributed to better leverage on the fixed cost base, most significantly as it relates to the hydrogen sites, and improvement in unit performance, as evidenced by lower parts costs.

 

Cost of service revenue for the six months ended June 30, 2015 increased 82.6%, or $8.2 million, compared to the six months ended June 30, 2014.  Gross margin improved from (53)% for the six months ended June 30, 2014 compared to (32)% for the six months ended June 30, 2015.  The increase in the cost of service revenue and improvement in the margin was primarily due to the same drivers as for the three month period above.

 

Cost of research and development contract revenue. Cost of research and development contract revenue includes costs associated with research and development contracts including: cash and non-cash compensation and benefits for engineering and related support staff, fees paid to outside suppliers for subcontracted components and services, fees paid to consultants for services provided, materials and supplies used and other directly allocable general overhead costs allocated to specific research and development contracts.

 

Cost of research and development contract revenue for the three months ended June 30, 2015 decreased $459 thousand, or 59.6% compared to the three months ended June 30, 2014, and for the six months ended June 30, 2015 decreased $826 thousand, or 69.5% compared to the six months ended June 30, 2014. As noted above related to revenue, the decrease is primarily related to a reduced effort on legacy funded projects that are complete or near completion.

 

Research and development expense. Research and development expense includes: materials to build development and prototype units, cash and non-cash compensation and benefits for the engineering and related staff, expenses for contract engineers, fees paid to outside suppliers for subcontracted components and services, fees paid to consultants for services provided, materials and supplies consumed, facility related costs such as computer and network services, and other general overhead costs associated with our research and development activities.

 

Research and development expense for the three months ended June 30, 2015 increased $2.0 million, or 145.0% to $3.4 million, from $1.4 million for the three months ended June 30, 2014. This increase was primarily related to increased investments to support continued growth, product design and performance enhancement programs.

 

Research and development expense for the six months ended June 30, 2015 increased $3.7 million, or 138.5% to $6.3 million, from $2.7 million for the six months ended June 30, 2014. This increase was primarily related to increased investments noted in the three month period above, as well as costs associated with ReliOn which is only in three of the six months from the prior period.

 

Selling, general and administrative expenses. Selling, general and administrative expenses includes cash and non-cash compensation, benefits, amortization of intangible assets and related costs in support of our general corporate functions, including general management, finance and accounting, human resources, selling and marketing, information technology and legal services.

 

Selling, general and administrative expenses for the three months ended June 30, 2015 increased $2.6 million, or 47.1%, to $8.0 million from $5.4 million for the three months ended June 30, 2014. This increase was primarily related to an increase in personnel related expenses to support the growth in the business, including an expanded salesforce and additional staffing in the executive and finance functions.  Amortization expense related to intangible assets was $0.1 million and $0.6 million for the three months ended June 30, 2015 and 2014, respectively.

 

Selling, general and administrative expenses for the six months ended June 30, 2015 increased $6.5 million, or 70.1%, to $15.8 million from $9.3 million for the six months ended June 30, 2014. This increase was primarily related to the same drivers as for the three month period above.  Amortization expense related to intangible assets was $0.7 million and $1.2 million for the six months ended June 30, 2015 and 2014, respectively.  Also, the prior period only includes costs associated with ReliOn for three of the six months.

 

19



Table of Contents

 

Interest and other income. Interest and other income consists primarily of interest earned on our cash, note receivable, and other income.

 

Compared to prior year periods, interest and other income decreased $17 thousand to approximately $32 thousand for the three months ended June 30, 2015, and $31 thousand to approximately $63 thousand for the six months ended June 30, 2015. These decreases are not significant.

 

Gain on bargain purchase. During the three and six months ended June 30, 2014, the Company recognized a gain on bargain purchase of $1.0 million associated with the acquisition of ReliOn.

 

Change in fair value of common stock warrant liability. We account for common stock warrants as derivative liabilities with changes in the fair value reflected in the consolidated statement of operations as change in the fair value of common stock warrant liability.

 

The change in fair value of common stock warrant liability for the three months ended June 30, 2015 resulted in a decrease in the associated warrant liability of $0.7 million as compared to a decrease of $9.6 million for the three months ended June 30, 2014. These variances are primarily due to changes in the Company’s common stock share price during the respective quarters, changes in volatility of our common stock, and reducing remaining terms, which are significant inputs to the Black-Scholes valuation model.

 

The change in fair value of common stock warrant liability for the six months ended June 30, 2015 resulted in a decrease in the associated warrant liability of $2.4 million as compared to an increase of $58.9 million for the six months ended June 30, 2014. These variances are primarily due to changes in the Company’s common stock share price during the respective six month periods, changes in volatility of our common stock, and reducing remaining terms, which are significant inputs to the Black-Scholes valuation model.

 

Interest and other expense. Interest and other expense consists of interest and other expenses related to interest on obligations under capital lease and our finance obligation, as well as foreign currency exchange gain (loss).

 

Compared to prior year periods, interest and other expense decreased $61 thousand to approximately $60 thousand for the three months ended June 30, 2015, and $62 thousand to approximately $150 thousand for the six months ended June 30, 2015. These decreases are not significant.

 

Income taxes.  We did not report a benefit for federal and state income taxes in the unaudited interim consolidated financial statements for the three and six months ended June 30, 2015 and 2014 as the deferred tax asset generated from our net operating loss has been offset by a full valuation allowance because it is more likely than not that the tax benefits of the net operating loss carry forward will not be realized.  As needed, the Company also recognizes accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense.

 

Liquidity and Capital Resources

 

Our cash requirements relate primarily to working capital needed to operate and grow our business, including funding operating expenses, growth in inventory to support both shipments of new units and servicing the installed base, funding the growth in our GenKey “turn-key” solution which also includes the installation of our customer’s hydrogen infrastructure as well as delivery of the hydrogen molecule, and continued development and expansion of our products. Our ability to achieve profitability and meet future liquidity needs and capital requirements will depend upon numerous factors, including the timing and quantity of product orders and shipments; attaining positive gross margins; the timing and amount of our operating expenses; the timing and costs of working capital needs; the timing and costs of building a sales base; the ability of our customers to obtain financing to support commercial transactions; our ability to obtain financing arrangements to support the sale or leasing of our products and services to customers; the timing and costs of developing marketing and distribution channels; the timing and costs of product service requirements; the timing and costs of hiring and training product staff; the extent to which our products gain market acceptance; the timing and costs of product development and introductions; the extent of our ongoing and new research and development programs; and changes in our strategy or our planned activities. If we are unable to fund our operations with positive cash flows and cannot obtain external financing, we may

 

20



Table of Contents

 

not be able to sustain future operations.  As a result, we may be required to delay, reduce and/or cease our operations and/or seek bankruptcy protection.

 

We have experienced and continue to experience negative cash flows from operations and net losses.  The Company incurred net losses attributable to common shareholders of $9.3 million and $20.3 million for the three and six months ended June 30, 2015, and $88.6 million, $62.8 million and $31.9 million for the years ended December 31, 2014, 2013 and 2012, respectively, and has an accumulated deficit of $958.4 million at June 30, 2015.

 

During the six months ended June 30, 2015, cash used for operating activities was $24.3 million, consisting primarily of a net loss attributable to the Company of $20.3 million, coupled with working capital outflows of $6.7 million.  The investment in working capital primarily was related to inventory build to meet our backlog, as well as units shipped but not recognized as revenue in the quarter. On June 30, 2015, we had cash and cash equivalents of $109.1 million and net working capital of $135.8 million. By comparison, at December 31, 2014, cash and cash equivalents was $146.2 million and net working capital was $167.0 million.

 

Cash used by investing and financing activities for the six months ended June 30, 2015 included purchases of equipment, exercises of stock options and payments on capital lease and finance obligations.  In addition, during 2015, the Company signed sales/leaseback agreements, which required cash held in escrow of $10.6 million, which is presented as restricted cash on the consolidated balance sheet.

 

During 2014, we received gross proceeds of $176.7 million from three underwritten public offerings.  Net proceeds after underwriting discounts and commissions and other estimated fees and expenses were $165.7 million.  In addition, during 2014 we received $18.3 million from the exercise of previously issued common stock warrants.

 

To date, we have funded our operations primarily through public and private offerings of common and preferred stock, a sale-leaseback of our building and our previous line of credit. The Company believes that its current cash, cash equivalents, cash anticipated to be generated from future operations and, to the extent exercised, cash generated from the exercise of outstanding warrants will provide sufficient liquidity to fund operations for at least the next twelve months. This projection is based on our current expectations regarding product sales and service, cost structure, cash burn rate and other operating assumptions.

 

Several key indicators of liquidity are summarized in the following table (in thousands):

 

 

 

Six months

 

Year

 

 

 

ended or at

 

ended or at

 

 

 

June 30, 2015

 

December 31, 2014

 

Cash and cash equivalents at end of period

 

$

109,139

 

$

146,205

 

Working capital at end of period

 

135,760

 

167,039

 

Net loss attributable to common shareholders

 

20,330

 

88,644

 

Net cash used in operating activities

 

24,255

 

40,780

 

Purchase of property, plant and equipment

 

1,388

 

1,413

 

Net cash (used in) provided by financing activities

 

(11,425

)

182,923

 

 

Critical Accounting Estimates

 

Management’s discussion and analysis of our financial condition and results of operations are based upon our unaudited interim consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these unaudited interim consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of and during the reporting period. On an on-going basis, we evaluate our estimates and judgments, including those related to bad debts, inventories, intangible assets, equity investments, product warranty reserves, unbilled revenue, common stock warrants,

 

21



Table of Contents

 

income taxes and contingencies. We base our estimates and judgments on historical experience and on various other factors and assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We refer to the policies and estimates set forth in the section “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates”, as well as a discussion of significant accounting policies included in Note 2, Summary of Significant Accounting Policies, of the consolidated financial statements, both of which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

 

Recent Accounting Pronouncements

 

In August 2014, an accounting update was issued relating to how management assesses conditions and events that could raise substantial doubt about an entity’s ability to continue as a going concern. This accounting update is effective for reporting periods beginning after December 31, 2016. We do not expect the adoption of this update to have a significant effect on our consolidated financial statements.

 

In June 2014, an accounting update was issued that replaces the existing revenue recognition framework regarding contracts with customers. In July 2015, the Financial Accounting Standards Board (FASB) announced a one year delay in the required adoption date from January 1, 2017 to January 1, 2018.  We are evaluating the effect this update will have on our consolidated financial statements and have not yet selected a transition method.

 

Item 3 — Quantitative and Qualitative Disclosures about Market Risk

 

From time to time, we may invest our cash in government, government backed and interest-bearing investment-grade securities that we generally hold for the duration of the term of the respective instrument. We do not utilize derivative financial instruments, derivative commodity instruments or other market risk sensitive instruments, positions or transactions in any material fashion. We are not subject to any material risks arising from changes in interest rates, foreign currency exchange rates, commodity prices, equity prices or other market changes that affect market risk sensitive instruments.

 

Our exposure to changes in foreign currency rates is primarily related to sourcing inventory from foreign locations. This practice can give rise to foreign exchange risk resulting from the varying cost of inventory to the receiving location. The Company reviews the level of foreign content as part of its ongoing evaluation of overall sourcing strategies and considers the exposure to be not significant.

 

Item 4 — Controls and Procedures

 

a)        Disclosure controls and procedures.

 

The chief executive officer and chief financial officer, based on their evaluation of disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q, have concluded that the Company’s disclosure controls and procedures are effective for ensuring that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in filed or submitted reports is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer as appropriate, to allow timely decisions regarding required disclosure.

 

(b)      Changes in internal control over financial reporting.

 

There were no changes in the Company’s internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

22



Table of Contents

 

PART II.  OTHER INFORMATION

 

Item 1 — Legal Proceedings

 

An action has been brought in New York State Supreme Court by General Electric Co. and an affiliate against the Company seeking $1 million that GE claims is due under an indemnification agreement between GE and the Company.  As previously disclosed, GE seeks indemnification for funds it paid to settle a claim with Soroof Trading Development Co., an entity that had paid funds to GE to become a distributor of the Company’s products.  The Company is vigorously defending the action.

 

Item 1A - Risk Factors

 

The following Risk Factor is in addition to the Risk Factors described in Part I, Item 1A, “Risk Factors” of our most recently filed Annual Report on Form 10-K, filed with the Securities and Exchange Commission for the fiscal year ended December 31, 2014, sets forth information relating to important risks and uncertainties that could materially adversely affect our business, financial condition and operating results. Those risk factors continue to be relevant to an understanding of our business, financial condition and operating results and, accordingly, you should review and consider such risk factors in addition to the risk factor included below in making any investment decision with respect to our securities.

 

Our ability to obtain financing arrangements to support the sale or leasing of our products and services to customers may affect our sales and profitability.

 

Customers representing most of our revenue lease, rather than purchase, our products.  On occasion, these lease arrangements require us to finance the purchase of such products, either ourselves or through third-party financing sources.  To date, we have been successful in obtaining or providing the necessary financing arrangements. However, there is no certainty that we will be able to continue to obtain or provide adequate financing for these arrangements on acceptable terms, or at all, in the future. Failure to obtain or provide such financing may result in the loss of material customers and product sales, which could have a material adverse effect on our business, financial condition and results of operations.

 

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds

 

(a)  None.

 

(b)  Not applicable.

 

(c)  None.

 

Item 3 — Defaults Upon Senior Securities

 

None.

 

Item 4 — Mine Safety Disclosures

 

None.

 

Item 5 — Other Information

 

(a)  None.

 

(b)  None.

 

23



Table of Contents

 

Item 6 — Exhibits

 

3.1

 

Amended and Restated Certificate of Incorporation of Plug Power. (1)

 

 

 

3.2

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Plug Power Inc. (1)

 

 

 

3.3

 

Second Certificate of Amendment of Amended and Restated Certificate of Incorporation f Plug Power Inc. (2)

 

 

 

3.4

 

Third Certificate of Amendment to Amended and Restated Certificate of Incorporation of Plug Power. (3)

 

 

 

3.5

 

Third Amended and Restated By-laws of Plug Power Inc. (4)

 

 

 

3.6

 

Certificate of Designations, Preferences and Rights of a Series of Preferred Stock of Plug Power Inc. classifying and designating the Series A Junior Participating Cumulative Preferred Stock. (5).

 

 

 

3.7

 

Certificate of Designations of Series C Redeemable  Preferred Stock of Plug Power Inc. classifying and designating the Series C Redeemable Convertible Preferred Stock  (6)

 

 

 

31.1 and 31.2

 

Certifications pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (7)

 

 

 

32.1 and 32.2

 

Certifications pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (7)

 

 

 

101.INS*

 

XBRL Instance Document (7)

101.SCH*

 

XBRL Taxonomy Extension Schema Document (7)

101.CAL*

 

XBRL Taxonomy Extension Calculation Linkbase Document (7)

101.DEF*

 

XBRL Taxonomy Extension Definition Linkbase Document (7)

101.LAB*

 

XBRL Taxonomy Extension Labels Linkbase Document (7)

101.PRE*

 

XBRL Taxonomy Extension Presentation Linkbase Document (7)

 


(1)           Incorporated by reference to the Company’s Form 10-K for the period ended December 31, 2008.

 

(2)           Incorporated by reference to the Company’s current Report on Form 8-K dated May 19, 2011.

 

(3)           Incorporated by reference to the Company’s current Report on Form 8-K dated July 23, 2014.

 

(4)           Incorporated by reference to the Company’s current Report on Form 8-K dated October 28, 2009.

 

(5)           Incorporated by reference to the Company’s current Report on Form 8-A dated June 24, 2009.

 

(6)           Incorporated by reference to the Company’s current Report on Form 8-K dated May 20, 2013.

 

(7)           Filed herewith.

 

* Submitted electronically herewith. Attached as Exhibit 101 are the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2015, formatted in eXtensible Business Reporting Language (XBRL) and tagged as blocks of text: (i) Interim Consolidated Balance Sheets at June 30, 2015 and December 31, 2014; (ii) Interim Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2015 and 2014; (iii) Interim Consolidated Statements of Comprehensive Loss for the Three and Six Months Ended June 30, 2015 and 2014; (iv) Interim Consolidated Statement of Stockholders’ Equity for the Six Months Ended June 30, 2015; (v) Interim Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2015 and 2014; and (vi) related notes, tagged as blocks of text.

 

24



Table of Contents

 

Signatures

 

Pursuant to requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

PLUG POWER INC.

 

 

Date:  August 6, 2015

By:

/s/ Andrew Marsh

 

 

Andrew Marsh

 

 

President, Chief Executive Officer and Director (Principal Executive Officer)

 

 

 

Date:  August 6, 2015

By:

/s/ Paul B. Middleton

 

 

Paul B. Middleton

 

 

Chief Financial Officer (Principal Financial Officer)

 

25


EX-31.1 2 a15-12551_1ex31d1.htm EX-31.1

Exhibit 31.1

 

I, Andrew Marsh, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Plug Power Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 6, 2015

 

 

by:

/s/ Andrew Marsh

 

 

Andrew Marsh

 

 

Chief Executive Officer

 

 


EX-31.2 3 a15-12551_1ex31d2.htm EX-31.2

Exhibit 31.2

 

I, Paul B. Middleton, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Plug Power Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 6, 2015

 

 

by:

/s/ Paul B. Middleton

 

 

Paul B. Middleton

 

 

Chief Financial Officer

 

 


EX-32.1 4 a15-12551_1ex32d1.htm EX-32.1

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

 

18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Plug Power Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2015 as filed with the Securities and Exchange Commission (the “SEC”) on the date hereof (the “Report”), I, Andrew Marsh, Chief Executive Officer of the Company, certify, solely pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

This certification is being furnished and not filed, and shall not be incorporated into any documents for any other purpose, under the Securities Exchange Act of 1934, as amended or the Securities Act of 1933, as amended. A signed original of this written statement required by § 906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.

 

 

/s/ Andrew Marsh

 

Andrew Marsh

 

Chief Executive Officer

 

 

 

August 6, 2015

 

 


EX-32.2 5 a15-12551_1ex32d2.htm EX-32.2

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

 

18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Plug Power Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2015 as filed with the Securities and Exchange Commission (the “SEC”) on the date hereof (the “Report”), I, Paul B. Middleton, Interim Chief Financial Officer of the Company, certify, solely pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

This certification is being furnished and not filed, and shall not be incorporated into any documents for any other purpose, under the Securities Exchange Act of 1934, as amended or the Securities Act of 1933, as amended. A signed original of this written statement required by § 906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.

 

 

/s/ Paul B. Middleton

 

Paul B. Middleton

 

Chief Financial Officer

 

 

 

August 6, 2015

 

 


EX-101.INS 6 plug-20150630.xml XBRL INSTANCE DOCUMENT 0001093691 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-06-30 0001093691 us-gaap:RetainedEarningsMember 2015-06-30 0001093691 us-gaap:AdditionalPaidInCapitalMember 2015-06-30 0001093691 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-06-30 0001093691 us-gaap:RetainedEarningsMember 2014-12-31 0001093691 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001093691 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0001093691 us-gaap:EmployeeStockOptionMember 2015-04-01 2015-06-30 0001093691 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-06-30 0001093691 us-gaap:EmployeeStockOptionMember 2014-04-01 2014-06-30 0001093691 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-06-30 0001093691 2013-01-01 2013-12-31 0001093691 2012-01-01 2012-12-31 0001093691 us-gaap:RetainedEarningsMember 2015-01-01 2015-06-30 0001093691 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2015-06-30 0001093691 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2015-06-30 0001093691 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001093691 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001093691 2015-03-31 0001093691 2014-03-31 0001093691 us-gaap:MinimumMember 2015-03-31 2015-03-31 0001093691 us-gaap:MaximumMember 2015-03-31 2015-03-31 0001093691 us-gaap:MinimumMember 2014-12-31 2014-12-31 0001093691 us-gaap:MaximumMember 2014-12-31 2014-12-31 0001093691 plug:AxaneSAMember plug:HyPulsionSASMember 2015-06-30 0001093691 plug:HyPulsionSASMember 2015-06-30 0001093691 us-gaap:SeriesCPreferredStockMember 2015-06-30 2015-06-30 0001093691 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember plug:CustomerTwoMember 2015-06-30 2015-06-30 0001093691 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember plug:CustomersMember 2015-06-30 2015-06-30 0001093691 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember plug:CustomerOneMember 2015-06-30 2015-06-30 0001093691 us-gaap:SalesRevenueNetMember us-gaap:CreditConcentrationRiskMember plug:CustomerTwoMember 2015-01-01 2015-06-30 0001093691 us-gaap:SalesRevenueNetMember us-gaap:CreditConcentrationRiskMember plug:CustomerThreeMember 2015-01-01 2015-06-30 0001093691 us-gaap:SalesRevenueNetMember us-gaap:CreditConcentrationRiskMember plug:CustomersMember 2015-01-01 2015-06-30 0001093691 us-gaap:SalesRevenueNetMember us-gaap:CreditConcentrationRiskMember plug:CustomerOneMember 2015-01-01 2015-06-30 0001093691 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember plug:CustomerTwoMember 2014-12-31 2014-12-31 0001093691 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember plug:CustomerThreeMember 2014-12-31 2014-12-31 0001093691 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember plug:CustomersMember 2014-12-31 2014-12-31 0001093691 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember plug:CustomerOneMember 2014-12-31 2014-12-31 0001093691 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember plug:CustomerFourMember 2014-12-31 2014-12-31 0001093691 us-gaap:SalesRevenueNetMember us-gaap:CreditConcentrationRiskMember plug:CustomerTwoMember 2014-01-01 2014-06-30 0001093691 us-gaap:SalesRevenueNetMember us-gaap:CreditConcentrationRiskMember plug:CustomersMember 2014-01-01 2014-06-30 0001093691 us-gaap:SalesRevenueNetMember us-gaap:CreditConcentrationRiskMember plug:CustomerOneMember 2014-01-01 2014-06-30 0001093691 us-gaap:TreasuryStockMember 2015-06-30 0001093691 us-gaap:CommonStockMember 2015-06-30 0001093691 us-gaap:TreasuryStockMember 2014-12-31 0001093691 us-gaap:CommonStockMember 2014-12-31 0001093691 2013-12-31 0001093691 plug:ReliOnIncMember 2014-04-02 0001093691 plug:ReliOnIncMember 2014-01-01 2014-06-30 0001093691 plug:ReliOnIncMember 2014-04-02 2014-04-02 0001093691 plug:AxaneSAMember plug:HyPulsionSASMember us-gaap:SubsequentEventMember 2015-07-24 0001093691 2015-03-31 2015-03-31 0001093691 us-gaap:CommonStockMember 2015-01-01 2015-06-30 0001093691 2014-01-01 2014-12-31 0001093691 us-gaap:SeriesCPreferredStockMember 2014-05-31 0001093691 plug:WarrantIssuedInFebruary2013Member 2015-06-30 2015-06-30 0001093691 plug:WarrantIssuedInMay2011Member 2015-01-01 2015-06-30 0001093691 plug:WarrantIssuedInFebruary2013Member 2014-06-30 2014-06-30 0001093691 plug:WarrantIssuedInMay2011Member 2014-01-01 2014-06-30 0001093691 2014-12-31 0001093691 plug:AxaneSAMember plug:HyPulsionSASMember 2015-01-01 2015-06-30 0001093691 us-gaap:MinimumMember 2015-01-01 2015-06-30 0001093691 us-gaap:MaximumMember 2015-01-01 2015-06-30 0001093691 2015-04-01 2015-06-30 0001093691 2014-04-01 2014-06-30 0001093691 2014-01-01 2014-06-30 0001093691 us-gaap:SalesRevenueNetMember us-gaap:CreditConcentrationRiskMember plug:CustomersMember 2015-06-30 0001093691 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember plug:CustomersMember 2015-06-30 0001093691 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember plug:CustomersMember 2014-12-31 0001093691 us-gaap:SalesRevenueNetMember us-gaap:CreditConcentrationRiskMember plug:CustomersMember 2014-06-30 0001093691 2015-06-30 0001093691 2014-06-30 0001093691 plug:WarrantIssuedInJanuary2014Member 2014-01-01 2014-01-31 0001093691 plug:WarrantIssuedInFebruary2013Member 2013-02-01 2013-02-28 0001093691 plug:WarrantIssuedInMay2011Member 2011-05-01 2011-05-31 0001093691 plug:AxaneSAMember plug:HyPulsionSASMember us-gaap:SubsequentEventMember 2015-07-23 2015-07-24 0001093691 2015-08-06 0001093691 2015-01-01 2015-06-30 iso4217:USD xbrli:shares xbrli:pure iso4217:USD plug:item xbrli:shares false --12-31 Q2 2015 2015-06-30 10-Q 0001093691 173523949 Yes Large Accelerated Filer PLUG POWER INC 3105348 7128563 23637500 4000000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;text-indent:11.55pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Common Stock Warrant Accounting</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company accounts for common stock warrants in accordance with applicable accounting guidance provided in Accounting Standards Codification (ASC) Subtopic 815-40, </font><font style="display: inline;font-style:italic;">Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity</font><font style="display: inline;">, as either derivative liabilities or as equity instruments depending on the specific terms of the warrant agreement. In compliance with applicable securities law, registered common stock warrants that require the issuance of registered shares upon exercise and do not sufficiently preclude an implied right to cash settlement are accounted for as derivative liabilities. We currently classify these derivative warrant liabilities on the accompanying unaudited consolidated balance sheets as a long-term liability, which is revalued at each balance sheet date subsequent to the initial issuance using the Black-Scholes pricing model. The Black-Scholes pricing model, which is based, in part, upon unobservable inputs for which there is little or no market data, requires the Company to develop its own assumptions. Changes in the fair value of the warrants are reflected in the accompanying unaudited consolidated statements of operations as change in fair value of common stock warrant liability.</font> </p> <p><font size="1"> </font></p> </div> </div> 4244442 4219442 2 4 2 3 1188000 770000 362000 311000 50 30 20 0.60 2426000 2391000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Interim Financial Statements</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The accompanying unaudited interim consolidated financial statements have been prepared pursuant to the rules&nbsp;and regulations of the Securities and Exchange Commission (SEC). In the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly, in accordance with U.S. generally accepted accounting principles (GAAP), the financial position, results of operations and cash flows for all periods presented, have been made. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the full year.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. These unaudited interim consolidated financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form&nbsp;10-K, filed for the fiscal year ended December&nbsp;31, 2014.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The information presented in the accompanying consolidated balance sheet as of December&nbsp;31, 2014 has been derived from the Company&#x2019;s December&nbsp;31, 2014 audited consolidated financial statements.&nbsp;&nbsp;All other information has been derived from the unaudited interim consolidated financial statements of the Company.</font> </p> <p><font size="1"> </font></p> </div> </div> 1937000 1679000 P12M 167000000 135800000 21171483 18745872 244342 100 219342 100 54000000 13000000 10977000 P5Y 10431 11076271 5554594 176700000 17700000 650002 395558 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;"></font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 83.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:64.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:31.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">At&nbsp;June&nbsp;30,</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:64.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">2015</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">2014</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Stock options outstanding (1)</font></p> </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,576,278&nbsp; </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,200,768&nbsp; </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Restricted stock outstanding</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>395,558&nbsp; </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>650,002&nbsp; </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Common stock warrants (2)</font></p> </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,219,442&nbsp; </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,244,442&nbsp; </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Preferred stock (3)</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,554,594&nbsp; </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,076,271&nbsp; </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:64.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Number of dilutive potential common shares</font></p> </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,745,872&nbsp; </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,171,483&nbsp; </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 21.00pt; display: inline;"> <p style="border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="margin:0pt;border-bottom:1pt none #D9D9D9;font-family:Times New Roman;font-size:12pt;;"> (1)</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="display: inline;color:#000000;">During the three months ended June&nbsp;30, 2015 and 2014, the Company granted 440,000 and 435,500 stock options, respectively. During the six months ended June&nbsp;30, 2015 and 2014, the Company granted 650,000 and 686,000 stock options, respectively.</font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 21.00pt; display: inline;"> <p style="border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="margin:0pt;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-family:Times New Roman;font-size:12pt;;"> (2)</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="display: inline;color:#000000;">In May&nbsp;2011, the Company issued 7,128,563 warrants as part of an underwritten public offering. As a result of additional public offerings, and pursuant to the effect of the anti-dilution provisions of these warrants, the number of warrants increased to 22,995,365. Of these warrants, 219,342 and 244,342 were unexercised as of June&nbsp;30, 2015 and 2014, respectively. In February&nbsp;2013, the Company issued 23,637,500 warrants as part of an underwritten public offering. Of these warrants, 100 were unexercised as of June&nbsp;30, 2015 and 2014. In January&nbsp;2014, the Company issued 4,000,000 warrants as part of an underwritten public offering. Of these warrants, all are unexercised as of June&nbsp;30, 2015 and 2014. As of June&nbsp;30, 2015, the remaining warrants have a weighted average exercise price of $3.84.</font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 21.00pt; display: inline;"> <p style="border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="margin:0pt;border-top:1pt none #D9D9D9;font-family:Times New Roman;font-size:12pt;;"> (3)</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="display: inline;color:#000000;">The preferred stock amount represents the dilutive potential common shares of the Series&nbsp;C redeemable convertible preferred stock issued on May&nbsp;16, 2013 based on the conversion price of the preferred stock as of June&nbsp;30, 2015. Of the 10,431 preferred shares issued in May&nbsp;2013, 5,200 had been converted to common stock as of June&nbsp;30, 2015.</font></p></td></tr></table></div> <p><font size="1"> </font></p> </div> </div> 674000 327000 303000 257000 18778 5200768 8576278 P10Y P5Y 3.84 10185000 12188000 16095000 12524000 8750000 5655000 898000 898000 1096392000 1100009000 1174000 722000 22995365 204151000 182954000 192746000 160502000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;">2. Summary of Significant Accounting Policies</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Principles of Consolidation</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The accompanying unaudited interim consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Interim Financial Statements</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The accompanying unaudited interim consolidated financial statements have been prepared pursuant to the rules&nbsp;and regulations of the Securities and Exchange Commission (SEC). In the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly, in accordance with U.S. generally accepted accounting principles (GAAP), the financial position, results of operations and cash flows for all periods presented, have been made. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the full year.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. These unaudited interim consolidated financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form&nbsp;10-K, filed for the fiscal year ended December&nbsp;31, 2014.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The information presented in the accompanying consolidated balance sheet as of December&nbsp;31, 2014 has been derived from the Company&#x2019;s December&nbsp;31, 2014 audited consolidated financial statements.&nbsp;&nbsp;All other information has been derived from the unaudited interim consolidated financial statements of the Company.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;text-indent:17.3pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Cash Equivalents</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Cash equivalents consist of money market accounts with an initial term of less than three months. For purposes of the unaudited consolidated statements of cash flows, the Company considers all highly-liquid debt instruments </font><a name="mrllPB3"></a><font style="display: inline;">with original maturities of three months or less to be cash equivalents.&nbsp; The Company&#x2019;s cash and cash equivalents are deposited with financial institutions located in the U.S. and may at times exceed insured limits.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Revenue Recognition</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company recognizes revenue under arrangements for products and services, which may include the sale of products and related services, including revenue from installation, service and maintenance, spare parts, hydrogen fueling services (which may include hydrogen supply as well as hydrogen fueling infrastructure) and leased units. The Company also recognizes revenue under research and development contracts, which are primarily cost reimbursement contracts associated with the development of PEM fuel cell technology.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;text-indent:11.55pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-style:italic;">Products and Services</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company enters into revenue arrangements that may contain a combination of fuel cell systems and equipment, installation, service, maintenance, spare parts, hydrogen fueling and other support services. Revenue arrangements containing fuel cell systems and equipment may be sold, or under a limited number of arrangements, leased to customers. For the above multiple deliverable arrangements, the Company accounts for each separate deliverable as a separate unit of accounting if the delivered item or items have value to the customer on a standalone basis. The Company considers a deliverable to have standalone value if the item is sold separately by us or another entity or if the item could be resold by the customer. The Company allocates revenue to each separate deliverable based on its relative selling price. For a majority of our deliverables, the Company determines relative selling prices using its best estimate of the selling price as vendor-specific objective evidence and third-party evidence is generally not available for the deliverables involved in its revenue arrangements due to a lack of a competitive environment in selling fuel cell technology. When determining estimated selling prices, the Company may consider the cost to produce the deliverable, the anticipated margin on that deliverable, the selling price and profit margin for similar products and services, the Company&#x2019;s ongoing pricing strategy and policies, the value of any enhancements that have been built into the deliverable and the characteristics of the varying markets in which the deliverable is sold, as applicable. The Company determines estimated selling prices for deliverables in its arrangements based on the specific facts and circumstances of each arrangement and analyzes the estimated selling prices used for its allocation of consideration of each arrangement.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Once relative selling prices are determined, the Company proportionately allocates the sale consideration to each element of the arrangement. The allocated sales consideration related to fuel cell systems and equipment, spare parts, and hydrogen infrastructure is recognized as revenue at shipment if title and risk of loss have passed to the customer, there is persuasive evidence of an arrangement, the sales price is fixed or determinable, collection of the related receivable is reasonably assured, and customer acceptance criteria, if any, have been successfully demonstrated. The allocated sales consideration related to installation, service, maintenance, and hydrogen molecule delivery is generally recognized as revenue when completed or on a straight-line basis over the term of the contract, as appropriate.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company does not include a right of return on its products other than rights related to standard warranty provisions that permit repair or replacement of defective goods. The Company accrues for anticipated standard warranty costs at the same time that revenue is recognized for the related product.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company has also sold extended warranty contracts that generally provide for a five to ten year warranty from the date of product installation. These types of contracts are accounted for as a separate deliverable, and accordingly, revenue generated from these transactions is deferred and recognized in income over the warranty period, generally on a straight-line basis. Additionally, the Company may enter into annual service and maintenance contracts that are billed monthly. Revenue generated from these transactions is recognized in income on a straight-line basis over the term of the contract. Costs are recognized as incurred over the term of the contract.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-style:italic;">Research and Development Contracts</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Contract accounting is used for research and development contract revenue. The Company generally shares in the cost of these programs with cost sharing percentages ranging from 30% to 50% of total project costs. Revenue </font><a name="mrllPB4"></a><font style="display: inline;">from time and material contracts is recognized on the basis of labor hours expended plus other reimbursable contract costs incurred during the period. All allowable work performed through the end of each calendar quarter is billed, subject to limitations in the respective contracts. We expect to continue research and development contract work that is directly related to our current product development efforts. At June&nbsp;30, 2015 and December&nbsp;31, 2014, the Company had unbilled amounts from research and development contract revenue in the amount of approximately $0.5 million and $1.0 million, respectively, which is included in other current assets in the accompanying unaudited consolidated balance sheets. Unbilled amounts are expected to be billed during the following quarter.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;text-indent:11.55pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Common Stock Warrant Accounting</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company accounts for common stock warrants in accordance with applicable accounting guidance provided in Accounting Standards Codification (ASC) Subtopic 815-40, </font><font style="display: inline;font-style:italic;">Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity</font><font style="display: inline;">, as either derivative liabilities or as equity instruments depending on the specific terms of the warrant agreement. In compliance with applicable securities law, registered common stock warrants that require the issuance of registered shares upon exercise and do not sufficiently preclude an implied right to cash settlement are accounted for as derivative liabilities. We currently classify these derivative warrant liabilities on the accompanying unaudited consolidated balance sheets as a long-term liability, which is revalued at each balance sheet date subsequent to the initial issuance using the Black-Scholes pricing model. The Black-Scholes pricing model, which is based, in part, upon unobservable inputs for which there is little or no market data, requires the Company to develop its own assumptions. Changes in the fair value of the warrants are reflected in the accompanying unaudited consolidated statements of operations as change in fair value of common stock warrant liability.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;text-indent:11.55pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Joint Venture</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">We are party to a joint venture with Axane, under the name HyPulsion (the JV). The principal purpose of the JV is to develop and sell hydrogen fuel cell systems for the European material handling market. In exchange for initial ownership of the JV, Axane contributed cash and we contributed the right to use our technology, including design and technology know-how on GenDrive systems. We are not obligated to contribute any cash.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">We currently own 20% and Axane owns 80% of the JV. We have the right to purchase an additional 60% of the JV from Axane at any time between January&nbsp;4, 2018 and January&nbsp;29, 2018 at a market-based price. If we exercise our purchase right, Axane will have the right, at any time between February&nbsp;1, 2018 and December&nbsp;31, 2021, to require the Company to buy the remaining 20% interest at a market-based price.&nbsp;&nbsp;See note 9 regarding our agreement to acquire the remaining ownership of HyPulsion.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">In accordance with the equity method of accounting, we will increase our investment in the JV by our share of any earnings, and decrease our investment in the JV by our share of any losses. Losses in excess of the investment are not recognized and must be restored from future profits before our proportionate share of profits can be recognized. As of June&nbsp;30, 2015, we had a zero basis for our investment in the JV.</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Use of Estimates</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:31.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The unaudited interim consolidated financial statements have been prepared in conformity with GAAP, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Reclassifications</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Reclassifications are made, whenever necessary, to prior period financial statements to conform to the current period presentation.&nbsp; These reclassifications did not impact the results of operations or net cash flows in the periods presented.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Recent Accounting Pronouncements</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">In August&nbsp;2014, an accounting update was issued relating to how management assesses conditions and events that could raise substantial doubt about an entity&#x2019;s ability to continue as a going concern. This accounting update is effective for reporting periods beginning after December&nbsp;31, 2016. We do not expect the adoption of this update to have a significant effect on our consolidated financial statements.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">In June&nbsp;2014, an accounting update was issued that replaces the existing revenue recognition framework regarding contracts with customers. In July&nbsp;2015, the Financial Accounting Standards Board (FASB) announced a one year delay in the required adoption date from January&nbsp;1, 2017 to January&nbsp;1, 2018.&nbsp;&nbsp;We are evaluating the effect this update will have on our consolidated financial statements and have not yet selected a transition method.</font> </p> <p><font size="1"> </font></p> </div> </div> 11500000 530504 4781250 0.8 1014000 1000000 1014000 4000000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:3pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;">3. Acquisition of ReliOn,&nbsp;Inc.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">On April&nbsp;2, 2014, the Company completed the acquisition of ReliOn,&nbsp;Inc. (&#x201C;ReliOn&#x201D;) for an aggregate purchase price of $4.0 million. The Company acquired substantially all of the assets of ReliOn, including patents, technology and other intangible assets, equipment and other tangible assets. ReliOn is a developer of hydrogen fuel cell stack technology based in Spokane, Washington. As consideration, the Company issued 530,504 shares of common stock, and assumed certain specified liabilities of ReliOn. The total purchase price is based on the issuance of 530,504 shares of Plug Power common stock at the closing price of the Company&#x2019;s stock on April&nbsp;1, 2014 of $7.54. Results of operations of ReliOn have been consolidated since acquisition.&nbsp;&nbsp;The fair value of the acquired net assets of approximately $5.0 million exceeded the purchase consideration, and therefore a gain on bargain purchase of $1.0 million was recognized during the six months ended June&nbsp;30, 2014.</font> </p> <p><font size="1"> </font></p> </div> </div> 5000000 587000 200000 5027000 168609000 146205000 109139000 163582000 -37066000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;text-indent:17.3pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Cash Equivalents</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Cash equivalents consist of money market accounts with an initial term of less than three months. For purposes of the unaudited consolidated statements of cash flows, the Company considers all highly-liquid debt instruments with original maturities of three months or less to be cash equivalents.&nbsp; The Company&#x2019;s cash and cash equivalents are deposited with financial institutions located in the U.S. and may at times exceed insured limits.</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;">8. Commitments and Contingencies</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Litigation</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Legal matters are defended and handled in the ordinary course of business.&nbsp;&nbsp;We have established accruals for matters for which management considers a loss to be probable and reasonably estimable. It is the opinion of management that facts known at the present time do not indicate that such litigation, after taking into account insurance coverage and the aforementioned accruals, will have a material adverse impact on our results of operations, financial position, or cash flows.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Concentrations of credit risk</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Concentrations of credit risk with respect to receivables exist due to the limited number of select customers with whom the Company has initial commercial sales arrangements. To mitigate credit risk, the Company performs appropriate evaluation of a prospective customer&#x2019;s financial condition.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">At June&nbsp;30, 2015, two customers comprise approximately 42.6% of the total accounts receivable balance, with each customer individually representing 23.4% and 19.2% of total accounts receivable, respectively.&nbsp; At December&nbsp;31, 2014, four customers comprise approximately 69.9% of the total accounts receivable balance, with each customer individually representing 30.2%, 16.0%, 13.4% and 10.3% of total accounts receivable, respectively.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">For the six months ended June&nbsp;30, 2015, 95.1% of total consolidated revenues were associated with three customers, with each representing 68.8%, 16.1%, and 10.2% of total consolidated revenues, respectively.&nbsp;&nbsp;For the six months ended June&nbsp;30, 2014, 35.9% of total consolidated revenues were associated with two customers, with each representing 20.7% and 15.2% of total consolidated revenues, respectively.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Restricted Cash</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company has entered into sales/leaseback agreements associated with its products and services.&nbsp;&nbsp;In connection with these agreements, cash of $10.6 million is required to be held in escrow, which will be released over the lease term.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company also has letters of credit in the aggregate amount of $1.0 million associated with an agreement to provide hydrogen infrastructure and hydrogen to a customer at its distribution center and with a finance obligation from the sale/leaseback of its building.&nbsp;&nbsp;Cash collateralizing these letters of credit is considered restricted cash.</font> </p> <p><font size="1"> </font></p> </div> </div> 0.01 0.01 450000000 450000000 173644532 173644532 378116 173827314 173827314 378116 1736000 1738000 -71980000 3877000 -20277000 -9226000 0.207 0.359 0.152 0.103 0.302 0.699 0.134 0.160 0.688 0.951 0.102 0.161 0.234 0.426 0.192 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Principles of Consolidation</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The accompanying unaudited interim consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</font> </p> <p><font size="1"> </font></p> </div> </div> 5200 13892000 10448000 15491000 11653000 9926000 5908000 18121000 10483000 6800000 3319000 3494000 6772000 6114000 939000 969000 -0.49 0.02 -0.12 -0.05 -0.49 0.02 -0.12 -0.05 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;">4. Earnings Per Share</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The following table provides the components of the calculations of basic and diluted earnings per share (in thousands, except share amounts):</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:41.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Three&nbsp;Months&nbsp;Ended</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Six&nbsp;Months&nbsp;Ended</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Numerator:</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 20pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Net loss attributable to common shareholders</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.88%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,253 </td> <td valign="bottom" style="width:02.50%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td valign="bottom" style="width:01.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.88%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,825 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.88%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(20,330 </td> <td valign="bottom" style="width:02.50%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td valign="bottom" style="width:01.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.86%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(72,084 </td> <td valign="bottom" style="width:01.00%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Denominator:</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 20pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Weighted average number of common shares outstanding - basic</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>173,439,391 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>159,916,449 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>173,402,611 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>146,905,767 </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 30pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Effect of dilutive securities:</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 40pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Options and restricted stock awards</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,120,364 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 40pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Common stock warrants</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,054,486 </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 40pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Preferred stock</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,065,880 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 20pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Weighted average number of common shares outstanding - diluted</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>173,439,391 </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>176,157,179 </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>173,402,611 </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>146,905,767 </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">When the Company is in a net loss position, all common stock equivalents would be considered to be anti-dilutive and are, therefore, not included in the determination of diluted earnings per share.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <a name="mrllPB6"></a><font style="display: inline;">The potential dilutive common shares are summarized as follows:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 83.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:64.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:31.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">At&nbsp;June&nbsp;30,</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:64.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">2015</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">2014</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Stock options outstanding (1)</font></p> </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,576,278&nbsp; </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,200,768&nbsp; </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Restricted stock outstanding</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>395,558&nbsp; </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>650,002&nbsp; </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Common stock warrants (2)</font></p> </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,219,442&nbsp; </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,244,442&nbsp; </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Preferred stock (3)</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,554,594&nbsp; </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,076,271&nbsp; </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:64.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Number of dilutive potential common shares</font></p> </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,745,872&nbsp; </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,171,483&nbsp; </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:64.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 21.00pt; display: inline;"> <p style="font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="margin:0pt;font-family:Times New Roman;font-size:12pt;;"> (1)</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="display: inline;color:#000000;">During the three months ended June&nbsp;30, 2015 and 2014, the Company granted 440,000 and 435,500 stock options, respectively. During the six months ended June&nbsp;30, 2015 and 2014, the Company granted 650,000 and 686,000 stock options, respectively.</font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 21.00pt; display: inline;"> <p style="font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="margin:0pt;font-family:Times New Roman;font-size:12pt;;"> (2)</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="display: inline;color:#000000;">In May&nbsp;2011, the Company issued 7,128,563 warrants as part of an underwritten public offering. As a result of additional public offerings, and pursuant to the effect of the anti-dilution provisions of these warrants, the number of warrants increased to 22,995,365. Of these warrants, 219,342 and 244,342 were unexercised as of June&nbsp;30, 2015 and 2014, respectively. In February&nbsp;2013, the Company issued 23,637,500 warrants as part of an underwritten public offering. Of these warrants, 100 were unexercised as of June&nbsp;30, 2015 and 2014. In January&nbsp;2014, the Company issued 4,000,000 warrants as part of an underwritten public offering. Of these warrants, all are unexercised as of June&nbsp;30, 2015 and 2014. As of June&nbsp;30, 2015, the remaining warrants have a weighted average exercise price of $3.84.</font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 21.00pt; display: inline;"> <p style="font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="margin:0pt;font-family:Times New Roman;font-size:12pt;;"> (3)</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="font-family:Times New Roman;font-size: 12pt;margin:0pt;"> <font style="display: inline;color:#000000;">The preferred stock amount represents the dilutive potential common shares of the Series&nbsp;C redeemable convertible preferred stock issued on May&nbsp;16, 2013 based on the conversion price of the preferred stock as of June&nbsp;30, 2015. Of the 10,431 preferred shares issued in May&nbsp;2013, 5,200 had been converted to common stock as of June&nbsp;30, 2015.</font></p></td></tr></table></div> <p><font size="1"> </font></p> </div> </div> 2000 0.20 0.80 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;text-indent:11.55pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Joint Venture</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">We are party to a joint venture with Axane, under the name HyPulsion (the JV). The principal purpose of the JV is to develop and sell hydrogen fuel cell systems for the European material handling market. In exchange for initial ownership of the JV, Axane contributed cash and we contributed the right to use our technology, including design and technology know-how on GenDrive systems. We are not obligated to contribute any cash.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">We currently own 20% and Axane owns 80% of the JV. We have the right to purchase an additional 60% of the JV from Axane at any time between January&nbsp;4, 2018 and January&nbsp;29, 2018 at a market-based price. If we exercise our purchase right, Axane will have the right, at any time between February&nbsp;1, 2018 and December&nbsp;31, 2021, to require the Company to buy the remaining 20% interest at a market-based price.&nbsp;&nbsp;See note 9 regarding our agreement to acquire the remaining ownership of HyPulsion.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">In accordance with the equity method of accounting, we will increase our investment in the JV by our share of any earnings, and decrease our investment in the JV by our share of any losses. Losses in excess of the investment are not recognized and must be restored from future profits before our proportionate share of profits can be recognized. As of June&nbsp;30, 2015, we had a zero basis for our investment in the JV.</font> </p> <p><font size="1"> </font></p> </div> </div> 10600000 58856000 -9577000 -2436000 -667000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;"></font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;margin-left:54pt;"> <tr> <td valign="bottom" style="width:52.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">At&nbsp;June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">At&nbsp;December&nbsp;31,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:01.26%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:52.50%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.26%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:52.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Risk-free interest rate</font></p> </td> <td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">0.28%-1.375%</font></p> </td> <td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">0.21%-1.35%</font></p> </td> <td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:52.50%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Volatility</font></p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">52.92%-134.4%</font></p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">119.16%-136.62%</font></p> </td> <td valign="bottom" style="width:01.26%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:52.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Expected average term</font></p> </td> <td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">0.92-3.55</font></p> </td> <td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">1.42-4.04</font></p> </td> <td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The following table shows reconciliations of the beginning and ending balances for financial instruments measured at fair value on a recurring basis using significant unobservable inputs (in thousands):</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;"></font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="11" valign="bottom" style="width:57.44%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Fair&nbsp;Value</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="11" valign="bottom" style="width:57.44%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Measurement&nbsp;Using</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="11" valign="bottom" style="width:57.44%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Significant</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="11" valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Unobservable&nbsp;Inputs</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:27.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Three&nbsp;months&nbsp;ended</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:27.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Six&nbsp;months&nbsp;ended</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Common&nbsp;stock&nbsp;warrant&nbsp;liability</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Beginning of period</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,649 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>25,742 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,418 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>28,830 </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Change in fair value of common stock warrants</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(667 </td> <td valign="bottom" style="width:03.02%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,577 </td> <td valign="bottom" style="width:03.02%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,436 </td> <td valign="bottom" style="width:03.02%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>58,856 </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Issuance of common stock warrants</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,773 </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Exercise of common stock warrants</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(36 </td> <td valign="bottom" style="width:03.02%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(83,330 </td> <td valign="bottom" style="width:01.22%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> </tr> <tr> <td valign="top" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:38.34%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">End of period</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,982 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,129 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,982 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,129 </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 0.00 P4Y15D P1Y5M1D P3Y6M18D P11M1D 1.3662 1.1916 1.3440 0.5292 0.0135 0.0021 0.01375 0.0028 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;">7. Fair Value Measurements</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The following table summarizes the financial instruments measured at fair value on a recurring basis in the consolidated balance sheets (in thousands):</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 95.00%;margin-left:24.5pt;"> <tr> <td valign="bottom" style="width:29.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Balance&nbsp;at&nbsp;June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Total</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">(Level&nbsp;1)</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">(Level&nbsp;2)</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:15.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">(Level&nbsp;3)</font></p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.58%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:15.72%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Common stock warrant liability</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,982&nbsp; </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:15.58%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.54%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,982&nbsp; </td> <td valign="bottom" style="width:01.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:11.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:29.82%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.58%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:15.72%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10pt;line-height:106.67%;text-indent: -10pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Balance at December&nbsp;31, 2014</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.58%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:15.72%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.58%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:16.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:13.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:15.72%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:29.82%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.58%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:15.72%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Common stock warrant liability</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,418&nbsp; </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:15.58%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.54%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,418&nbsp; </td> <td valign="bottom" style="width:01.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:11.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The common stock warrant liability is measured at fair value using Level 3 inputs.&nbsp;&nbsp;Level 3 inputs are unobservable inputs and should be used to determine fair value only when observable inputs are not available. Unobservable inputs should be developed based on the best information available in the circumstances, which might include internally generated data and assumptions being used to price the asset or liability.&nbsp;&nbsp;When possible, the Company looks to active and observable markets to price identical assets, however when identical assets are not traded in active markets, the Company looks to market observable data for similar assets. Nevertheless, certain assets are not actively traded in observable markets and the Company must use alternative valuation techniques to derive a fair value measurement.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">For our common stock warrants, fair value is based on the Black-Scholes pricing model which is based, in part, upon unobservable inputs for which there is little or no market data, requiring the Company to develop its own assumptions. The Company used the following assumptions for its common stock warrants:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;margin-left:54pt;"> <tr> <td valign="bottom" style="width:52.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">At&nbsp;June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">At&nbsp;December&nbsp;31,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:01.26%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:52.50%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.26%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:52.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Risk-free interest rate</font></p> </td> <td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">0.28%-1.375%</font></p> </td> <td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">0.21%-1.35%</font></p> </td> <td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:52.50%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Volatility</font></p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">52.92%-134.4%</font></p> </td> <td valign="bottom" style="width:03.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">119.16%-136.62%</font></p> </td> <td valign="bottom" style="width:01.26%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:52.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Expected average term</font></p> </td> <td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">0.92-3.55</font></p> </td> <td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:20.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">1.42-4.04</font></p> </td> <td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">There was no expected dividend yield for the warrants granted. If factors change and different assumptions are used, the warrant liability and the change in estimated fair value could be materially different. Generally, as the market price of our common stock increases, the fair value of the warrant increases, and conversely, as the market price of our common stock decreases, the fair value of the warrant decreases. Also, a significant increase in the volatility of the market price of the Company&#x2019;s common stock, in isolation, would result in a significantly higher fair value measurement; and a significant decrease in volatility would result in a significantly lower fair value measurement.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The following table shows reconciliations of the beginning and ending balances for financial instruments measured at fair value on a recurring basis using significant unobservable inputs (in thousands):</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="11" valign="bottom" style="width:57.44%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Fair&nbsp;Value</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="11" valign="bottom" style="width:57.44%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Measurement&nbsp;Using</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="11" valign="bottom" style="width:57.44%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Significant</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="11" valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Unobservable&nbsp;Inputs</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:27.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Three&nbsp;months&nbsp;ended</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:27.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Six&nbsp;months&nbsp;ended</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Common&nbsp;stock&nbsp;warrant&nbsp;liability</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Beginning of period</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,649 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>25,742 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,418 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>28,830 </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Change in fair value of common stock warrants</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(667 </td> <td valign="bottom" style="width:03.02%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,577 </td> <td valign="bottom" style="width:03.02%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,436 </td> <td valign="bottom" style="width:03.02%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>58,856 </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Issuance of common stock warrants</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,773 </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Exercise of common stock warrants</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(36 </td> <td valign="bottom" style="width:03.02%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.10%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(83,330 </td> <td valign="bottom" style="width:01.22%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> </tr> <tr> <td valign="top" style="width:38.34%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.22%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:38.34%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">End of period</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,982 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,129 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,982 </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.74%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,129 </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.34%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.22%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 58856000 -9577000 -2436000 -667000 11773000 83330000 36000 28830000 25742000 16129000 9418000 7649000 6982000 9418000 9418000 6982000 6982000 27000 2000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;">6. Income Taxes</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Under Internal Revenue Code (IRC) Section&nbsp;382, the use of loss carryforwards may be limited if a change in ownership of a company occurs. If it is determined that, due to transactions involving the Company&#x2019;s shares owned by its 5 percent or greater shareholders, a change of ownership has occurred under the provisions of IRC Section&nbsp;382, the Company&#x2019;s federal and state net operating loss carryforwards could be subject to significant IRC Section&nbsp;382 limitations.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Based upon recent IRC Section&nbsp;382 studies, Section&nbsp;382 ownership changes occurred that resulted in all but $54 million of the Company&#x2019;s federal and state net operating loss carryforwards generated through June&nbsp;30, 2015 to be subject to IRC Section&nbsp;382 limitations. Of the net operating loss carryforwards subject to IRC Section&nbsp;382 limitations, $13 million will not expire prior to utilization and are reflected in the Company&#x2019;s gross deferred tax asset at June&nbsp;30, 2015.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The ownership changes also resulted in net unrealized built in losses per IRS Notice 2003-65 which should result in recognized built in losses during the five year recognition period. These recognized built in losses will translate into unfavorable book to tax add backs in the Company&#x2019;s 2015 to 2018 U.S. corporate income tax returns of </font><a name="mrllPB7"></a><font style="display: inline;">approximately $17.7 million that resulted in a gross deferred tax liability of $6.8 million at June&nbsp;30, 2015 with a corresponding reduction to the valuation allowance. This gross deferred tax liability will offset certain existing gross deferred tax assets (i.e. capitalized research expense). This has no impact on the Company&#x2019;s current financial position, results of operations, or cash flows because of the full valuation allowance.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company&#x2019;s remaining deferred tax assets have been offset by a full valuation allowance because it is more likely than not that the tax benefits of the net operating loss carryforwards and other tax assets may not be realized.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company recognizes accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense. The Company had $0.4 million of interest and penalties accrued at June&nbsp;30, 2015 and December&nbsp;31, 2014, respectively.</font> </p> <p><font size="1"> </font></p> </div> </div> 400000 400000 4188000 -1145000 9716000 -3571000 3725000 -483000 4195000 8153000 -31000 -32000 3170000 488000 11134000 11100000 1054486 11065880 4120364 1490000 768000 94000 49000 63000 32000 212000 121000 150000 60000 221000 176000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;">5.&nbsp;&nbsp;Inventory</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Inventory as of June&nbsp;30, 2015 and December&nbsp;31, 2014 consisted of the following (in thousands):</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:60.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">December&nbsp;31,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:01.16%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:60.76%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Raw materials and supplies</font></p> </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.86%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,299&nbsp; </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.86%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,502&nbsp; </td> <td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:60.76%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Work-in-process</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,764&nbsp; </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>237&nbsp; </td> <td valign="bottom" style="width:01.16%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:60.76%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Finished goods</font></p> </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,826&nbsp; </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,997&nbsp; </td> <td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:60.76%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:60.76%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.86%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>32,889&nbsp; </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.86%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>24,736&nbsp; </td> <td valign="bottom" style="width:01.16%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:60.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.16%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 5997000 6826000 24736000 32889000 18502000 23299000 237000 2764000 44715000 40229000 204151000 182954000 25707000 24742000 1000000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;">1.&nbsp; Nature of Operations</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:14.4pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Description of Business</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Plug Power Inc., (the &#x201C;Company&#x201D; or &#x201C;Plug Power&#x201D;), is a leading provider of alternative energy technology focused on the design, development, commercialization and manufacture of hydrogen fuel cell systems used primarily for the material handling and stationary power market.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">We are focused on proton exchange membrane, or PEM, fuel cell and fuel processing technologies, fuel cell/battery hybrid technologies, and associated hydrogen storage and dispensing infrastructure from which multiple products are available. A fuel cell is an electrochemical device that combines hydrogen and oxygen to produce electricity and heat without combustion. Hydrogen is derived from hydrocarbon fuels such as liquid petroleum gas, or LPG, natural gas, propane, methanol, ethanol, gasoline or biofuels. Hydrogen can also be obtained from the electrolysis of water, or produced on-site at consumer locations through a process known as reformation. Plug Power develops complete hydrogen delivery, storage and refueling solutions for customer locations.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">We sell and continue to develop fuel cell product solutions to replace lead-acid batteries in material handling vehicles and industrial trucks for some of North America&#x2019;s largest distribution and manufacturing businesses. We are focusing our efforts on material handling applications (forklifts) at multi-shift high volume manufacturing and high throughput distribution sites where our products and services provide a unique combination of productivity, flexibility and environmental benefits. Our current product line includes: GenDrive, our hydrogen fueled PEM fuel cell system providing power to material handling vehicles; GenFuel, our hydrogen fueling delivery system; GenCare, our ongoing maintenance program for both the GenDrive fuel cells and GenFuel products; ReliOn, our stationary fuel cell solution providing scalable, modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors; and GenKey, our turn-key solution coupling together GenDrive or ReliOn, GenFuel and GenCare, offering complete simplicity to customers transitioning to fuel cell power.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">We sell our products worldwide, with a primary focus on North America, through our direct product sales force, leveraging relationships with original equipment manufacturers, or OEMs, and their dealer networks. We are party to a joint venture based in France with Axane, S.A. (Axane), a subsidiary of Air Liquide, under the name HyPulsion, to develop and sell hydrogen fuel cell systems for the European material handling market.&nbsp; See note 9 regarding our agreement to acquire the remaining ownership of HyPulsion.&nbsp;&nbsp;Also, we sell to businesses and government agencies.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">We were organized in the State of Delaware on June&nbsp;27, 1997.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Unless the context indicates otherwise, the terms &#x201C;Company,&#x201D; &#x201C;Plug Power,&#x201D; &#x201C;we,&#x201D; &#x201C;our&#x201D; or &#x201C;us&#x201D; as used herein refers to Plug Power Inc. and its subsidiaries.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:17.25pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Liquidity</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Our cash requirements relate primarily to working capital needed to operate and grow our business, including funding operating expenses, growth in inventory to support both shipments of new units and servicing the installed base, funding the growth in our GenKey &#x201C;turn-key&#x201D; solution which also includes the installation of our customer&#x2019;s hydrogen infrastructure as well as delivery of the hydrogen molecule, and continued development and expansion of our products. Our ability to achieve profitability and meet future liquidity needs and capital requirements will depend upon numerous factors, including the timing and quantity of product orders and shipments; attaining positive gross margins; the timing and amount of our operating expenses; the timing and costs of working capital needs; the timing and costs of building a sales base; the ability of our customers to obtain financing to support commercial transactions; our ability to obtain financing arrangements to support the sale or leasing of our products and services to customers; the timing and costs of developing marketing and distribution channels; the timing and costs of product service requirements; the timing and costs of hiring and training product staff; the extent to which our products gain market acceptance; the timing and costs of product development and introductions; the extent of our ongoing and new research and development programs; and changes in our strategy or our planned activities. If we are unable to fund our operations with positive cash flows and cannot obtain external financing, we may not be able to sustain future operations.&nbsp;&nbsp;As a result, we may be required to delay, reduce and/or cease our operations and/or seek bankruptcy protection.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <a name="mrllPB2"></a><font style="display: inline;">We have experienced and continue to experience negative cash flows from operations and net losses.&nbsp; The Company incurred net losses attributable to common shareholders of $9.3 million and $20.3 million for the three and six months ended June&nbsp;30, 2015, respectively, and $88.6 million, $62.8 million and $31.9 million for the years ended December&nbsp;31, 2014, 2013 and 2012, respectively, and has an accumulated deficit of $958.4 million at June&nbsp;30, 2015.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Net cash used in operating activities for the six months ended June&nbsp;30, 2015 was $24.3 million. Additionally, on June&nbsp;30, 2015, we had cash and cash equivalents of $109.1 million and net working capital of $135.8 million. By comparison, net working capital at December&nbsp;31, 2014 was $167.0 million.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">During 2015, we had an increase in restricted cash of $11.1 million </font><font style="display: inline;">primarily </font><font style="display: inline;">related to sale/leaseback transactions, as described in note 8.&nbsp;&nbsp;During 2014, we received gross proceeds of $176.7 million from three underwritten public offerings.&nbsp;&nbsp;Net proceeds after underwriting discounts and commissions and other estimated fees and expenses were $165.7 million.&nbsp;&nbsp;In addition, during 2014 we received $18.3 million from the exercise of previously issued common stock warrants.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">To date, we have funded our operations primarily through public and private offerings of common and preferred stock, a sale-leaseback of our building, and our previous line of credit. The Company believes that its current cash, cash equivalents, cash anticipated to be generated from future sales and, to the extent exercised, cash generated from the exercise of outstanding warrants will provide sufficient liquidity to fund operations for at least the next twelve months. This projection is based on our current expectations regarding product sales, cost structure, cash burn rate and other operating assumptions.</font> </p> <p><font size="1"> </font></p> </div> </div> 183597000 -11425000 -83000 -1386000 -19934000 -24255000 -71980000 3877000 -20277000 -20277000 -9226000 -31900000 -62800000 -72084000 -88600000 3825000 -20330000 -9253000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Recent Accounting Pronouncements</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">In August&nbsp;2014, an accounting update was issued relating to how management assesses conditions and events that could raise substantial doubt about an entity&#x2019;s ability to continue as a going concern. This accounting update is effective for reporting periods beginning after December&nbsp;31, 2016. We do not expect the adoption of this update to have a significant effect on our consolidated financial statements.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">In June&nbsp;2014, an accounting update was issued that replaces the existing revenue recognition framework regarding contracts with customers. In July&nbsp;2015, the Financial Accounting Standards Board (FASB) announced a one year delay in the required adoption date from January&nbsp;1, 2017 to January&nbsp;1, 2018.&nbsp;&nbsp;We are evaluating the effect this update will have on our consolidated financial statements and have not yet selected a transition method.</font> </p> <p><font size="1"> </font></p> </div> </div> 447000 415000 -14020000 -6642000 -22626000 -9865000 1719000 1967000 1555000 2199000 392000 64000 -414000 524000 1388000 104000 52000 53000 27000 5710000 5950000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Reclassifications</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Reclassifications are made, whenever necessary, to prior period financial statements to conform to the current period presentation.&nbsp; These reclassifications did not impact the results of operations or net cash flows in the periods presented.</font> </p> <p><font size="1"> </font></p> </div> </div> 176700000 18300000 165700000 27000 2000 131000 18317000 1311000 1006000 5312000 5989000 379000 422000 2652000 1398000 6326000 3425000 500000 11634000 -938081000 -958411000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23.05pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Revenue Recognition</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company recognizes revenue under arrangements for products and services, which may include the sale of products and related services, including revenue from installation, service and maintenance, spare parts, hydrogen fueling services (which may include hydrogen supply as well as hydrogen fueling infrastructure) and leased units. The Company also recognizes revenue under research and development contracts, which are primarily cost reimbursement contracts associated with the development of PEM fuel cell technology.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 11.5pt;text-indent:11.55pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-style:italic;">Products and Services</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company enters into revenue arrangements that may contain a combination of fuel cell systems and equipment, installation, service, maintenance, spare parts, hydrogen fueling and other support services. Revenue arrangements containing fuel cell systems and equipment may be sold, or under a limited number of arrangements, leased to customers. For the above multiple deliverable arrangements, the Company accounts for each separate deliverable as a separate unit of accounting if the delivered item or items have value to the customer on a standalone basis. The Company considers a deliverable to have standalone value if the item is sold separately by us or another entity or if the item could be resold by the customer. The Company allocates revenue to each separate deliverable based on its relative selling price. For a majority of our deliverables, the Company determines relative selling prices using its best estimate of the selling price as vendor-specific objective evidence and third-party evidence is generally not available for the deliverables involved in its revenue arrangements due to a lack of a competitive environment in selling fuel cell technology. When determining estimated selling prices, the Company may consider the cost to produce the deliverable, the anticipated margin on that deliverable, the selling price and profit margin for similar products and services, the Company&#x2019;s ongoing pricing strategy and policies, the value of any enhancements that have been built into the deliverable and the characteristics of the varying markets in which the deliverable is sold, as applicable. The Company determines estimated selling prices for deliverables in its arrangements based on the specific facts and circumstances of each arrangement and analyzes the estimated selling prices used for its allocation of consideration of each arrangement.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Once relative selling prices are determined, the Company proportionately allocates the sale consideration to each element of the arrangement. The allocated sales consideration related to fuel cell systems and equipment, spare parts, and hydrogen infrastructure is recognized as revenue at shipment if title and risk of loss have passed to the customer, there is persuasive evidence of an arrangement, the sales price is fixed or determinable, collection of the related receivable is reasonably assured, and customer acceptance criteria, if any, have been successfully demonstrated. The allocated sales consideration related to installation, service, maintenance, and hydrogen molecule delivery is generally recognized as revenue when completed or on a straight-line basis over the term of the contract, as appropriate.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company does not include a right of return on its products other than rights related to standard warranty provisions that permit repair or replacement of defective goods. The Company accrues for anticipated standard warranty costs at the same time that revenue is recognized for the related product.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The Company has also sold extended warranty contracts that generally provide for a five to ten year warranty from the date of product installation. These types of contracts are accounted for as a separate deliverable, and accordingly, revenue generated from these transactions is deferred and recognized in income over the warranty period, generally on a straight-line basis. Additionally, the Company may enter into annual service and maintenance contracts that are billed monthly. Revenue generated from these transactions is recognized in income on a straight-line basis over the term of the contract. Costs are recognized as incurred over the term of the contract.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;punctuation-wrap:hanging;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-style:italic;">Research and Development Contracts</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:23pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Contract accounting is used for research and development contract revenue. The Company generally shares in the cost of these programs with cost sharing percentages ranging from 30% to 50% of total project costs. Revenue from time and material contracts is recognized on the basis of labor hours expended plus other reimbursable contract costs incurred during the period. All allowable work performed through the end of each calendar quarter is billed, subject to limitations in the respective contracts. We expect to continue research and development contract work that is directly related to our current product development efforts. At June&nbsp;30, 2015 and December&nbsp;31, 2014, the Company had unbilled amounts from research and development contract revenue in the amount of approximately $0.5 million and $1.0 million, respectively, which is included in other current assets in the accompanying unaudited consolidated balance sheets. Unbilled amounts are expected to be billed during the following quarter.</font> </p> <p><font size="1"> </font></p> </div> </div> 22896000 17321000 33425000 24009000 15741000 12579000 19391000 15324000 6481000 4415000 13731000 8428000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The following table provides the components of the calculations of basic and diluted earnings per share (in thousands, except share amounts):</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:41.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Three&nbsp;Months&nbsp;Ended</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Six&nbsp;Months&nbsp;Ended</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Numerator:</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 20pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Net loss attributable to common shareholders</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.88%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,253 </td> <td valign="bottom" style="width:02.50%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td valign="bottom" style="width:01.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.88%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,825 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.88%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(20,330 </td> <td valign="bottom" style="width:02.50%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> <td valign="bottom" style="width:01.12%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.86%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(72,084 </td> <td valign="bottom" style="width:01.00%;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">)</font></p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Denominator:</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 20pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Weighted average number of common shares outstanding - basic</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>173,439,391 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>159,916,449 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>173,402,611 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>146,905,767 </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 30pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Effect of dilutive securities:</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 40pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Options and restricted stock awards</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,120,364 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 40pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Common stock warrants</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,054,486 </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 40pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Preferred stock</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,065,880 </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.00%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 20pt;line-height:106.67%;text-indent: -10pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Weighted average number of common shares outstanding - diluted</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>173,439,391 </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>176,157,179 </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>173,402,611 </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>146,905,767 </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The following table summarizes the financial instruments measured at fair value on a recurring basis in the consolidated balance sheets (in thousands):</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;"></font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 95.00%;margin-left:24.5pt;"> <tr> <td valign="bottom" style="width:29.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Balance&nbsp;at&nbsp;June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Total</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">(Level&nbsp;1)</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">(Level&nbsp;2)</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:15.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">(Level&nbsp;3)</font></p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.58%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:15.72%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Common stock warrant liability</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,982&nbsp; </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:15.58%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.54%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,982&nbsp; </td> <td valign="bottom" style="width:01.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:11.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:29.82%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.58%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:15.72%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10pt;line-height:106.67%;text-indent: -10pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">Balance at December&nbsp;31, 2014</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.58%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:15.72%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:12.58%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:16.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:13.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:15.72%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:29.82%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.58%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:15.72%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.02%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Common stock warrant liability</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.40%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,418&nbsp; </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:15.58%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&#x2014;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.18%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.54%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,418&nbsp; </td> <td valign="bottom" style="width:01.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:29.82%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:11.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.62%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.02%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Inventory as of June&nbsp;30, 2015 and December&nbsp;31, 2014 consisted of the following (in thousands):</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;"></font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:60.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2015</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;font-size:8pt;">December&nbsp;31,&nbsp;2014</font></p> </td> <td valign="bottom" style="width:01.16%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:60.76%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Raw materials and supplies</font></p> </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.86%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,299&nbsp; </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.86%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,502&nbsp; </td> <td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:60.76%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Work-in-process</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,764&nbsp; </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>237&nbsp; </td> <td valign="bottom" style="width:01.16%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:60.76%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">Finished goods</font></p> </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,826&nbsp; </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:16.16%;background-color: #CCEEFF;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,997&nbsp; </td> <td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:60.76%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:60.76%;padding:0pt;"> <p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.86%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>32,889&nbsp; </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.86%;;font-family:Times New Roman;font-size:12pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>24,736&nbsp; </td> <td valign="bottom" style="width:01.16%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 12pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:60.76%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.88%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:14.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.16%;padding:0pt;"> <p style="margin:0pt;line-height:106.67%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 9258000 5439000 15751000 8002000 1255000 3435000 686000 435500 650000 440000 7.54 158283000 898000 1096392000 1736000 -938081000 -2662000 141572000 898000 1100009000 1738000 -958411000 -2662000 47337 116667 3435000 3434000 1000 53000 -53000 131000 130000 1000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;">9. Subsequent Event</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">On July&nbsp;24, 2015, we entered into a Share Purchase Agreement with Axane, pursuant to which on July&nbsp;31, 2015 we (through a wholly-owned subsidiary) acquired Axane&#x2019;s 80% equity interest in HyPulsion for $11.5 million, payable in shares of our common stock. In connection with the agreement, we issued 4,781,250 shares of our common stock and agreed to the issuance of up to 3,105,348 additional shares of our common stock in certain circumstances. The purchase price is also subject to certain other post-closing adjustments payable in cash.</font> </p> <p><font size="1"> </font></p> </div> </div> 1153000 1153000 16664000 16664000 0.01 0.01 10431 10431 5231 5231 5231 5231 378116 378116 2662000 2662000 1000000 500000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:28.8pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Use of Estimates</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:31.5pt;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">The unaudited interim consolidated financial statements have been prepared in conformity with GAAP, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font> </p> <p><font size="1"> </font></p> </div> </div> 9418000 6982000 146905767 176157179 173402611 173439391 146905767 159916449 173402611 173439391 EX-101.SCH 7 plug-20150630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00100 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 00400 - Disclosure - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Nature of Operations link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Acquisition of ReliOn Inc link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Commitment and Contingencies link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Fair Value Measurments (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Nature of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Nature of Operations (Details 2) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary of Siginificant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Summary of Siginificant Accounting Policies (Details 2) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Acquisition of ReliOn Inc (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Earnings Per Share (Details 2) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Fair Value Measurements (Details 2) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - Fair Value Measurements (Details 3) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Commitment and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 plug-20150630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.LAB 9 plug-20150630_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT EX-101.PRE 10 plug-20150630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.DEF 11 plug-20150630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`$U>!D>0&ZUDM`$``(L6```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V8RV[",!!%?P5E6Q%CIZ4/`9O2;8O4_H";3(A%'%NV"?#WM0-4;916 MT!)I-GEPQW-O,LY9,'G;:;"#K2PK.XT*Y_0#(38M0'(;*PV55W)E)'?^UBR) MYNF*+X&PT6A,4E4YJ-S0A1[1;/)2@S$B@\'C7@B]IQ'7NA0I=T)5I*ZR5M>A MRG.10J;2M?1+8N>MXM2[%````*P(```L```!?.0Q(OW[CMB`PD.MQ-*O>X^NO`ZIK`XTHO8<4M?' M5$Q^#*G*_=ITJK$"2+8CCVG!D4*>-BP>-9?20D0[8$NP+,L5R*V.V:SGVL7. MU49V[M,41Y26M#;3"&>6X9MY6&3I//B)]!=C;IK>TI;MR5/0!_ZS#0//>997 M'L=V+YRO+0O]C^AY%.!)T:'B1?4C9@,2[2F]@OIZ`(4QOCLEFI2"(S>C@KN_ MV/P"4$L#!!0````(`$U>!D=+^1`9A`$``(,5```:````>&PO7W)E;',O=V]R M:V)O;VLN>&UL+G)E;'/%V$MN@S`0QO&K1!R@9L9Y*\FJFVS;7L`B$T`)#]FN MVMR^E$5%'QYU$>G;@`!I_-_PD^5=&_+MDUQ=K+LV5'4?9N_-M0W;X?T^JV+L MM\:$HI+&A8>NEW;X>NY\X^+PZ$O3N^+B2C&^O\)50B,9CQ1@_#`L/G6R__6;X[G^M"'KOBM9$V_E%AOA;(3#J( MTT$,";+I(`L)FJ>#YI"@13IH`0E:IH.6D*!5.F@%"5JG@]:0H$TZ:`,)HER1 M,<C-&; M%;T9HSC-&;ZOH;3%Z6T5OB]';*GI;T%F)=EB"T=LJ>EN,WG:B=ZB!D>`"T^-A0(``+()```0````9&]C4')O<',O87!P+GAM;+U6 M46_:,!#^*U:>V,,:H&B3$(W4`=,JK0,MC#U?G0M8=>S4=A#LU^^2E"R4D`(/ MXP7G_'WGN^\^$T;*=H=SHU,T3J!EVT0J.Z3@G;=V+AWZON5K3,#>$$31;JQ- M`HX>S[GWS<.E011A_3*JD7C/)3[M-4"@Y.:!4\"FZT MU;%CTRU'.?+?`@H&90Z19T:X7=`M,?50@0DY2!S364$,TF*)^A_Z9+GTJ"?;S,C1`)M9J#,#88;=QP@]QI\SJFC;MV2I'F^=#M>=MP`A0SF-6_*''OE<>6T:+M4RM,\%O;9[M&M'9D5\%BV4=6U^+ M07`[*!"T.D3Z56?!JVP'?>>1A7`2[2R>@W'_28JBI[T0MP.OUOT^!0,5L:ER M9$?VH,JC:'AU2:K56"NKI8C(7!'[`A(41Q8>27@.GG7F\#XG=/255VF9CMF, MC'@I)[\XEW)"I_G%YX!=-W)^@,L,[LLOM&T6*\R2!,RN*$"LE*`YD[/8/>/8T6@5H(;#^NQ-L35UW_#O0$][?LR[GW/:NX#2/N^VN$?&LZ];< M_M&[[\V;SC_\AQ;\!5!+`P04````"`!-7@9'1-8(NSX!``!I`P``$0```&1O M8U!R;W!S+V-O&ULS9--3\,P#(;_"NJ]2]MI$XJZ'@!Q8A(20R!N(?&V ML#:)$D]=_SV9U[5\77;C5M=^'[^.DU(Z+JV'1V\=>-00K@Y-;0*7;I%L$1UG M+,@M-"),8H6)R;7UC<`8^@US0N[$!EB197/6``HE4+`C,'4#,:E*);GT(-#Z M'J_D@'=[7Q-,208U-&`PL'R2LZ1Z-CMC6U.R45^5T7$M`BZMTFL-ZJ8;RWZG M8F<$WX23'-30GO[^Z8$R+.DK#T$/56W;3MHIU<6!<_:Z?'BBLTFU"2B,A*@* MFF/G8)&<.[],;^]6]TE59/DLS:[3;+[*%&\'2?[YF\TW/1#_%O'9X.T M7=18PX6[)8VBY=(G@10$Z;5#;!D>97)PC$`8``)PG```3 M````>&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S M:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N M+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\,`*I4Q>M5II`,,X?+&A`T%116F]?(+3E'S/X M%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53" MQ,!J9S]6:\?1TDB`@LE]E`6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@ MX_%X.+;+THMP'`3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMH MG`J-6T_3:W?=TXZ)QJW0>`V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2 M%;7E0-,@`%AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9R MG9`%#@`WQ-%,4'RO0;:*X,*2TER0UL\IM5`:")K(@?5'@B'%W*_]]9>[R:0S M>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+`GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,B MUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0'`*D"3&6H8;XM,:L$>`3?;>^",C? MC8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[`?_1 MVC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO`JQ`GH9%LE M"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ MZK:4OK4F.$KTL@'37[]EUVY".E,%.70[@:0KX#;;J= MW#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B M(>ZAAIC/PT.'>7M?F&>5QE`T%&ULK"0L1K=@N-?Q+!3@9&`MH`>#KU$"\E)5 M8#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6Q MP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>; MG*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4< M!A87,N10[I*0!A,!S93)1/`"@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E M$A2*L`P%(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TSU#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+? M.7#;.MX#7N83+$.D?L%]BHJ`$:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4 MJUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5 MBZPYC0IO0=5`Y3_;U`UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%0 M2P,$%`````@`35X&1SD;&)-3`@``L`H```T```!X;"]S='EL97,N>&ULS59= M:]LP%/TK0BFCA1';V9IVJVT8A)'"A5/TU")I\@1EJQJ+&7*^40C*D M]%1605-+C(K&!#$:3,)P&C!$.$QCWK(94PW(1KF#+AQ]'$T"A\N;G;Q<[MP`8'C^%XD,)I>PN#II.-P/Z]>VZ&>/H_Z/\P[ MQ%=[B#W1GL!K$QCT54WC4G!?W`ET0!HWCV")J/:/C'LNJ)!`Z=/3&2S"$W@]D> MH71[>QI(XQHIA26?Z0GH[?FJUIOC@F,GTOH=\*XD6D63RXT`.^B\F9`%ED/F M"*ZA-*:X5#I`DFIA1B5J(UTH)9@V"H(JP1$UE.N(WM"T.:;TWGQ>O\LM[JX$ MSL><<0B!4;$V=2%ZTU\#6]1@D\UQ;](>QPNZHY[E1_@X.NW*?PV"V_ MIJ;35\VKT5?PK+^G3U>$CLU\GW)'YMK?F"`DG*([I MAN]6VO3]2GN=.W42:=F<#``#("P``#P```'AL+W=OI(WG=^?F?=SY6U/\5]K8V?NT6V":&9CT:^W$"M M_&O;@*%W:^MJ%:CI;D9VO<823FW9UF#"2(['LY$#K0):XS?8^&Q+\_]"\XT# M5?D-0*AU#ZL5FNS].S]?HX9K<)[`0C7-=U7#(KO7F=#*A[,*`U2+;$)->P># M!ZYM/K:H8V,ZGF:C"-M-]=*)TE;0PZXVZ/_;OLA$!6O5ZG!%P>[&762YG$@Y MZQGQLVN$.\^!\8%09,FUI^8^^^6(>_K0E*+TMGM>YZQ1==)QK!/SZA&`.6@P^#6OV( M*['(9F,"WJ+'%6H,#XNLN]<09S)Z-I4N_4]WPG3)V2VQ4*829R8019R;?O$H M-3$&^OB\Z@9VV;AAHRD#3%X&6P98,-&.@V&'*0IR0?<_G&^Y`SY0SM/B\NP9$PR@'O M/5`WX>ZYN:446O?`.W%5\X2K%*&M05RI>^!IR[F9>4+-3PJ=N%:Z!?$-E*5+*NL;PN&W)B$"3!U/B,!2N9)YP%! M`?)CCN(BY@D3]U=/'-$AJ,&_XAAN9)Y0\G$9D[VYAGG"P[UUZ;=5`B6YC3)A M8VIGB:-3"`KUD,3-E`DS#Y*$Y*C!T9KP=;A>^'S'ZX%(7R8+ASRALF,%]SG8K*MLYY**ZHNT4`5"T_?C4"56QFK4;KT?Y7)-)Y$L?V-*M1% M%LM(JAA;K4_HV87Y:E57;/7D7?WY_G]02P,$%`````@`35X&1XW^.P5-`@`` M]0<``!@```!X;"]W;W)K3,:!7OR!L3<]^7G:A)%>`VG(4>H46#UN9$^:1F=2 MY+\NZ0=3&Z?C(?MW4ZY:_@$+LF?-G_HD*[7:*`Q.Y(ROC7QE_0_B:DAUPB-K MA/D-CE M``I]=F3LZ&O`WBKB94`\`.)I!;&Q)\OV9+`G4WMB[.G]^J:*G55DRX#4"TB- M?34#L(KU,B#S`C)CSV<`5@&C9<+*2UA9/YQ!.`E:1JR]B+7UQ_>(U$A:BW"2 M*(^S_('MF'LYN4V2S)3B).DR`D9>A@FK#-G7Q>P'S2I.49PG^0,PZ(>Y\SFW MP0;-`UL,(C_%'E(XM\NQ$LFZX9,>;OOP/4$L#!!0````( M`$U>!D>2X]Y2/P0``(T5```8````>&PO=V]R:W-H965T&UL MC9A-_?<+=./! M&;FC2PSD:?$*I`?!^M*TW[N#]WWRHZY.W>/JT/?GAS3MG@^^+KO/S=F?AO_L MF[8N^V&W?4F[<^O+W5145ZD4(DOK\GA:;=;3L:_M9MV\]M7QY+^V2?=:UV7[ MW]97S>5Q!:OYP+?CRZ$?#Z2;=7JMVQUK?^J.S2EI_?YQ]04>"F5'9"+^/OI+ MM]A.QO!/3?-]W/ES][@28P9?^>=^;*(S\OGRM^F_-Y0]/?3!C@\]-U4U_D^?7KF_J MN625U.4/_#V>IM\+_B<75!8ND%0@KP6@V0)%!>I=08K)IG[]5O;E9MTVEZ0[ ME^/=AHK.&8VR+!"I2#7,&F(D8)[X!)D\@AI MR;!`)7F/$R@Q$ARG5_,F+80,V&NFKU]0:.E M980:95B-DM:$G*B)`3#,1"A"U/WW11'LCR*CQ;00%II"#7%+B"TQ8+D%2?&3 MBGG_#0M-H86XQ^V6&!B>@T)P(V8&ANH,I%'C$C5%ALRM!3E999QG@]C]/&&UJ?GE MF\M#*\AA36S90,297.8QS<_GB M_RK;E^.I2YZ:OF_JZ8/9OFEZ/[0C/@_]//AR=]VI_+X?-^VPW>+70MSIF_/\ M\?/Z!7;S/U!+`P04````"`!-7@9'%F_WOT4"```C"```&````'AL+W=OM M0@8HVU:9O?MM^X&#D\+H@=#RO%^?II6:]8R_BY)2Z7PT=2NV;BEEMT%('$K: M$+%B'6W5DQ/C#9&JR<](=)R2HPDU-?(]+T8-J5HWSTS?*\\S=I%UU=)7[HA+ MTQ#^;T=KUF]=[(X=;]6YE+H#Y1FZY8Y50UM1L=;A]+1UG_"FP`8QQ.^*]F)R M[VCY/6/ONO'SN'4][4!K>I"Z!%&7*RUH7>M*:N2_0]'/,75P>C]6?S;35?I[ M(FC!ZC_549;*UG.=(SV12RW?6/]"ASE$NN"!U<)\.X>+D*P9(Z[3D`^X5JVY M]O`D]8:8/>`/`?\6P.%B(!@"P9<``C,SKQ]$DCSCK'=$1_1JXXW"N2ZB*CO" M5%-3$J;S2?=>\QAGZ*KK#(@_07:`^/-$,1#1#4%J?*N$/TH$4PD?)/SO\\&8 M#Z?Y`/+!O6)JD!8F`8BW\O`\5%B@69/0:A*"27@_2#0U`01[88#GJ<)&S;I$ M5I<(7*(%%T`B?U'%`LV:Q%:3&$SB!9/X$1,+-&N26$T2,$GN!TFF)H#@./ZZ MBE.JL%&S+JG5)067=&'7IH_L6@LT:[*VFJS!9+VP/H"$D0>?A46:(V>=L&>5 M,MW7/%D8:SPYG M�DZ\8C^?:_(/\/4$L#!!0````(`$U>!D>*5+X5FP0``(D6```8````>&PO M=V]R:W-H965T&ULE9A-@_J4Y6EN]ZHR`/!F`F*]'!< M;M;]V+=JLRX_FOQPS+Y5B_JC*-+JWVV6E^>G)5\.`]\/[_NF&P@VZ^!BMSL4 MV;$^E,=%E;T]+9_Y8R)TA_3$7X?L7(^^+[K@7\KR1_?CC]W3DG4Q9'GVVG0N MTO;C,XNR/.\\M3/_@TZO# MRSQ^`XD&\FJ@2`.%!FKN#!H-]-T,`6CO5RY.FW2SKLKSHCZEW?/$'UN\ZIRT MGA=U[ZU=M+H??.Y&/S>A6`>?G1]$Q`C9(B*GD1@0?B&"=GYO$&+IFT'TYD0, M$1"A(F+XTDGRBY/),.40IAROE01[_;6]&NS5V%Z!O;D-,>R1(ZP$(%Q+H::I M""FA0S=-Q4@YZ?@TE0PSAFI&^K17EP9=X>TL>JP+$*N$G88B@)3B>AJ*`>(R ME'R:2H`RRLX09;RB#(@BXMT"TF:!T`2,%`03(\,D(0@8,^?A#;UZ0M#C"#V` M",48045`\5`*(@$Q4%(J020SP1F%=>9K7=:KR\*3Q0A=@'!N-+'"$5),*2+G M,5):W;]4-[J0DM:)KW4YKRX'NHA9MFZ(V%*Z@-*.4;+0E>544A.@G!,SLL69 M5U8_W.H2A"YD)"=BB1`*0R+S\>#)$-,E"'%N[0Q9W"\+*B"5B"TR]"L1(<6E MH_*%E)'"4,J`$D;/>`RY\"L3N'53RI!AC%CG""FM)+&]Q$BU!4E3CR)B3N@Y M29-^:5#0+9&.+3(K9PV9-<2,4<02Q`,FA*$3AQQ73+`9^OS]!H?:;HF9MLA( M,G'`*#)M"A](2A4P;D8-X_Y.@V,?055<9#CCQ".;^*CI:/PM`H>B;*D>`1EC MR)`!063E!O:018M+264-G@@F*2P8NY,[.>>7]70/'$DVU M#^+HA$R;M?MP;LY.B$E[7X5O MSDZ#,\&D9--<,G"A8':.O$OW<'.P%%"GG9SAP5^EA;C?6GO&WBP0,"OVP/0T M%B'64F*:BJ_..($E5VQ4/:;%^>NTD+@]4N+D/'%REC@Y3YS\7^+\15I@4:2* M-#+MF:OMG7XYSM^\MP.JG>-&D25[Y)4)0S7;R8`JXY@.1[5L6JV_@`LHNXZZ M*T!FEMH!-6V_R*G#;3SR^J5:3:H-1O=L15:]]S><]>*U_#@V<'5T&;WO)1-4Q;]5=Y;6399&S5[ M:#7LLW1W^9%G;TWW->PR`C>E\*,I3\/%[^7V>?,?4$L#!!0````(`$U>!D>+ MJS!W$P(``$L&```8````>&PO=V]R:W-H965T&ULC55-CYLP M$/TK%O>NP<"21`0I7U5[J+3:0WMVB!/0VIBUG;#]]_4'$+H+22ZQ/;SWYLT0 M#VG#Q9LL"%'@@]%*+KU"J7H!HX'6!U_)4*!.`60I[WJ%D MI)(EKX`@QZ6W"A:[V"`LX'=)&CG8`^-]S_F;.?P\+#W?6""4Y,HH8+UN7-#]*68!WF MG$K["_*S5)QU%`\P_.'6LK)KXYXD04L;)Z"6@'I"GV><$+:$\$J(;A*BEA`] MFB%N"?&G#-#5;CNWQ0IGJ>`-D#4V?Z=@H>'"B&AE(*V:;IJTP96)7K+Y+(47 MH]-"T`"R=I`DG(9L'23H$5#G'S6!O+$,R-+1=(*-0R31#0]W179?1"9MAIW- M<-BKT/5J?I\?=?QHR(\N$@WR;(_0\C=HX5#A+DFG0MI5"/KH% MV[6P))C/_/N%Q:.%Q>[U^[FZZ,7>5S](:G\@O+$YE)<&>*WW![6T\K+W!TJ.RFP3TWTW[-Q!\;H;W?WW(_L'4$L#!!0````(`$U>!D>Q M=6I>(00``-X5```8````>&PO=V]R:W-H965T&ULE5A=5HWE^7> MKTZE2K==4)[Y/`@B/T^/Q6RU[-:^E:NE/M?9L5#?2J\ZYWE:_DE4IB^/,S8S M"]^/^T/=+OBKI3_$;8^Y*JJC+KQ2[1YG3VSQ(D0+Z1#_']6ENOKLM<6_:OVS MO?BZ?9P%;0TJ4YNZ39$V;V]JK;*LS=0P_\*D[YQMX/5GD_USUVY3_FM:J;7. M?ARW]:&I-IAY6[5+SUG]75^^*.PA;!-N=%9UK][F7-4Z-R$S+T]_]^_'HGN_ M]-](P#`Z@&,`'P(&'CH`,`#>`\1H@,``X3>T[K=+4L]<6K M3FE[/[%%`R_;)$UFK^JR-4.KNL6G=O5MQ0*V]-_:1(CA5YBDQTBP0YXQS8#P MFP+(*OB,8N!=.+<3K'N$%",U3"9Y^2>)M4PP9<+UL`"'Q:<3")-`7"<0F.!N ME++#%'T;B`EC'L,T3TCRA,AS-Z[PF@9ASGED M1ZU[%,12CDP'4_&`C\%>$";9/`ZF.Y-D9Q([BT:&V&-`0#C-$I,L,;+($1;$ M@(.^YB3)?/J^2Q`C6"CYR#^`A%G+80%93[<\<8,F!B0AYA+8V+ULA=H+8W1A MQ@]CAQ2<-`G&W5V"`5T%./B$`34"=B"B_8@)!Z,P('>G8+0KL9!6U&U;H>NC MA-&&Q(PCS<=ZZD%"`D@')MH@F*2U>]N/=.Z'-@B&ZF?!6#\&%$612T.T33`4 M-V-C5`AJ?-I!))PV`!Y,W^$)?U?UR(`IE+T<6O:<3>L@,2`'/[)"[85QNC`T M$^:@.DYO6O@'=BVTOR-^:,%:"^*-A1N#,5ERQV0 MMR\$[K1($7?,0Q?P+LA=#[R$`9<\<=J8@ MZ-&+#XR>5C.$#LZ!H`<>12Y,M)S!R'G,EQ$$,FZ>E`Y4M*)!.D@-0;=-$;U3 M,'M!M/8AGNX]0=!=[\2,2)R])%KY8)3OD$+0RARP3Q.T^H51?S@R7`3=_7ZU4]':%D;;8X:&H`>79XJP'%=5WKO#L?VVE=JZ;FX%,SGX-*M\-%IG9U^U&V M@^N/'_N+6I_,:>IPI+OZ"U!+`P04````"`!-7@9'LTP*JST$``"T%```&``` M`'AL+W=O+^V`D_]HT/\>'/P_/JVCD8$JS[T<7 MQ7!Y,[DIR]'3$/E?=/H>#>,K4,IOR^JWHB^VF;>Y!=RW&MRV>!G@[.AD\!]WD;4BIFP9?QM&W MK1!J$[Z-CA`C%Y@=8F9$.'@G0\@592XG<_EU@-PB5/PX`K@(L$P",`G]V$'L M',1+![%U$"4?2:H)4]LT+&8M(ZG4U[`<84ID.GI,)R'S23"?[+&#E,PGM0YD M])%HLLS'8K(T^QJ3(P8\B"B2B$(B@B%B,4I*AHARR]1CC6B2B48F3)2=Q4`, M"4/%.4J2QU0RDDHV>="*"6(A:Q$)CX1%1(:9AD>FP*2,H#4W^3-&>7`1-!>K M(5IS5`2&B2'EV%A8HG62>O"19(4)B7/C,[U`IV151[(I60PDBBF`'%'K3`F? MC&@)$U9X)%/..\2LM4B8-9$[6"PRCS4N$II/XNJ$(Y1@)&YAY`X%0GE(JJ`E M4:3X*C@ZB&&+`3$>VZ&@-5$X4616^0Y!:R%B3HP0%@OML?<)6AF%5;28E0GM M7A2[<%!`E?19-[0XB@QGAY'''8(&J5C*,$'(Z6B6@4>ERX@4"^F$U&..):U_ M$GLHMCP1M!;`EH.#)3[B)27-!_4/F`XA1U#LLP=)6B0EMF;`-0`(XJK.03QV M($GKH\0>CRON'8+&-\!M00ZV*(:OZ=`MGD1Y!!\7M*))[/(6*YO(*'4Z(KPJ M@)8LB9+%-D8.I$'XO"9:C"2V5VP+@*!UZI,1+3,290:X+LR!5*HBCYT'Z#X, M4#Z`*VH$#1U?ICQF#VB9`909X&1F!GEL84#+!Z!\Q-P'!H+6,=O9.Q0HCX\, MH%4&4&5B3F40-.ZH7$^2.V<:DLSG3=!R`R@W,9M[_$GXOHY"-UF`*L+NW>#: M)Q6E7%4Y9RDDVH<2K4J`JA1SJC2#4OGYF_LC)8M+(A_A!UJ[`&6)ZZ-V#A1E M;.WD#I?J-/)9K[3(@7;I,^<-#J084(X@*3_7YH.R;I@W]SJWA[4 MS*/S0=R+'`^3/HWOQ%-NC]/>W6PWU^)D_BK:TZ7N@M>F[YMJ.E#RNW_4$L#!!0````(`$U>!D=\ M=#IMH@$``+$#```8````>&PO=V]R:W-H965T&ULA5/;;MP@ M$/T5Q`<$+^LTZ$0GP6\+H-C&)WB^(KS'Y61]I%BV`@LI'!1&6*SR!4E$H-/X[ M:[ZWC,1MO*A_3[L-[B_"P1.J/[+V73";45)#(P;E7W#\`?,6[J-@A)M6:=(Z3G\XGVFW"7PF\)7PF"7C4Z-D\YOPHBPLCL3U(LYN=PAP M&T6",G%)+3ATJ7B*U6NYRQ\*=HU",X9O,.<9LR)84+_9@M-;=)[H_'/Z?J'O MMP[WL\/'SP7R12#?"N2WM[C%G!?,UP]-V.9,-=@V71U'*AR,GXYTK:ZW\Y2& MR-[A9=&+%GX)VTKCR`5]F&P:0X/H(;3/[NXIZ<+[61,%C8_A0XCM=*6FQ&._ M/)#UE9;_`5!+`P04````"`!-7@9'S,8"0Z$!``"Q`P``&````'AL+W=O;0O@R+N2VAYHZURW9\R6+2AN M;[`#[?_4:!1W/C4-LYT!7D62DBQ-DA],<:%ID-_M3%A`1\"Q@L*N8!.]GQ->0 M_*X.-`D60$+I@@+WRP7N0,H@Y!N_39J?+0-Q'<_J#W%:[_[,+=RA?!&5:[W9 MA)(*:MY+]X3#+YA&V`7!$J6-7U+VUJ&:*90H_CZN0L=U&/]DVXEVG9!.A'0A M_$RB\;%1M'G/'2]R@P.Q'0]GM]E[N`DB7IG8J.8=VE@\ANJEV.R2G%V"T(1) M5YC3A%D0S*M?;9'2:_0TTM/OZ=N9OET[W/[C\+\"V2R0K06RZR.N,:<9\W5( MMMI3!::)5\>2$GOMQBU=JLOM/*;Q3#[A1=[Q!OYPTPAMR1F=/]EX##6B`]\^ MN=E1TOKWLR02:A?"6Q^;\4J-B<-N?B#+*RW^`E!+`P04````"`!-7@9'LJ'3 M_:$!``"Q`P``&0```'AL+W=OO_5&BT<#XU-;.=`5%&DE:,)\DO MIH5L:9[%VI/),^R=DBT\&6)[K87Y?P*%PX%NZ%QXEG7C0H'E&5MXI=306HDM M,5`=Z'&S/Z4!$0$O$@:[BDGP?D9\"\F?\D"38`$4%"XH"+]9>D:;S:AI(1*],H]X_`(TQ9V0;!`9>.7%+UU MJ&<*)5J\CZMLXSJ,?_CM1+M.X!.!+X2[)!H?&T6;OX43>69P(+8387:;O8>; M(.*5B8UJWJ&-Q6.H7O+-CF?L$H0F#%]A3A-F03"O?K4%I]?H/-+YS_3M3-^N M'6XGA]N?!=)9(%T+I-\$OF%.,R;]TH2MSE2#J>/5L:3`OG7CD2[5Y78>>9S) M)SS/.E'#7V%JV5IR1N&ULA5/;;N,@$/T5Q`<4AR1M%3F6DJY6NP\K57UHGXD] MME&!\0*.NW]?P)=:JTA],3/C<\X<&,@'M.^N!?#D0ROCCK3UOCLPYLH6M'!W MV($)?VJT6OB0VH:YSH*H$DDKQK/LGFDA#2WR5'NV18Z]5]+`LR6NUUK8?V=0 M.!SIALZ%%]FT/A98D;.%5TD-QDDTQ$)]I*?-X;R+B`1XE3"X54RB]POB>TQ^ M5T>:10N@H/11083E"D^@5!0*C?].FE\M(W$=S^H_TVZ#^XMP\(3J35:^#68S M2BJH1:_\"PZ_8-K"/@J6J%SZDK)W'O5,H42+CW&5)JW#^(=G$^TV@4\$OA`> M$X&-C9+-'\*+(K).+O-(:+S[^G;F;Y=.]Q.#N^_%]C-`KNUP.[V%M>8\XQY^*\) M6YVI!MNDJ^-(B;WQXY$NU>5VGGB:R1>\R#O1P!]A&VD:?$)4$L#!!0````(`$U>!D&PO=V]R:W-H965T1Y*2+$N2>Z:X MT+0L8NW%E`4.3@H-+X;802EN_IU!XGBD*5T*KZ+M7"BPLF`KKQ8*M!6HB8'F M2$_IX9P'1`3\%C#:34Q"[Q?$MY#\K(\T"2V`A,H%!>Z7*SR!E$'(&_^=-3\L M`W$;+^K/<;>^^PNW\(3RCZA=YYM-**FAX8-TKSC^@'D+^R!8H;3Q2ZK!.E0+ MA1+%WZ=5Z+B.\Y]TIMTF9#,A6PD/26Q\,HIM?N>.EX7!D=B>A]FE!P\W0<0K M$QO5?(BVSQX)=@\X,R3:0\P1)5P3SXC<=,GJ+GDT.7]-W"WVW;7`W MN>\?OA;(%X%\*Y#?W.$6M9$0N-"^,W'9KI04^*P7Y[' M^D;+_U!+`P04````"`!-7@9'N.T,"*`!``"Q`P``&0```'AL+W=O)"TR*/M2=3Y-@[*30\&6)[I;CY/(/$ MX4@W="X\BZ9UH<"*G"V\2BC05J`F!NHC/6T.YRP@(N!%P&!7,0G>+XAO(?E= M'6D2+("$T@4%[IU7_&W7KW%V[A`>6KJ%SKS2:4 M5%#S7KIG''[!M(5=$"Q1VO@E96\=JIE"B>(?XRIT7(?I3S;1;A/2B9`NA!]) M-#XVBC8?N>-%;G`@MN-A=IN#AYL@XI6)C6K>H8W%4ZA>B\T^R=DU"$V8=(4Y M3Y@%P;SZS18IO45/(SW]-WT[T[=KA]O)X7_TSV:!;"V0W=[B&G.>,=]=LM69 M*C!-O#J6E-AK-Q[I4EUNYRF-,_F"%WG'&_C#32.T)1=T?K)Q##6B`]\^N=M1 MTOKWLR02:A?">Q^;\4J-B<-N?B#+*RW^`E!+`P04````"`!-7@9'-I;?`J$! M``"Q`P``&0```'AL+W=O20//EKA!:V'_74#A>*([NA1>9-OY6&!EP59>+348)]$0"\V) MGG?'2QX1"?!;PN@V,8G>KXBO,?E9GV@6+8""RD<%$98;/(%242@T_CMKOK>, MQ&V\J']/NPWNK\+!$ZH_LO9=,)M14D,C!N5?RMWCOF"W*#1C^`9SF3$K@@7UNRTXO4?GB!?"N0W]_B%G-9,(X671 MBQ9^"=M*X\@5?9AL&D.#Z"&TSQX.E'3A_:R)@L;'\$N([72EIL1COSR0]966 M_P%02P,$%`````@`35X&1Z[690BE`0``L0,``!D```!X;"]W;W)K&ULA5/;;N,@$/T5Q`<4VTG3;N182KI:M0\K57WH/A-[;*," MXP4<=_^^@"]U5Y'Z8F;&YYPY,)`/:-YL"^#(NY+:'FCK7+=GS)8M*&YOL`/M M_]1H%'<^-0VSG0%>19*2+$N2'5-<:%KDL?9LBAQ[)X6&9T-LKQ0W_TX@<3C0 ME,Z%%]&T+A18D;.%5PD%V@K4Q$!]H,=T?]H&1`2\"ACL*B;!^QGQ+21/U8$F MP0)(*%U0X'ZYP`-(&81\X[^3YF?+0%S'L_JON%OO_LPM/*#\(RK7>K,))174 MO)?N!8='F+9P&P1+E#9^2=E;AVJF4*+X^[@*'==A_+-))]IU0C81LH5PGT3C M8Z-H\R=WO,@-#L1V/,PNW7NX"2)>F=BHYAW:6#R&ZJ5(=[N<78+0A,E6F-.$ M61#,JU]MD=%K]"S2L^_IFYF^63O<3`[OOA?8S@+;MN_%(E^IR.X]9G,DGO,@[WL!O;AJA+3FC\Y.-8Z@1'?CV MRRO-+B`U!+`P04````"`!-7@9'U$8& MCZ,!``"Q`P``&0```'AL+W=OM#;&]4MR\'4'BL**OXRIT7(?IS^U$NTS()D*V$&Z3:'QL%&W><\>+W.!`;,?#[-*=AYL@ MXI6)C6K>H8W%0ZB>B_0FR=DY"$V8;(4Y3I@%P;SZQ189O43/(CW[GKZ9Z9NU MP\T_#O\KL)T%MFN![220?M[B&G.<,5]=LM69*C!-O#J6E-AK-Q[I4EUNYR&+ M,_F`%WG'&_C-32.T)2=T?K)Q##6B`]\^N;JFI/7O9TDDU"Z$-SXVXY4:$X?= M_$"65UJ\`U!+`P04````"`!-7@9'`7/WJ1,"``#C!@``&0```'AL+W=O*]D4WSA2A2%H)W2+;$%"_9:K@P(EH92:NF,Y0VN#?1>YFL M%P6^&R&'24>8@\,,"*S5@Q9I%**GEI[.TQ>>OAAGN.C=LWA>8.D%EF.!I3OB M\M\CCC$'C\GF3;*@2>8$5A,F'K.>-UD%359.()\P\9C-O,DZ:++N!?)XPL1C M'K@3>=`D=P+IA(G'+.9--D&3C1.8*KS'/%#X)`ZZV+"1F"K]`'J@]DD2]G&_ M83Y5_0'T0/F3-.S3_Z_)9NH"#*#_;P`>-2$&XFI[K40G?FM4WX.&Z-#/][:= MXR]X6;3D"C^)N-:-1$>N="NT?>O"N0+M'S]E$:KTBS,L*%R4F:[U7/0]N%\H MWOHG97C7RK]02P,$%`````@`35X&1PR@KWJO`0``%@0``!D```!X;"]W;W)K M&ULA51?;]L@$/\JB`]0'"?NMLBQE'2JMH=)51^V M9V*?;53@7,!Q]^T'^$_=*EI>#'?\_MSIP/F`YL6V`(Z\*:GM@;;.=7O&;-F" MXO8..]#^I$:CN/.A:9CM#/`JDI1D:9+<,\6%ID4>)OXRIT7(?QY&LRT:X3THF0 M?B*PT2B6^9T[7N0&!V(['F:WV7NX"2)>F=BHYBNT,7D,V4NQ^9;F[!*$)DRZ MPIPFS()@7OVJ14JOT=-(3V_3MS-]NZYP.[IG][<%=K/`;BVPFUK/KG+*&G](UT"";4+VR]^;\9[.P8.N_D5+K^"XA]0 M2P,$%`````@`35X&1[?#[:*F`0``L0,``!D```!X;"]W;W)K&ULA5/+;MLP$/P5@A\0RK+=.(8LP$X1-(<`00[MF996$A&2JY"4 ME?Y]2>H1I3#@B[B[FIF=Y2/KT;S;!L"13R6U/=#&N7;/F"T:4-S>80O:_ZG0 M*.Y\:FIF6P.\C"0E69HD/YCB0M,\B[57DV?8.2DTO!IB.Z6X^7L"B?V!KNA4 M>!-UXT*!Y1F;>:50H*U`30Q4!WI<[4^;@(B`WP)ZNXA)\'Y&?`_)%)_BM-Z]V=NX1'E'U&ZQIM-*"FAXIUT M;]C_@G&$;1`L4-KX)45G':J)0HGBG\,J=%S[X4^:CK3KA'0DI#-AET3C0Z-H M\R=W/,\,]L2V/)S=:N_A)HAX96*CFG=H8_$8JI=\]7"?L4L0&C'I`G,:,3." M>?6K+5)ZC9Y&>GJ;OI[HZZ7#]=!]N[LML)D$-DN!S3CB[ON(2\QIPCS\UX0M M]E2!J>/5L:3`3KMA2^?J?#N/\1#9%SS/6E[#"S>UT):P0``!D```!X;"]W;W)K&ULC53;;IPP$/T5 MRQ\0`[O0:,4B[2:JVH=*41[:9R\,%\7&Q#9+^O?Q!1,2H20OV#...O5$;=:#P="5-D"I^I&#-";/[60G&H3RH:H00*M'(DSDD111CCM M>ESD+O<@BUR,FG4]/$BD1LZI_'\&)J8CCG%(/'9-JVV"%#E9>%7'H5>=Z)&$ M^HA/\>&<680#_.U@4JL]LK5?A'BRP>_JB"-;`C`HM56@9KG"'3!FA8SQ\ZSY M9FF)ZWU0_^FZ-=5?J(([P?YUE6Y-L1%&%=1T9/I13+]@;B&U@J5@RGU1.2HM M>*!@Q.F+7[O>K9/_;O1;FO')RM4(S)EEASAX3+PABU#Z\ M>[;_6F`?!/9K@?W<8OR^Q37F'##?J#+=-$EG@=TG)@'SC4ZR39-L%D@_,0F8 M[(,)64T'!]FX2Z!0*<9>^^%8LLL].R5NNM[@13[0!OY0V72]0A>AS8RZ@:J% MT&#LHYL4H]:\!$O`H-9V^\/LI;\6^*5U!+`P04````"`!-7@9' M(+9S#KL"``#A"@``&0```'AL+W=O`YW\&^?ONK'934.@QDT>5+0B#'=O3 MHKR)P@\Q7D3I#?""([?V;V7ZBDLTG# M+X$X4;TGX*/"&VVBG`-AW-3$"]/YI'L_9@BDD^A#&SD&=9CGELF&F;ECAHD7 M2Z3Q,+*X:[*\;[)R)F086;<#RH>9C6,@N#*1*FIO95%;6=RM+'(&\+X!;@WB MK@%V!C?U2`U3V[);)D<$#T,O%OJ&L]NB=*F%"P2L;&@MRL<=(MI$5RDL6="?L/6_AA*X?A#&0> MTT]ZDR;&`Z*1K!>603$B9)A:.J<\Q_']9)+>9!(;:*R"%H$@AS@?68P.2]3: MR$=&YN>V]'-;.2Q.$!C9`FN+$=`9YV"=TMXZI6[/CFS'N64@)J/K?N&'K1R6 MI,!G?V2]66P.S#JN=_0502P,$%`````@`35X&1Q^39GX;`@``6@8` M`!D```!X;"]W;W)K&ULC57)CILP&'X5BP<8,'LC M@I1%57NH-)I#>W:"$]#8F-HF3-^^WB`T)9-<@OWS;3;VGV)@_%W4&$OP04DK MUEXM9;?R?7&L,47BA76X56].C%,DU92??=%QC"I#HL0/@R#U*6I:KRQ,[967 M!>LE:5K\RH'H*47\SQ83-JP]Z(V%M^9<2UWPR\*?>%5#<2L:U@*.3VMO`U?[ M7",,X&>#!S$;`YW]P-B[GGROUEZ@(V""CU(K(/6XX!TF1`LIX]].\VJIB?/Q MJ/[5K%:E/R"!=XS\:BI9J["!!RI\0CV1;VSXAMT2$BUX9$287W#LA61TI'B` MH@_[;%KS'.R;/'"T94+H".%$F'R6"9$C1%="_"DA=H3X2DC-UMBEF(W8(XG* M@K,!B`[ITP%7"LZUB%(&PJBI/1"FN-'52QG"K/`O6LAAPAEF:S'P/F(_JN03 MQE<)%F.$WI)%:`7N6^PL(HL_2>%$DL!2(YP*Q%0B# M?T-F!M/:E5H,A#`('MLDBS:)LX'W;?86`],D>\8G7?1)G<_-9TGF/A8#L_0I MGVS1)W,^T?WU[+(EG_^7[6!Y]$R:?#%-[M+AOL(W]2U<[6S7N\J418?.^`?BYZ85X,"D:A#F-I\8DUC% M"E[4IZE5HY\F!)^D'F9JS&WOLQ/)NK&33W\GY5]02P,$%`````@`35X&1WCR M^]9Z`@``?`D``!D```!X;"]W;W)K&ULE5;1CJ(P M%/T5P@<,M!1!@R3J9K/[L,ED'G:?JU8A`Y1MJ\S^_;:E9=!487R0]GKN.>?2 M7MNLH^R=%X0([Z.N&K[V"R':51#P0T%JS%]H2QKYRXFR&@LY9>>`MXS@HTZJ MJP"&X2*H<=GX>:9CKRS/Z$5494->F<GX:.PI\WM*W]7DYW'MA\H#JR(U6EF*3R7T/ZJ:D2QV/+_EV7*^WO,2<[6OTICZ*0;D/?.Y(3OE3BC78_ MB*DA5H0'6G'][1TN7-#:IOA>C3_Z9]GH9]?_DH8FS9T`30(<$B!XFA"9A.@N M(>B=Z;J^88'SC-'.XRU6JPU6$LX4B63VN&:3)7$=W*CH-8=PD057160P<(39 M]A@P(`+)[I2`OBL=&HGDL<3.8M)ID8 MK<7,>!6Q4R0V!/")B,5$TR(+I\C"$*!;D41CFEZDQ\2A^CR&[7H8"&]Q#_TD M3C^)\1-/$Z3.M4U[%RF:)E@Z'2R-@\63UVXQR;0(")TJ.JPH9FQB`)R5`M.. MT8QM#*#;A6DE]&1=MP84S5A3$+EE3,.A&;T`D+M8](5BW?T$XCG%QF:SSY!Q M=Q0P+87@#(K$76PR?Q.#U.TBG;&-+0C-^/L`[FX!IA40>J9C03.Z&KK[!9I^ M07?UQ./%LZ#[Q0M&AUU-V%E?`KAWH)=&]&?=$!TN&ANH#\M/>)ZU^$Q^878N M&^[MJ9!'KCX?3Y0*(N7#%VFFD%>A85*1DU##1(Y9?SGH)X*V]JXS7+CR_U!+ M`P04````"`!-7@9'VICIF+,!``"$!```&0```'AL+W=O55G(L^&LA4>%]%D(JM[VP&6_PRL< M"D_LU!A7(&5!IKZ*"6@UDRU24._P_6J[SQW"`_XQZ/4L1L[[0KWUJUE`8L1W278=38*V%*.-3&A;F-U7!*AL3(+ISYZ>(IWP%02P,$%``` M``@`35X&1UP_&:00`@``SP8``!D```!X;"]W;W)K&ULC57;;MHP&'Z5*`^`[1Q(BD*D`IJVBTE5+[9K0PR)ZL29;4CW]O,I++2F MY`8?\IW^'\LN!L;?1$V(#-Y;VHEU6$O9KP`0AYJT6"Q83SKUYX,J26@@C")6AQTX5E8?9>>%FPLZ1-1UYX(,YMB_G?#:%L6(FU,M M]08H"W#E54U+.M&P+N#DN`Z?T6J'#,0@?C5D$)-YH,/O&7O3BQ_5.H0Z`Z'D M(+4$5L.%;`FE6DDY_W&B_STU<3H?U;^9]V;#HS#O9+#AW-3X@<(;H24/(E(7:$ M>"XA<83D`P'84DPC=ECBLN!L"$2/]?%`*P7G6D0I!\*HJ1X(L_FL=R]EE,(" M7+20PT03S,9A8'X?L[68++D/V7V"`)72&S4:H\;3J)&+BAX+Q*-`,A6(C4"> MW6;,#*2S95@(@BBY#]IY0'>3)-XDB2UECD#J[47J!&;T8NE-L'3-C.[7N;&8 M!$+XV"7SNF0N9GKKDDY=+":-80IGM"/W^N2NFOC6)Y_Z6$RV2&>X/'F;_C3_ M`"+HS6FVM<07QVOC0.FLOB/D-T(/S_K.8=!G'S"Y27I\(C\Q/S6="/9,JDO) MW"!'QB11*G"A_LQ:O2[7!25'J:>9FG-[W]J%9/WX?%S?L/(?4$L#!!0````( M`$U>!D<"[A3DT@(``'D*```9````>&PO=V]R:W-H965T$?``.,K.+NO:B,SN]:*]9C6)W8F4FGOB95>J;`Z_+3*IA M??3$N6;9OA&5A><#0+TRRRLWB9O86YW$_"*+O&)OM2,N99G5?U]8P:]+%[IM MX&=^/$D=\)+8ZW3[O&25R'GEU.RP=)_A8@N!1AKB5\ZNHO?NZ.+?.?_0@^_[ MI0MT#:Q@.ZDM,O7X9"DK"NVD,O^QIK><6MA_;]TWS715^>^98"DO?N=[>5+5 M`M?9LT-V*>1/?MTR.P>B#7>\$,VGL[L(R>=4\K^8;TLJ&!;X5 M^)T`3@N0%:";`$\*L!7@N1F(%9"Y&:@5T)N`3@H"*PCF9@BM(+P3>*8=33-7 MF\V*8`(TC M*X/`<6)C$\&P8SQ5Y&"EOCM4A6\,QE.DA@CP1)T/3=:/33;69&+)7BT"HG%F M:QD('J\(:E<$]7N';!WTL0%N#7#?`-L*[M8C:)C*++MAOD4^0>-4:B@4WB]* M'UI9*Q\@!,:QM<4"'X1X'-M8+`PIF'![M1CUPREL:S$$(S"C'V2P'\3V(WAL M0`?[0:U!^'^AI-\/P\``812A"(Z3J25)%$&*<31.KFZ>P*=PPG-M24PC0`(Z M8Z+!X$0#.]&)HE+#8*BV"\6/$X6#B4*3B(*)1(:!@&`JZ/=DJ+CFP5KW=8E:P^ M-C<7X>SXI9+F[ZJ+=K>C9U\?=G?Q%[A(X4!\!1?KH?A&W[*:0_.6-HG/V9'] MR.IC7@GGG4MU]#;GY(%SR=1LP).:VTG=`[M!P0Y2OP;JO38W(S.0_-Q>]+K; M9O(/4$L#!!0````(`$U>!D=6KQ=W^`,``/$5```9````>&PO=V]R:W-H965T ME!#M&QOPU[^DO]62S/QP.=4ZW0]!11[2*(K#(LW*V6(^//M1+^;5 M1YMGI?Y1!\U'4:3U/TN=5^>'&9G9!S^S]V/;/P@7\_`2M\\*739950:U/CS, MOI'[%S8@`_%GIL_-U770=_ZUJG[U-YO]PRSJ^Z!S_=;V$FGW]:D?=9[W2EW+ M?X/H?VWV@=?75OUI&&[7_=>TT8]5_E>V;X]=;Z-9L->']"-O?U;GM88QB%[P MKT+U9RW_-UK].)!\T@V$W)9GCXK7_ZN:`QFX>?O1(P](I9 M`C-./%H5/LZL#",]R'0XLYX>_BP-PRE)./=P*\MQ[N762+T-4F^+U-NY]<8=BYV.Q>`8 M\SAFF"Y_7"3*HN`)HN#``1E8&5W*`EMUC)W9BDQSSB-@\.&C+&:+A/ M&H3>,%>(^ZQ![&%#^APW$.?=QN,YE&PLQX3P<5O@AHW,P^TLI^)KSC-&]^F` MV.,!YH!!A-MK<8O7[GV$V(TD&1_S,T"24"5BS#)"W.LO@?5(>0Q^MA!-$L%B MU-"4NS4%K7FK#""2,.^N;3G.&6K7)NYUD,!"J#`:-'*FG48WI)VZ2YV2Z;0_ M68C%3`K49*?4W1J=SL02(.*KOI4#\O3&O;Q06%Y0&R+E[ASP6W+@/O12,9V# M[P`-JQQNT.XZIU#GJ,V52O>@Y0U_(ZF[**F:WJ!?`"(19YCMC";N[B8WY(BY MSQ,,<9YX`0C;7>8N20;5IH2G2`#J_YM^:2F\>KMS2M_U'VG]GI5-\%JU;54, M+W4.5=7J3B6ZZS2/.MU?;G)]:/M+V5W7YHVDN6FKDWW!>GG+N_@74$L#!!0` M```(`$U>!D?5"YW`Y0$``%4%```9````>&PO=V]R:W-H965T@J1[R>PQ]W@E869>^%EPC*(C@V`DV;O/0:[*M$*(_C5D4DL^D"S'QA[TX,?]=[S-0*A MY"AU`E;-A52$4AVD%GYWF?^6U,9E?TY_-M4J^@,6I&+T=U?+5L'Z'JA)@\]4 MOK+I.W$EQ#KPR*@P3W`\"\GZV>*!'G_8MAM,.]DWT6Q;-R!G0%=#$&T:0F<( MOQB@)3-U?<,2EP5G$Q`CUIL=[)2!D>SH]V&#P(``"(&```9````>&PO=V]R:W-H965TG!BG6*HC M/_NBXX"/QD2)'P5!YE/*$W!%Z: M5ST)R M!TGO(:MI(U83YHO\,64Y2UDZ2G9/T??SAK&B;+%\3%G-4E:.DG_2B]4$B^1C MS?Y_C2W$G]Q)"OQL9I5`%;NTTE[),3J.PVUD[O1-7A8=/L-/S,]-*]"!2349 MS#4^,29!X8-%ZJ%:#>SQ0.`D]397>VYGF#U(U@T3>?PLE'\!4$L#!!0````( M`$U>!D?\J/JKQP$``/\$```9````>&PO=V]R:W-H965T&@U;K?8ZQ.+7"BGD0/G7G3",F)-JD\8]5+ M(+4C<8;C,-Q@3F@7E(6KOO$JD+YT3^>@$FAD,0!5/AC9Y;;0NX M+/#,JRF'3E'1(0G-(7B.]E5N$0[PG<*@%C&RWH]"O-OD:WT(0FL!&)RT52!F MN4(%C%DAL_%/K_EG2TMM<7\D"BK!?M!:M\9L&*`:&G)A^DT,7\"W MD%G!DV#*/='IHK3@$R5`G'R,*^W<.HQOMJ&GK1-B3XAG0I3^EY!X0O(/`8_. M7%^?B"9E(<6`5$_LQX[V!BZMB%%&RJF9EI0K/MOJM8QWVP)?K9#'Q`O,B\?< M1E0>DQ=[.X+))-`LA1(G$`2AO<%TE4'J1>(_NXR=YAN MG,.(V>RV\6U0-8)V:;2];R5;M9)Y*_%]@U)V?X1N29=@H=A3;'WIW11@@-1B1\R@+4FMMH3A@TVH:YB>7X@XZ)%OUT MW!D&PO=V]R:W-H M965T4?9!R\Q%MY731J^]4LAVDT0\%.) M:\2?:(L;^#+IS5>.&5[3Q&+YL_6>P.8!((9KX4^&. MC\:>"G^D]$--?IVW?J@R8()/0ED@^;CC/29$.J<;%[2V$M^KT5?_K!K] M[/IOTLS(W`)H!'`0P&12$!E!]"V`DX+8".)!`&)]-'TI^B`.2*`B9[3S>(M4 M>X"-Q)DRDUV[R#+A>?%:K]R(*HSRX*R/#P!&SZQF8QH^9O6&2Q\C!(`,1 MR)#.I-`FC<9)H4D:SQM$UB`>&T3&X$?&,7.P3#J_2>S<).Z+C%;S!HFSS&1Y MF:DS06H,LL=E[BRS>LSL+;.>#Y(Y@V2]`0@G@E@&3`2QS(+.63F#K(Q!-!'$ M,O%$$,LD\T'6SB#KOCEB,&\`0F=WZ.6%[0&`,P0`"QK$0B"=.(\!RA:$@>XP M<$&3#-!4NP[0@GX%[@L"1`L:Q4)P(O%^@'[^TL'HCF[1%?]&[%HUW#M2(:][ M?3=?*!58FH1/B>^5\KT]3`B^"#7,Y)CU;[)^(FAK7\S#OX/B/U!+`P04```` M"`!-7@9'XKS\O6@"```3"```&0```'AL+W=O M"'P\[_L=C(G)E=!/5F#,K:^Z:MC*+CAOEX[#]@6N$7LE+6[$FR.A->+BD9X< MUE*,#DI45PYPW="I4=G8::)B;S1-R)E798/?J,7.=8WHGPVNR'5E>W87>"]/ M!95O?:6VU@2"OA5XBL;W%NR]ATAG_+AQV%EN[($ M7.$]EPY(7"XXPU4EC43BW\;SEE(*A_>=^S?5K:A^AQC.2/51'G@ABG5MZX"/ MZ%SQ=W+]CDT+@33DDA`(ESD4:&`0-FHYD(3B.Y1KR><$0!HU4`>RP#4/*9&C)-1/Y, M#0]-MO^93)8)NS+A<%C0#`L^-O`[`W]HX!N#NS8BQ31Z%IJ)0G\Q#64:`D'D M@VDJU]3"]^)I:&NLXABZC]L*1ML*3%O!OVF"85N:>0G#:!K*#+0(HADJ-Q3P M83A-;345Q'$0/NXK'.TK-'W-I=&,YT71$ZLB&DT3F31SD]',RVS'AHDA?.:K MC$=KB4TM,RMFHYEP$<^LO4Q#7NB!F76 M!D<8B"O(%0,``&D/```9````>&PO=V]R:W-H965T1EW+A'Y4Z/0>!W!YYD)E_5$6JZL?J M$,A3Q=-=$U3D`83A)"C2K/27\V;MK5K.Q5GE6BR*M_K[R7%P6/O'M MPGMV."J]$"SG01>WRPI>RDR47L7W"_^%/*\IU4A#_,KX1?;N/2U^(\2'?OBQ M6_BAUL!SOE4Z15I?/OF*Y[G.5._\QR3]OZ<.[-_;[-^:>25*7+>24NGCRE^O^) M/-=XI9/4F3W99*N;)IO%%[WZN:00SX-/G<@PT&->#4/#869E&3+,)`YYUI:! MC@GJ6M""P!9$^P5!DX!,IO<34)L@ZB>@1@&]5ADW3-EVI&5(^#09AA($&I02 MH5(B(R6ZWF7:E](R9)A(;HE!$0P5P8P(=C_!!'TC$Y/`H0U35,'4))A>%\GZ M;6@9&"96+1$-$\EMCD&9,U3FS,B<76_19UXM$P\S*\-$X7TA,2HD-@D<7CD) MT5?6+#N^,T)0$80XM,-"$8STHX.H@QC`Q8!)$3FDH'A+Z`,MP>U,(I>6&"AB M8RVQD(L8W-;$^#IR&)0$-S9YP-D$MS:9WF_)RD+1S&$?W)O$FBIV2!'CU<;N MU4*(JH#0H5H+,0?_`^X],(YA#A,`!KY&X8%J\2]2L(X9F]L6&AG+]Y&U05Q^ M-.#6!`=K)A9B(]-JW4$.TPIP:X*Q)G.85H!;$QZP)N#6!`=K)A9B(]-JW4$N M8G#_@O$OQ/O=V M#SG?*WT[U0+;DV#[H,3)'FR[T_7R'U!+`P04````"`!-7@9'#P&&E\$!``!P M!```&0```'AL+W=O]WDM;,I1R%?5 M`FCTSEFO]E&K];##6)U:X%1MQ`"]>=,(R:DV2WG&:I!`:]?$&29Q7&!.NSZJ M2E=[EE4I+IIU/3Q+I"Z<4_GK`$R,^RB)IL)+=VZU+>"JQ'-?W7'H52=Z)*'9 M1P_)[E!8A1/\Z&!4BSFRV8]"O-K%MWH?Q38",#AIZT#-<(5'8,P:&?!;\/R# MM(W+^>3^Y'9KTA^I@D?!?G:U;DW8.$(U-/3"](L8OT+80FX-3X(I]T2GB]*" M3RT1XO3=CUWOQM&_V<:A;;V!A`8R-]R[W)[C4GZAFE:E%"-2`[6?+MD9M;0> MQA@I9V8"*E=\L-5KE1:DQ%=K%#1DH3EX#&-<6W/]YP6#1MOIG9E+?R/\0HMANM_S3Z;Z#5!+`P04````"`!-7@9' MG!FZI8&UL[7W;CAM7DN#S M\"L2AHRI`K*H(NNBDKO;0.GFEEN6-"K)QF"Q#TGF83&M9"8[+RJQ,0_^B'D9 M8/;G_"4;MW/+/$FR9'L7VTL8MEEDYKE$Q(E[Q/ES73=16V1_;]73LBV:OWQU M=OGHJ^CS*B_JOWRU;)KU-P\?UO.E6B7UN%RK`GY9E-4J:>#/ZO9AO:Y4DM9+ MI9I5_G!Z>GKY<)5DQ5??_KG.OOUS\^VS2B^^-U M>SN.3B_#/^Y8SS?=Y^61=^HVJYLJ@1=?)RO5?>KMJP_?16_?_/3\7?3R]=/! M.=]OUKU7)Z)4WO70V&T;_\2Q`0,$9*X[S(D]ONKXLD MKWLCRG:?PDM5D@-D4O4Y^IO:=)][VE85#9S5]54MVJZ'H^ M5_`4/)/R\T-+D,V\4^NR:F!.6$W2M#V:_/<^F1I,N8!X`5_N?%)0&WSVWZ8] M>)=%7>992GMYDN1),5<`+#AU-1RA#S?/HJ,'Q]&#*"NB]\NRK0%V_16H.5#+ MA,[%^1!"D[J&,7O'X&E2+^G(S/&#^GN;?4IR>+XW"<`#.`M;>56B=9&JG/P&=J(`.3J[HS0?3R_CB[#%`H5ZK>9-]4GF?2%52PS!KF1FX<(H[3=89[B;'7_>; M=Q*?3T]YVDD\N9QNG?5UV:BMR(%S=YO!+P)'6D+WJ3>$E&W("/^FJ2S/DEF6 M9TVF^J1F*&B=;$(KA-^K5EDJ"6`R;>=-=)=4R*\W"`U5?>J-\TPM%*PFA=^! M'MO>[V]F>79+0*Y#J`F#9-[?X'9BW?*@<,8:.:/>C7F^A]<764%,H33+#J]P MY\JV//!.I0H4`20.($$!'ZVO^^0-<#0D''_AKX/4X>G`Z/IT` MRJL(&$L+#\!223.(CI+;VTK!EA1PMT]E#K215!M8)AS.E`\!CZ9P^P\FE_'E MY?EQ-#F-S\\FHEU$2=LLRRK[ATK_%+VL:Z0?8BY6SGP37<13>"%I(A"KRF@7 M]!RP3K6:P9*&V">)KV69`YG4_TI\H]GTF:B#T"T[_E-T?G$:GY[2OULV<)05 M\[S%M>N'@/LWH([5;;4Y_B::/#J+KX`GG4W.P[O"!R[/SX%13?&!G9N\3M,, MX0U$@GSZ!*:3(Q$XHX9="0,O5X"E)9Q8X$JP4/@[=+(=)K?(YEF/\;Q2=8UC MV8/A[/F;Z.S153R97(:WN\\6^0C4`6SN/"RQ2^L]^L8%[#/L-D%_]#9!GK%4 M308:1'V\M^3?,NA]#^Y;LS'1V"P!`SU&:9GG255;8C[^S1/T#L#O-6)&Q^CW M&JT<5EGO/>2].)X#]AZP?>7ZOJCRW]Z)A^#C82`_'3C!\8`UZ!$P*N<*M;(: MM9\W:]3P24KO>QS.]K8M>_SA75A7T#K'@"H!!/`IFZNAGT$U!;-AS@IV"L_D M)6F=2"1@A@V/RSQHX,>G94VJXWK[VO1C]?8UZL>J+UWKX"9%C^O#+,_A+,71 MK2H4VJ+$PM-55I`ACLKMH`HH-`&",2_KWJ^@XL+1J1O'O`C+H^\2H"(@TQE8 MD_AQW<+Z`ZK?TR6HS'A6HT62Z2,&L)K?2X$++&L`-*_!)CC"G1W+PD&T@6TS M:QMB+4T9P=MH6*^3(F1DN9(I2K-/6:K@E`!2YL`0^@=B]W1ZHWAV1;[M'L3P MG9Z>]"2IL_F>/.I9EK<-*T-[/,TCWZGL=HDO)<""$\! M8VWA;D\]M>D5P._+A/ZN40,,VGGBZ!4A[F7PE&R9Q]>*GY/"L_?Z83:4"C`[ M:&WT"4DG.&8?S:3B#'Q-M,)8Z1$(DBE2Z7U.%*T(F`0:\ZCF`M""]A<_5ZY) M@*O/JIIG`=[E2M%]9]JVH_"LN]_0?&';DXY!\)8-@I.G88/`'W.;XL]6JD]_ M8<)[+TI#&%;NF,_"QL2V$X)NKA=Y>7>/\V9?>5&5J\@*H6MTQ0PX.]*?V[KA M:8'**@5B=)X!R16:$.%;_$Q^MQ81CS+)#)T,#_VLXR9:^QZNKH,+_P1M4_%J M<);<]T_UOHZ"-'"R^YQHL9MF];JL@;9V+3XLC^L.I&A-]*)C MM,&Y!K,01D?"C(Y:9#((ZAXTM_@FP[OMNK%B].%YCJO8J&9=5Y4S^!9OS.M] MR&(7E;XDE.^@TK>B^-P;$^Z+[U2>O2F,1Y-6GLSAS8#*`?KT7"G021:XQB\F MA!Z$,K/;_2'$CK4=$+(J8+73S^SL3/-CW)D00=^?Z[!'L M:*((LJ')F$^;5^>@]8<F M0?218/I8G^DTFFUD@.UH?[Y8J#E1IOH\9VQBY"B:"S,IBR`^/>5$%):L$.K> M(UXR&%B)HYFZS8H"5XUT3^&B>[R-HGO[>\3/%B5:/VQY]*":-&VE?"-[X)DW M[C/CSD,83?ZF7B=S]9>OUL+BOOIV,HY"$XR>J7I>96LM5IZT=5:HNAZ]S=O; MZ&UY!R0"^L`XCHY0)_OUE_\6M>S77_Y7!)N!+^R3\-UQ#.0<)4A.Y"H5NB`- M/T+**[6:P8$' M*00SO'W^0^RLA8X8_K7&@UW7.)T!`SDVS;,/9Z`7*YA_N9E50#W^8V2AUW6) M2@UF1K\FG),M1E(ZC:V?YB%W8:0ZG%]:_5"MTCB*6T)M!XAV0-$,:LBLB^?IY@Q]! MO^)9E(R!FN*&GE@J>/DN:T#CXT%`50/XCZ._ZG$RM)HK()^4ET\3S)-J5C*R MZZANT>51B_,.CB,L,E?M*KI-:D+&J[??@4S$@P"KIB]1Q!&J5@J6#^"%PZP_ MP`.@L18*WYQE)`=RR`45*KPRI2F"4;^JL9HD#N*1%"`20 M=$[JK$$+'QTZ=;M"%01VQ`RZ659E>PO[T:02?2S*NP+W5RF30S&.G*,JIX6< M]H!1&-H@(06%`(QF=/HY!`(#P:8HJ%&"B4WSXK$`TFY*;SE$][6F8/0_945+ MQII,ZA")UK3LF*1M@PX!>$?6<)+,`3U,WAGKCOU#^$D!>>:B_&5%VJ*HAP>0 MAC_R,FMT;0!L7X-RO(RN8<%`CK_^\E]``9B34#=X`MBT[',+G&,F_$X!7MUS M37*@K2*U@&E8=@:XQ'J=9QI;1_#@QSQ;-&"Z`S[I4)W42_@B6F:`1?0LKU1G M>J)[_%5PO6X[*T;RJ.&<*N1M;>4<4>10[$2LC4:=2&Z1G$'7&,&W4!8#_A>Y M^IRQ5XP5NN)35I4%LEC8W0Q8\R)K`!YO6AMAU1BET\"1,-#+HN]4\0P/9$R+ M\S@OD#=POAX3EK62;""2!CJK=A5\L`ELD-U/]DU&HZ76-*#"UIELP_MFM:Q2WP_A/]&S]<*=+DC0&-;S3(<$!` M`@D(3<81YE#5^!Y]P3(#ED>HKX$]E17L27;Z-[7A?0%M%BB3H60@!F#4,-'0DO$$#Z#H$:D;CE1G*SPVN`1T9@JCJ7FMY.#@F;H0L@S( M.PAW996G=T#],0D/XI8HX$6CP)/K<8?8\%4<)@4HSBUY@]FCB+/,8;A+!J55IN M`7KO$`]`+!3)GCZ*H\GCQX_&HP]%CI(7'T>9ISZCLR;%$X96"IZ%NPPSA_@$ M5@`BJR/'J"1[&K+^YD[I3P`0JTJW-7Y.1%%%ID\F[H*.1QEU='*6BTUM$4_; M9:3#\1H1`T?;PV,71,O*48-A9*1&.J1B#19@<<(*X!?V(*RQ1^@#CS5&^ MS"AG2T^,O]F)<)G,U!"PFJ4A>`U78^V7%#@MT=P)C/0L6ZL/D6YASD='IP;$ MW9&"5%O!),S9O+("?73>DH/*4:/\&!T)Y<]K9(=V!9KAL5R6J!:?H&4&+^,# M(+<31["O%!CJBY;6EFNJ(-S68L8RMCWRN,MRU.?7:-&V:YB_0+6T!$Z*K*VL M/*03U6!D:?R'HOD#.%].X`;6]Y?-9F.>TM$6F`5,:/:]AV:(+.)NO_CN_# MH6]KMK*00[=(B7LL?4SVQB"WT:TR#FM70<#%(=M`QXUX+8851%?0#F]=:-`R M34!BFJ)#R.S&@S4B[XI:M;<\963 M!HF\]7:#>*1]Y`C:U/&;C:.7"Y1W*)S:0H?'D.6YYP#M#](,S&$BMK\@MRJ? M]`)$L28PW$J%JHNA-)*IJV2#`ANM63U1#41#),E,Q$X'HAC=/+!ML'/,VS.# MZY05BSS94*(6VONPCH=H69+3KK-X^:U6"@-NQ<>J73?S#?E5%"&!I/@RD2P$ M$'3%7)(*74O4_@9(N4VZD"#3W)_51'X0U.]MU!%Y7$MQ>_O`/H%XRA!^/#Z+ M5L!&MT=OP81J:=IF0]R?I9P[ROB^NQN=V M&9VLP/%HKQ"*6>QVJ$1WL)8'TW,+6"!)$R#%!6M=SL+Q#DDH'?86/Q MQ(,E4D!7B-"39Q<6ZN/HR89L'-"IZE("+]VW0CF1O)')Y:/QJ1EK](S=`]ZR MD\+S>7PA;9B! MD@4P*/L&6?I9+1$^/O2K55;7YA1+`D\-/)YVNE!B$)@`(ED``.8+NSK@K8!@ MH9DX2NTNO4T^F%RYI]>X]YQ(S+I2GS)0D0#6G($73$8"W?P],$58H."4'`Y$ MVAUVZ.CF8JL*P'!+\.,GMEL$>$[(B7_O)L,2UD\LUD6&:4TGEN3LRNR#W3PX M+`R3-3YGG(%J"P).@KFHHVLG$=)A'`B.R(%K,@Q("2&"J.!4LT;[3$7&L-(% M*XIU(HA(7@WP5`;LO-[%B9,!9!#`RJWVEM7M`GD7UP5H[=A(5XL-9$BP4X0? MJUX%6H$-J/J`0.90"*&,3L+/+*_05\VV>UF(LL@P0H*<-S*RM8L]!T1,"DID M#`O9\`R,F,@88TSR7L2]7:U%./<"C>UJ)7Z!F^RVR&#?&,Z5J#F^_K9$GTPO M4!<.)DW!NM][Q)&$(A&ME`VETT!@J2,D+!`G3%KX%B@Y8%HTQ(#0L[`BS[C) M&Q&-A;+&30:)6&^$F^`#8H1I"M9V\QT([7QS@LZ&U#>BHVOT>3C[HL7,]0G@ MS*9:ZZJ&A?*9GBF%$1)4-Q/>B+,'8N\O96LOS&)M/LSO`Q*[D#6F4B`W6+<5 MQID;?:RJ5OO6@0Q;\6]I4-V`D5JQ/*;231W9>FH8;W1T\_SI,?%0?`'-!K%6 M5TF1L-$"G`7-89MU$XO2CAO(:@H0@')!%C_&,]`4Q8-"].R^52B,?R3L-B`Z MA'U@^B<*^HPT$K`SK8?LP_AFK%-987PV!4BQ-N2YME1Y]-WU]=OCN$,_K$NC M9&`MEV#3T1Y=Y1*Y!'(7"@'7>I7(KBPR5DFJF)N&Q]2ZCT9T;S`R!%!)UQ!! M(2$.*7+'+L23QJ,3BQ;-G#F/2LTDBQ:6BRKA>/145:3G9TZM,`4JR[(A+0#% M+VC!+>96,JIH7CIW1.%@8+18:+63,@T]!M"&>'"@!8.E*+U3LH]6J#JD!+U: M?=&AJ)=EFZ=LI23Z7/[<%LRQ:04.FR!7CYYD]^"D*98-^Y`JU90>>+KC7C.X MN`869<0+`&HT.3WY6PS#YRZ6N(`5\32DN8^)9[BXL_0BK\<+N3X8F_A`)\00!TC^?WN=55^`O7 M)-"<"OE:6:B-XUU@=92##GAT@%N@ATB_6E%X@0'@M@+NHLQZ M[%:\+?@+M[PF]J09K9!];.B[SVZ7(-,D`)ZJ64/^S*K5WCTW=+'"0#AS>5J) M72=[EC@AP4/49;01\L44N@F(6-6LI%8$3-2]OB\PH%QI*%7__#U7KD@D)BG@^ MMD4YX$'3@@N7XJH;[(5;^"]I>\N^;#VF>G).&G,\S;%QE_&63<@2?ECK&!$, MU8N!&B??47^)-BFD7:]1$%H/=6\O741)!5"M44'23#@+4F*R9#A2B4EES<1B> MT[EBS"9`+#^#'+'1$&>8#C)3A3*14L+"0V*\D[#5H*P'#J`=.5H^>D\CUF$K M:5F=H'\2+;2HG/W,GLI(46L9H"IM,MV,SN7NA8M" M/TE&4/*D(6S(@Z6A)/NFTS2'4V*#0ZC]Q-D5=%/2U)W&&@4XS)^+1]L M/IB%,Q%)2KRZ;MR$N\[.^&W7+<.Q-\[`3)K^LQTTD*\)8X[Z1HX"@Y)PDQ'1&AT\2#P:Z;0CYGU$KFEPYBMV8!^K8;Y>&?+.A,#XS`H M4T!K!-#.C1[V"2Q,&_VB,`U+J>XX6*9@R$`60%9;O2CE9$UA&(V)@!-#SQJA M2*!"XAE4@41TO,8JE[0KE&(V+7&&M4)G3NUQ/#H:+@AB`[U:SBR\N<@^LT&M M<<'G>U[FN;@NC0^!@6.[U_#6DKK$=S;D<:P0DT2$6G#:L<!_F`R4$Q;A?S M89Q#6K=S=&"@#P*/"E@=?/33>^)M'XW*PY9.P+`I&IY`"*/N;DGN",Y@8W<$ MZP=5@@6I)^0O)Q4AP@PDDPVD8:F56,TP@-PKU&3'G@::EN1=:8SZG@!IP/!< M"8XY+%HT&^[*B@*9F?1H[<*&%9`JM15/Y/JN);L82[&0`E#C7F,I=5GI)%U] MIE*U$+EZ6Y9IUP2@"BOQ?#EBI#\MQ]L3G;BPHF"\I(MK$/O'1DMBO1O9L`\O M"D>B'4)Z$(4)T#_B3*M-!YK)(EE'`&CE<"(^L?X'."8WBQG`^!I244:TF]ZE M.NV1:C9K);$88[%42FNCLB=?8_4D+#%IE0!;@C34@-Y%V,',$-4W8VM=O4.LIU8Y(HC<,"8[>($(33+*)N+ M'`_YQIHQ>^T[O-4O.ISCZ"G3::4Z;,`D`VQ_?^1U77CFF*9/]:Y'^I-GI3AR M=^^.#_Y9M"ATFA-I'9#769OD9W$#<9`)'BQGIU_C MX;B`_^$XU`-#XEQ\KBW"&$UXLAGKDAEJ4>[C2S0:P0R(/S`5JV@)QD3-<5L\ MS.N\U5Q.^P5T1Q<&!_,6@R&)XN+`3-[L6$1Y?T(7([))";"25L1% M7*18S-%[!5P,<]HJ(NY:"#7&4!%M'\!"IK$X[P7D-FW"[IP2?=D!SXDCDK.R M&]NT7(ZTUI*M[$?TRT"6OM?P@RL8``Q[M=KRSS;F';2%'%!.P9,TFKWIU'B@ M30(?R;_/I'_"5AZ`F]7S@`.@ M/G0WC`S!1$_8(2I/.-2V*)'$\"^AF/'(;2X0_20=26R$=-01IM;C$

"`5, MK.WA\I-;;%PDQ0Y4H23VQI44E21U+0O"JK;1S3RY0R+#?K/D M(`J#7C05FZKNEOLZ;POSI;Q9DXQ`)Z0DQZ3;)R;CP]LO.#:LV.1CT)R0< M3><=Y]0"2T`CGIK#$9?U@T^D96$<'@"M;*!:1U8,S-E;A#\]07?+RQS5J;=`19[K^9S,#:>;`G$5K\610^Q:35GDS);NP>_\L)(; MT:XE0?6^S97&H^^I:N5'KEH9[:IJ<:M8ADI3N.#X^Q^/&9%K6\_.P3,-C^]_ M1"S\<64L+YVZ7B[?9FKT2E1X(3'OB44@)HHJ)]GPSO^>-`5]V%O)B+5>0#=D MQ*70[+NR]=)8"WJRQ(*,PE9CR?Y,71$G_5(=OSCHS1+(C8:KH]1:RRZ0(J>@ M[.%TO!WXIHZN1/^CC=+X9,M[V]`=N\@-89O57+JOLO;``Z/^CT<"-<:9:N[0 M+_!]`N8#&.6 M]E4(4GQ9]&(%=)GZ(11*521HF>137(/?NT90.]MP5CLUDM6.VJ3"%8G/+%5? M,H;.SW[%:=B4P4[UT$)5SD":Z%W[#6V1MFXD9-*452?CD)W8&'J`\VW*;*T_ MTBY&/XF%WS/72*1T>'@@G'"<1/]052F&SD)R_4.['X\^,&-[+OY9CE#^3@E@ MG.^"=@\BVR3<:#FHR=>F;W%M[D?K+F8%T)%78L1S,P\F082;HSLC"L.]@*2P M1-**M.,$:,71XGOO-)X[IAE*^--^_M!RQ"[IY`<[FGQE&M,;"W+>M)2#!,W2+[EZ`K)W_9TBQCL9.6 MRS$K;!ZFJD)R?_M+AR_50OM/V;?C$U;M-)WAE/>N.7Y)DE:,!^T_0#4O+=?6 M5X_^(YY2AYX3+WE52;,=R43>F8J%F.$RV+WP(L81.8XEO/0YX[Y/V@=0V:P< M.#"@YY%;PXHUZR)BSY1-(Z"E@%K"#!4'MTFS09/V28FNYZ,7US=/,(>%"0YY M,,;AR;U+94G66R/U2@:DM#TZU5KO8%P\0NCZ7UT918L,&Z%.!(#FB!8U5N/8 M%P]27PW@_NUUKH#!ED8(28 MAAC!4-?`R?)H&O(PV:`*FR^#XT1'O_[RW_P%]AF2J(/3O-DH>ASJPF*4F MIA.Z$*P[C(##CB:2R`+(6815R#',P2DK5AVW>3F]SGRQDV)C'^L\--9@SSB= MA&P93K8)V3$-5>_8Z4V?@)MU^9'LJI^`1\-B&RJ,Z@30?!3(,;X`O>7B]-QT M4/6-OMB*?K1J)%]8_#'*E](&:`QT\1G[Z,DZ<6W7H=)?B5/Y[C=78W:(.H1- M3/"3/(F32ZLT38DZ.Q5IY-'XXAR!'Q1WYC!X2H MQJ&MCBOTPM*KY#G*N3#`ZZ!1])R*-=>$ZU\#/92Y-,L9_2[Q7/&.]K.U[.Z\ MSV6>BX*/5^SPA4*[G]B/K\!D_5=)(;:^UD;Z_Y.?4[=I6*V!USOIOO,DG[L% M#C/J2\SZ)_<5UE:*>Q$&"0CI/AH3.M:-_";:Y/$WL!K,F74;G(]N`(#>%YY1 MX/UUOO6WUUAXGX"]\LUHL%%NH`1U]&!T#/_R?X]'SU114B4*CO/3%_1/CDX8 M8"/;LX_`QBD>VI'ZS>C-VNI=3G&B'-0[%,ZC7W_Y3_-OZ,(5_XE.\VSOMR_< MB2!\1#E6/A,D_[KM!&O+/U`J>%S'S6Z^T]EX^F2:$`%*E1,#*>*>E8KM<8W= M4+]QX)FL#"T#ATF4@^'K$H41*;)Z+A\`2+`U56OI<"8?'T"9$Q(:$0$2W;D] MC'WX'4V.1^^ZJ'4>".,T.IH>=W$9'9T=(X$+RLS2[6Z\38QPYF>627FIZJ'J M8*EB[B@;M[@>>/;\G&][P:?.SRY`V)SZW33]N).I@-W)'W=-?'EA)[Z\NN0K M9[9,/$+0@0K\0T(:\"0HN!_%D^E5?'%YYOB&:W*^2DK0MM);KY"?GG>NG>E4 MZ;*\Z=:1*<,6FJ5'];H)5NT4EM76@E$I:AG"DX_IEX[+#^OA@Q"?GL679X^( M;+X(Y(&-3'"L^RR<32/M&>U1G*STW-QL]'LME"KZ[K7.H&O,]U>:Q8GUVNOS M;URZ5KD_&U^=PP$!/L+Q`9^_2+BY4N*18-U@%Y^QY8_WNE!+0[ODDSJYE%X* MGH;+[]=2FF_UU-[*^^#2B-#7;#FON/>^H`P13@%T>Q%/`>WH?]1Z*RY?AP%< M)3HT8?]^`&GD9]5(ZC$6OF`5,FI$/Y751VR;+_TT1R_P>I.E2CF[#1\)7(N`"47OD\_] M'L;N;_MIM)?CR'UI](%B7U0-7%`U('M+GI;8'?WE.XS&2T[FV=64STS+RCRI M*',X-1M0)4BWTM4;NE@CHQQT$\[S(@*I34=4)H2"R?3QW6H=>9TLX#&HR=< M,K6F/%7:=O?QNFE32FMWO[3;-CVP]=;%P882F@\Y\F`P`L!@M.U6`E;O%^S< MYMSIQ"C_!+-JZX!E&R@TU]HYZW[CQ=ARQ5JPZ$\3MVC&160E==&D_I9.>^A@ MG-P%$WNR03D`;/KLY/)"PC!2I"P*&35Z,69Z=R`W_0BE&KDW75^K#F`8Q__02`1- M.N,Y7X2&@"P6R:=2"H/*\B.Q`01.FE)[TCH$3$TE%"NE"LYY6:W+BD>3TC^E3?@A;)@^!]()+MQ52-^=-6H3"FE#M*PNIR9167UJE%6=N M64C>8#%7XN7?.CL!$90GI!WM(3.N\"$JP\MAQC"\]`@B[)CD.@E/'+9.XU8H"K)"ZJPC'X$UR]'`V6U?SU+=9=>$YHEL!1T>OT&,?38[UIZGY M!`9*R"UB^0:IINC3TO]UYNJKN/<;QQ-";/]>HD1,T7!4MDU&WPFKD3=%4SR'!=\ M`J.N,U-JJ4]\#G*WYCP?XT9T-J\+% M8.X`R@GW9A$K3R@\ANWP)3V0,N02E^Y6EO.,1R\D,2>8`1R[KW5C5UN23/_/ MY)AV++&=2::N3&$2];BN2\>Z%C0(%<^#S.SP.L2SWF7UQY,%NFR-M,*C,SH= M3Z^^/IF,SQY=?(U_3.@/^/QCB>$:8F@7T_'C*7Q_=CX^_WHTF3P>3R[QS\OQ MY?3KT7.=EJ\=148;Q+/6K6GE4YUH/)Q>Z#TF,575?J/G/I5+^= MJ+N4GE+LA;&Q2JPN=<'H7&,['4SR M"O(,[NGK+]=D.,)@SE)WS9-3;'N(-065HB7JZ_H*P\QOW^;D%6$6%)LYIFT= M4OEO5Z)8.7#W'N)F73W*ZGTC1^^+/N!@(Z>3X,@3\B]I,(FVNM$7BK9Z7^S0 MC[XT&/ND?ST8Z5KXSWUN)*Y'Q_3/RZ'[XH*1T.=.8\OAIX_EO\^+M+_*T,VG M66.24I[JW,M`$TCGV;K_<$^[W_KT7G[2JW&T=9#1*[!I^6ZZT2MURYVLJ'L/ M-QE8<&2.\Z>*-+=^'ZJNQ8C)',L,"9[Z,@.;U`[<&*B./<-D1Z$S&0^-GL6* M:"<'T6T'H^\2G9&W[W(#=`-3IR0(T0 M*6%=D@3UY13\$MV'E1M@Q9)FV"0?N>,3*9:41,<-M:1$5V2IEE,)AJMQ)3"$ M`Y+8R6E+;`5%DI*L<+P4*!L&O`\A1X7GD<`JN@*]J$Y.#G>EI;8)VW]E=X^8 MMG+CJ_0RJ-DS8]S;2Q5H<\3Y=DZC?QKO;NFWOB.WC"X+<7K]2R=;IY4':%Z@ MOS$ZE+O03C<,KD[U.@68#$.F#KH3S-:9NK=36)":9-AQ3T^#">_/QX__L$V=@1K[=1Q-+L>G^#^[Q=/Q MV;VV.-(-M'9UAW]\,9XX(WM.#9/K3J'E?@,U%*<&7NY.O3U=7HVO>$^3KV.] MF^FN.;LHVVL_@,2S"XV>>^_')>G!W4Q/QX\$)Q?WWH6;_H*](GO]**@3`CL& MN=MZ[;1;-Y4[_69V7E2U+(6A?+;E")9F^%BIP?\J;T9@&LN[84,((Z6 M:.:0Q3&ORCOMY2!&3GY/Z>5F&AWPO;!H5?F^4(IYX(9SQ3+1#V`4!9?,ZI4VZ2\?@=3MN6Q>J,K1-:+@QN7]O"3>IH%H\C@+T;[JU'3\Z MC?+1T8HE0M(R?1G M[3ZPEU+U&)MV^^]A;C9GUY\[)4L>"2><=AF9>Y&O#8K<*DXW*4CN99&AA3M? MX,A']DK+<._MS;'-E*612:)A[:&I#A?_`1"9+15%?0PO/[BP?0/D'G#JMF92 M.[I&ZM#9LG1(`#&Y-(^N)O'TXG3+B&P1XMNF>Y.;V=RN\=NS>')Z$9^=7[G) M5EO&Q,(M\9MY/DJIC.TE5G-/'!M3U2]SQ`,4K>9$9TP[7;9=D`W1Y;X]WZ,C M_>EXX&+J4#?XOW'S0X_[?Y(>]SUR"/2\WXLB#KWR#[WR#[WR#[WRRT.O?/^8'GKE M'WKE'WKE'WKE'WKE'WKE'WKE'WKE'WKE'WKE'WKE'WKE'WKE'WKE'WKE_Y&] M\ONN[NV]\_?S?!_Z[Q_Z[Q_Z[Q_Z[SOG_)^S_WZ/?7K]^/=BEH<._H<._H<. M_H<._H<._K^I@W^/$W<[^N_%C`_7`/Q37`,0R-CHM-[?,U_C__?+!$*`5-LN M%]@7KEL'.=Q0<+BAX'!#P1]X0T&_O7=T])Z"N[VR`3`A5=KFVACZ'3I\?].= MXOWRT%G\T%G\-W86WT:WNUIU[R6T#CV[#SV[#SV[#SV[#SV[#SV[]^W9O9=6 M99X>'N:?HZ=WK_4DZ[+[P,B^&L,1,;Z)5XYOX@?=0@EP]A MU^47][KL76OF.*AT(T:ML(>;8O8P]/],>[MA&C>$NH4PXZC?;8NJ@VQKL;UH M]]"2[-"2[#>T)'N=-.("?F.]A$?/5)-D>7T,-M:'FV?1T8/CZ$'TT,G=^H`5 M5S%\"9_?:[SV3O*Z&D>G<@5A]TSNYA M98?>16<4>:&X27C?&XJ7U/5>M'VL@E?ZB0;2DW=+J3.;LZLBQ28GE>/`Z$G( MK7@#Z>!A;AN2)E//OS$PSQMGGL"='*;]8J?/BI?MZW=W<1,E0^`GW4*EDL[5 MT;B[+WQ'C=[]5P800+FX5)V^5:??O:3?=_P?0(5:M2L3+#!)%W?(QD'S^B3Y MR&X^'8(X[E7&RC>=]%0)VU&Z>FPK:OM)K$X@>.%Y-8SQ04Y+G:-LTWLB+@X6 MW_BB1?9C:#-`=LROMS<\R;9W/-%\JI>*T19CP\+E'&SC,><#SSS1N9]OG3#, M$.ITSNVV1&^DCMYE/N2`[@'BA^3S;QIVMYL^V/W=!+Z[/[PQX7&CG7`Z#J\])P7G*@S25,>B,IP6^=E&`*+NZJZ1V`<$]L<8K-S?AZ M'/U'-`B.J^`.;1ZZDTY@X,4A)XZ#ZQ0+JI"44DHZ@YSP5G$>T&_+]L#`(JC> M+%FZ2[T,;N!=(!W"KI]O6=3MHF#AIJ6UE_Y7&X#60V<-+GX#88TOW-1!2NQ8JS MFMD-H^R-%6TQF62].[KWB(&0ML8TT!,>`T[^X1=ZOO_A1^^YO6?A0,D6_/!! MLQ3>YYV5D9X7/?&;%%:T]LQD-1M'TZNPXO]#LC%O3K;]V+]QG6_0F M(*`&@SE[HGVZ&]UG?2U_[\C/((&$/<-;H;$=5!*CZ4UHPA*NCS6,R->!8`:_ MM87DKV'7-E3)1*X^2YD%"TX;&38@"X:#]UB/Z[;?=@[[N]9AD3"!!UX0T1TF MZWMZV(=WUO.%2U7Z+K?W%@?WO5GYL%NY!R;?P]SC(9[#.2R?LF'?NKT.%[8Q.2*J-2QSO.G[/D\@S[:>M276S_V;_N1XAR^TLTXCZ72MTJ[ MGN2>'C)P-H-1=&#WN;M_2+;A^0@0\\HYV## M(`#WBGD1ITB/Y">>Q76Q_B`(C@6\#7V)XI`]@"9-TOSYC9T-T:::_ MPOE[5'@NSX'=%OIY)SF>W4/:?&E0Q$U[_B-"(7CUY-`A=V)S_F*UB4B:N<#KD`L3_55C=@Z`%WH.`# MU-O1[_&N&Q-&_Q'U(BZOJ%4YP8X[E5-RZPT0')`KTGZN-F"/%A]#+U_W[S!` M)]53Y_X-^$LGRO96JIN@>#=X#.N,\\&!W/=YVNW<$"^UZ/,2O!4BX$*[SQXQ M@;?G>SP+,2Z\)>*W3M;'P6 M<@9RP<8]:`ROQ@@`_R*$Z=W#A]"+5V/TQ\(K)KYHAA!.+T-[P*LKOFR&("*# MY-B]+_ M,/YWY!6?2NX58A3N`9_@CUHVW2M`>MUKVD^5T;IU?JA3OQWB85TWW_YO4$L! M`A0#%`````@`35X&1Y`;K62T`0``BQ8``!,``````````````(`!`````%M# M;VYT96YT7U1Y<&5S72YX;6Q02P$"%`,4````"`!-7@9'2'4%[L4````K`@`` M"P``````````````@`'E`0``7W)E;',O+G)E;'-02P$"%`,4````"`!-7@9' M2_D0&80!``"#%0``&@``````````````@`'3`@``>&PO7W)E;',O=V]R:V)O M;VLN>&UL+G)E;'-02P$"%`,4````"`!-7@9'@`M/C84"``"R"0``$``````` M````````@`&/!```9&]C4')O<',O87!P+GAM;%!+`0(4`Q0````(`$U>!D=$ MU@B[/@$``&D#```1``````````````"``4('``!D;V-0!D>97)PC$`8``)PG```3``````````````"``:\( M``!X;"]T:&5M92]T:&5M93$N>&UL4$L!`A0#%`````@`35X&1SD;&)-3`@`` ML`H```T``````````````(`!\`X``'AL+W-T>6QEF<#``#("P``#P``````````````@`%N$0``>&PO=V]R:V)O M;VLN>&UL4$L!`A0#%`````@`35X&1XW^.P5-`@``]0<``!@````````````` M`(`!`A4``'AL+W=O M!D>2X]Y2/P0``(T5```8``````````````"``847``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`35X&1XI4OA6;!```B18``!@``````````````(`!=1X``'AL+W=O%0``&```````````````@`&/)0``>&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`35X&1[-,"JL]!``` MM!0``!@``````````````(`!YBD``'AL+W=O!D=\=#IMH@$``+$#```8``````````````"``5DN M``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`35X&1[*AT_VA`0``L0,``!D````````````` M`(`!"#(``'AL+W=O&PO=V]R:W-H965T M!D&UL4$L!`A0# M%`````@`35X&1[CM#`B@`0``L0,``!D``````````````(`!D#<``'AL+W=O M&PO=V]R:W-H965T!D>NUF4(I0$``+$#```9``````````````"``3\[ M``!X;"]W;W)K&UL4$L!`A0#%`````@`35X&1]1& M!H^C`0``L0,``!D``````````````(`!&ST``'AL+W=O&PO=V]R:W-H965T!D<,H*]ZKP$``!8$```9``````````````"``3]!``!X;"]W;W)K&UL4$L!`A0#%`````@`35X&1[?#[:*F`0``L0,``!D` M`````````````(`!)4,``'AL+W=O&PO M=V]R:W-H965T!D<@MG,.NP(` M`.$*```9``````````````"``?9&``!X;"]W;W)K&UL4$L!`A0#%`````@`35X&1Q^39GX;`@``6@8``!D``````````````(`! MZ$D``'AL+W=O/+[UGH"``!\"0``&0``````````````@`$Z3```>&PO=V]R:W-H965T!D?:F.F8LP$``(0$```9```````` M``````"``>M.``!X;"]W;W)K&UL4$L!`A0#%``` M``@`35X&1UP_&:00`@``SP8``!D``````````````(`!U5```'AL+W=O&PO=V]R:W-H965T!D=6KQ=W^`,``/$5```9``````````````"``256``!X M;"]W;W)K&UL4$L!`A0#%`````@`35X&1]4+G<#E M`0``504``!D``````````````(`!5%H``'AL+W=O&PO=V]R:W-H965T M!D?\J/JKQP$``/\$```9``````````````"``;9>``!X;"]W;W)K&UL4$L!`A0#%`````@`35X&1S0:4*,Q`@``*0@``!D````` M`````````(`!M&```'AL+W=O&PO=V]R M:W-H965T!D<8B"O(%0,``&D/ M```9``````````````"``;ME``!X;"]W;W)K&UL M4$L!`A0#%`````@`35X&1P\!AI?!`0``<`0``!D``````````````(`!!VD` M`'AL+W=O&PO XML 13 R33.htm IDEA: XBRL DOCUMENT v3.2.0.727
Commitment and Contingencies (Details)
$ in Millions
6 Months Ended
Jun. 30, 2015
USD ($)
item
Dec. 31, 2014
item
Jun. 30, 2015
USD ($)
item
Jun. 30, 2014
item
Commitments and Contingencies.        
Cash held in escrow deposit | $ $ 10.6   $ 10.6  
Letter of credit with Silicon Valley Bank | $ $ 1.0   $ 1.0  
Accounts receivable. | Credit risk | Customers        
Customer Concentration        
Number of customers 2 4 2  
Concentration risk (as a percent) 42.60% 69.90%    
Accounts receivable. | Credit risk | Customer one        
Customer Concentration        
Concentration risk (as a percent) 23.40% 30.20%    
Accounts receivable. | Credit risk | Customer two        
Customer Concentration        
Concentration risk (as a percent) 19.20% 16.00%    
Accounts receivable. | Credit risk | Customer three        
Customer Concentration        
Concentration risk (as a percent)   13.40%    
Accounts receivable. | Credit risk | Customer four        
Customer Concentration        
Concentration risk (as a percent)   10.30%    
Revenues. | Credit risk | Customers        
Customer Concentration        
Number of customers 3   3 2
Concentration risk (as a percent)     95.10% 35.90%
Revenues. | Credit risk | Customer one        
Customer Concentration        
Concentration risk (as a percent)     68.80% 20.70%
Revenues. | Credit risk | Customer two        
Customer Concentration        
Concentration risk (as a percent)     16.10% 15.20%
Revenues. | Credit risk | Customer three        
Customer Concentration        
Concentration risk (as a percent)     10.20%  

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v3.2.0.727
Acquisition of ReliOn Inc (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Apr. 02, 2014
Jun. 30, 2014
Jun. 30, 2014
Preliminary allocation of the purchase price to the estimated fair value of the net assets acquired      
Gain on bargain purchase   $ 1,014 $ 1,014
ReliOn      
Description of Business      
Purchase price $ 4,000    
Number of shares of common stock issued 530,504    
Closing price of the company's stock $ 7.54    
Preliminary allocation of the purchase price to the estimated fair value of the net assets acquired      
Total Net Assets Acquired $ 5,000    
Gain on bargain purchase     $ 1,000
ZIP 16 0001104659-15-056946-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-15-056946-xbrl.zip M4$L#!!0````(`#5>!D=FLY#C'8\``)8."``1`!P`<&QU9RTR,#$U,#8S,"YX M;6Q55`D``Q:"PU46@L-5=7@+``$$)0X```0Y`0``[#UI<]NXV9_;F?X'5#O; MV9V19/'083M)QW;LUFT2N[;S[MM/&9J$)&PHDB5(V^JO[_,`%`^)NBS).H+= M:="2)QIRYGOO*UJ]42'4LWV'>;WWE9C7+&XS5OGKAS_] M\=V?:S5R$5(KH@YY')+/-`R9ZY(+/PS\T(I@`%*K)0W___SN$W%\.QY0+R)V MTNN91?VTWWG(G!XEI%G7C'J[76]DO<\M#JUA/#&,7M?2-Z/Y?>^$=(Y:1WI# M:Y+.2;-UHFGD[+-L]_(8N@3P\OC[2C^*@I.CH^?GYSH^KOMA#SHUC"/F\_[3$;Q`7,U:0ZL96GYDM@2.@1OW"LWQ0>`_4^;9==L?"'(V6D9C MU`$$H&=90=JG:_%',7SRH@0FQGU3U]JSH)(M*L`J0MXAI4ZXW:<#ZXYVB:#< M230,Z/L*9X/`1>#%LWY(N^\K"'%M!&;]A3L5VBB.0AK@ MC9T\9L[[RL=8BNHW#?[%<;X]^-]:WXR&_)'@]>T^`C%#V;W\3\RBX84_"'P/ M?O*S%\;35F>.PW`PR[VUF'/M75@!BRSW,QT\TE#B!]-#-Q@B^06_F8-/NHR& M1.!-"[0:`ID^@$=2H$[H2^`RFT42 M%N(P:"=U/`'^9":*E0^C9C-Q?'=4.ET&X%$1PG='!6*\"VC(?">'3V2%T4>` MZP-R`P6K`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`R M)P4BK=/U7H7."6R3A-[UI%9)#<#+QG>,?S\? MGE//[@^LL"@,9[:-9ALS$)0]68_N>,*L9*2)34D70&<63;0<&^FS];L?7L0\ M\@/;W0PKG$;>PT;B4NNM<`F(*NOA&.ZB4)JZDB3?>GIR^4;JX@BZF7#XD;9R]I75A9;RW7`JR M\D2]F'ZAXV59Y:&NH(FEI/V!U?#-W-.W/%%T:&K8#^G!+8E*$<<4,6.R4L6= M5<6#BQ*5&FXE1%0JJ,)#I81;CPW?5`WG[9;8QUS-`4:(*E>SI2!QUW8O[:4^ M'F*HJ#1R:]&BTDD5,RI]W(VP4>FB"AZ5-NY._*CT<75]O/+C4"GDP2MDQN:# MTLB9]]GM76+U`',Y*K&ZG43.-FX;/!0U/+AP42GA-F)%I8(J2E1*N/40\2W4 M<+6/U#R$XF*6X3X>BYM]?VH)9KM[WG$U)L+C@>\='@LG\-IU!K[ZFR1*#7?H MPJ=79R"2^*]C2&S42'$3V/H*]]>,#LR4IS;7Z\[]_T:/66QTLVWXK#4SKD< MELU6B:O:WW1S]RY'R@:/'[FX>#.ZA.`^FLB(C+W?#TG[8:Y66@K`:&[NG=S//N*Y%H)U>7WX1WK->/,C\H>7[->4QA$;ZBCV%L MA4.,K/>#OU/Q2SR(N0C^0+=E+"4*GRTDDG:04E#`[9`6NRPA4EXW5L9@B\;` M7,P8O-$6`F4,WMP8O&7Q>H="?SMIY-V7DE^E(30/BW?L\5:?(^?84*;J5NT41GM;CQTWY<=N/RI>'\_*-QA-NA=+U=G^87E)0=+<$Z.T7*UM M`K\=J;=IZ]ABJ$M!,%`0]&]Z1_Y0M?==J+T;M8:^@"B(9GIG95%H2E'04!1& M&^XT57O?8NU=P^UV\P5`&^W*6U$`VM]T(RTIB)?WE_,>Q' MZOD#YDT;&!6+G?"^%5(^;>3)(=X=Y3"0C(@#EXY+!CR_=,6Q@/$W#F4G9_#"P9=7 MKM4CB:3=T>Y\=>M:+@?:3@R2C7T1AR$^9-RVW']3*[R44K[4-+51YF[6B-F< M'WT['J1-;H4:7<$SOM2D_]+E?%-'FS8APK3\=/C_91.FHTU.)V%Y#4'S9F?J MB),3X@*ZU#Q:H_:OX@PX1#;PI;"F%R)AYEY[#GWY)QTN-4/>7$\=<6+"[`#8 MO="HFSC"U-[SP^7H_\D*>Y2X5)3WW[Z^C=R>_/;Y1VY_G*1G[$XJ)Q2 MF."R`^B.(_YKN9([&*IA0:8F=9LM(T)T!^"KH;3B3-@]'W6@9[6:CL5DD-YLWGH>CV1#_+(=B M9KF3EDG=%NSHK0^AX?`!L#QWX?U2ANLO;G0*'NU?>M$I2?XF/!JZ$)4,P)PR MK^;2;G32"*+3Y'>(\(D'%>SUIS_^X0_8,2AV$PV"V+.C6,Q?>PXAQNU;'KSK MG78!PEK7&C!W>/(`L3(G7^@SN?,'EB??D(T/8C22<0L^'(TD<-XX%K# M$\(\%Q1?@O,7:Q"<>H\\.,7F1]@^#^51,`=F,OJ?IM6;@`(2LL8\#+Y.\!$^ MVPCTHN,S%<1]]%TG&0D;@[=N`8@CN-=/,`LLY`3F)G^G#JHF$?SZZ07-V2D`@[ZK+3&5 M_DSV_OB4DYMG>"X<@Z5@$A!4B<4)!9IAPBR%AKC,>F0N+-L`&!`>VX@)"&9I M0N&XVQ?L`9Q0E032, M.Y(T:-:5)"NG9YW\!KZD],)A&AM7'M8=(MP`3:[/B&X%7DA"XU1"/Y#XL6?% MX&')99;#,N0(M_O1<@4)>)]2H!'`8Q'7]WHU9$XZZ+!*GOO,[@/)@%)/EHO+ M-5"36O"L,`3!88%$(Q\1R2!H#RO]?`I_5=@#T(@;;P M9N`[U*V3A]D-K,WW70KSRQ*[/\6M#%BZI.A24K' M>81:E:H'ME5V+F7--Z/L8>WJWR&1/:"31W.I:KR.JCRZZ=Z!HV6%=O_,\_/3L7,@U;1V08[85'2V(NTR, M<\C,C*^9AIN3FT64]F6.<%7[,72]T4V]E"\;$X$M.O/@ZI1O'VF+S"NJP M@6S"+#>]E)++-$"DRB;[E*5?M$R2L)VD?"<9XU6-9.4:R91L(DNH7L@J=E,6 MY/*+?>N)DD=*/4QV@[F"=D$<8AHWS>Z&8(MY1AI,EH>T%[M)3C+)>MYG&7ML M'K4IYU8H\KF`&L=T-69,W6&UK%ST MM7Y?)ST*MAP`$#4G&B#1 MNY/96Z"+J!IT7?]9IJH16[FGDX^@Q#QWQI6!Y5"9*"\?$P>1*7C)\8G!1!8: M*QLCBH`@0FM'E+:>TJ3U:'111QE80YB=T)=`IJY'DW1C`'<(7N1"Z62ENE.A MO:!A!!X@/.NB%(ME&*6CZ_L1\(H2Z&6[/N[GY(F@"ZZ):I0H)5B>%X/(S5?P M5*U+A!ZE."=K,!B@SZ$M\-L?L`@&%;+'Z:ML"^_[L>N@)(74$@!`G]]Q445\ M!02YPDNQH%E:%RF=!>F&-..RX@/JGJ?3U`G.)`'E)C@LJET!F3,ITAJU?U9A M0C( M;:THN'`LD(L?/E$L`=^&N/9!)`QB&%Y8`;J:XLT7&I75Z)8(H;1CHYV%,@M, MMS)PBX=96JM]_%K8DM32:)-Z^!OZ4S*?<$Y=1B'"?8!%_Q*B9W1S[BCW(PY-YDCLM0N74W_G.#R-M#ER`'4^&]P M!?EW07ASGYN8KW''6V/OICZTLBGV)BN! MU_OD;^=4@7[X$ M3/+H%A;2\,'_&C&7_5<\.1M@!F,EI#1C!:3FPY9#^]8:"D?PIIO;)G6=["L4 ME:RU5N4;Q^V?[&LUFTVP>FPO,Z=N4.APK1B,Q*\C>WT+@Z0)'9Y;P5]N)PYH"MP@(.9CO MRH3NJ]>UGOP0-V.=^_[W!__!>CESG'/+_LY+S,\JVSH$#@447@E1`2<>A0Q3 MG0+EV2<_%Y>]5A.`U%,HI\VQ*B#SY=$X!HGL+`-(5H--'6-W./*5\R[R`U)X M!X\\K24S-=9PYJ#Y[%@.Y!2%P'*0QN)LD]'*#C@ER;FE3VTLU6,<986)PD1A MHC!1F"A,%"8*D]W"9+)'>6TJYS`^,R?JGVB-QL]IYTC>V$%=-T$&=V:*WSRP M[-'OI/^C'SHTK-F^ZUH!IR>C/T[EP*1CU&'L`IF0+*=%WS$*TY_RMX/G\UC/ MPPFBR!]4BO"V3#%JCMBY`:?[MDBD6E_NO=(:K7JK_?/K_-T52\=%CB0BG$;.I;.;IX+ZJ^Y">9HTL;R&AILO]62=U94OZF[#/$ ML3HC^,^BC%__B#V:*\TWJAN06*VNZ_LKL?)WJ`R7,EQS<=3,NME0QFJ=Q@IS M7TH8E3#NBC"::H%<;8$$02Q?'1\M^WLO]&//P;C"#T_(3Q<7EY=75\M2)KL+ MJU'79A$J">A(+6FXT;55WGSE!\DI@%RIXA?MUXU9N+41=;W.R&8LW51<%P14 MI`%R*B3LVFD%K!H>9WI?D?]-(^9-)K:93;;9;5;W=R9!6 M;-U_MC:K>J-1;;?6Q%:Y!.P[6]>U%!R$P<\*Q\DM4SF;O],>[6ZI_S:5W#AN M5IO-M5INQ:!U,JC5;%0;#7V=-G@_&*2<[H5L\$7IY9>_Z,KA/ES/S*SJVG'5 M--=D%11;=X:MIKD^MBJ'^^`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`+@U=ZD2KYEG1-'*LM)ZGQRC8"AB!@$N!A`$O?7O]T]@QLO$B^`"-)3J5V+ M)##3T[?I[NGICJ@B.R^[VV<;D\!&8RVEU+:MMNE_Z^QS[=25Z_ M597L?U)/EU4^H#\M*%NB@;V2!I;=ZML#VDAV(L**I9DXUDY+(>!_9<$2[-V5 ML'=Q]Z$=J"K0J>?.;I!?//)82W664]B.SS$=H<-6F8+":I,EGJ-N.K60BUYGCS$ MS3N(86'A7(V\A8%<#MJ#ZCB%`2B)V,._%Z=5>C%9LOY=^NJ;5N#BN;? ML3=VQZYV_5O.;_4V6G]:@9V[TJ>7Y="):^BW=QZV@`G<7;HS9+7.9USVMA;UKE?#@8I-66-U[`XJ(O95RAJEK4/=`Y@WX)JN49]H+AZ3+4 MPQZ68M\#B:X@O*Q225L2FI> M7**S5&WOTU@>US9A&*;#ET=<]@CI?'X+#M"LD4[+LL<#G<&Y#-WN'>' MC_W.]\5(OS-:C9'2)+O!L0T^>E9W!S`BT(J_>>S&\ZEQ;"5,,AST.HN@K)YG M=W`VQTROWUNBSX;0)%-LLCG^PA[V M1-EHB9FWF;QJR#?';K6`9X&T*^:Y'X/]V\/)!C-]>V25H5P]T:[0;"&FV*J] M,]H!F&D(KI?LV',Y_AC$V`<=9/I""%YQ0QYSL*!('IVZ,C"W-%X'EK4[E.`' MI2YQWC3[_8/L68M]6)!MDU@-]IY%&#P38#>2T?A8.Y6>7(R)BTE;^YC/TXS, M&HUZ=K]70$D5RUS`W#(=MQ9(J],U>V:9>*N(M&ZJ+:1M:(UZW0UGJL8^&EF# M;G_%C*NWF"V'.``R^RENO4 M#1:XIH']96;8QCJA^<\Q"_H5=KL'D)N2T_)LZ3;T8K',)+UJM8WK9`ISSS&$ M52"ND5/72,G;I.54@^GG:I6]A'PY$C[\"K=QSTDK"7B!X\U\&6Q]F_6)!N[5 MR-\+VB^+KSZ@CFRC">=S%%8FOO>%$!1'=>=(LOHWO:U"ZSJ MD&YD+=*-O$>ZQO[A)3:7$W`P9PR/?A;S+*+$+YYFH:A%_!:]TT)^A9&;QB2, M8!^C(4&B/O4$'5.]N'[_]B7E".`+X[_"S?>U[\#]BV/8@9J]R#]80"_A>2_5U@ZSLD=Q1.U_/-(R-M MS+/M`BVRO]#0#9&%2^M>#]TN$EDVOT^/1_,R$&:[M\"RYJ!M']H:?HN[/Q[2 MWS'_.["`[7:G5^\^BOCD.3XS,Q&-RC#@1, M\6FPZLCX"4IW/=JX*Z!!#*9=GM^52UY)XLIREAMZY=Q7@A"$69#M-P&6`^?_7&SI/S6#GMZ1&<$0;"R`.*P?I! MS:1F.ZVN<,\%5BZQ$N(6[BR@NJ##R#Q=J2SII-BK@O]5OVLGP%#:]T$']$?:#V4H`];E3,) M0C^\_=X,-_BJ7CVWZIRA(``JJ?,$K;7F*3;JC88'"7&8"6%)IV4!*I0DC*$P MS#6_P0B_BB;F$B/F`BPR240T/F8RQ+A23[6V45(XH/354!-A`"%56VWC\RJH M%;#X[A/@I<$WL"O=%MI@2J]+FP:417YQK3A#*U5NF'N?B#B<`AJE^4K>\DUX M!X9=XL<8P`0]XWN8^8B7$,JCE$YG4J,9]Q'.0+T)C"6Q>&$`O,>7_8+*E8#+ M`Z?>6"DW>@?--%@V+LVCY5,`"NQ"P)F*.*<+P+`,,RBAEOEX4>0&C]S+FKM@ M3Y>@@J%HX,+;<@X%#<'@"<)S!CWH[)NYD9#MRP))84SWC^<$;N%-)P]MT0CP M6A'RQ=U%&K'YO@+0K4=H=LT#C\9H]\5`K0"646%HATO*,F"6O\&4CRD@'B91 M<9@%8KH<71V0N75#"E@W42O&B`-L7/`_V,CB+$1<>AJI#DMQP^@<+R_BZ9P1 MWOPMKS$:G%+!U>8?3[S(/4=1FN<_`.;S:#N&I]D=\WQ:?AIN*ZX%9/8N].^D M&R#1LD+*7(E9D!6&%]K'4C?,.!"0H`KNO"@,2,I@F'0]*W=8XZ\)!5TDTO"Q M%!WN`MK*:%::B5A27=,1L3R#P!V%+ZZLE5U>=;P9C2[5L[SE`ZINZ=D%,N#% MV"@<>W'Z(J)/@*[PV5KC;VUP*PQNPW1L,L9B9,Y;>5`[4UD.\GTI3'1/$[7V M!-5F04/G4>6;Q/-CJ=`7UJZX`W`T86@3\0A<=\_)_.P[%E%T3_KPR`/*REH< M1XEQBU016(:>@U^79;#`_^LH2:A;X#IBMA*3E2YA9;P_9BF:'2]RDBFJ'4HO];I M4!G74*SFEG4#2"/:"IBD2EM-OBUDOE>9JNDNP7V>N@2D+0I$)AY/!W)I$+$P M2NJ_P6A/FD8ELP=_RTR?LC^%(I>Y2W3'.E/(@+R),F5PP_1B)>@@W*23_5"H M/7\&+I"$J[AUMN0Y#LXPXW@2+4H[BKP97D!!*\.>4#H1WAQ[#_(8*Z6%U)]. MZ/O<225&GGM*Y$19?K]<&A,AOH,^)H64)#8RPT2>#],Q@P/[+V@NUL+E`IF+ MI[>6M5%J0*:K40O6;/@,;(CGE11,(Z^(JVN`16JF\2\B8*Z2B+M<:?TST-]W MTAL$C43G[=D`V?FGJUP31=V2CDRS%N+Y3-I@A;!;Q%/?5+%*V7\MV=MDJ5'2 M!"`5,X=2AI-PQX7S6)RMF(`(+.FFE^EE%#7C3TK\P#L\N1K-A8SR=UH%Q*S3 MP6TCO_*"H"UZ(11)D7:W2A99$Y%=I`EBZ,;S,?.!3H*P*,WG;=:]>JD[;25M M6))05"MO6C!L0LA]_'TM\\\5,OU<#)*_*P2RL[N_IT>+\G%5].-'CEX_>46`TN2 M$Z5NL#L_H@;OP3\X3HB7_F`<#!')/3W7*D\<:6^@DM!:GNR$;W"[JN MK*B4/Z]4$G@I[`:0.@F32%`>).UB,S])K:;T5">MZ2)1+&V53#6Y>?5&J==E M.CN:_??TXGT8?<.?,-\'S:Y)%":W,KZ!I2!2K][!0W.PBHS_)."9H5872D.W M,%N>4`JHI@BQR@M59,Q+B^4K;QM_I;F=LE(+,E/"-^`@`I?V"-S=/$!?3,Y$ M9C1B"-)1%['2?;DX$A_#2A&"B_BQBESKB&&NJ5:N$9V<@0YG!=2.KER5K8:7Y$.G8>.BYOL;>+)9Y2'0D)= MN/QWK3Q6`;.[=$N)HC1\8LE[05C`1!!3AX1YI-C>#!C:@ MK!B$(1TK3A.45893,8(BLL"/M*R$%7$0R'N/! M2!"3&\M5^`4\'X058XL4A\&M%K/@0/_'*IZ[TA==C4_:M-4F@IDE>`7>&\^5 M?59X)\5;B1:[[C;2-_;#X/:!QLI'@6Y&*(A:Z6/N)/;_#T[OS:F81I2)<.@4+PS*7M^L@#!;CHG(;N^F`XNR7I MEP3A#;K!,M`;S!*E([)S)1EXAB5BV!I^",(TA106PEHIOXB2'0)K4C8&!=A" MD"P,&T]E32CP8>DJ5+;KXS6D_/RLP.RIGSOVY6:^A9503CXM7CH2AKJ)A6># MI9E7B45.8FT@/+N!\&OHP2!_`CQ)Q$\._<^<&_X7-]*SK+G,"OB;T'LGT2OW MCXL'%O"6RK%!64._T_CW_"KQY95%_.[7/U]*Q:-N`%*%:DH)3^7WUS]1:Q34 M@#QOQP3O8NI0^>@M#5._3R*05Q;D3BK(J^OG)]^T\_'T0B4=!ROMB1>F(SQN MRP%IR35)1\>[24A3I&G8]^7OR4-,-Z<$EP/^6YX$44ST=#E>PI8G]MD#QK<@ MO#^?A/>XP_S"@W<1G8C*]=&.E5X^#&]\[S;U$G,0*'D`H3L]95/F]FZ[=F;/ MC0/+[XJ/6PY,(:+ M<0/$.,L-C^_QT'.I`'B7?/9Y84\ MFH%)@*3P)W7+28PMYEA@R[2I`%/0"<-KB-`--R=/-G'XC/R/+J%)EI%HJ M@K7+&)AI@9[#;_0O/HS79$3F8A4&2O5T\8P%PZ8)L*Y,T@:KL_CVG&!\S_LNC4`5GEH6']3L_4/:0B]5UEL)W[.8YLU[^5?=KSR._^IEYQN M97G]#=Q8INQ;GI(H(TP%;U:=$*W+O09$OQ*-1^\@H-]VY*<0A2)5EE0W2 MFT/UY762C-)5T%CHKUJVPW/,U!?5B(CLN7U'&6/*?!,U8_ M*XLAT[U=#YN/I$??:/]G:-([;.UJYC-742\58CUQ/5._A[R$4#(#L.),BW(! M.6969(5T6C*+W<,[A20DJ^50^G>HHE+EPB%F0;+,#D>J[, M:P-3.U,YJTKA8+0.ZS_G%7:47;!4$T<+ZW,(*U\HDAB%`?SM?!>UO^KV]\$A MN4ANP3I?;+/%@N+953*C??.>99U<9-XZ;GNA@8&;PM:/&S`Y"E@'R,M+5N'F MF1Z7R'TP8NB(8U`_9K(/#G:.CO&668+NMKHSM5#11X:52RD'=+P@KYS`=PZ/ M*',/C/SE-<"7LN$;AIADPDMYST9'!&A!7C`;8Y;$VC2"/D4_U/%-F@F!@797 M-L&4A@9FU\BYT[MDK%2),.T_%\BTAZ>+OFB6WY/ERV[B9@RO3ODH,UG=MGG` M:T:%R^M17KL`;#LVY93GDH=>\IPAF?Z47Z\DF/QR8R35+2XO>+CRK/A-B$G. M+SY<7+_!N^E2,Z*GBQ<5*>/5!4F=YWD\9*F[.8O2.LD270JI228?(-NN^6VX M,NZDXK5TGJ>4Q"1KLUB4ASS0MBGSR]L)^`:*W)SCA5EUR,5D_JA$OPRE;"0J MY:$^-!YI@D:]P$"=7)\\;_^H@H*R0OEEA/_B@>2?>#!W(5#' M\'(?(%G(>O#5ZI8;_[REH^.(SCA^!\;-BZ!31/3Z0E8]SQL%97VL)"2?"-T? MLTC*\K>+@V>'O.]QQ_@RG_%2_Z&%WU<79"_7Y.YA(7UJ@U$H MR;T?7K>DD5@<['>Z?GTYEOV^Y*_KVDE96>.`[.\4&2LFSI'\F?O>9?`Q<#8L M6M^S.[U.=PL,;;2JY\,4,+:=%3[_'KA\B8+=P="T>MLP>34DO,JR=R_'?X:H MU++Q+QRUY7R?BJB[1*-.>_@H?3;`Y6IZO,WK5[P!XXIYP94ZW_H%_OZ<1&BE;MT.I&=>5B5*M(R+/N)BS3[3%%SLUI[QN4C\MGAW]0M:=/+R MD_G,F^.2`='=@*YK@7]RV>^R<+;N[5']4R?<1P&`22OM?)%`=MI M/WX_:"\#XV(6>7[!:5YUMR._ARY3()^FB_$B#SB]?2T?R;]Y]_JENFQLL-M; M=.[!DL?BC65E#Q7B7K*(0U:709Y@Y?`5\J?P=K,LL)1G3^55 MI+RLT98:I%4H")4_MO!06\V#L3&6II[)TE"KTLYB+(I3F%ZFH7B!<3T+OU$: MW%],3`#8&)=^L5".H$P=%5P!QZ,%GD>A_W4QI[25GQVB&:EJGJMT;UX^YLN0 M)I&NKHN5R>,M%%\IYFLO0W(%FX5Q%=[SA1L`ZD`1M79>1J=<&+D52ZX7<78]*)>4LOC(Z\V5EYG#&E0&/"PRX<(FI MES.U*I6JY"K#\`*MU6EJ)%,[F('F`:+@1EH*^7NX^,*-*(J\%9)("F>LPGM( M*\O*VW0KDSXV*YQ>5^QGH_W]29L@MYT^HDH%9F=9"[W4$[@(BJTS+Z2,K&Y? M6J-Y!&9O;P/S:)\%E;&ENC+^ALE,ES(G%&6DDJYQO>&@M)#'Y]H3KBWZ@R_@ M=SNPQ`00B_\4JH9?Q&]91*6Q*++U&-;LI['6L1;1ML&>:>VWAW1OB9/+CCKUWA*Z#\1SN!0;Z>4%58X= M\V0?.WPSS9#%DV8=;3S>3L+#ME&@++%NB;9-6D$M&^9!=\??0+?=?@]]@FO? M%W_CMW*_H$+]4G^/941')OD$KI^K:2J=AVTX'2RE1/&B&Q5@6)>#1%$R#CL> M.,=BPEU9*Q+,9HK?IA/GM_8+*8S%8O!49U;N6;,HO,D*3A=JN\KL?2H5_9%J M&A'$J_J2RC0R6>09+[T&:1@Q;2U*]PM51J'JKJEJ5(H$8/0S]FNIY,28?9-M M2N@J'UD0WD4/_,C58?PZTT M-U4)+WFU-RT"+626:-I1`"5PN?^&3&',\T'E>/>3>4W!6#9)L_%/LOW M/CU!?UYN6UO5#@AX7^C+0H>;$941*IW3=*UV/[MH+X_`,N>R4*!<%=AI27Z3 M%0+3PN2X]]QY;J+*?*OMB:ZCV^VNK`E@CMI6H2CCBBG*A>V*+AXL\;'J?&-9 M`?")=?9'[5%MZ[0[L+J68?;;'?PG7W6G;6^W:BT,^T";MA[:[-P/1&34:YL% M`I7B']D-SGNLT+3<.@W#%1G;%1FFQ!I]6+-D#?/'5LH4UE-SKA6&_*_MU@IR M8O=2"=AZK45%LG:E5J<]4&S?VWZ%I\;XC3+W/H/7$7ET]0&C0B>'[,/6GJ>J MY_+:?"A-K']28[0;3'[)ZJ]4B3`(>+F3/>YSV0PMZ4!1 M?D2GW<\2)*ABGLK9D-[IA/OD+G/A1.%]>C>?_#HJEJ$:NV5USNDS!9=/3U(/ M6#(4FQ8@!_EEC>7%@DNY+XL\1:EFA8H]:8N#=3UU2AU+T\6B MR^@:CV%<.@B_XA'=M-@J7:"WXE)!QRS#^L1\50"X]HRZ3OCDO92+))Z$$>6& M;8.XY0LS*F^ILQ*XQ;GV`6HMLNJ%:<5]J:V19`[L?K?;LZU'`%IU46@78/+; M->E1I;S#@_HU#$CZBG=P"E-L>$6JP8OY@C'E))IOLQQ[,#3-?FUKV9QK`:]# M:V";W?IA>0X>:>A:#L$B5:2S@="M4VBK\L&>GGR+%#4@YG9S@P,\X0'V"_Q( M38=^Y_'E^`M[J#+U['Q@CH9+2G[=S'N"N-N5+WLX&#P3@#MFOED=Z]E`[.X& MXLBRECA_4P@+9PZ?/?$MOQBZYC+HRX!O2"-X!P1_N0\W1;'9LYX)Q;E]"DA>8:UNC&55PT1\SLX^#H;H M#V$2;8SICJTQ_1QJV>YHEGX&Y=P?/9=R/D4T?\%3OXU5A]W5J'Z6W;#?>5:# MHVS7'Z_!L9EV5C'9_G"HD5RG9A[U3(W@&G6RXF/SV>R,$T/S1OHX17+_F7@Y M1^Q^6&[0QK=-*..Y+(P31//&>KEK]362GT5IC';5S"J]#)[4MX^/,#%FTS2V M*]D+SY<71DMTUUE)>VN+]<\)&`5FFJNM^K!@!3WFR#L7>=$CCE]5P6.7X\(QK/PZ7EOK\(F])#M`?HN=+]3(9;.3(P7>7D5*"17PY_B4,77$-NJ#2$A[V<+10P:,\V0Z0[%HAL]M=/&C> M%Y+=SD7-7G=DUH.3;2$Q^SU[6TBN5SL1?Y9.VTU\&TI]J/^CO"] M5]U,TR1A;++A[(&Y4IZR=?;S>:?=+1REK9QN9X@VVC$6(>JTBZ'-:@':B'@K M4&36!M%&N\@*B#J]O2!ZY_E)O*ZI1!V,I";<`ZH:F&E_H.I@J,I052E3;025 MCE@=6VVE;MM(B6@`%0TB8Y/`/M(PU#CT_?">KGW1C7QU@TT6RG&R3/MK6'(M8J/[@+^AZ79@(>`[KGC\X?!:KWU0/WY>O MCIN6!55P[[GQY!7X<#^>I;$JB5JLT3YC+E[&^^FL\VP`GB.)R>E>'MFC2H M@F]AP/7H1W2=3Z2PFIU^NS_X<3>2[$F5,D44A6)W.QQTK':O(AR0'--JT^K5M M_56.3K]3G-7XA[PEEST@]\'E]P^*ZN&6_+?FW`3'&J;P4W9$3K)/(5:*R#^_ MQY(1FG$UXS:.<:^]A^=GV^KVG$.PK?PT%ZF1337VJLZ[;54 MA*G/3:>K4//?E=N#?#H:I\&BY#=1F$2 MN!C+#*-7QC_>OGW__L.';3&3UW;LM,W'$*7BYL:Y>K!6C^CW9(H%UF%=M6F] MRC!8K;]8O_:K==T%F2(=^(R(T$371-=$UT371/\.B5ZQ570@HE=E'>YJ`UJ/ MTKU@`=9N__%8-B!BL2S82V?\<9BU(L?TA@GX)#PJ-_YJFE_<'/DPK2,X"?FA M>F*"NS(<_OAZ0[@1[&4M=P9N/*:-_70F_\UR3PJ9*6,_9/$KC!MDOZ9WI5Z, M6E;/WI\A&TFRE[7X^)I;#\:M=FMH];3VU/S8$'Y\875:MMW1ZE.SZT;LVC\P MNPZL5F?8W=^9:23-MF/7`_DS>Z%EET,2R4TI<$>2SG,B")'*KK(S/9`*PPT3 M=#>?\U#O-(BAK`5-C"800ZL*K2J:2PRM*AI$#*TJM*IH+C&TJF@0,;2JT*JB MN<10\1]-C"80H\)4S<8CI*I(5QUYG0TYTW_'@Y#J5^JLSJ?7JM-^--$UT371 M-=$UT;]?HNNLSI/*ZOR+IN>NP>YXQ&ZY$218@QM+717S.H41)K&(68"K-F)E.#R=0;M49FO]7MCC29&DPFE*:.U>J; M6IJ:3*9NOS7J]%J#_N"X0F='9]\<9Z"PJ5)Z<(0@J$T9RJ M.?4X"*,Y57/J<1"F:6Z*/N%?BN_:38GOOA^/N1-C.)?Z%7AWW!#<22+J'Z;/ M_/6AD":Z)KHFNB:Z)KHFNC[SK_/,O]L4F_!R)MM981>KB(LX\AS,`!#8/-M@ M]RQR=0&GW?1#L[3`)KQ`./G'`Q8&/HVPR?=UM-EMF5B*I;]7;8OO@4A:,C71 M-=&_QQ2&ZH-[C3'DWJH,33+8/CI#OK)/MT=!%,ZIFU*.@BV94 MS:A'01?-J)I1CX(N37-1]/VGDZMO19>EN%N;'CWV.LO.,TEH]/&QP<5<=4`423 M3'.WYNX3)YGF;LW=ITLRS=V:NT^79,?CJC4EGB\_,N"U1?\X_775RG=R2#>* MI:]950;J["G0BL%_:]@>U@KM7Q,>&/&$&V_#*:B*N>$)^-U@1L!CPP^%,&:A M\+`21LM@OI\=!]!E2OZ?Q`.&!4"%<1\FOFO<<'@B$!Y(.G>-.,0O6!![YUE= M-2RGP2+>PDDC/@[QSR",85+'3UQXR9/PN#SF$75=@[FSRFSP.V=1`#P.@/%( M'DNT=T3T=\(#0$LVQ>$CW[]ZT\_#2"S]Z\GU?`&"S,(8H/&8G]?(*Y\-P?\9 M(IG"*@`0(+(PQJ'OA_<+!?2.CCZ%8%S:J[/S8X9%TCR&PWU?*=^?SCIG]!FV M7B?]K-Y7>R!H;9_-!'^5_O%:#FP,;5+P$@=RJ[7[)5W^1%AKY;;1[QX^'W4/ MJE2S==IUI"H[(!$\.D3@VG["HK/-]J#*UM.'2;;8&=7#7:R3>SGY3>B[A;&& M*?P7<4ZO7Y.`YY_L3JL68\^RCI=CMXS':\5UVHKKSV^X>?V98HY25U3%[ MFADU,S:%&;MZ@]QO@UP^L%:[8QV-U]OFAHF)]&"M>^LU11I"58RSF'_XPGQ9 MFX9K1HCMF31=(Y-;AJW>H-^R!L-\T9JLQT_67LOJ=%J#?D5DE5O`L9.UJJW@ M)!3^Y\5:RP6=WVB+MEGB?T@AMT>]5J]7J>;6!*J20/U>I]7I6%7JX.,@D#:Z M-]+!*TNF&B\L;7"?KF76;5GFJ-7M5J05-%D;0]9NMSJR:H/[Y`SNA:*$Q@N[ M/C5_'.QQ+&8<6MG=5F_4U99V4TF$I0,ICF5J8_N9M.QQ9C4V542;C9#3.*P[ M#5IHYM3,V5A:'&#C;$J"O`YRK?9[?L]JW&0)S7F.]3C8\8@Y;@VZO M-1SHL-=)T=4R6^;`;'6'MHY[-7AG.,X-]OA40;-15;6AK*^?:H[6'*W)=%S; M>E/\1?GQA"Y4-P2T3>Z1+OW^^NRINZ79`%'VE[LP3I:(7\)0X<<<"YWBHQ+^ M`KNLL@_5WV2%EX665E6W'68[SR">/PM_VM+"I207B1'38A]2AJDVE1;DWSO71)AEC[>Y8\G M$>?&%-Z?"(,'>,M_Z0*E@3>6J#H`WA9IE6H2W&+^$;S4[6+:6H>>ZMJ]5@_^ M%L7[`2TCXF+&'0SF^/.V48!!>`\50"`3YR0$_6&?_GX,@C5Z>(&@_\QE]W'% MJU7(L:D02ZN0W57(Q\#XQ.:YD()`[^,.:J'MG$!CZ/<)KY\'@0%A9GYBX^">*/D MSY)()#`+%CA!:#C\[-"K^*E0[R2$R:+PSA/R\A+]+G@&I%Q+7FL]`]X+G(@S M(4NH6%9K-.JU['ZO;5PN#X%9>W;7DHJKVZ6_[WG$8.)V0Q#AC_2957 MUIZ`_@_\)DI85*:!O9(&EMWJVP/2R3L18<723!QKIZ40\+^R8`GV[DK8NZC( M29E7!3K6RF&[07[QR&,2^HA/F8=%<')P)PQKZQCWBX7\T]F!#SV'X\`_V.UA M5V],W_O&9.N-:?>-B>HA+:1-LFF8P"`1AQ\$E<2B,E9/'"VFF\8UJ!(N40%I>H.M'.K:YO%=^6*%$3>\N8-&P?=_P-MA:7"0)6JE MV_5>E2J[XM$UXN8+?XC?^+"Z MG__W?PSC7]EC9#Y!B_^\+]19`XSA6=EG/O[I M#-P;*H_VU83_E/GBI[-S^^QG MH$2G`.P64"S`#S_$\T\\GH3N1Z"GB*?PT.5]`*PV\6:P>KQ4C[M1$?@+\?5R MG$';^ZI&^WKM3+B;^!P@63GN\K><_\ZF_.+!$U]G?G+[]=_SJ\1')K^^N/[$ MT;A:1$6WB`KK[.=.VRIB8M/UU(F&MZA->(0VR+R\O(L'%O#K"[FR`Z-M6!?: MQ%4(-M;\47;O%=F]=_:S,D0R@2P8)<6*:IUL(U"Q\])VL"Z(.$L")TYH_G,\ MCWZ%0@+"W93HXJ-I-V:[EYZQJQ0;_*I75VR47ERN"8(/O_)BV-$=NR^>&*0[6M*= MDS4&3VPJ]_8IU0F,3EX"J&,_)> M!-CNQF3N1N$M[.SCA/MDSAMB#KIFBM4@Y93ODRB<<7"JIK##1&@1@2BY/KHS M@+QO/";GC:MMB%X#9X=,IS!5)CD@+;DF4A21=T,E0AW8K0BD^_+WY#LA5R+H M"2XG`9"X,PG`Q+N=MU014H3$Y0+L3AHD?\#X%H3WYY/P'NVI7WCP+D++3JVO M;2@*8#73$#S$6Y;9-2D(!OJ<"-VIERSMMFMG=B:X(X]F8!+@*RAPI36U M5D*X',4Q"R"^XP[M]@4[FWZV,-86@A\"&W3$2V$3+.R;S!=B$4@"#VT6V,+7 MKJ[`9ME?UYR$AALC&.V6122`N&QV&X$+Q&6@C3DY'/FD)8V0Z;%3%Z^ZJT*# M_F6.$T8N"QRU198L@T=DD4]#*#+JWK#/)T M,Z??R%V4\;5Y5M59!EC!RMQA#"Q7S4$/_T;_XL.PB7"1^=B%@5(]'7$GO`UD MO6*8=YH`Z]X@?X$3BBXMB?XXH0UT%H5C#SRP&ZI:+>42=K(P(J4![)L!DS[I M@%:AT=))G@KNW7-RC9GQ7QZ%Z+I[ MOP35HU/O#65W)RC/1[W!X!FA7.VE/0FEU;4/@,MMH>SW*T`EJ*E8?`)%!^K% MO0Q^#P-0%6#6@")\@[*/3Q&47]`$]?Z3<)&%D)KC&5>R#2U&:A\;M+@5%D#. MEE!(VC*P?'KJ!Q="ST6E]_3>O5;S[#X\N_)\HYP46@/?FFVK?[Q\*S_O<5%\M_VVF85"CF1/;I8V MJYCS95&(ABQ1$^T8B5:=1CX>_7OB)9P^>^+;^1@O%V:)!Q&+>6UJNAD7Q9_) M'*UUK14:-9LP2J=M#7\\-]OVH/>CY@[-'4O<81)WU,(<H&D-HT1VVSC[2&Z:WZ]H'C M(+;V/S9BFO%V^<-T:V'2J[4MM7R[:ER/KW&[WZCL?T:QQI*QAMKO6>;?= MJ>\(XMA98V$KDA^/M3I="K,!`\Z1FN8T\Y5/X`X=WO`"[JPDI,PNS]SPP%.NG6% M=V6X[,)^PWR\)"3OJ8R]`#[@34TO$'&4T(T08ZI8!R^%C8&K4&TE'.]08M4E MQ4SJMDLB\&^\>^F-/0=K+"4%!H-A@<.$\8)NP(2)`$#$RU<[8KO!C%`+:*>3 MMJ97HE>B5Z)7HE>B5Z)7HE?2[)4T,,D>1E[*LB^'`9Z(^*Z,.-C#MMW52?:= M$TA8!H8!MH)%FN;9XPON#=K=BHC>J!1BC'_D>*-(2#TQNB/FEH78G%8:6FE\ MWTI#14DQ[I6C[P^,:6G=H76'UAU:=ZS7'==YT%LK"ZTLM+*H4%GHNY75Z:GB MB6]..CK[K:-3ME9<6G&=GN+J/:&WK$';TG?"*]5;7[`+74XRV0PN_TQ=X33C M:L9M'.->>P_/S[9ZVU7;[I%S\@'Y]BWU\\F)1HU]\H^J=UG^A>^QF_HN59V4 M%K:>T,*FU3:U%JZ4FP]1^DCSK.;9^GBVCCL'FF6.F&>W M=,^6KQ?O%A)MYB7B(PF;-E>3G735,DU`34!-0$U`3<`&V$K'8QF=>.&5-]E5 M9&RWQR,OK._H[M@+*&PJ)'9SBT5LPA(_5,\`P,F#1V5IPQ71]:4E]7@&7C%V M$O_I3/Z;W?0IW`,:^R&+7Z$;GE\B4H41!JU^=Z2Y6W/W27*WU6L-NI9F;\W> M)\G>HU;7'&KNUMQ]DMQM#5M#N[._R]90DNLP]RY"\';"@ENLX%2J`34V',H2 M,B@YR%`Y077DD7\/89Q#"OV+?G^P/WT:J;]?[L2.1T6\4:LWT.0[6O)9K:[= MU^0[4O+UP%[J[44^'>(^N1#W1R$2K*SY_#;2L9O=NZJ`9RLLO>?QV";<0]CZ MQP-F']675J(913.*9A3-*)I1ZF.40]JEIMD:#&P=Q]-QO%+/&QXYGM"QNXI5 M@-X1OD.B'S1HI"-&6F"UP!Z1P`[MEEW%N>H)".V!3+*]T+++Q3/)32EP)W95 MZ.`(^<[N3!X-732C:D8]"KIH1M6,>A1TT8RJ&?4HZ-*T/(>#(:0J#^?$TR3> M!ZZ^`Z@3[;_/1/M^:S34EZ0T=Y\F=YO]EFGI*ZZ:O4^3O;7RUMQ]NMR]O_+6 MN4.UN'''Z0T?GT9L.*J40JTJJ@4"8KAA@BV*-PUK:3)MKN(UF1I-)JUXM.(Y M+3)IQ7,49-**1RN>TR*35CQ'02:M>+3B.2TR:<5S%&1J5%BP*%.7\Z,VD88SU.BFLTBA_^]<]$G-\R M-GOU@7G1GUAE[$(('HM/G(DDXNYE\)D[210!C[QAPA/%=M;4Q!I^#@/'\ST6 M>V'PA3_$;_S0^?;S__Z/8?QKU>#)=(9/BO?/`/^,/LGADN=[PI\P5F MJ?W<:74H#;_7^^3^PZ^S1*-:N+9SY[X]B'BL-_&/.(B/IQD MPJ9JVKW'5[D*VD.O<3M*=CJ6>=@UUBB1'W__H.@X.#`AZQ9((..PLA6^\X3C MAV@2B\S&W<9:_5GE@F06>"$O1#H9TD]&3T-]EGYOR3%;YYO,DL")$YK_'+-/ M7F'U8##9&^.T/)<_12\6VT_2JX.V@80TB)*&,%/1,F@@6N>/GJ MN*E:T`QIK*WS8Y8Q)I'L<-]7H9N?SCIG]%G,F)-^5N^K")H#)&(SP5^E?[R6 M`QNC'FC)'U\7%9#BF?("'TG!6AEVLD;MH?6]W`*KHT7N&\G?.=^P./_[^7L^ M6^W^$??/3=>XS27&WO#HV;=1/9^_A#'S-6?NS9G]]J#*TS'-F:]?_,;ON)_3 MS'RIV71O-K5IO9I-ZV-32[/I_FS::P\TF];*IG8=;&I65H#C$&RZTDEI5EW-BN\QGC8!I2VO"7BT!+3K,)KN@C8/@>NZ&<@MKLJ&8DD=8O+^:PL6O=A#OJ*)U@MKN- M;;M"A4%R+M!\KOE\9S[OR7,?W8=*2XR6F(TDQFIW:R^WHB5&2\SI2$RWW6ML M&:H*;2FS03=>3\@C/,>G&AN.*J59]>W;1I,I]9LUF1I-)JUXM.(Y+3*E M@0Q-ID:322L>K7A.BTQI/$B3J=%DTHI'*Y[3(E,:5M-D:C29&A46;$H]JIVC MBB>1S:(S@'=.7],9P$=.0)T!?.0$U!G`1TY`G0'<*`(>WC+:T"XJ'[[_G8C8 M&\_E5^K#*P_ODYU[+@]O(S:;;(J]&LM)8+65=]RA^DF%*WIFR\!L%VU^:?/K M^R*@-K^.G(#:_#IR`FKSJU$$K,K\.O**"HT/(#95=1P<(8N7Z!K097J%XQ:77-83?T"S><-6>NA^%S7 M@M(2HR5F&XG1M:"TQ&B)V49BFEP+JD);JDF7OD[((SW.(X_C4XT-1Y6^H'P, M9-*UH(Z"3%KQ:,5S6F32M:".@DQ:\6C%30%B(M3AX$_-^XG/#!6#`/# M!V%LL#OF^?A#V_ACQ6SY3"Z"%\Y@NAN&DP(R8L#+#1,S&F*$[PA.,G+CX)T`?,!W!O><`C%L,$+HL9K98) MD4QG.+B`Z1";Z:IGD>=PF@2>X;$11CE)5N+X+T3&+!3"`P!;].;;<#ICP=SP MP_";P$&9$WMWG&8NX`-X[QN/13ZKA[SG.3@J( MSN%8L4I#(9)+F,7?A`O)BQ$AL,B*2CBF@)3V MCB*OM9&$]@.0/DRBE1H)Z%Y`.BBEDJR^\6%3/+]V)B&P"+$Q"M,T=$'O2+%, MWV@A7\Q8%+>,9`9OKU)$R(+R+1@[HME`[F)X`'X(,LY%=FT9$?]/XD4X79&M MB%E(K1@>C!C>!T5A;QM?"L]*F82SF>"OTC]>RX&-8:<- M8[^6.)!V;*];,I2>.)]<:9/UK':O<^`4X3VH4HU=:K?-ZC/!'8Y;9U/2,2S) M/4=>IV%G]-918^LBSFGT:Q+P0H&M3BO_8'7,GN99S;.-X]F5A>%*?%M'A3BS M;55_[^W9^';!>=\^)6BW_;:95U&.9$]NEC9K5DYLQ3F?FFA'2+3J-/+QZ-\3 MOR3XV1/?SL<15_$[#`1BY*XV-=V,D/XSF://==UA7Z-F$T;IM*WAC^=FVQ[T M?M3/1]B?N?[Q_F'$',P78'8_8+3[5=SZB6>-(6<-L=ZWS;KM3WQ'$L;/&PE8D/^H\PIWS""-N MW#.!Z3$\W;T`@9@LYAISC_LN);)@FDN:NV+EQ+M"!I&39O_A+Y%' M&7K9A&WC%TK6@R];,#F-IY)^9(I<.%Y.5/(")^),<)7O5LQ6')=@+3R(P#IA M`+N\X-O,Y?(-Y\H>;!L7O@AA!D.`:'MCSRF"DF8TWF4.:#K0(BB%)*>\V,?H M=3D]B9*L/$&#A4'+N"=D1UPD?DSY@44@`/$3D'T>KRU3)4MPI\O"P0HP M/S6/']ZOG48G[^V?2IPGL,G4+3$)[P70`UC<`0HQ*<&*BVXXP!E0MAO0%]0$ M_GDC&Z_)K+>Q%\`'D$V82,11@F1:FXV,";HX51)%T)O68.VI6^`5:JWODPB7E!84WAB(O+//'"YJQE7,V[C&/?:>WA^MM7; MKMIVCYR3#\BWLF%73C0Z8,X_JH/N_(LZ>WF=F!;>H$NJJ;5PI=Q\B$('FFU3RK]:SF63.6*>W=(]6[Y,M%M(M)E7AHXD;-I<37;2 M-4HT`34!-0$U`34!&V`K'8]E=.+7K-]D-U#"L3'CD1?6=W1W[-A:FKTU>Y\D>U/'>TY+-:7;NOR7>DY.N!O=3;BWPZQ'UR(>Z/0B184.GY M;:1C-[MW50'/5D9RS^.Q3;CG_V05WKKUI95H1M&,HAE%,XIFE/H8Y9!VJ6FV M!@-;Q_%T'*]4X9Y'CB=T[*YB%:!WA.^0Z`<-&NF(D198+;!')+!#NV57<:YZ M`D)[()-L+[3LY0+6[<<7K#QZ<1&XXJI5"KBFJ!@!ANF&"+ MXDW#6II,FZMX3:9&DTDK'JUX3HM,6O$$Z+ M3%KQ'`69&A46;$IRB/Q(#9D7PK#IKZM6OE/P*'?_TS$>>WC,U>?6!>]"=6&7OG"<Q']Y\:38ZEHVN/[,G3!P/-]CL1<&\"F)(N"V-TQX MXK>T?^$OS`M^"X7X&#A^XG+W8_">15BM6ACP-D;:/_/Q3V?ODHA&^6K"?W@I MY^N7\&O_J]VA#V=&$GCRP3_@#],^,USN>%/FBY_.SNVSGWO#8:\/:F7%BNM> M1J.PU]T)>^>CWF"@L9?R7J^(O=[3V+.ZMN:]C/>VQ5Z_?XJLAQ6+>*4JSC0' M`[M.3$F0:\7*-?.K19@6K-^A:IXJ&+51GW[1&IXJ&3"J> MQL.H:PY/%0VI4#QM<0SZW9-EALWMKOYH^/R:P0L8O,C\]"&/BQ6>Z:-,_E4- M]C5[\")[_+V(8?4QOQQG3Z^8^A.?WO!HU1S9 MNM[Z3(C2T'_)8C_KWRU@]$/$_Y/PP)F71EB%^QRO'1MDSDL_H M`5N39'>29.I`2\WF>O#(2'1R0E,-15*__S)`C^5R?!6%,Q[%\RL?EOC^/XDW M0^"J]$6M<\B_L(:=$%EG>!M*?53YU%L4NY%;+ M0+T\:\)HO?HLSXY*AQOKXONS)'#BA.8_QPSN5]B!`WBR,8'_YSJ3H!>++=SI MU7[;D'0T@)!<-`G@:G!9O(QK==N]6J']`^:)`*$QCP+F&Y]!)0=@KK\-76Z\ M^/CY[4OCFCO(BOFR[*'5,N()-Q)931($21@.*.3Y.(SN6>0*8\KFQ@TW?&_J MQ=PUO+'!#"=K)!/>!SP2$V^&;S.L1CECP=P('5"^`J@[-KS8\`2(/T`U!5!= MF([%+<,%R.+0B$'U"T90"1CO+O3OL*4H@O16CI573!N]%H:8L`A0AM.ZQLT< M1A=&#Z\>.ZBAPLBXC3@8#I%\<`*DB/:*VEI^]H`5'$OE@%@9&Q(F?UF)=Q(D+YD!K]:\Y MATFN*W`9,C^,+A*?A"DPF.\;-TEL_-#K&K`F'P9#KJN2MVYY@+_2[%&8W$Z, M7Y.`%T#NM`S<"Y'GRARX$=<9EQ+<)^'8YS]?&[V'L.1P( MT['/^SWC?N(Y$]#[I$GEG350&X2I9O-V+OCQIRS*'V>^$F6M&@; M`+?@CXU$W$E[F8\BZ07(F,&8W841!K",FS#\1ML=\I@+[S/GFWB4.5.!A'^' MQA_MZS9L$=$LC.3P9#/A8!&/DTAN5$N9&LP(V!2I'?G^U9M!?C^0E=,]'B$8 MF\%F^$"^N#\'>1RT!YE$+JNR51+EIXX?@OA#OSW,WE\K98#->$+&!(PB0!UC M,A',Y":D,`B/@+8[\,.4V/M^>(^-6I!2WDK!SL$@4H7C,0JZ`UX&^!Z@4SQ! M6FN=2A#&"Z\-PSML!NI)LB7`QM$Y1HW$`\%?JMG1J@A"PP.B@K(+'Z$Q[0E` M@7'J:1JS4!#GM11BB;!*J9)*!)WG,#$QQK!B`=K:8,RS40I`"N5\SX_#LPC3&@5OC9I)^[I+1F:-7=`==NQ$4UY1T^%AQ: M$T9Z_P"L$)!,7J48N0C%P<3T[@%3[LK;-:3/-;N\9 MU_49-(%'![15$F4]C<`DAPP7F!I=\J MAZ9"I)[;3TG6:AAJ@'QKK6#5`OE5Q&?,?R^M/M#DEVC;7TBSODIE80Z6 M=O\=0*I]65N2I_ND#5#%JCZ#%11Y&(I\BVY[A?";IFEWGUA!>?;5L-8&8X]@ M7+8<-X4-SWR9_Y;ZFUW3L<]%#&_<)'3+ZDOX%ESGRQG%18`F*HM@GY3F(O0= M`+[3ZW:'_078=X-JE^6%H(8C/(;"`W'%@]?QVN/MG99H=OH]D(-MU[@6M!W6 M2=_1T0O8I/CP!:+L5B9Q5+?4KFEU['YWRY4^"MSB8F,\VT>CFC3#[SQ^_X"7 M/[S@]IK4D)I"5B/3UE)4!NKI4&_46MN@.(TG=4>E8E"%3I82RJ MS543[@[4;M@*K,)*V6<-L7">'2'8ECB#Q9C+ M>@BD7?'FW?7:Q>@S?[*2-ND!51__F/W:X4UPR(>UH3CW8Y24)*$)_`\ M*#W;#?&@$$_V7E#:0)@(&$*\?'7?HL M9LQ)/ZOW5647!Q#%9H*_2O]X+0Z0P\,IB*/U.>]`_ M<,O5/:A234$8JST<5MZ-%S/P>/2,Y<\W[T?5;YM5EI,Z3#^JG5$]W*7F3G$/ MRL<:IO`O:*Q\NU`UZZDM=[D6O]IO M3[REVF=V;V#29>2!BR9SO9/9S/<6[LA4J0F;4<[M&9J8=!J[UDTXHXXF)MWV M\%&1VG!%M30QL>R6-1KE;*`973/Z23*Z.6SU.E8UC"YMA(82_]EMA9.P"/X* MHV\PX_DL"ATNZC,#CH,U=G5_#KJ3M0;];I4;F295?4;'H$I%?!R$TJ[91HKX M@Q=X8L)=XS8,7>V.51Z@:J1QUF\-K;YV0DZ5O+W6:%2IQC]V\C9N+SC.'@'' MIQ$.CJHC.M#0%-/,K9G[M"EV/)M]4QKA?-]ANB-)LVG6*<5W?!9Q2*_'MEK# M8:5':YHU-6M6$X#MM@9V10&7[S$&^UT8'DW53`U'B,H,.&"334V,Q8P$38P& M$$.K"JTJFDL,K2H:1(P#&)5-B>_(C[K1\6VYX.#Z6[%K[L^F>018!0'+(ER. M/W-L>+50[FGK*A&]T:C<$62#&:L`<8M[UT-K\;;QKA#^SN/]L&5U!_8:8&#L MK6;=IH+!<+A8[N')23^S^T_IC8"+P+U6]P$JY!QSV.LLUC'88O)JX=ZBEXQM MC=9@ M%O4BAM:HUZT&NE6E][9'5V_0&:R#9V5AO8T@V$)LNHL];Y\&(."7X[<1=[WX M`W.H.OTG]N!-D^F;,(KHLO];AO?<]R%6'PN9+11AVV;F,LR_LQA,F\OQ95:2 M7M?\.)*:'V:AYH/P+[G/WV1`N1\*'7U&["">],"R< MR*/B@(CZ-XF`M\6)(]ZRVYUZZ^U?^4_,SI]TR7F#!E+Q3P]O72\T; MWKW&3AK%1_)!BD^];&$O!F;XG%$3$FH-AGW"L-N93XW6L-J]@1V6;N=&S)U) M$/HA_#D.G03;2:G^'R[';EXM^/>.^R'U,VQA(?\IC[#Q1[&!$2`D&3,G%=#) MW(W"6QX8XX3[5/O$$',1\ZDP:()9!*H^`JS"E+)_67IQV``%Z/H(=MHL"J9@ MT=R8$:[@K6\\/O5F#[5SWU^<6DX5Z`U,$H?85$;UG)ORZ4W$`D[=6Z[>?VH5 M2(F4H4_J7A?U(TJYB#J,9<_^\X;%0-@Y<,1-Y+D+CU'K*R%"X":L&I1QC0#+ MG0$0^#O"SP.:PPO&$1-QE$@^&T?A5#50FB9^[,U\:H.''7<$+8_=,<_'H$_; MN"B`C\(!*\5F6P#_A$\]!_@.F!P;,U&W$N#Q&]1R.434AN1ACG_&H9J%JS$\ M,G;PB0F'E[$14)C(01*![-LV_IV.0UT%(Y`^5X)/$S@LN@FEK&##,5@/$X;O M@06*G2X`2)\G4^.6R58ZOUW]TC("W`L!:OH2P)D1J:8[(38\\@%=V#@&EB3+Y"YO6CC9C;)L.,A' M43_B;V$2&7P,\V'GHE60,@S2I%S_`A[\YGOC6+Q$N2#E="XF\(4Q`7O+N`.D M3/G"]*0_\%)`P?K/]34`'49 M2^TW]99W!SH+]+3/'SS58PR'X<&=%X6!K#"<=?!I&Y=)E#7^2DE+6L4+L"XN M%Z^,7WCP#A5;BX`K&0"@)F`'6;(%%*QDHI#H`XNLYX'7.,,'&&+%!+*9E50. M:G!Z_"T043X>!K4.\JF/XV8E-BHYLPGI#*2Y>10RL1K";/L/[: M^`P37@9R^(*=4EBEXOW".@7L-+@A@:J&88`Q%Q"3X0$KIP"W$4B8JIO,"(I; MV$//T]_DP]AS$J;K#3@`6\=A7&!")]<.@J'>!M%R8#@?]@?8KV5'1%]RY,2;"3E/&'GP$\@\ MS[JV%]R)2%H]E^\_*8,1F,Y#,P$FB+!_'(#]+5?9,Q9);F+&WR#QL8%Q8+06 M;ZA1+FPS'R*2?IKZXH'LINOV1=MX01]>8M]ED=P($%A<.DC4!4SW&UEC\&C> M<1G[5((A=97X@@2JL`]*C0SX?<0/2AV?]PDVCF>K-I74V<8^,[;HP` MD;9H--!$V!/$7$IE4*V:R. MUZQ_YIZO_PTD_;%P4")*OS(5;$&+D7H*CVEO#8V%V).TKF.1J[W3EV=ST+9J M8Z5-0ZMR4P'KY[1Q7;_8DGN";8!*QK!L3EJ(-0+KH[%`)JCLB0SV`W=E_U+9 MA98K,SN\IVTUW?=:RM'!5\>)[.VA!6]N+2]MQ>`6^&C]X2V2RN;&'_+)T(PIT@6IY5[2")D5+Z-F M%/A)/;CBE)FW&"9Y'*7L5&>6S4)0#I3./84(1.Z1*:\D>V4:@GN2H!=4#"2X MQ3BS]$8?9N@'Y*"DIJIT2-/FV&3Q3#QX&1\`AY45/-HIYS%@CF#S4WDCLDN4 MIXQ0XASJ*.-RH"KX2#.8/\"X5@@V,!JE853B!]H+O&GJP_\G8;`>V3H\-88I M0U&1.*4^Z. MQT[QM#:F['AD0/EXH3%ZD3EH7Y$!Q+0SN/3<4M;/CPVD=\>H+3K`$)8IN30& M*W966O",$3CFB M]('SI&)%80`(;DX M8C!<2H1.9\9IY/`4.HNG$PE@&F))J43RZ5:[3GCR!IA(_#@;\"8CORN]1-C` ML.\TG2$`:/_$:#4VF%MF/E5_98.:?V<;]LPO"T%)0L&,8!'GHLQK_SWT`0;MDB]]%Y2IFLU/@> MV]WS(AN5FJ###H,1U^*CN&5DC=Y(H5$3.-A40#94XA)*YP^CMIWU3L?9?K`Z MA6_2T$,\B;@T>(3W`+MR$$^$`7L>S+FZ`4BY6;K[0T]QQ413K98]W9X?]M&@;^L%;-/V%TG`>:+IDFLAN]R\<85)28Z`T+ M?>37=HG7@K0GN)1>C"R?J#!;;I[DFCRC_H;\9MP#<7^PNCGOMHT+UZ7(,)BI M&*1>#(7DK'J/@NM*H*3^AS]0#=^!U:#,[Q_,SJAMEM@5I6W17*(G[5[.V&WC MS9S"V.!8"&3[56\!LSW2+(>69O8'[4XVJ.;!_E-81[6C10N MB@$/5QH@.1*ZA(2(6C5S5_D6=`Z/S@^M?-!O#W+5+(_]<4^@*/=]Y,5@[QFS MY,;WG.SX9K7=@_*?C4ZGGA#9;DBA-0-HXTT)'V.N M(LVI:R-CHR`OO1S@-?W`#*8T1,MP>#Q M`5D!4/1.T[V6NMG>JQZY6F;W!/<+V,-`SS3-_:KIFMYQ^OI">SF-L)GXE M:>"^F?\!2/H8?$C]THOR_ M$?]OL@#9@/HWM!"K1/+`'`T[BS#FWA8$G3[0'$KO3J6/6#\54- M\)6R!C#Z*B^RH:D2!FA\7#QX(GOJ,Y=?RVZ]L,]'EK6D M@S:"XB+-#/\2OB4[L7CU[PT38%@^AG,+XU?:6S-5]5G)_X5`\"'8=L%<"^-.1AZ-7(;CU<_G_63D2?6&WLHC. ML#T\=-[39XZM6XV<`XPR"YQX3*W;KC>D]C$P+I+;1,2%!%&*!LMCLA3GR0P# M;W0.H2*<,C=;YFU,0FSF&C"9>8&Q%)G^"X(HHZLJ/GLG\S+DK;G$AT$8AILP ME3#&`!?>K`N3&QCA!B_%X<4[2H\I9Q,5$D"R"%)R*..:(4!B)1U[H"N.&`RTHGT(&I]>>S/0IE=P-*0U`QJ9DXHL; M9I>@8P1#S8VXPK@E,_"RK#?V'(9!+0(G"W4!NK"0O8S-R7`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`'*[TJ+JS@/XM MX*AZ!;L9`CVK,0O8C8<68G\-H,"6"[`&U2U@QCSWO)(*K@S(R%(LU MNM*LPZP`D'QKAO>]`IFXMW"'15#<;`$FUW,IP.-)Y2XC5WA/BM(U"]F%(97U M*%Z@48&N-):K9N8'C05MJ\,6-:!,E?X0A=./0B1X1:\VO\$KS@\VUS/'XLQ+,&+JMGIH M?N$X40*;RWZ1*]M!8S8=[GP'T;'-)"-9.M1=0V_@' M"XU"-H?I,S@2,CAQ.?XM#&Z_\&CZ5EZG^PTO:US>^-[M!C7N#?4J=T+:LJ^.45?B#2N_P"OW+L*MUX^KU%D!^9>6\@=PO;F/9H^(Q`[D;[ MOKUPH/,LF-P22'OQJL9V0*HKFQ07#NB?]X5[O/LIT`7#[:G9]H9MBZW&["_< M4-@6N')R]T5^1?Z=NB&_%^K.1_:P,S07('QJS@I@W.9PL3?LFON"2)D@G_-$ M$)V<>(RADLW#4S+SIT#PTPM0K>64YPH6RLN_A4NT*M'JOUQDN5>RUFJI`-0X M7%/>J95V`J"\*"II5B@1-2Z_E%Z[SU_.RWFEDU/Z5+$>6BNKY21KAV>%I.&' M65IZ%H9:JDR=5:!ZL0QBWO(`V[S-B^73EL8I5UI[26#0%697EI`K7TJFXFYK MD;JV5E.6SY8BE%:6W;ZF:[@1]Z8W221X^8UB*P=*AI,]1/*Q@0SEK1U/N=>I&MU;KJ=8V2BJ_0)\6V$O55MOXO`IJ!:RL MB/DH>&D--`&;+M7R5GK=\+VIA\HB2#`3F]H3%69HI-*"\RD%4E+3R/582EN&)UCC3$\S3'"F[_5 MK0).*0)J\X\G7N2>RU+SV0^`>5F`P_=E#<&L_5!6]JJX%JP0&_IWLIZ/1,L* M*7,E9D%65)D2T@TS'GNJA5?6KP.'2=>S[("VL3+Y=+&XBU;/L*L;BY6<7R$`56[".:_HB]7D!78'],M88 M?P6`RS=+TB*5.#898VFY29H&'3DO?5\*$^*8M/:$I;G=$FR2O1L..,0R,;%4 MZ`MK3QL48)%+M(EXA-<)G*PQQQV+YGEI43K8E%;6XCA*C*GRD^HM0WVLOJSF M_W64)-0MF$(69TV8/[\O^D] MBG4`47FX,6E*D6H1M[SU"4@;5$@,O%X.I"KJA^51RF437O2-"J9/733 M9$WE:D_D[I(K.Y0IA1QG59MIP_1B)>@@W*23L3BG5`\SO"?G+F[ZA#,YPPRV M]02V_.*.0AJGB()6ACVA="*\.?8>4$BCC!92?SJA[ZL"2PJ7*7*B["J&7!H3 M(;XSI[I($5*29#LU3/)2P88#^R^V(FGAEQ4O;;BK28?9+UF[(<*>LK\BAG&@+=P%15N3R]9'H;ANYB MP`5/?M666[1^EJ>5I;=96L-\2G6Y>7H;47)N61NE!F2Z&K5@S8;/P(948!B# M:>054>D]+%!8H&8:_R("YBHIK:I'#`'Z^TYZ@Z"1Z`YG-D!6K,]5KDE:^JZH M(]LJKRZ>S[BJ;YB%W;#M@O1-%:N4_=>2O4V6&CQ,MU=]*D,N&6ZY>"#.5JA" M*GN7JD**,HJ:\2WJ12AG`3YCD3=409&5=\M\Q'*P\<`>3 M"\""P=8V$6E@H;1I"^M\T/(!+13-5;E-666"M%I_OG(JKY'6U2B4^WB:V@2N M++$K5+M),OPS`R]>(NC\6%TQ5(8B<61EC]42!_\8A,AU^ M4CQTR,S])Q,Z5N9_5)IP:%G#T6+6EIQEF[EWS&H;V-9B1LSV<^^6K&:O2`3; M>=W;)HMW.YW%-,]5NY>,4OUN\/UF"K,N0=@N_%5=[%(3/6` M[7H+8V`_$\JVA&S8M88[`.9,N)O0[2*5UGC%HVNT?ZGZ(J;9>GX"6_07JM+8 MO-3%!KM$#0;MV8-BN2$G>Y"I&%?:,CDM,IT%+9CO)'YZKW-,#HZCVBD2.X*' M(=D5_1#IL!DOR#P-$P'/B188EW@PH7Y35N?+5\=-RX+HW'MN/'D%NNC'K#N= M1"T>:LVPETUP^]-9YXP^BQESTL_J_1MJ+GJ.YT!L)OBK](_7[].C MZ[7ZM%[%<'$X>V6"7`:8A_2/=R/\STA_)"Y;^ZLU6FOI>!_N4BSYEG-LT?&LUW-LYIG MCXQGM9[5/'ML/%N'GOVNW!K@T=4^#?9AOHW")'`QEAE&KXQ_O'W[_OV'#]MB M)K]XVVF;CR%*QL55T(*)791WN:@-:C]*]8`'6;O_Q6-X397$<>3=) MG)9T<*B(L4QO4`U3&^T7-T<^3.L(3D)^J)Z8X*X,AS^^WA!N!'M9RYV!&X]7 M;7XZD_]FN2>%S)2Q'[+X%<8-LE_39.H7HY;5L_=GR$:2[&4M/K[FUH-QJ]T: M6CVM/34_-H0?7UB=EFUWM/K4[+H1N_8/S*X#J]49=O=W9AI)L^W8]4#^S%YH MV>601')3"MR1I/.<"$*DLJOL3`^DPG##!-W-YSS4.PUB*&M!$Z,)Q-"J0JN* MYA)#JXH&$4.K"JTJFDL,K2H:1`RM*K2J:"XQ5/Q'$Z,)Q*@P5;/Q"*DJTE5' M7F=#SO3?\2#$0LPZJU.G_>A<+TUT371-=$UT372=U;FA;7CT69U_T?18#14+ MK-_R0BNS8EZG,,(DICX`6#GK7);!.HE(QO,KCD-F0I@#N]6U1RU[9&HR-9A, MO5%K9/9;W>Y(DZG!9$)IZEBMOJFEJ@/CBMT=G3VS7$&"ILJ MI0='R,&J..@8O^94S:FG0!C-J9I3CX,PFE,UIQX'89KFIN@3_J7XKMV4^.[[ M,39\I=:OV*]`=L=VDLB+/2[TF;\^%-)$UT371-=$UT371-=G_G6>^7>;8A-> MSF0[*]D"7<211ZU/18S]U-@]BUQ=P&DW_=`L+;`)+Q!._O&`A8%/(VSR?1UM M=ELFEF+I[U7;XGL@DI9,371-].\QA:'ZX%YC#+FW*D.3##>PVR(6Q/69;L=N M_Y^ZT]<`_:(99?6Z#YK]UNKTNJWNL*\)JS6`U@":49K!*#JF>%(QQ:N(CWD4 MI6%$[;!JAU43O?GQ0Q.LPWZO-1Q64,OYM*FD15,371/]>PP@?A>IE$V5^8,C MY#OK9'LT=-&,JAGU*.BB&54SZE'013.J9M2CH$O37!1]_^GDZEO192GNUJ9' MC_W&W1/TY_7;7RG1S2C6+I:U:5@3HK@9;"+(>%.7\Z,VD88SU.BFLTBA_^ M]<]$G-\R-GMU[4RXF_C\10&PA+CBT37&\-]@3XJ+P'TG8_=?$'%?^$/\ MQ@^=;S__[_\8QK^6!_G`O.A/YB?\0@@>"WC]-X_=>#[51_O$F4@B[EX&G[%F M6@2SX22B/#0HHP`#()_Y^*>S=TG$L+K&5Q/^LSIF[^N7\&O_J]VA#V<_JQA( MML!"/$324*HA)*3Z+-5*B>^;3OH5H!7/?:QNNUXVD.29`A MDBF``R,*(\:?O8`%CL=\>%'$43(%P(0Q500W6&R,@3-0:27<"`.#&5'*`M3\ M1,![-!`0GXYJ&1XRW3`?1H7))AR8R7A!SX2)8($K7K[:$74-IFHMH"V^^>@L M1;XJ"$TF1(5]P[#[^0GEZSSF6-1$3Z-LFS?T2O1*]$KT2O1*]$KT2O1*FKV2 MY3=6&X(%ER7M\-[Y,7M96ML.]WVUF)_..F?T6/?ONC.HZ M&/I+&#-?<^;>G-EO#_J:,ZODS!>_\3ONYS0S7VHVW9M-;5JO9M/ZV-32;+H_ MF_;:`\VFM;*I70>;FNW.$;.I_+Q'OJGRKG:].V1VVN9CZ"C<'J('=\;('DTDEI5@F5RKNAG#(!I2VO"7BT!+3K,)M&V4RKRM(;ODJKFM=F1S4C>;!^>3&'C5WK)MSQ0_4,8)KM;F/O,O9;HZ&5 MIP7KXY/-38<54JSZEN7C293ZC=K,C6:3%KQ:,5S6F1*`QF:3(TF MDU8\6O&<%IG2>)`F4Z/)I!6/5CRG1:8TK*;)U&@R-2HLV)0Z1#M'%4\BFT5G M`.^)SOW7![>1FPVV11[-9:3P+)[[[C#L4-3X8J>V3(PVT6;7]K\^KX(J,VO M(R>@-K^.G(#:_&H4`:LROXZ\HD+C`XA-51T'1\@AC+>C08[FE@98BD>#',TM M#3!+CP8YFEL:8`,?#7*:9C'KDV!]$MP@-TR'(K\[`NI0Y)$34(7XP_,B_YD?L(OA."QN`C,.&)+XC.+_PA?N.'SK>?__=_#.-?RT-_#.YX$(?1_"V\"G^5 MWS(<@!T^?.;CG\[>)1&+O3#X:L)_5L?L??T2?NU_M3OTX>QG%63/5E0(N$NB M2;V#E%.?I1XI,7K3:;T"M&+ZD]VO%=:,6@831C@V?DT"7BAIT:&2%CV#!>XC M%2^0J,`?,7=QB'C"C7'H^^$],([QP@O@FS`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`1F53XCORHZZZ<;NZZL;CI3$6"FIP']9Q M^PL/>,3\B\"]<*>871!CR8P[_OYAQ@/!'RVGT2V6T^B>&4G@R0?_@#],^\QP MN>--F2]^.CNWSWX>6;TA2'H!\(U`J`[L[DY@][KVZ*!@KRY>\A389F_0,YN` M[BWA!A:Q]@=[PB+^A@GNO@VG^#M!5"4SFU:O5P9SY91[@[4E]NRN7158%]BC MZI9/08^\F>>/7+$Y?G5QSR+W5\I8??R(DGF2>%RIZ>OCQ^XA\'@5>4YYH[L07R_'L':K M+'YO$@'VH1`7SG\23W@$"RY\YB>W7S]SW[L,/@;.ZK7VBHNUSGX>M'O=A842 M'`OP(0HGH0_NDW@/D\;S%7":UE?;W'!OZPVMH5W&\=(4>X&0(>LZ9C'12+Z$ M!`2O#\A1XI4+QTFFB0^/NI?QA$?X6,0G0&HP``"9X92OQN>R=3$:-FE=X,$A M?S#_BGGNQ^`MFWDQ\S=V1U:#UR":7-,>F:QC8_08MX#./&0BO^YY% M`=B<8L-5G(_L86=H-F@A7R*JL3C?AA;G5K]?`S=MX;)TP6FI$X+34CL[+VL_ MK8-LWADU9SD[*9T&D6-GG=,;=LT:=,ZNZWA&E?-1B(2[8'X"OJ351J:1V-N_ MKIKUEFW7@6T/%E:[W6JV04=N6HOW#SQR/!BK2=@PS7Z_OS$Z5JUF(VQ0(>)# MQ%ZV!N<9E_.LFP:@IGNRJ-EA`WH^7.!O[[P[S^5!C:*_'W?T5OB:FZRG<6C8 M=2M_)@3LL14\S=+V%DR]IR9_WFUM3W/9[IPH7FI5>QM@(KD1_#\)0HF'GD)W M`%A[[OQ2T,HA830*Z&GP6+WM8P_:P5F@O`^/7Q)\7JOUU M91N%EG'/#:JF!X+O!7%H,(,L".,JB9P)F!'&Q6W$2;:->R^>&! M`>CSX1L`D`H2![+>-CV3H!=PAFX_6B/TB6+IL M0I%'6L?HM@9#LV7U.H^,2/7OZ&T7D8-CX=LL<#@^GLSP6[ME=GHMNSLT6+99 M/#8FK,'A$=H*AN-%3C(5,0XHVL87&'^6TFI&1PZ>,$"#AHCJ'_S8-_7-H] MKR(^!BD-5AZ`;8-O[CX&\@`7Y]H7L+6( MJQ\N:6WOAZR>]21,JUU?;QX5<8Z/,^=!J1%,:$W7'CAO,`W&,^ M8S+2@>^-PVB*$07R^7^YN+AJJ5!&Q"D280#,3"8$H@\]9=^XP3-1)3-S>UN M3!2![F!N5W_4Z0V*I_U;PE+#0C:Z$+2XD$'?[`W,P:A)"]GHS&YI(7:W8_5- MLTD+V>C.T(J%V"-[5/-"EM["GM7.(21D-225+V(GZ>B-1F:_VWU:.IYI$?5* MQO-2HB:I>&P1_]_Y^8:AR?@X__>N?#S>1#W_\_U!+`P04```` M"``U7@9'AF;U:ZT+``"!I@``%0`<`'!L=6`L``00E#@``!#D!``#M75MSXCH2?M^J_0]>SLON`P%R M3RK94^0VE:IDH$AFSWF;$K8`[1C+*\D)G%^_+6.#`\*RHU+O1`RFY6X8 M#]^M\9)8'&HX M)_U^%,LV:G\^/[V$E:\2CPODV;-2H)-DO&5)?JE6T7L:%Q<7M?#7"EC/LJX8 M=7$']ZSPV:48^_BZPLG0=Z6N\-F`X=YUQ7>#?E4R4#\]JDO\O[T(H%'ZQBWU M.'6)(UF]0:ZLQ\L`8\$KEM3^H_,X5Q.IR:?OF'CV@4V'-2E3TU$60M,R=>U# ML$T?\E:OY>-)>UD9I$JK26AOZ=!G>(`]3M[P$^5K!9VBW"CLB`\>7/J^7LPS MI9^(]8YPVZ4\8/C1>X.*4#:^PP(1MPBV+"6%L=C(M0,W=/DG^"VJOWS/FKJ, MA(WP2&#/P<[T*1'R-=#QUF' MK4A=J*J'>#?4!X-W'R%?CGS'->P*'C^1O!Y7ZXUH+/HM>OSSB:`N<8D@F#<] M\#AJ_QI0UX&YP?W_`B+&\3M=U,7N=25?O+99$`OU39'X>7IT'A\ M?G)RV+@X2]0ZX5]--@\`,3O6#O]<G".\1I`8`1H4>F$7J'>Q@@.QT,D^<@ MI^]-%]XA0@L`C`@]-HW06^03@=PG#%/^5M$=6A+<"(8/CEH.1\LG/!^+)V-IL9%A@*%UHFSDI M@,C4&<]BQY_;:ZH+;#.3)=&9.KUYQ4.Y!\S&DVCE+?098^@?FD,9'&D*P4@W M$#)`\DK;*(/LPGK,\8$R$=SUP#5U,,W=05`+;C>MFGA,C3+B&(_R`W MP`K6%L7,X:P@#RD+3QUHQL9S'8=,JM)&Q'GTHE6T*IJ;+KU#9!9!:&I7VK3M M8"@MCIUPQC"7]O#HV708)C]\QZ+5>T4C=>2^B)9=\H$U(#>UN^[(!`H/._>( M>3!YX`FLL"@G-E%-MO(+[I`'E`1KZC+JE6'$`S;.':67!7>(5$UPN:NFZJ:Z M=D'JP[YEVP7;\B5&8!- M$2\4,Z?G.F7-H4^?K+1]HK)0324^3BOI8!L#GJZ+86J2DV,S)[L;Q.I#,W7B M/DUS5?.7%-D-VG(1F3J5;C/LPQKQ?N3#R@!#EQ(N%G0&18V2N\%M6:"F3J0[ MF`M&;%@&I(\BRK53=C%SR%;/BTIA,+6C;3/J8R;&;1=Y`K!('+[,R%=WO%E% MMH&_PO7_M)W9,&/'B>OWPX/7)G-YH'Z-M+U:C6(F\[(2!E/[Q^]48*UIZ+*@ MR5P5K+6I^ZZ/GD!>GT#-)Q"A_O4,:?ME61G M;B#,169JK&Q6[0',04S6!TIA\X/>Z,Y/J7O&&EC\N<:R%37C/#*VN=T+"F2'JBQB9XO.%SM?L,>&,,%0$UG M2#S"A33-&\XF7*_P+C&_`N+<79U-N4`%@F66^_&C9CXH;S-CI:HP\ M&H###C=G!$N*?GF'>OS*M9.Q<]LVBZ[^"?>9[\@;<;#G\(G)IMD.CT,?%FGJ M[&EM%>8XT1IVW5<&7B#BM(GDF;3KV1.4*'-HCHKDT,R]Q"IX"?QF[E=8/'RL M.+B=*;E].3(;;:T:5M?+ARF^];61EI?X2(!.BSLIU.)`N57T$P3&G)]L8T:H M`^S*T\/X#D_^7FQZA8INJ"W*VK49E:.&L%_"`*;&XUX&B.'PXW=RM@I3U:PVGRZ\!X07 M`&[JJ;JOD/]G.,KZ(_C9T;=9DM;19MQ*PI&SG98G,_]:O;D3PM/CP0HWTBN\ M!VZS@B&T=I]G;O*U[;,U3E%Z%T?C6..GGY>:6R8_>LO7["@W=?*+[H$OE#9# MY!+GQNWA+".*[_!1AX\RR^RE%^3AC^B_V`+ZHVM^XJ]ZI%[WH^T7.LKVTF%* M&R:.7-6WP)46KMC(OD=+M_A>NDL!4\0.HHYMFN,@"]_0E!&\I<\O%IZ09"G; M2^:(H";XPIHX77:2%8V1N\6ZL:S% M15QQL!A/O@(1-J[)+ZK#KD54[*.G%#6'L:=GP48VQDZ8(YP2$M;I4O0U[(.G MK&@-4[=O%8::?+!QA5E(B@)SO.2#9B&ZF$WUA>4)]OQUR]IKD_EBYO"^)OYT MEB8:)C!WGI'LZV22?RNL&K\?8683KIY??=5;?4>@MH8]\(Y5K6'NJ MHK@$JCWUVD2=XNY-7G>TV/PU2^TPMZM8(#<7:U/-_+[7P[9H]>Y'X*)>'W>0 MP"VOT*>(BJ@PQSU6#1NLC%IGAI!RZ^('G.6\(]QV*0_D-0/1A]/NY-=J7;VS MF\?UDWK#JEHS-?"?J2;KGY&N?U6,/JJ9\:&\^9\V^A6_#GI_!D=C!+D<_.PE M\'V71/%M>5T9>\M(52B@PYQVFL9+ZK?^2L,R]13>%-D?E/V2N5JP#N'%J%:7 MW$*""X(Q-0PSQ?,@;Y0;8">^WUJ?5G7)+:2U(!C]$$O:2'E5FQ@V&FC@R?\! M4$L#!!0````(`#5>!D?)^Z[&[Q(``)TM`0`5`!P`<&QU9RTR,#$U,#8S,%]D M968N>&UL550)``,6@L-5%H+#575X"P`!!"4.```$.0$``.T=75/C./+]JNX_ M^-B'NWL(X7.8H8;;"E^[V8()!''^:C#LGCCU!AG&\NW^X>W*RN[<:?6Y2!LWPA6@.=O>3_\3/]_"I M\;'_H7^PMW]L?#P]/CG=^V`,;A.X6\;!V!$#GB2`KH/_.N4_GM@#C5?JG%)K MBF;FC6>%_)SM3'U_?MKOO[R\[+X^$7?7(Q.&:N^PGXR20O!/O1BLQ[_J[1_T M#O=W7ZF]8S"Q8QH^6^,A,3BC,`/]?/:3 M&Q<=C1]\S_IKZKDV,^.K[X'C+W8,_KRO]\,,;1SWW'M!#K9V+6_6YS#]]="' M[&MIKE\?_U],G_THE\TW'I6NPJL+7"W4,PFYEDP>3M3!S,9J]E M8G]@65Z`?>:-[IAJ+`=MQ'+51W1`#@=;$,1!2Y(86&RV48?;YFA\CUSV>XBM M30R@!&,K7%Z9!#.9TSM$'J8F01LI5HZL%=ZN38=\,]T`W2*3?PX]ZB8*5",$ MQ^-Z2BS!V`J7%]YLYOBG5"`24N(8D8>PQZ&<0FPU M4,7^1IAO/'JV-S,=7".)1=1UT!NBZLW0[`F1.HG-XJV!TBDCBEC!$^HE@JB1 M7B'V>NT!CT=4CRA5Q]A&]G)MX[/ M'[RW=[3']L/&Z@'L0_H9QNHAAC]O?WEQO>GY==_)O0_FD\KI;KF$W+# MO(,0J-\FH9%4V8HU]S"7^^#5H65TB\->SHXU)[U'F$V< M[>S'V,;$F\D%O"3!TV8EH(PP;\Y9,-UV%)0C[#*SE.04(X%M2"'%14A3&RI3 M2RM'PLY;4,J?'PZ/3XZ.CCX>'!Q]/#D^V/]TL@T]Q6O#-A0E9!&`[GA0[N%P M2;G-A#HYO0G@FE)0-D!2*T=I>FFE".@'(/V!;3O1\^],QQ[B"W/N^*:KU$3) MF*UJY6!#K93P`D%#EA7,`I>'82-_B@AGBJ`I=R'/:(A9=(C4VM(?OU7-'6ZJ M.7V^`&CQD83)E46YGQ-";E4S1QMJ1L@!`!W<\V0(1G:ZY[[9$7D]@2 M#5;&`B&"T%-T9=;FQ/$(^S(T,!#34)8Q*DS#(B"$^'M-$\W.UB)KT/24VCV$ ME38ZI#1`LADGA88PLVK0F)0_:&K[@OPH%+WQJ&R!R\%`",)K4%&.*VB*"?F) MK.8R(+P)`3$*[;`.&II4V!3&0RRVH0C[551^L2(B"-%\77ZS(NL=L8/(J]1A M"&I,$%;0]:>"AC&HV>^(-42BX/\;A>31JU=$+(=*U]\U\$#85S;M$\2<=\0( MEI:\N14H$8%W""K^]?U!IRUA)8A+Y]FQ$5[;#:S&;U7O']J;_BN.ZU-VL;6* M?Z.T0)7VJ@[NQ)3-\\J55I715'UCZEP.=K;W]O/=[A$ M*'E#RPJI\:\EVG\#;VBQIL@.7":0\X`Z&%&::C:FYXO4)V7+2V4T;?AA`6V* M=A@I-*!&F#6UEW:U4C8!+)PBVOB?!"%E;X;&."#-,R4F6::H'%-O666@6VOJ M5&/]#3:2P(:?)!GQDR3"`J88!$*0HFUB27!28`/F1"DK8:J'M%?,U&$E$]U7 M7K:Z6O@4\!?M?X:,(9F&*'9WA''DF[!4@`0"D.5%X44 M_:UF""H?M]9)&QP4TP;+YX0'85)/,E:/,N)G=2^;$,VU6^1//7N(G]E\"T_] MZ.40U(-;:?DS\00I<@6I_T/,#NAH(]/OMV('@.L+J5$W6:8A@.SL"R93$#"@ MS4@E$8/>B>N*'>HQEELFO%DP4^HB!P-A3RXPH+3@J150,VL)Z*FOE77L]%7,&0#OW:!X0:\K"Q<&$ MH#"-DJ=5F;6M,![(LJRRQ^R1!VW.?B0]@E[[:]?MUE+Q@U<3HX>!/!&?`P"Q MY%>UN20=GV,&P/PI<^W%;Q$J6OB+G"Y'!X&#_(%4P0%8=74,\)DJ12Q M`6`JE2X*A51_U63O#83"=G4VJZQ_M./%;3%7HQ>,")TZ\SL6:;#/YD26\*\P M'D+J93-CJ,!LXQW-8EKNGCW+:%XV;1D2XK)S\&1%[9+8%7&/WCE:-FW9YXLK[#,\7^<>CD]QC,8Q\Z$L M\LO(UI\.H:)>OYDU(BIHG1/WB"(F[^D`VY?H&;G>/+RY]XGZQ+1\R=I4-@C" M,;O-%J0R#AMW'A<>]7G31W169&EN=#1^]'S3O2/>?Y'EB]/@2T/E1VP=E['>B]#M1P'>B](@"W(O!^#V=7,_:4[?Q^ M\YCPOK$/;#-$2W(CE;&`R-YK*;HR:]"276^U)J/M.[4,^KTP\\8*,Y))OX%Y M=*DZT]C1TQ6YH_$WC^?`DN.U<4U`XD?610:AG%>#4UF7_0[8Q`]V'%GY$H.Z M;:3F$\H-IN7+7DFKDX0_+)Z)3:'EB?CHW@Z#8>[>"5C=JRU*DD.Z:(!XA_?[ MM*1LPG3G[_=I-76?UONM2^^W+KW?NM2FDB^\V9.#PPLY^5MH'7MY.^NA@+#77?>"'#T..[$NUMK6O4D=O5CK_?XD`+,UY6OND>5- ML/,_9`]MMGHX8X?;$MO=HE4^A.VF;]C7CLNX9WMI9EDS9']!9;V;C3T-0M-G M#6Z^'F&\<1O;CFW!"NT;FIX-FF,GS/#<)!.FC+A>\`O[>\7S8,;+`_K6IH4, M4CS:CE%IB:G5#&K\+M4[1,*ENV('\U&Q@SG&:#"41HBS0XW*R>9TP`S#=MS` M=Y[1`[("$AK"U:OE!DP.44%M-@]\,\H]Y\6HEU6MYR&M]MEO4OK"#IR@&`(M&FBAE(E8$""3S6FJ8F0YX`1_=UD/F^H./T&Z" MV$PW0MX`J.L!$>8<+NX8RC!/E7E1O-@;JD9`",7E%ICQ9BHV`"AFR<7O)B$F M]DF1PP-J=&]\D5*(`:I2=;RD>`209:O45$L5!&_]JD=%H%>TNM16 M_](F*?LN'QZEQX?XUEPPF'UY#5@-#VBI4AE;4@I6<[,%>5^C)Q*8A#_V4%OH MHD$04BL;2%[$TA;$_YN)ET\]TI:^8`R$@MH&PA=P!&/"7L#ZRIR@"M!P, MQ-LIFPK*@#;FJ3<)='SQ%RSJ$UY6PH M!66/3DVX(;2<-ND.:A)3XPX@[F9>&C;]BM'RIE-[B*,69Y$CT!H&H7^T,8>@ M)8'&U?<[XGX(V8-G1,P)BF^I%35^:\!O56$?MJPP->N-:RI;O#X0*:<`LE5] MG&Q9'P5NH:VB%QYFID)#MD(:HUD=?>W+SU)IC-NJ8C]N?_73$$&KS:C7ID/" MZP5NDA$MZXJ.451B] MH1`*,A4,NDRM108A*?%\D?SYJ\/V:\2:+F[XVQKTEEGE8#@MMMM::97B@*3V MM'T6B:[LL14XX"W`&@9?.J?E_/Z(6N[*"MVDYL$OUT,\#WP:,BSN5-4:`75Q M+K5OH6)%'`+0V17UG9GIH]$XH33Y8Y4(43>\5$(!H6:\L5:KL0Q`S2G/%( M]=;MYIX++Z*3SQZAT30GFG?#:^ZY70DR@1@CU'AT6<97!B\Y&%`Q9]/3*FTD M.3D`T%X=JWJAH-E`^>H&0K-N(\(2.I'-8ZRN-NM>.]AD4\MT4YP+HGZ9J>F. M!K5!:LR<=*4!MJ5`]Y*KD^(E5V4]!>!ONJK#//CXZ))>9$VQ\SU`C3<:R!_9 MRHMJ>1.Y8ON=^O_;ZB,HTWSFG;4K(0`(24)JE.%D!@+([K5@:`4!`XKZ;IF@ M9L%,*>0<#(2876`9:2GG*(8@9_.U7,Y9&`B!29F.0(8!P2A&*>41DMH991,,@G$*$ M9@R19+ID`I?.LV,C;*_I(;+#(1Q:A&8260FUFF:[\&8S)WSY*&/Z@D4]C%^$ M+2:7:L=W/A:/[ZQ0&R:VC0SRKISA843SM^Y&K[3BJ[\J3R8#;NFP79:6\\4Y M$_UT9A+5=>_EP^#DP]2ZR1V?*^$*@$3!=Q"A[ M1CA`7Y"ZX40""R'#L8Y>).P`4(K`/93<$*L<`>>$T48Q!ZA;8(NN!7W([&&>*4GD\!#V1QDEM66AT* M/MZ25D"O1AMJ:FMOA4E(E+\5HP`"8=$HM:+5/:%Y\IL4XPB+M_8RH#9%J=)_ M07HIFIN4W^.+5RZ_%%";&^]*\DO1W*C\&)2&!6;`VJR_5Y-AFNHFI7CM!:1< MB&FH-LO6E628)AI`,%"(,6]*6N-4`]IK:BMG0[WU;*N13#8/\@3&5^LF5B:< M%QJC0"9*A4K,K$0Q@%(]M:D&=*JG#G5!+3GD"%;7QL6P$+)% MI8:H4!*HW5+`CPW,3>(O>`),60T7@<(I@^NN/&(^`.CB'LT#8DU9^#28$!3N MS?*T*GU=A?%`EB65]64.I>ISUD029_!J8O0PD.=O<@`0_%-E8TIVJ#EF`$R, MU=L!K[X';)MUB_RI9P_Q,Z)A*W?Q6X1*G-EF*.%45+7#[8WX!6`#,@*5'K%L M$!`W6(=]9VZC+&&["1_YZ^(N<#G/#X,'N:,404'PEGK6E;A($1L`YDC.&90E MON7@[:6]RUA0;7VZ?7;Z/*",64H'%K-%&LI\E6,7R*SYG@*D90"2F$+/V&QE") MW\X9!2HC>Q"5_Q6S=R"*>K:S423;X;?Y>D@-"!;3O1,U:T"*H!D<$")U]*DP``$+$ M!``5`!P`<&QU9RTR,#$U,#8S,%]L86(N>&UL550)``,6@L-5%H+#575X"P`! M!"4.```$.0$``.U]ZW/O?X*XOFR:/A?IS>7*(C]?(.C#/E%KR>2 M/53]3A,2W&.$OGMU\O;5'_[PZG7=^]1+:6M*CY-Y\^JD^J;D'T<_HC]^\_TW M;UZ??(?^^.-W?_CQ]?=H^:%J]X%JL"9=#4,2_?(C^[\598B>4_)CZC_@C7<9 M^UR?/W_UD&7;'[_YYNGIZ=7S*@E?Q MOCUY]9P&7R%J]BCEO`V8E,VIA(W63V_+MB??_->'RULN_$L2I9D7^74O2I-H MN!RT/Y"JX'/RPP\_?,.__8I:#Z$_)7&(;_`:\<]^S'9;_.>O4K+9AHP6_^PA MP>MVUF&2?,/Z?Q/A>_:3,@O]P"QT\CVST+\5'U]Z*QQ^A5C+3S<72BU^:-`J M.G%UC,S[C=!'C`?6^9+^U5`+/VQD6/QGOOD[B33\5A!AQ MCTY_#U<60Z34O:%X@M,X3WS<:VS(^O;]S2K9:4^&TSAZ^>FVAS+_43)!7A0@ MP09)?'[\DY"OU]@MV'*6:R]=<;YT!KGWO"V#WV^_P6&6EI^P4?[MR]S_\A"'`17C]PC_FM,9X%C72['_ZCY^_";`1'@=_6/?V>A' M?Q?SS0V^)VPVB[*/WF8?Z#7-@#I:EV+,S51M`#I9IZBV8[`(-FJJB)&=:NB5 M<<\=)=NB\=[7@(=:FR+E$)._`SJT6D4\.IAEU*8>2=VR'CWL!%FZC`H0(SS5"%Q2Y@$3X'WHW;=HO?\]X!'7 MJDHYTAI?`AUA[3+:CJR*&F+DI@W+SBC;Q`LOH@`__V^\4X8%A^T`CR^M:LW( M;*\1T/&FE_7(V*P@BSA=1`E/-0+/\B1A/D12WPO_#_82];2J:0IX''8I6`Y% M53N@H[%37.L%JR",!&7$2$\^S1:N%F\V<73+5LVW#QXUWE6>L5,3=DZF]D]] M)\`#U5SI/?34]``Z>'L(?BRN])B),SZDCW<:*>YO=; M@1^SK6HU!VFC">A1V2[ID<.0$T4EU8EA5`#Z#=[&24:'/-ODS/?WV0V:@Q^& M>D7W0+.U+>B!V2'RL4!93/L5>23H3[VW4PW1NSQR#,I)NQF-8K/);#PVV\YF1+:HV#XFI8:S&)5M\@XU+HM-R$%& MY@!GZ%?K]R3R(I]0K>.4:"XJ]>P*=!3;&*#UY%W3#^`8MQ+?>C<@CM(X)`&_ M`'KJA>S.(EU&89PY'/'+-*7\.\;V02/@H[A=*7F\-EL`'ID*0:VWYCDY]+DD MZ.ARR"A:N7:B(NPW\J7#MK-P*86*AYZUUQ"\@ZGD/6Y$+JJE(`R'&UK+4CN/ M4W=XZ_;,2Q^64<#^<_YK3AZ]D(J5+K,S+TEV=`'^-R_,59=Q3?L"=]!>)I`= MUJ@C8`?N)[_U4*?D^6US_H?$:(&\#)6\$&?V!8^^P/+ML#T MTWB-A+`CVH$&[$D&VA(K?$^BB(V)<>W1"?V.+>$P*O/].*<2W&`?4VE6(?Z( ME5&9HBUPT->JV(C*VAH"!G6]O-9164$5)179!8IPYB@FFTI'=RYX$3U2#(B3 MG=KS]IH`=[@VA60_D[\'[%ZM8MJ.N(K8`GUTY4OC*#2.+G'FA9/IX(:+2 M:#HHN$[PUB/!^?,61RFF`U3P/;K3=^?BI<,.1C'A3.%Z7?/H M]'I-YT\W.,T2XF*TQBT`VXUYDJ+CMB5Q_`OFDLNNVPKAD@Y1:GFYES M2M79II7+T#C>XB3;75-%>-X4JN26W490KYH[N@!W8A.%FU&PNCU@YS42VS[H M$\07:,O(+[CGXI*#PVTMUUJS_7;/]_--'O*;-@'>)M@G(L$;_>YW;_ZP>'/R M1][S=V^^7WSW]@=$#;'%?D8><6BU1%;DO;K$+!%<*?.G*&"WX;>$Q2WL&VJ0 MDSTC]N@&U,?[*EXEO3+HX]C7RWR`?"A9_G!'>X#@@;8%$Y0S+G0"XVQ0R+X= MS_G;T&YJS:^;FA=LT*70G'&:%O?`_?*=`'BR^/;-:X%_)XN3[]\<#7_#A$$? MXPP;'=:U-@0*A]W*R8'.82O`X8U&6-LASDAJ#JZF"6"FUVO*`[F,:D"H#&)W MA"IW_NR'.7N_^5,XEO?VY6,BGVQQRN M0@`I/)UW2V<+"K,T6P#WU19U9)>4O@;L>6U2VHXW3@NUWW:?QJV&U\;U3KK6 M7>;B*6HG`>\?`PTF<3SC_KAI5$6F\XI+XJU(2#*"TV44W$K95L]YKM6.1RX] MN@/WK+Z&D'W/M"]@[^RM@O7F1LU()'7GY)V_FW&A_P+=X`#C#5LIHFOJU#A) M<%#FW6'&N6UD/SX?)/OQ(%AA]@1.VV$^>&#P&$[=>AX^/_2#L<8HA_(V;D1] M2Q7#FH7#5W+EU?!K;\>PI>,VEJHQ<`?5*]GV)J+9$K!C=@A\](N!@F[EF6Z? M18REY5;0=>J&28Z#0]A1&T39'KXSZE7=\\?VQK!=LD/F(\8KHXS:IDQGCCFR MKN4%9J=7L8+B5E;VQO"=@; M.P2VSAU7;HD4=!W/BV-KF0BZ+K.KU#>9KE8AN>=7B3JBULY.P-W23.EF(A5= M#\!N:BBX?6H(Z88>DA@X]MN1U99(MEW57 MQ,>=R<-9A72,8KQ?#=\9S?QP5BXXPJBN/6#_-!+;=OB6Q/GM&$%>5YEJ&F\=5>.B M&!>O@U[NV%:3ZI!O6$4^?&F!O*>MLA%0M],K5;U&/6@!_>VI6F#K4[F-.#`/ MZ)3';(?BIXB.>10GR%NOZ3CS,IRR!X5T+47GC;+6$19%D!(L7A]F,2)IFO-B M!T5;T>+W:;4A(D;Q"J_C!(L$HEMOQZN#D#*/(0Y>3?NB=7A[%A2E'3`'#U7' M4RM6JN5N:ZLSHM=V`(I@YLKJ]KAF$=0;"#W@3E=-'<9FU^#:@EAT2PIV;S[` M]\(6=11;6H#]K$W*`3:QG.]=#;1I!<)O[O"&AEA>LC-Z@:-N#=R?.M24?4O1 M%+"?=4EL/4Q+NE#>S8REJ/0R9EN]C.'+!S".6=95$,NG998E9)5G3.2[^-K3 MQ*(V=.;ES.:FT;AY-Y'Y`$`/78:"AD5=K$9P72"9+UNO"\ZC`,[UJ]O%XAMW?%V[["/ M-RLJTML3_NFW+NNI]GPX/.>GPOT>!\_R.?"(#V#;WK0JD,EY=#.9&3`G[K*P M'C]FX$)I:^@=-@/NK"K%&A>+Q6/SCG-13$9N0H,QM*Q:U+_ M=_3M=Z\7KU_S_VGFZ!VF>[+[^$9W\X>WBCV_^L'A[\FW[ MQ,T:?/_MMXOOWKYA#0#-X\L@X+6PO?#:(\%%5%R=5?Q0ZM;`0:%#S<9CQ?:F M@"&B2V+K8\**+F*$V:`O2#MZICB^GJS:RDNJI]^NYZ1/B8^0^)"#[O:4F1SSFK5(/ MBV.G!DS,/$6-IH9Y"&?ILK),YI$(!^=>PJK7 MII*\[_":^$2U=#?J"!PXS)5OUI?IZ@48'GH(;[]I+UB@D@=Z(7M!P>;K8?W_ M!Z%ZQ#?CM$6S)[#`LI&.G=-T550'@JX3GLT4RZ_.'8S6AL#12JU!I^\JCR&B>W[`Q*%88:]P8. M`CW-H+E6INH*&!+Z:C#<%3+*BCT#$\S$B@I1=HCS`W'C=#1C=%T6.TC87I\H MOZ`+LR`.0R])Z]/E@VTO9QC"[9,NJX-M,T.W])H79JC4UF#%?I?Y8(12\N&P M0;!`-0\0>#"XXKUQX.#B"##'%[=8^EBSZC%'AV^JV^GLHOG<''U/ZL&=?,0+ M878./I#"MLY-6NWAV+&[$Z@8=)NCBW;C]";[@9KF\W#RP;?#FN,:R![@=`H#VMP[4%J[L:=N/3>/56_H M*9K.R5,'VM=J\])1GW4:W:<:2]OB^A&?6X6##GS'O-\%J[FKV1]N1QFU4+9: MY9N\0EW5PK2U)7!XU:BGO%PNF@&&59VT0UTO%V0=;8&,H-^9XF9YZ8CN/%`\ MSN.+M$UWT7EU:^">V*&F[(V*IH`]LDMB^U$;I7'(MMCX5EQ!GF>KOJ+3M2C+ MY?*1):^RD':,V99FP`>K2K'F<\EF&\##4RFJ_5-(0=!Y"J.Q-'/X>L@+<5I( M\5,:\!1PK`Q="SK M-3LOV2-K=XN31^)C0^=KMIZ1_[6HJ7)!J>E,O+!-XH$M4-\\_!U-#//-T[AYG<9I= MK7G@?QN'ZJ/8_5;`G46A5O/HM=$$L.NH)+7?@4QY8CM.$3&2K@[EQM%K"V7U M*10L(WFM%:1&LW"M?:4./:ML`=ZQ#@0]=OR5!%UZU>!*I:.M(87`92BYC()W M=2!Y5L21F@5FO^Y`GY"]'=G9"P:N#H@+V]9X*V.]0->HWR\8?-`#NR3EK;T5K1;%:P<+-#/JZ"(27G M\EXO!2B<9A1W>$4.H:+"$,K&P-U.KV3S4F];2\#.UR&P[?`LR?)90A26N6BM ME3+-'#F%EJ(^C.N*,*?%!8*S>+,B$=]1.O62>X]$U]2J#U3LG^C?-]B/[R/V M]%%4ZE68S9H8<'\^SDBRO]M1`HP'1RID_2RN8(LDO@M4<$8E:QJ$LW_6W!=% M66Q7%2(<68M;(8[0JK#/MF#F!ER!&V$Z['WOD80GH%@&_\C3C&V37*U_]I+$ MBS+5,J2K#W`D-5)9!DQM!\"X:":W[5AFU(NT*C5]MI]>N<]X_3\.4N\.`EHI);L+C*\23]27V"GLS'?X"W55)IV3([@(6%T MPR0-I/%VXY:0.FQ.EIQ$Q40[8]DZJTJ]AE0QD3P!WZ?L19YS'3?AO@"->JDHQ)C0:`4:1=3MNQQ^J> M-WU_PC*'G1LPP^OZ(N1*%F[F[>G*+OBQRNM>Y*CBV)>FL,'BE>^ID+*J4R&4M/$L!1V<8@,FCWZ0\8TZW4L$_8T$@. MCBIVBW(FJ#@BP=+5:M>16<2.5%"R0P'V0SH).LSRU\#(Y:-'0@9K=[&4ZK`H M"7GJI<0W05HC*L#1P](LRJBOFP1@#+'59,#(L63*YELY6V;!EQU[4LZNT,2% M@5I#D7+CFR4N+#@""*]_$Q;I%7]/9!%]A&Y@FNGFH7,OB4ATGY9U"+@1V/5\ M$N;4^SKR")KW!C[O]#2#/-\8=@4\S_35P-8U2CYU.8YB_A"/5`0WYPD,I[+& M(5!4Y3E^!(8'?2PU4U\W]NRY^?%X7@O(/0=(=<]@"%JMG'U="P@RM$S=>F8. MN:>FSB6+IC-RRGV)AW3+@C8,QQQ*T3(N@.:<>/?X8[Y9X>1J M?5`W5#>#]J4!W)&M3"*[=R\"@)W>3@];#RFYH8(=$OQX,IN#XKIC3MX&9T/3 M6D9,ZT^E?;S"/E%E'WDM#J32KL)"!0R:5M[N3V6>V-)E%@-T49&8'[YT:C(1 MPHP9A]ACS&C6*2.4>>%,==IVM18;I,LH8,?I"7[`44H>BXM3'3N`_:D`QQE+ MLS325?0C`1AG;#6Q3\VDK*[38(LNG3XD;S'!1TQM=.<]*PRI[P'<)0S4W:N* MJ6H.>*B;2&T_K.6QVSABY?4*V/BF?!:3WM3K.CB;SB#%87/[H_L)=]M^S4FV MZSKQVF\$W'?;E6ILJ35:`/90A:`CS#7RJ?#OD>`+(%`3@C#?B2,FZO*9J*YR M=_4!/FJ-5&X-N=HZ`![39G);[Q%SHJBFBCXSN@<'JU-C;"70NWCCD?TTLEUM M@8]=K8J'P+O7$/!8U6M8C`O#J+B?Z+(@Z\KAQE7/G8,L@(.P9HA=>>R2XB,Z\+:%+ M+JVS=?4![GA&*LM.J.T`V"'-Y+8=OS5UQ,C3A3$J&#AVU4G5?DFBEP4#AT[L M^_DF#]D:D6=F:-D4T3MTC_[0G;NO*1J.;MH9LM/WUL':$VI.14+*UAU$QV`` MS!SN0.(NP5Z:)[ON8+J])7#'UZ@GNWA+,\#.K)/6=IR6-$&$U>,KZ+(L2D87 MSS@HKQQJ?4[9&+C;Z95L5D!I:PG8^3H$MAV>)5E4W8UUZX(CJ2E/A^_PFOCD MX(1PTJQ>#!3P.RS^>]%X4B?VO6[B,'P?)T]>HKJZWI\*<.>U-,M>1JT^)`"[ MNZTF1V2^XGS0BY(C>V+5>JJ'/C/&J.#L""<`V\?EJ2>5YB)-!0AX/!B;YSFH6E?*H!!Y@AE;/U(A/F")Q),D>"Z M$`F2%^)V[$O6/$`R[^K:#_7I-299GK@J..O,;L(HOD08'-B(J\)#H$T'I7G" MC8EY#/!&1V9^@&.DS1B((QC/&'(FL-PAYO!GA>):OL.WA%H09M]=;7E&T_-G MG/@D53X!MJ$S3^SI-HUQI--&9'ZX8Z#+F'$.;U)P1A5K4/@RNH5B3A;A@JS# M!PIZA#T>4/2$YHDH!L8Q#V:^#$PQ4<;:911A"EJRLB'W(EGE:M<(9ZZ]'?]X MR;9!%B7<+"J\2=DVAA`=%/*,:L=6Z)E)6%,F`+4%X4O9>7X0 MH]%A]'"EY`@**T8S2*#0U@0.MF%^SYS\N]??OWW-79Q]HH4[G7_W[@S4N>V, MP#R[7T_';AW$?L[FW;9]+TM%K)/F52_JBZ?T1+AY(-RH8HUJWLZS M#SLP4XTFB%52:[6+PXS$=07;]"YFE;DCGX2XD=;]+AX&BD9B!1RLQC1P\['7 M\'P``]ZHZMJ_L:J$8OEE*K'08>T/5O%C9N`Y!Y,GEYWW8#;!K8F,H0;.E&=:6>G>T6:$LIB@+= M^-><;!E`+/@_2?2(!6`P(`@Q/_HJ^SF,PR2SL'2`&34(685XF:8X4^4AZNP$ M'`C,E&Y$.=H>@.'`4'#K:5`BSQRA9H`$!TUUKG>O- M5?/+J;.[?SK214G%O0Q'AZ0CW@9]">D&^D\>B=CZY"JZ]4)\M;XNYOMK%B6< MEP&"PDK&G8%[:S\CR-YKUA.P-_=4P';@,S;E`I_.2.](NHU34LY.)5/$N:** MK:OZGE,:A5H@X-;PPLXX'=)SVVKKHLB5T['%V8L`<+CH;PS]^UI5;\"P8:'$ MP*]&ZXW`*D>5XUW`"6UR]L"NJJ9[&W8\L.>($1)O14*Q.9H]>!F#%;;QB%[D MS'QLQ\_AIMZAH9:^'^=1EMY@'Y-'EH7/&P>@M:#O?=#Q6\3O#6(\$[O,9)@H/S9[9_P4KS\.1XVOUX:V*S M<_,^1M+[OPFE60%#+X5L/:=@@K"@+N+AF&=O]/.$E;4I`^5_G?PW'/!P;1O7 MIP*'%OD89UB*B,[$CV=L4&7WV2&*WA!Z#&GO.RO4Z%#!^I(F)2L%QP._T3@& M"J91&)*KEXN5:V_'1&-W(7P_R:GAZGV,WHNI#F*S@X$^1C+;--!1FA5$]%)H MK(V%@KFX:B38(XD_E#W)26Q5&64KN"R05UBD##T6J+A]A9X\]O`^VU%L2G'R MB*6@)%2;SR5#+P*L8>&L76=PZ,QA;%Z$0#NU?V-8?[` M3?UAZ%9PCIH7_)[X`$]M]83FB:(&QC%`4PV5^:&JB3(CH6O%&M)K,0=FVG]J MVV87AQ="BOQJZ5V\]'_-28(;%^[H$K7K(FHO`L"!I;\Q9$`Q[PT82"R4L#X2 M*5BQQY`%L^HZZD+<1Q6OHYQ?2IW2*%3\![;5!?="ZH$U3O.41#A-<4KQ5>1% M*;Y19?GK26)NL&%@$"UP:/K/"3I,U!@2/&I^5>)S/ON63,'`QZB&D0#D!H?D M*EKPI^;TGWR]XRF,,2%^)+&/<9"R<*CEDK])S-&+`G3TZ&^.!GB8=X>,'19: MV%_%$+P0^QT0XR8_A)DB\C!=KKBSR@S>Q9BOY8Y>#,('D?[&L-L*`0PA%DI, MN/4!:D-U+)LT-E1)907`&ZKO2>1%_@`;JGI"\T0/`^,8H(B&ROS0Q$29D5"E M8CV##=4QS;2_H=IF%U`O[&XH#";$IXM$)KKQE8"#;L!!Q%1Q_8659A_``&$L MNNTXK\GQ>170+=F!%14O:EG(D#15AK%%\;.X)%<5G#%8J[5T`>Z\)@JK=AWV MVP-V6B.QAUE!%^3K0D7NMQ!&UKBL1,3V#(J;I0X#_G+3]7VSJJJ;NU$V0G-Y9]F"FMY#&N MB]O,Y5-H3R3M?:&]J*[$3@!4,_P@IGC$R2IV;0RV'[-M&*0H0+5OCC0.^8ZG M%Z$\"G#RE)`LPQ':YJN0^+3Y&K/Z1P-682NAOJ%P:86S.#U(!F#>"RCD]52[ M*KC6W05ZI;4>&MB.]+L'+/;NXSQ;A_$3#W!\2IJ.:OYR/T`!2;"?A3OT1+(' M7G1-1@>OX1`3%UV;P$!5Y+0WE?I"U^H']]MT=71_I$=A:Y-^ M0-&OM^K*&R(SJU)M+OM`MT$@%;6?6GEY`R>5:DP[]'6ZD*W@[3*.[N]PLBDR M.EZRS>@K&F'=\ZE3M2_;CP)P_[P/8;;2U,^XO:1NNZD2 MGW*&2.+H:O-G2J-SX0O&M?\K!9+;>=P M(^3HLV_XP-+?&'8W/P##BH42$][T`'5_;"R;\#7HB[RTPU:RSKJR"83;9.?K M-5T-7ZW/GWU^>'U#X?DJXO?X(WXHSN[E/GHAPT:%:7N2`(X?-@:1$:1/?\`8 M8J6&K<<(9BPN*=DAQH_-Q1Q)V:AZWETO: M];[&"8F#_7=(TD"=XDA#"8[S3'T`+O5(&K9.AYG+A*' MU.SY%D&''Z+/3`C$I7#T:M>IX6:!6$6"IK-XLR*1"`-(:`B`'G7A+1:96=F-RR!RP=$YFF.7`_ M[U*T<>%`T1:P+W>*;'UB7A!F)W^(DP8T6KLF*5W[F8U7[52D;#RC$3LV/L`O:#B>5%OVZ MYI6.+O,;M=K91==^7N-V.-"MB*-_O756*&X*_9PFRXLW^,Y[[C&7Z'J`]\I. M=?>RXZF:@_;);JGMARRCC2AQ[/(V1(N*W=.)MLO\!F['=*)N/Z^A.R3T!^ZN1V+9#EQ%'G#KZ MP#.=8?[4U>&TTZ9NU[S3U6>&`UD[\V@[S&PH#P?#TEB6Z`.8?"936W9AAT^_ MXLV&9%P(]J(EYO<=<,0N.QBO@/K2`.[A5B9IO/[J0P`P`MCI8?T0H^8FGH') M_!S.<496Z)KT>A/Y$GQ$.RWVHS!W+QEN!M&Z"?K7&T?[@I"LX`XK;O-5BG_- MJ5CGC]P4^HE3TQRX_WL'<:B6T?"4G$%^*EP@Y]+O[K?#ME5-V+M'\A+M(@2ZP&?,#/TPV039%B MS`MO,R\3VS9"GTSAH[T[`_56.R-4*0",>T)/#-!?$=MQ+9W&L;(F#QAY]5ND MK?#L*EL%V92IZ+P0I95,$Z<\G\XX!2=4L4(U+U0CC$"]:4$/D"7`)1,S"V<, M^P)%2BL3&.0-FT^DTTO^,3*%00M_IC.()J?BE-G1Z1(JQS?8C^\C8KZ.,>D' MW.F-56_F/^_H!-C9S66WSW7..2")!3P7=V*&`9).:3KS.F=(ZC;I.9?5>*2N%8N'Y-^8A6*S].,;+Q,66CEH!%P7VU72G;. M9@O`WJ@0U';4?1+%Q2J"\+QN9(5=5DTD<2*2IM.53>BE*<^\Q7-_!?_(!;J\ MPZF?D&U+L'H$&>#>:FN89HG%?C0`>[RU*O;K[287>)C@W"0.8>,C?I(6&$D< MT3]]^8#%;,?1@@QPV+`U3+-N6C\:@&'#6A7KC,WXJ9$SLL$2'H9,;A^*(7@O MK6:#J\.KD/X##O*0Q5E["7-87E)_&07O2)AG.+CS5F'G77][:L`!YD@S-2Y9 MVI$"##?':F1]?;'@RX/Z@Z1,"\2Y\]/2@C_ZS"5P#T`0+.;'FVTW(D]XCBFMLIUG%'!B!>&.VX(\HB+ MO5;&,]5BT9&D@`+1$`:JCFPLZ4`_OCE6+5NOHN2HVR342^0C'1*MXV0CLJ]2 M=\D\PEP'93'WM6TIH?`M*F!UVL-%G/9HQY7E*CRZ6B.),RI9H_+4@S-'^^CM MX,C'N:7HR.H[=EQ$DU4^J[,\2>A?/R[L`0$/JMP2RS3%_*'L)?%6).2UPXM\$,%51!?*U"YTGN15,7J" MQC`\9H,L`YJT'7X&8#`+C!I2SR$$T+7E/L91TC`>:\67'G?8?XC(KWF/Y%3'$@<.H,,:L37=U5&4 M`4/FP`H>GTG*R'UEX80'+U`E'ZH%!`.<0,Q,N>>;K=@-S%-JRRRNM@AQZ]U4 MB-#8G%0^1?$JQL8OED4^'36%&2XRTYC)7L#S.K$:H:<=BCO!Y MI*8#XJ@F[%D@63#$)4--T>`CZ)=BZ0%/742UY5@JX*Q(W=3=&BB8&:I9'8^H MFT(_`3&0W'8(1]ZT1Q(CJM)27]QADL5ZF5R6Q9/JUJ6G.^E?'%T[5]O&9("Z MZ[&&:=_,,J,!.'JP5F6('9.JIJ3,>$1U\]^DWPP'<:OJ M7<.YT6EF`[M=]D&'>,D#?19<'-?\G5;[1;?Z1RR=1$7AB\C_@#4CGYE4GU[2[!=-%:9WK<)=/PZH8$B8K9Z+.@ MZ>*5_1AJ75GMH(PVYU_2#RXRO.D1J&7W$ M&<"9U8?367K%)Z]!07FN2`S`TQ'B-$LOTC3'P57"_LO6PA]S!EE7:W$G5'QK M;DH[XO-#@R.,V($;%I3GA3#'*#ALH%UD\RA%08(9BA-4"K-`0ASFS+?CW7*W M`2T79JR-(:YM%X]RZE-UPOD`AKM],Y5';N0^LH>Y+J)SAS,`%<[.)(?9T07WE>)C<`CBF'RC3.N*IO`?MZBY#6 MYU*,%.*T'%UL'EJ7+:.%7I`(!7$8>HGTOO;K451\Q,DJGDS)LS!.>69+KF;Y MV#C>;+UH]_M4`,:0%UIP]G.<_$(YGGE;DGGMUPM:&@%%`;U2]:V5_1;0=V?5 M`ML.M((<*NC120AYXO_J,A$;G-%AB)X>B/^`DGI#-Q9706COD-!Y-&!!@/?H MD9#?PQ'YI]C^I:%!3$=T@MBCS&RW0"3RPSQ@I.YCZFD1 MMT)8?/T*+<.8?O5$L@]?V0IWF-`H2I(%O6>X&>"M7\ M6C4Z9%(28':'S$-;+\F8:]5J%"TGWH,>_D>E%-'>#^M@$WHM6K5U@HT#"K5VKN])SWY+@8A=(' M!W%[-E*U!3Y^M2HVR@ZU-00\9O7RVJ_0V,"LANKHYXH&Z\]Q%+TL8WMWWG<1 M^0FFPEQ$-SAE:Y$,\R))"CMHF@/WP2Y%93=4M07LB9TBVX[1DC!=1Z*:-*_X MY6:_:Q)-DUI3G]7T2C![9LH?G:8>^RE8PY5'T2E+O"CU?,>Y>*^3V,IKG%A6N5%LD+2JLY8J^OR4Q.E^ M5-RO)U`GME"_VEPQZP9]PZ6G%M9Y(1\PNF>4Q(Q&HG48/XEQS0L;!P$_MO7" M:E>7_FIT$ESE?%^YR!19;!M/NYTSD854B+=&C7)7G)F#3=^)K,"I[`&?XE@] MC<.`14M>A/(HP,E30K(,1R/BY`<2D4V^$147WL?)S^S@Y)R/R5,<$OR(T[L' M+SM_)BD[=K@I?H3T9Q*&U'Z/),"W^7I-?$('QDBM)=? MI,MDT]1"3%98+BW-/[G'$9.8+LDX0*USOCO/UF:*%GSR>L:)3T3=I3C/TLR+ M^,%HF3!HP<\YVWHGHF3"'K"EZ(G:EF$E,RY**^M*I[9TWEQ3`Y='H=3"$T^> M,QDVA9A(R(FHH(A+BH2HJ)05,6%1*2VJQ$5,7E0(C&J)424RNHL1$[H^P!EG M%M=L)\[Q!SEPW"=<.JWP62K=`#ZK\CP3O[5R0W>;-5?2?8TS*DD%!B$,>.-H6/VL+SOSU+#4 MFV66`RX3[G"RN5J?/]/%2("#HC[Q[HRM9ZGX:0%M;>!LW!.H@UBH7X799MV@ MA\D]M3AF.Z6,;>FZ?<-&,RZ8EA/33FRA,+9BK;S:N=M$FLX9^IKJ&T.?Z#9WZ-O3XBCH$[2^#.@; MRBXFT"=X`82^@8SPH>?`<%A@/EK192-FA7LQX'$M."&)%8";TLP;<<(>5^T^>ANL M22:J:`I\I.L4;%R3;FD'>!1KQ;6^)"T118RJ\^RA-WA+K?9`I5O>)YCO&.YK MKLTBVJ<_\('T_+9 MB_#M4IUG=+\!4'=5*U-M##6^A;[_TR[LJ/E%.01)N9)U>=F3:Z$4`*!39&Z/7(MB`1.:Y*\QB3+T-THT3PZRA+I<"#`]KYXB:JH'LKW&"7OD MXMVK#E3[]`<.";U-H5\I*#H#!H3^.@RY?A!!=<4-U>R@K"3&LD:M,RES>F^5 MRA^QL&C7Z(; MR?+'<+Y\NK?"V1/&$4JWV"=KPK(3D0U&E(S'7NMM\M`32:XG7C!"_JE4DQ'B MXK'5]G5UFES_AC5H5X48^,_1.&QU-8>!M_E2ZPS]QST;X-%.#/;2!_[J13D[ M=/QV@>A<^$?^FK3\[,T/Y8<'GC'^A(LW8B.GMGBA>&W@N_@4%W5!@].=>`C\ M:1M'Y\6KUZMU^0/RW[,U.\6DW&J*$L4Y*3:HR)*H&0W`F+$A_E[J";SZV5IF MZUI@E@3B%)=UF`-TNBL33#"Q42DWR_-=10)"=#BS.L3?Y::?UYR)>BOM;E-Y M"_?6+C@0,G9V`SI[]E&[>5]7U`+P'9BBXO4L( M\CP8E1A87;A21)UG<9JQVDC4\6KG3Z_6=W'FL60Q_\!^QMK0C]JUK=[_M>'/ MH-2!CON1S%A%A<.1AA[UC:"I_2UH.NL4LDB3?\JF=2X.*N1!7"#V<>6MRZ:W MUF]WIXW)_K\U!P^GYF!2O@"1YHU`LIVOLIWK(\24FHF?<19'G%U)JOI3`3IY M'&F6[D-%)0G`896M)D,O"5.Q"RB?O:?H<\D6S)W%<8T#Y.I!2WW@&O6NUG^+ M6:;#JN!YN7)5V-":&'`4.%=[36FU MMP2F$O<4EFK:Y%'8I-H`\A0FF1Z`SN+-BD15^D-6L93_XXZ5<5GCA`IYTF%9 M0Q(S`9L^!FF#&)/^,P"67FH<#2<2MP5J\$,20[<`,HE%JCUVZ^/8T>#A!OOQ M?43^B8.+@!WRK`E+_['DU9%+V*1AVR7]F(049VG0EJ;Y!@\7CK.:@FOTYP M2#94HF2'O)#C)J\-+RZ>;1N@6U7V23.R$7G7/9*@1R_,<=DCHK8NZL*##.6. M,?HT/^UO#ILGP.3?#A8??\V%;],SR-S#UW%PDW&;$#>G,\]T*$>%N8C\>(,O MX[1K/UW5%CCB:%64<:.U(6#OU\MK.TC9\!1DT0M&^&NTS$1]/AXXL;O+'B_" MXCHJ&DE]ZNP)\[8?W3GESYC=2*)`]$A%N<=4I!5.WI$PIY_=\AIY5W5YFF7P MCUQL[W>X[_%4@3OZ0&:3(>%(DH#!8RC-[-->^`G/4$=GQ%(65`B#A``'P,/% M(X\8G:_7[!Z`:P1R;<-W.(K9\LLM6DF_9%$EE*LN_WAW,?_LE#VZN/9VW`@L M3?N]*/BC,.\@A(%CUG#&DV'K>*J`D6M`Y88`K[)HKQEDQ6O1\N6*/T`JA$.R M=&ZP#(!5K[:\8A[?BV/G>0GQV:0@B@![3UX2I.@%B8HRP5\#1[PS+PP+C>B" MLBB$<134*2E^"1BG-U=O<&LG-W=4Z]#*"9PQF9#LNJ58@'%L)#N>R57+JZJA M,X*L.**1;,KK,EY3YOSTE==\/\K8.JI?!'1UFJT_?"E)SA["NC5S`V.57$7! M4"$9XJ)!AK+Q[%D;02#:D4"FJB3X@,N?XSK.V)[\GKH)OLTW&R]AF_;+]'T< MAO%3^@YG'@E5.]:#$@8*4<,;KRY3.`15@$`U@G+'/`@/2A3:EG(@OX@@!&QY MK&YY)0OR4K06TJ`7A3P'CCC!^Q88!GS78;P!$8JC:1$N2AMZ;;91-X6,(AT* M5KB@:`?]Q6"7V,?X<,3W?%G(4/@L>U:5/++K+7&"2)KF'K7]7JI==MX7$.EY7V8E1?RWND#QAD*O`QSJFS!)1JC+6W`DOKRYGY."6TX5/!=&5$7 MLWCTSB_AI!-G?!C+\K<-@TFF=`"'D^N(7IP,&7_=5#MM0A,]P&E;0\:X;C4K MF%,WA8YT!I(/"G8Q?X+;W*@=VQN58#.B\I,KJ8<<()H>E5""QXN,0[G[MO\> M1M<.,M#H5)/2-1PV@@XN6IF'AI76K=2I4R.,H*]BB_AP1I\`1J94\,V0(4MS MG^M-FVZ'32!CAD*A"B[VOH>.%"IQAP:)O0W*:>%A:"4/=EL/768"3!A=J[=# M`H&X<76UUNY'M:EIVA$R:/12OH(2HU[0`::?$D=4JY;S%?I[PYROGSWZ8!S@0F;H[>6>AN``\*QM9$6'*!LE"X1JB5`I4IE]OQ**UYHJQ&+I M6<3U`O29B^:P].HM%4]4>P^]-+U:\]A-5[U8TQZZ9W:IVG`R56/(_M(IL_7* MG!'D%Y!Y).ZZ7K"LG[9&<&M#X,-4K9P\/@];`1Z8&F&/&Y%7U8AT6N9W-/WB M+OTFG"AP0B>XL^8BO[4@L%D/X%YHH&YCNE`W!^R7)E);1TN<-CK;OP_IJ)+N MI"I3NAAO^(U1G]^QS`C[>ZO?#O:YJ0U.C1I#]0?C56M3DQTC:$?E!C) M;G]7:,MNN[+S?7;]M#KL)YP;NY5*^;&:B"<37SL=5>O2%05U=,&U9/0=!<63 M:;SWP_)JER?CX<][O$I884W:\*TQ"+5VFA$2J956P=%ACYEADD:!\8"I9,K& M\%NWZ#2"_H<0)3,!A%/CZ=[V8W/$>CL>8A65@-EZQQBPVOK,"*^4*JO@ZJ## MS-!*+?]X8%7PY,/W6[=@-;SZAU@E\0`$5:-IKOREW6W-''E2?TDB?)'AC6HG M[P\QG+!]9\>SS)X[C%ZP"$HF#GY(X5=Z\&843/$ZILKJHSG!P,5[SA'5_:CZ26&D-SPRK%UNXCQ2Y":(\F`;X)C3U&8UE?."W35+7-=Z0*-O#QG2 M3%2M3U`UC:&#F)'L`Z"77Z[&JO'Z5-84\HJ:0LU,B%,?HXYIAY_UJKHX.P6D M[H0WVJ54W'QW3J"Q^#B3"MSOWR`VZ`<4S7JKWKCCWM4)\*+/7';[1%IR0GK. M8U'FLZ_8.+KR/KKR=0`BO;<2NF1P^S#K@DH4 M4=J[&^_I@T>-2;R0E1FYS;?;D"YG/^+L:GTCT@2KZP'UHP$<'JQ,TBR:T8,` M8-BPT\/6BRIN"T3YH8HA+]-3LA0E[D4F5\[65;&+*2W#S+%IF",M^`#`C9_C MY)>+Z#J)?9SV0PMMS[E@1+?ZK;FVYUR\O%O]5B]7=YN#EQM(/X"7EUP09P/- MR4>T0:7X/:,]X-;DU9;5A"?1/2LU?^8ER6X=)[P@Z6V^^@?VL[OXDFR(V`=K M/8;I30&H'Q]ACFI#LU]WZ%N#/=2) MC?(>!Y1?*-9"+`<=BMBTH1M4Q=B+XLQP6#E#Y//G+4GXG]<)B9.[^%-&0O)/ M<8NS[>[/6#R^'%0W-ZDE[G:2;X22SF(E2+A:Y+DTJ2.;G!!=.ZR[XCG`]7-J%IANR0A4SX M>P"V`O+C^X@PZN_CA"Z*/D4)]D)6RN\T)V%V$3&+ME_PLJ`!>1:R-4E=*Z4G M`>BSB+4^`\T22\S(( M3CW_EU2]`K`G!1EBCS205"?3B@YTP#U6K<&C\[SFC5:4.2\A[#TC+Z!NQ`0H M"P"SRB39[O>(ANE;[),UH7Y6>."G5[>OD!\G6TJ'KNU)Y,<;S*DD.,N3R;=\ MW!FY'9B1Q!N=%D:F[!'EC[@`[L)J5[;Z9#+NN@96,8[=';B]*^X/77#)J)4N MB;>BP3Q[6:(XJ^CH`A3;^R@LGZWIV@,^5#,2VW;HE\0Y!$B$G;Y"'U5CKA<* M2KV9`X<%^9W+T_)"U?-G;T,BL5N`(R]D.B\C:@IJ-9QF2]]/#A^FVU,![N*6 M9FF>J/YGR145;%V=ND]KFX(.#0,*[9DI MMB5#=SCRWB/)W[PPQTL:.V5,KQ3]/ MO92DN@)Y0]('CCV#FU)&I<&(`\:KX76T/O.EDB`N"BKXLH4Q#7(JWMQ_9>[N MB]U5YCO=24*_3_"O.8[\G:8"BEG/N;A?M_JMCJ7N-@>7,9#>UADDPJBB[+Q* M2J5YF][::BEF/>!J>L[!YW/)KW849GC!>:*W#K/XGJ<985D9KM:5.:H_WI'4#V,&.!E1K6A4D*9JS4L`06TI\U2\>@,:E=[N+,"P]N"3I9'Y?G93N>\=QL M6=S:![C[&ZFL6`0?=@#LX&9RVX[>J?E$S6[71S[M MQ>]R[-O+;($\(M^Y>-38IF_URK&8SL&S1]=]@`6!)&.Y^`_0521MB',Y6\)G MU!05G>[0`>K`V"N8P^^P,K?>=*A=Y-O6KC[VVP!'PU:59.1J-`",,NUR6N<* M*Q++CLJRP[-`[C_CF+2H:]C7LZ@T.PX>@YQ1"<$XM

31D,H+)4.T[-VH[&G<&SJ"]3-#`YO,ND)& MG9X:')$64?!I0$CKAJ8C>)C<$&'-:-X1$>O/5V5WV'^(R*\Y'OV=BH8E=+29 MP.!#AT\J?I!Q;0JU)WSSLD"5-*@6!]!+F&'M/,4BJX/M;Q-'1E^*Z7C^]O!D MC`7%T9CR12S51C5V;;>LI,[S2WEBI;PI5\;,XBQW6<*JMGH96K,?Z='QJD\R M;K[9\C2(-R3]Y7V"<4:W!B+Y<,ZVK_`0\:=$++T4>RY3E4]AV>/^MS1#GSUOL M9SCX6\SJ3;,3L9X`H20P0XC0&Z,+)-I[SPPF.I08&BA*=JCF!PPI1C*(I.\< MX.$.)QL+HQ7=9@P%LN*F`,#ZS-3M&Z*/YNR,"SP/'T3W2L>R>G#6HBL,GWY' M'DF`H\!RPM_K/F,?;S.$J:_+?6?J\ZTJC.;[)3>@T_R@QJB4#DJE=P2'`;P9 M__A;>T:G0L.QF0O:#&S8D:[]SN;$9VA5A[A"TWUOALNU,+C6"^?(YWA#&Q_S M#,OJMP,,9LT`J][T(Z%L.]/?!N1VZ`X+?Q=($A=]9@*C0N+YP_%(OT232JJ^D\RQK*$_9WZF4 MF"*7?U=2I*0@K_`KY#XO15NBG9])]G#P8Z5[AFS^MM6;-DZK:[`,S&LNT\,8 M)N[*BG4THSE,`Z/H.W3NU2108P3TH MBY\*V&;@+$J%!27*"Z5&M-=MYB79["U63X9:N\&?E11&^\DCO+381>2'><"J M#)U["=.WN8-(O]7]`3G*?TPQCT(DUS92W$ ML7C]MA"]:>(1T5LP^NT@]9Z^(%&9R&@4?$5L[GMP.M375!(BL7<5A4_4'8.<+W7H9'V><9U=SGSSCQ20H15L]3 M"A!/[_`V3DFFL.E^&^!`UJI2,P&SU``P=+3+:9]"F5%#!3E7N9&'U.C,2Q_0 M`[L:2M>&6*@7M*LWG4.QNQE7Z[,$!R1[[_D<13YXSV23;T[CA(I(,>;,V])O MLIW"2CU)`'='&X/(WMJG/V!GME+#/KERQ"<;P0Z5_.AD+SBBBB4J>;H!A&FM M@C,J$)^$A5UXN'-+F=)AS,*A$.]H/!/]X@X]SI@_15DB8A*2_J*[(:YL#!P1 M]$K*OM_>$K"7=PAL/=/)9,4[<>>WG@]4/=V=XLA_V'C)+YKL_P;=YC9\%8IK M!_)>GSD-:97H`P[NBH'SL@"'VI>B:;/Z&W2;W2AO5UP_RIM]9C7*%:*/,\J= MIJ&'J?MT/K[T_3@756PQX3M$VGSRFN;`?;I+4=F756T!^W"GR+;CMR2,:LJ. M\]"/KVI247987HIOO][@1QSE^"/6EWE0M07NDUH598=L;0C8&_7R6I=-9%11 M0191NHX=<1PM"X*I0]=K"?OO*,]^*SNI!W`W-%"W8SU7-@?LDB92#QCC,=KP M%G!,JGYKMT:/N8WC0W7U&VQ5\SF-XQ:I!Q_'L)9H#C6>T'?Y-OV![MHPL*L/ M=/\U4;GAP;H.D'W82&[K,2T.>-KVS9V&BY-HG5"*[ISV@_>/.#G+TRS>4&MH MXL76AL#=4ZV<[).'K0`[HD98ZW%84',>_'WT-OAJW=!0&_KIV@,?F9VJR@-4 MV1CP..V6V7:X,LJLL#RGC>K!ZS3B&T_=3@5-_',;YO?,Z[Y[_?W;U]SGV"=_ MKW"D-493-`'J63J%F#.U?>_8?X+8S]F-5QY8&!A_@(VJ+963U=5`)%K'R49$ M6EN<9'1DL?M%68PVW*_\DG7Y5)?V(MGN8(MK-"`9Q0`5/4>!Y;A*C8`,5U'[ MZ9JRT1S0X4"I`WRH6LP%(0X%'A4C2G1`L;BYZ!P@AM._FF\I20@H,8)F]$<; M`2KNGN)NJ)`;S0$J#I0Z@(JJQ5R@XE#@::`B>XI!0,5P^E<.14E"@(H1-*,_ MVAA005L9Q!7-9K.`BT/%#@&C;C,;R&@1>2+08)QAP,:`-JB!@ZL'`3K&T([_ M>"/`QWMJA&[T:+2:`W@:,@8!'`-:H/(L1A,";(RA M&_OA`%U`N>S(\:_M`!1VS)75WCZYG$'6?`.AAWSF=>DZ;_V8^I8>VN`QY/R^ M+_O'G$'+U;K:X6S%(I->0!VQI]IU/-#9!7Q\8*[!P/$"#1)83!!Q?OQYO`>,?(;KLYN;""/-R\R>:/T`>,,!5YV>/]^Y"AC?#NVX-S'RGC* MPX#9A>@L-A'86V$(K6?4XS2)O9PWKM` M-7T@0): MOXVJB").U7V.B#TUNU:^FN;S&J;:5:^J[7R&ZW`KP,,AJUGO'K$0/&6U;7": M+OU?+-JH,L&IL M+A.]BB-=[3&6R+M/,`[8@G*%$6$Y?0->T:F1-))$R!<[U,@G"54TS7@BXXG7 MB5.:L.2%)&:HYH8$.U3R<[!RG-(:RX-Q0PK2RK'A+@2X8LY^&^"^TZI2XTV>W`"P_[3+:3OB"FJ.?6@4G5R^<'WN M=I^]-M#=ITVEYI/6YWFX3ZNW`"P^[3+:;U09=1@I`'B2_!3*E5P%F^V.$KYUM"2E=^XYT5"TM-=W>;: MV['/N/RU2:+@FAJ"//YYMM&.\P MOF6[T5=;9B!M**QK#QS4.E5ME!52-08,+]TR6P_:@C+BI)&@[3B0'D];H63, M23K<;-^_5J`/LM6M@;MEAYJZ>R'P0_`NB0<[:H<1EQ]JJP^N->WG-VHU8:ZJ M\;Q&[E`!9_O8=1LJ`M'6F:_JL[$KVL[+1S79V-L:SLBP#`!4`'`!P;'5G+3(P,34P-C,P7W!R92YX;6Q55`D``Q:"PU46@L-5=7@+ M``$$)0X```0Y`0``[7U;<^.XDN;[1LQ_T-0\[)F'JO*U7-71O1/RK8]G79;# M=G7//IV@24A"-T6J0=*V^M`(I@&/SRX?#3P8<1"-S0@\'LEP])]-&)7`@__-?_^;?_]?._?_PXND#` MB8$W>EZ-O@.$H.^/+D*T#)$38P&CCQ^S@O]S_G`[\D(W68`@'KE9K5<8S]?U MSA'T9F`T.OUT>/SI[.S3P:;VN1/ATE@>%7/TZ7#]F_S[8?#3Z.OG+Y^/#@Y/ M1U]_.CW[Z>#+:/Q]7>X[1C"%HH(^#/[\B?SO&7]P]!;!GR)W#A;.;>A2/+]\ MF,?Q\J?/GU]?7S^]/2/_4XAF6-3!\>=U+68)\J^/>;&/Y$HN\ M#R.L]B"BWY;X2%X+<$O'R*X6/I$%OW9'('I+Q^6 M?C+[2"QP\.7X@.#_C\N,&OF?X\"["F(8KVZ":8@65/L?1D3^CX>;K;8062&B\^DS&E+H_M\7W&&.:DI9_AF?/JKP2/-"JC52/Q1MG> MB>;7?OC:KK&`<;8!P-,,&8SP;K;I*,<3IVE$?X[`7PENT-5+8X-5 MA1@\.^U@EM(\6Y4'Y"?GV6^(ER5*[PC?`E!%A@EC)1W@6H#BB3-DW7L)8@$<&C*.0/\-8_ MA3'YT`%NZ<'HXR@75/RK$WBC5.JHV:DU!4JL$KI;;?%)-$.(1%0C/_D7#^'X M.8J1X\:Y()\H^)'63C% M?^`?_2O]^`.80?+-(+YS%J#45%:Q?WTY/CT[.3GY>G1T\O7;Z='AM[-"BXO4 M&:/MUCO(S;^!_UIAT[:ELA*?E_0,^Z,[A_Z:(%,4+F1UF34@5`04(@^@7SX< M?A@E$6YFN"12'7\7MLEQ/6&Q-38I_GK0MA`"R6QPI-$&>"<`0PS)N\2C),<8 M6^6LL(H846:>8PWF&>,6>J25U[XSJS'+UN\';0XQDLP,)QK,D**XP*U#CG^# MI_"W_PM6S&FD5&[09I%'E)GG5(-Y+A)$,%_CM:SC_S_@(/8XQBHZ:",I@*;-BM?0!^@"DVR6 M1ES4FVVKE`5V$N/)#/-57_=*!X,'L`P1<5.08+HD8G>LVN(6F$H!6&:S;QK7 MWYNQ^QK_I,YJ#=2NF.0RYZT# M?YS4A0@9;]SA`?'&K<7AOQ92%CXBH]FB.VA"Y9 M8%7T`%R`X3_[X`XPAXFZLE;101XA\XQA6.9?1_FPK5XL8I6QA<"8!Q7#LO$] M`DL'>E=O2Q!$`(]VDW@.T);F&*:7J&D5(YKB91ZE#(LH,I2PU_C29JX>R2B: M.8P=7Z.9'P#6"W3QWKM^]<.PO*B:H6109$$CE)8L!NY1N`0H7MW[3NK-PK"7 M9)/-7ASPJMA!"&6$VE<-C*BS6T`2_N1P?@0>.7E90C(6D=]@.(/S7,/1> MH>\S""!3U0Y*-$;*C`@9%DD*>Q\&%PHE[#"Y"!`S2F18EN4:U29[BDU9C2L9 MUE[N%CK/T(FU8S6@D.?F2K&T.'IN=^K8!:LKTKZ$#N6)!=P1@^=&)? M+EWVZ.@P/_VX=U9D$2QP!-86-ID8[8Z$)'#:0P.4X+96-,=F0GUY*\F@`-62 M>>,>A5[BQK\[B-Q\6U$=.*S]87UA^YB@@%.[0[`;&EQFC7T`+R!(!+-#?6'[ M:*"`TQ)78=$M.GGVX2Q-T,2G`[^2?;1H@-<2UR)UH4@O'1BE[2.$"E!+_(?2 M)-@'^ZN9OK6#4;-7JC0KWH6!J[):V)0WF0A=^!G4@%NRG\C6S$2!#W`VCSD7 M5F6JV,X19>S:]QN,`(3485M8#]6%&U0*V6I>!;26[!S*:R#AM,"N8"LI&B*W M9.]0`"Q>*MI.`1'4KG8)FI>*3V!!'K9#*ZGS2D9IV[F@`MN2&(42Y/P^UGA! M#F/&<8S@!].VWSO0NPDR!S[K MQ+N^M'TD4`%JB7=J[+K)(O%):A*Z"]MZ)#--(T^>RKP#\63ZY+RQ8R)4I!05 M^NW`"N9TH`#MCJRN[MO%#@R`E[\245#-)9A"%[+6'N**]O&F(69+7&1/B&;^ M7PG7']6"]E%!$F-;YU=MRGPS]B;2>Q+[C"^)T1(OF&CKUC!\WSA:].XH# MX)6?'"]JJ]KF0EH3A%$Y^%)>;$C4'SXZF&"V)ZJ^\K")<8G)JV$0&E:7E MT(-S*K"YRTI&:?N,+UY.#CTZ8LLEGX*6.:!(2P[>X+*8NO(P5HR].P_C^H?1 M9#I9`I3>7Y1T+A[Q'_S8R!Z%T]&6=(.]BNF9];KM#$@V=ZJTCTQ$>Y MF#']5*#R[6-C"0R6>/H>'9_D*J2`22*ZB)VNL:ZH,>95LEW-":$L-@O-_@C0 M"W2!I.4+I6TTO@B>=G\NXSY0Q]]GYWJY0M!I:!98T'E$#-YQ6NF?-"=EF9BTJ[)Y,Q MGZ9-?\":QEHB3S=<8A7XX3+;VU(M<"9;A>I#-W8G>"WQ9=8K('L"B#EW<^H, MG1S-05KBY'P$OD]RO(,`(,?'\,?>`@:0*"^&+X!/#;G*MG"D!=K>G*0[3FJ1 MNB^#V>9."X,9-25MH8$L-/:;X\/:!]P$F'8@BO,7XE+8#+O7%[;%]`KHV*^8 M#ZO+GR<1#$`4782+9QA0&YT[:.;`X#[!\Z43@5_QWQ^`&\X"4F'OJUUON\M31BZA*^0`\$7E2*Z[A9 M+-G!*2HB;"%(:\PY?QK[9HV9\;;ZROC%@7Z:JZP0>YG=^#UW(NC*#"-B*;;P MJ`O8.96&_E!>GD\DC]&GB(EK&_H)IK@@1$ZRMBW$:0,W)\S0';NU.E"AAW%D M:&-528[8'']7!IRI39(26>D](P4/M?:PO&YH\3L@2?FQIE[P=F\&[I+%,T"3 M:>5&*6_\4))A.87:ZZ*C^$']22D9JLCT*GN76U'*?M)+21L=13/6$4S/#9^M MY(Q%=XS@HL^QRD6?K8^,LJ\8?.&G<$LLW45ASM5DL11G%)*KK7UW/2@77$/C M-'/##7R%4J,70?9:3@V;&*`*LZL5ZVXRQUW"R/7#*$&`->RS\PP*QOT3.NYO M/L`?^(N?^=^C]8<,'OJE7@:H9BP\Q7HY/CL^.CT[.#@Z^J(KBVBF^R?B[&-% M*6X5,J9/*ZBVVILE,#$'=*V&RE[FP(-1&)`^,WZ#K,F86\=+4+ M+`ETEIB<\58&U_S<.E9101VI)?YAB8*4LPE"M_F5;)T`=R278A-CPAU M8=:ZD47EF9BV?%@"!$/B=4>Q&>X("Q*V]LN/!FE=VTX_9I!DN*?!_1)"^J!X M^!%'5%TIWR\3A)?:]Y29]-IE'GP#Z#$KWHE3R_)F%R5!>T*FCA1CR4:7H8UT MW.V"<#Q)QC&N(VY(DTY9.3:MD5EZ)K^;4U1M`+HR8ZR1E.<8Q3L,8)ZV7 M'CPYFZO[AT8Q+^N([:G'$60<][IAB>I@ITH_Z\>Z_'IITS$NKV\"Q1JVP<1=H9`I[&:DZ>-3^\/)G6G/ MDG"?2X#;Z\+4]@'):HMB^#?O>(-3PSB:[8P-52*JJLF2Z;*(DUR'C9U@!I]] M,(XBP$P:S*_TSJI6FNIAH-H<7IQH\NTHG<<.X\A5(ZO4SUV'?I_A/7&^403L M/OE^MQFV-P.>IJOT!#XQP"0@SXU.IM@$6.GQZMYWTMNP]$4D!C_E*K_SL1.- MM8T5,";?K?VO/V@D6.,7)-J>UVZ[4@QX0*)\;K'6;78M5^`MD1>PI=7#_:9? M2ZU9\MYB50MCUR4+BPA;`\`73M8:F:K&$:ZEU65H)*F%MLX.8R;)J@9N@A=L M!CRJ,E_KY=;91]*(X+?U8!C,EGL$E@[T+C,FGK M[#"8>'=A#`JC]$6"$'L#*5M]'\FEH(E>7!-FT"F?]^^=%=$".?!P793@5D+G M&?ITC:J\E.()VT>J-=:+)9DHJAK)A_3L<1%IAI7J[2.99%2@/49\UT%@K8._ MC&-2G\$_;732U3F2_I<#Z[1`=C11%_&%'$'&4*VC^$)5J)8$X.#)/',!CMV_ M$HC`UED#GN-%ISOR`HQA3,=,J%*LI4ZL<4]5])`?M(*(IIP1P1KJ11+XG3D]=MZ7;4_W&JIDZX2 MOIBY=+^&@1.X'2S=.8*,H5I'2W=5J)8,3E6GR@/N0`BZ>$8F:I)V1VU7,X8= M'5M=QBLEH0E[%N>%*3X+_U)"?&,O.Y.MV$P>P)H MD1UXWY(-PN39AS-J<]8*64'"_A"LK5+:QGL;,UC):[BUKV=_V-52)QWEC=+M M3KR:3H$;3Z97;WA'$AJ$:>)&LM^,09?5$0,EB^M0785_*AY?*G7PQ@/O0BM\"A+;Q,J$:54 MUS*&R*#K:`EMQILI.@BB*>OEKAAB5^K3FP#/>2"*R:NWS*.I39'!C@="$%VM M."LKB%ZRE%["R/7#*$'@SHGQ_R?3+,:VL`GFYB4]/,#_C3Z.-H+P/U)9)`_I MEK1>\I`R'(]5.)_J/(VUQ;1L'IGJ+V\2*P6-Z4LBQ6_MZ^1@]):XK.?>])@L M%@Y:3::/=E3M89E\TL4*7QAM/C$J?,/@ M_+]5G8@26'(J:,GUY$0P(O%SA5X6>%RK/V%#G_OLP[`V(HT9"^0-O)6JJ6OH M0QT_:'AO!--,?`_`QW_B_:CD>'%<'2\*\LB8021.@E$JTN#AH29U%VN`X!21EC4*)=E M<"\N(Q=,\:SBA`UXC7]Z@A=$7X^/OGP].=7DC2\U4-27F>6-Z;Z-5%_C?E<" M.M2.G&>464GVX--J#RZ*,+CCKIM96)C4]UUN23W^J$J#1-V45\68GBIADFUW ME2*FX79*DM;NR7F3WE5_J>N61,@HEV)TS\S@2O1,3DE-%QO*#1+W3'85@WJF MT"2EZPEJF(;:,]?92+\#A_Q[40Q2$/31LVH?)>)&5-ZH)-#@[KK6P08*:Q_+ M+ZHU5V^A1:(>RZUC3)>5,4MM8EUI5$/MM"3<&-+TL>1H,Z0>-Q`H^*R_5GON M1N;(";Q16:K!W7?3\JBL#N'\JUA7U[.5PB:*>KR:$&.&@$:F+3]CV1+W4`>) MQ^0Y`G\E6-+5B\*D_JWN."N7-%J+,G@\*`,7.+38Q;4\;U-JC:AC,\L;TX=E MS;+U*HT2JN'V4)EC:*7CZ*,#_%_SX^C1/_*__:?9?7SP)].;UX$QAVB35N(Y MG%W%N-ZN=K*L#$W[DWF,P"8:@`87V04(Q]^\^YRBBADV5JL\4&MW`-*2Z_R, MR':Y84"F[D`9TAZC)?EELM2\V;-G\G.$L-[`B=$,G_9[0XS9HG!M/$MF4M(& MT]ZJU0=J]DY@6I("G0R$\>H[B.?D]A/)UU:8-5FQ#;PZ`^5$VZ:=DCAXH3!K^Z,7U=,7R[%;ZA'EJ7`D;3IU!4NO19M4M7HD:IU('T[T%' MCVXHO&Y;^B@N7L84GI;,8GF]28#WUYCB>"*DEX$5AX$.OF',6*$:G=J_%K0O M)CON3ZEZ-@JY"P.TI1-2BIKZ";CS`/Z5*$0^MQ(^6!+V"-^2DWFFAK:[XX\@ M?(X`HN\^WP3+)"8GDH&+.W&FM(8T;/85^_C8H1YZBPC8>`7UKIGR/`F%_!W1^:KP+SIK"Y=%1B MP]6O>UK`9"YM=&8.*;1\_`99![&,TL98LU,[5O>H++<.%`UM&K ML)YQEENDF<+^#Q3-`)1O7%1F$.<4&*7FL94!JMV%O M'1VOVL!-#!8*8_JZBG%\V-W`SM>!)1O$&MQI)%J>>S8B+P#A/0RB+P%AA=XE MI`M-IND13_I;>6(U$&XACZ%& M-!J&&5VH),48NJBY/KI`V79L,.;]K0?B9<0C8!Y',W;=9)'XI%678`I=R(JR M$U<<*#T:`K/F.5K&XV&9\IJ_R%8C8*`,:0FP[;4W8YBR/P\@J?&C]?-'^N[$ ML0Z%0/Q[B/[$;<\>J:SSP%4*#\1\6[%#RBDW&#,6JRBAO3TP0F*.7RE,=BB3.H]IUZ M].C0:PO47<$PO+CB$"G0$)5VQPQCZ*F%4WR$_E>$=YQUPY%7Q,IL2E@'5["_&`Y^&J3^%U$GC, M)^UV^.4A<4RW6CK:N=6Q=(?I#B$[WZ%:E*/P]3W(SW?8=_!C-Z/[!,V<`/Y- M+;"5*P_O_HO/L4VF-7G5&&&5'H& M*+F:Q@PPG1IR/1RU4(+V_4Y#1CAO31F1UMQS1G"4H'W3TU&6I.`93[:`)(0! MD-X#-A\E9^^?+LR.-YJOML34EC#,A7^L,*]G?)S/' M!->L6V7,-"RG;573BO'88MS4Q\`W;K&,#<85XK'$NR*:DZH_!4"PD6HCTCCJ M=#IG=ZX9IO_&C+SV:>NYNS%^I<'10=F"59(TT(CVB8:Q/_OGZC[Q(]R6Q_$C M>Y-6+66"BYFRPLPCBL[G3$$>M#^7DY?,PO!/GD- M<+OF<'D/D$N,/&-Y]:7K#X],?/O+S"XJJM`^/#$FFGI4#W`VCY_"^]S)YGDP M;>\:[DU^UY<$F!5];TQ*]?TY>QFH17/:=VEJA`5D.0&#V09W!GL#\RD\!UD: M&.]\E8:J_5B&P=4;+@+)^SJY&JE6:X,!=_?U_:3SKA39Z_']H:[CO0A@/+M@H9-W8H MJKG&7R'&Q^G^FI<>[V\4 M>/\=PB#^#?^#\[9?0RGFFKN;(V(UX+OQ\9E`JWV(0NB"$0,(16C!L/>XA&%S MTI;@!.V#9$W^]8T6)M/?0N)<7C_UD)^`,T;,9L(LIVH/RN'$$6B^+?;^%H9! M].KH>8RZD(,*S7H^OBV@(H?8/O[S)G#5,E8=5S-6%<22`]OT\:T1ECR4_%2Y MU2_"Q3,,N*]Y\HN^O^>Y^P%!QGCO+WJ^O^C9`+[Q5GY_T5/.P.\O>AIFSO<7 M/=]?]'Q_T;.OQ2M)B@:]+`_O$W*"*,5S**"/C`CCZ*1L=S9U&N.W=^1Y?QQV M=_3K[W'8H8]Q[V]S[N!MSC:9_WN;RAZ`&\X"^#?P;CRL:#B%A/_C*`(;[^XX M\&[QCZ%/WY+#OTL6P+L#HNM3/7W-1@+N4E66W-[O6&6[X;"QW-T%\7JG?:]+ M1W)+S2RZGSMHAG?W^1'RK_CO&^V-%^3$6)[5$L+>R2LB;U,E]GID?[*CPZ_\ MG>)[@.AZ2NW8ZZ1Z[)4+'&&)(RIR*.==954P%DKL8OJ?;NB@#-WJ[7.77(FUU$F6;8+2'3[X"$L>&Y#>]MG5GF-KF$ M?H)_EOI.)DD?(O3^2-(I$,+JTE&H5V?K0A25.JUK5Y#Z[@E9XXYB2 M#..(U0U<.+X_6::!6D'^NELKHM9+?&=H)QJS MY(EI.;6$`;9-1`-D[W-XO`>H6TI]IVAG6K/DW("QFF&90&W=R)*RIS3L0DN< M!ZUW'=[/\'#*IF$[J:9AX[@XC<^VMF,G)^LAX#F@=((OX#Z,BHSMRE(GMJ:1DM:-\;,HR\M>-@::K.]%(5]Y00S77#VG/]!.\`T\0=BV62DF`R+:_"Y>X+=_$18ZBJ$INQ M`Q4P5R1:T\)=^$X43:9TP.6E@6:5-\;:.[1D#7V4U&/47>1BB[F7CZL%S;.] MDAFJ9I2$J'V'V=$8`!#N#Q?;BR[N(\F<&L9Q0=*6-7U9$:0E;,CTE>VP)HAF M#>-E?6:5-XX)6F8$-?48M3:H;;K,U%!7PS@VJ!E&TK`F3Q:,_6H&(+UP>A-\ M=U:XS"$[-06O_#",+)^A0AGK0(Q\#9Y1XB""YEC:TM5*EIM;$K"I'N82FO]V M@@S,B;3)*W4LM[@<7NWNY8Z>+GMUD/>$O\)9W&V5,<[X6A9T8I68FX1T$\-* MU`&"*+/6)I#U?%6--JTT])RJ^K[1JI!?MK@LC)G9NWII.9.\K*?M7HG9?C"`*+`]4_!&`-X!< M&!$WDS@&C%-M7[G42C\]+/BZ?V.K='7I*D-6ER-36'ZO6:*LF!Z"!#?T.#8I M>OAP?U@@I8S,\E\&O@(JWJNE<-.Q,/UQS,X2+JRWK^-(.P5EK#KKG%4]WS8E MCVX%F*(KM41ZI]5$>FM)0\F?MX&^>5JK_JHFMZ2>+`A9@QZY`3)X&BP!ZJ:PZ&\DP9E"0,-IVBH*V("WQA*\5\7N(_KP)[E'H M@DB-)^R:@V>'(C1+G"AK^-+^&H:?&"7;-P7-"$9IVMT3'G&!G*R\6 M&;R5!0F]6[L/*@F]>U_/D1203\X;B-16=%_J5G1$UH@*&\ZB+L,OL:CCE.QD M^SY9TI>'@AG)R'GA(+2:AHB0D1B<$Y#\,_GT*LJ+'GG3ONGQ%[2&DH:I"=YK4#T6^.GX#OP"'_IN'+:GO.L^J>DT@=4;&CHMRA;#_72MF` M8N5_Y!?5T?77+LMIZP2JSACRN>S9_$*%=1#!=.#";3M0)JMIO\ MB_$*(O:"2JT5HOT0L/.%4+X:6-&;A'+KGVH=<]FS^V6/I':8)XE:"<'7$E7+ MCR!\)H%P1#MT2"8'JH&+:Z7/TY<4(+="ZNN[YA)3FB@/Y"D61QWQ?KWQMA7F]VJU.$KAS/; M:,YF2]O-W;D52AAG>+[6&5:R?W?U'09PD2RX9MTJ8Z9A.6VKFE:,QQ;C.F]B MXQ;+V&!<(1[;CA&ZG> M4'^]G:YI//`XEC[P.%8^\#A^/_`81'#4A>.[B4__^A#Z_G6:IJ3_X*CZ[QHS M=#4^^MBI9FS;"Q2&DM]A/*\H*MK65/10.O_.`H>H+(4;$*V_90QM]=*1TRUZ MUW9'76%)4_(\Q@Z*!]@A&%K[U8$TDN\=NN@='V[:Y'KI1V*/C[ZHGT$^]=X3==`2VLMOZ M/[ZE_2``,R?.R@ZK)YB\V=#\HL[0.T,#=7>46R_=;EP%WBY=@A?A8@%C^I9G MX%V$`#67HN.2T>Z+$#L/$18 M(5B+%\X2_R9>,7BA(L(^VK1&;\GV&JO.Q5I,,Y>3^!7>A8GZPO:10P&G4??M M*^T^7YUCW/.%@_[D7&H053/0P-+VD3"N#%JC+JE4$>3MYV9%$%4SW\PREI(Q MN`1N2T[EQJY+,LN3S1&`=._$C9EG%1\`-21L6J6&$EY+*$'=0P_@!00)N`/\ MC!6U96TE@SQ86]=^YZLG_$VUE4)>PWQ6M%PD<($:E62RBAQ_46UIL*EAOET% MII%9WO/16C+PIYO="GCN!,"M8SXU!(:MH88R7DO(\=WY(T07212'"]P2SA10 M+3@`&BB,_)+XC-KWWSD+,)ENM9P[W#/+&V=*26M4S:@&47LG9KR_MD9>.TC7 M%3'.@FJ&V!A2&ISIMIL$]7ON^D+&V$]:_PR3\1&9;K2GUU!LM'4A:XS&1Z1] MVRLR&BXET=<*Q>PQG`"3]@@X@>FNPP2)+;&%S=45]2X[BLRQM91H2P@EB'P#_X8I4TWHLI2 M3`7BH,S*=04SRQMO6K4S/S63 MZ=5?";FQ`N)YZ-T$+R"B]QVJ/P5`,.JW$6D2?J_O$CW!;'L>/[!FE6LHXLS>P26DND02IW9*] M[!!%QW*LXL;QH#L_4,,#.1W&/$\BW-@H&KNX%T20-&5S@C"9_A:2>Y!Y;O*T M%-HXV$NF;B;,="*H'LETJ`4;KZ'7J"<=@7.5T*1,W@21/TD?S%/WPEF@PCP% MH7O`P+;:Z.'8T'PF1F4]Y6?OCW-LPNRW31DI)7SOF-E<*SV$J[5@*&/17(-_ M['DP;>H&8LVYJ&IU6YC3">X>8J`VW#CD1D#\_#FU8A8R@'_R_P%02P,$%``` M``@`-5X&1Q"[F`7H"P``O'(``!$`'`!P;'5G+3(P,34P-C,P+GAS9%54"0`# M%H+#51:"PU5U>`L``00E#@``!#D!``#M7%MSXCH2?M^J_0]>7G;V`0@PR4Q2 MDW,*M[HM(X:%J8VIM.R0ZYG(1/7/U^\*:+E0^V"!+- MX'XJSD"1K3<^]UJ,S^%%1YWV][O;L=8Q(E;J5-0O8'`PB>E74^ZV!+9;<_;4 MA@9%_+%YU&GV.AME2+DR34*%1-3&$1?%V0+'X74#AR M6[N0X;@=-,:D;J'L7OO[+:&/$25TVSE"RYA\AL14DX8-.3:[P&X0KYJGT"DC M)[^82.Y&VY7H)#8(AP8F^L3&L2NK]S>GK:UJVQ;$8KB&>T MF7X%$!&#L3&R,$0L2P\21"F3>HCK9]'3Y9+0&0L?P4.EW9F">0*OMM2'A_L; M8U?5?6(,HO4@N6!4,)A9%>AB72)M'#PCE&C-H?\> M09"Q8C'P.2G)"D59@:PO[;2`M&P?HM20_J8_+SD6(%+[2/7%D#LD,7':R+5] M=P_&C6;%?.'3").W@2I^*(:SX1('WM`NJ6<$M)K\'="UPD%MZX,:DQO!O-X)S!! MJ*6EUB#F@'A)A.TRX7-\0Y_`7L;7EU@BXH:@&=I-('T$D#H`S(8=OL02K`^A MC'_4F.1A$M8ST?\^=:ZH)')]`UD0][05(3I5*,V#Z>A4#:9(0/(CHHX52+,2 MXFK$]LHL1XA#\P)+`H95SC-37&59YW'UK-/ZL"V['HGFZ%@T9XTELQ\7S'4P M%U<_?!@LZ;BY`Z<9WX]ZVMN*J(9Y+RG^[U;P@AIC(\9?D82_V=K"2&'"K`-C M,C,+!C+JXF$'8,:^YR&^AC%#YI3,(&#!5&?;S(?9B0R`]C- M`AC*U8-L(]G:B+8BV36L1EC[-D0EH5\_G-UC%_[?4#L-8P&5&;9>%K:$'`6= MDC2DD-G8-4I&E*X0I]"IQ0CS\0)RAC0^F78S,A^SR$02+!!A:1DU)-5*M<(: MK00$4W%6^[[$]_`03]`J.^$DF\S^/\GSOV*V-'<-@1&":T3XOY'KXSN,U'>= M\Z;!R"1Y1(8K$E"DJ*P(T[PDS4!IQNIS%JN- M++UVL26M!JPDPYX*_,,'FZ^>\D93IMT,SFE>UAQ)L`(1-2*O4/.\K/:I5`-U MH0;J[E\#61^B3_42TVZ)]@1-W2RR!50F!'N0=/?*DV[K0R"KQJEB]IT/4+K9 MC,QQ%IG$-DD-R![YH$[0\K$Q4)IA^I2%*9,9!DNO-69[KK46;#L6$YKW'RNN MO-9;D2\%K%L9L6XI9)D\PPB9U:U!JYY$DN(\L&#H[8EA4,US.MQOM].2L&P-A.;$=UE7Z4>LWL6?@6X%9&9$:NTWU)# M]3*H,G&TD*X,K$S`-(!5Q\4=-FL*?]68H3!#5+)U4X^DEVSB%(!DI#7#57U+ MIT;N%9#+!$(S<1EVF6A8AET=$E^"7F\7]'JEZ)4OF:71Z]7H[;NQ6A`ZRQG, M*.ZXS5H'T?TV7`M78'*IS)!5V'S]OX))_5&':N_QS-('6\_4B=7SAB#>TE5' M;?6SA3YKJU!K1N>:_P1S6RO/C4B4?,-Y5HUPVD/ABR,1B-L9*9F#MR"$+3&7 M,)[:D?(-J_UJ9@$6NYJ5@N\0K8*.LJM5VWWK$(URT717HX`%NV]CSY=V^CAV M^&3[V+8^M`VF,2XMFGO30"NA%MF:YGEG%\#QJ8Z_M_L=)N=DQ:H$.F] MESK[J?):>N3<8U!%$9?S+:Z]%#'>W%"@12Z/^M#<,%?7P'B/@DF#7,8V=J6( MGNREC^'J@DJP:!;U+;[,0@'34\#LHD;^I145%8@8U)N/M]X97ARB,P\5?/Z\ MQ>I:E%$0"-8/U,'\`BV)1*YN^8HEP*#4.V]4(R6NJ_;$SQN2^^"R(/;IVR'. M/$8A$>'K&XD]-76#/9"J2")]91Y@ST8("G\JH:1H< MZP-\6\L?%4IB4P+;@PX\QA'B*T MLF4(6CFR9>2FM-NRECL^#\^"ENH^I+A0^T3;P>H_>6:%^B?:#E=_F-R+$=AJ M/5@;KIG/"TU(-AZ>!0PB`I4!W3T1CY`P@*;#63R`DQ95($Z&,$(EGF.^AX4S MY(I*)L8ASF"A!Z%4G_G\ACC/;MJN)W@E!RZT;YFZ`]<6JC)Z_I9F5T!V@KDW MG%VM)(:YQPF-6*LE"?4N<0?IO>=["9.K,B01CO0X<%O1:D=;(X8#M+6_0A2/ M^YEPDWI^<)'FG^N1[ZH[[L;]<4;YO,:#LR`X*7Z'Y8(YZI>H0J_TW9/Y0D[8 MR.?V`A*[ON/HLAFYPV<*$7%!ECW79(GXL`@33AH!Y[D\!6J M7?Q4>S/U0_A+/3I7-R==0-19SQA_1MP18W_Z'VP#PK?$(S(Z8A\X:6>N=U55 MO-!)5ZLE"=P^`A7YA#U(XI+_ZB=]3PV#_=Q82>Z[,/4[8!*T@ MW`Z0_2@BX&,W["WA15VEHC?B#F-S[!"YIY-,%RCU0T42'JE&OA68I0KBOW9J M'V/^1&Q\CY\P]9.S<;KA_>"FI\+A4@>SH2]5*%%7"J>*:0&UQ3MN!Q/ERC"<+;.R5_>CD@DI3^N*: MN>K"S_`W#CGS]RO)^[43?*:FN'"1$,-9&$V'7)?300T9E0=F$D.FO^-(-ZG_ MXMHI.!3&$@?,-I"$H<]$8;+R92"^IM4Y\1S+;XP_@H+A'ELR=F?;#B-HI<=V M!LP19S;&CE`+.JHCZA@U2R0'H)V(5PDJ4[]MT9J`]8VJUG`A.JA`H>C\MB#V M(J@U!M@E,#.)R0+)JQ41JMJ'B8SYW,;B&Q@.3E)K0V-_-E,'J:B\)3]\`L%W M/6'7/G72]QMJ''[6"P^R0E9'EFZHG5FQS;0]3I9`PQ MDQVZ5==XRGT8L:!SK\RT/-I?;%\VYJ'UYA[[*')%X4QEIIMX5X7R%\6Z.*%[ M<;!+0?@O1$,$/Y:AG4-Z:&!GC\.WMM.4=-/[R$^RV2?T1I4]!WL5X68,=-P) M@W0$9@BU^*Q[;%G9%7?^5Y7XOA*"C'?UOA?Q@B(.JI7-9<_!1KW<;-0'SMN% M(=^_TOVDO4^V.[\*@B0LW=QW5JA.= M!X%!M)@6+6T^4!Q:!`Z*EM*VU^G,I.^D-O^&%4S8Z3_!E#;'$8PC3M2O9`L``00E M#@``!#D!``!02P$"'@,4````"``U7@9'AF;U:ZT+``"!I@``%0`8```````! M````I(%HCP``<&QU9RTR,#$U,#8S,%]C86PN>&UL550%``,6@L-5=7@+``$$ M)0X```0Y`0``4$L!`AX#%`````@`-5X&1\G[KL;O$@``G2T!`!4`&``````` M`0```*2!9)L``'!L=6`Q0````(`#5>!D<$")U]*DP``$+$!``5`!@````` M``$```"D@:*N``!P;'5G+3(P,34P-C,P7VQA8BYX;6Q55`4``Q:"PU5U>`L` M`00E#@``!#D!``!02P$"'@,4````"``U7@9'V?W=)84K``!Z+`,`%0`8```` M```!````I($;^P``<&QU9RTR,#$U,#8S,%]P&UL550%``,6@L-5=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`-5X&1Q"[F`7H"P``O'(``!$`&``` M`````0```*2![R8!`'!L=6'-D550%``,6@L-5=7@+``$$ ?)0X```0Y`0``4$L%!@`````&``8`&@(``"(S`0`````` ` end XML 17 R9.htm IDEA: XBRL DOCUMENT v3.2.0.727
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2015
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies

 

2. Summary of Significant Accounting Policies

 

Principles of Consolidation

 

The accompanying unaudited interim consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Interim Financial Statements

 

The accompanying unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). In the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly, in accordance with U.S. generally accepted accounting principles (GAAP), the financial position, results of operations and cash flows for all periods presented, have been made. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the full year.

 

Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. These unaudited interim consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K, filed for the fiscal year ended December 31, 2014.

 

The information presented in the accompanying consolidated balance sheet as of December 31, 2014 has been derived from the Company’s December 31, 2014 audited consolidated financial statements.  All other information has been derived from the unaudited interim consolidated financial statements of the Company.

 

Cash Equivalents

 

Cash equivalents consist of money market accounts with an initial term of less than three months. For purposes of the unaudited consolidated statements of cash flows, the Company considers all highly-liquid debt instruments with original maturities of three months or less to be cash equivalents.  The Company’s cash and cash equivalents are deposited with financial institutions located in the U.S. and may at times exceed insured limits.

 

Revenue Recognition

 

The Company recognizes revenue under arrangements for products and services, which may include the sale of products and related services, including revenue from installation, service and maintenance, spare parts, hydrogen fueling services (which may include hydrogen supply as well as hydrogen fueling infrastructure) and leased units. The Company also recognizes revenue under research and development contracts, which are primarily cost reimbursement contracts associated with the development of PEM fuel cell technology.

 

Products and Services

 

The Company enters into revenue arrangements that may contain a combination of fuel cell systems and equipment, installation, service, maintenance, spare parts, hydrogen fueling and other support services. Revenue arrangements containing fuel cell systems and equipment may be sold, or under a limited number of arrangements, leased to customers. For the above multiple deliverable arrangements, the Company accounts for each separate deliverable as a separate unit of accounting if the delivered item or items have value to the customer on a standalone basis. The Company considers a deliverable to have standalone value if the item is sold separately by us or another entity or if the item could be resold by the customer. The Company allocates revenue to each separate deliverable based on its relative selling price. For a majority of our deliverables, the Company determines relative selling prices using its best estimate of the selling price as vendor-specific objective evidence and third-party evidence is generally not available for the deliverables involved in its revenue arrangements due to a lack of a competitive environment in selling fuel cell technology. When determining estimated selling prices, the Company may consider the cost to produce the deliverable, the anticipated margin on that deliverable, the selling price and profit margin for similar products and services, the Company’s ongoing pricing strategy and policies, the value of any enhancements that have been built into the deliverable and the characteristics of the varying markets in which the deliverable is sold, as applicable. The Company determines estimated selling prices for deliverables in its arrangements based on the specific facts and circumstances of each arrangement and analyzes the estimated selling prices used for its allocation of consideration of each arrangement.

 

Once relative selling prices are determined, the Company proportionately allocates the sale consideration to each element of the arrangement. The allocated sales consideration related to fuel cell systems and equipment, spare parts, and hydrogen infrastructure is recognized as revenue at shipment if title and risk of loss have passed to the customer, there is persuasive evidence of an arrangement, the sales price is fixed or determinable, collection of the related receivable is reasonably assured, and customer acceptance criteria, if any, have been successfully demonstrated. The allocated sales consideration related to installation, service, maintenance, and hydrogen molecule delivery is generally recognized as revenue when completed or on a straight-line basis over the term of the contract, as appropriate.

 

The Company does not include a right of return on its products other than rights related to standard warranty provisions that permit repair or replacement of defective goods. The Company accrues for anticipated standard warranty costs at the same time that revenue is recognized for the related product.

 

The Company has also sold extended warranty contracts that generally provide for a five to ten year warranty from the date of product installation. These types of contracts are accounted for as a separate deliverable, and accordingly, revenue generated from these transactions is deferred and recognized in income over the warranty period, generally on a straight-line basis. Additionally, the Company may enter into annual service and maintenance contracts that are billed monthly. Revenue generated from these transactions is recognized in income on a straight-line basis over the term of the contract. Costs are recognized as incurred over the term of the contract.

 

Research and Development Contracts

 

Contract accounting is used for research and development contract revenue. The Company generally shares in the cost of these programs with cost sharing percentages ranging from 30% to 50% of total project costs. Revenue from time and material contracts is recognized on the basis of labor hours expended plus other reimbursable contract costs incurred during the period. All allowable work performed through the end of each calendar quarter is billed, subject to limitations in the respective contracts. We expect to continue research and development contract work that is directly related to our current product development efforts. At June 30, 2015 and December 31, 2014, the Company had unbilled amounts from research and development contract revenue in the amount of approximately $0.5 million and $1.0 million, respectively, which is included in other current assets in the accompanying unaudited consolidated balance sheets. Unbilled amounts are expected to be billed during the following quarter.

 

Common Stock Warrant Accounting

 

The Company accounts for common stock warrants in accordance with applicable accounting guidance provided in Accounting Standards Codification (ASC) Subtopic 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity, as either derivative liabilities or as equity instruments depending on the specific terms of the warrant agreement. In compliance with applicable securities law, registered common stock warrants that require the issuance of registered shares upon exercise and do not sufficiently preclude an implied right to cash settlement are accounted for as derivative liabilities. We currently classify these derivative warrant liabilities on the accompanying unaudited consolidated balance sheets as a long-term liability, which is revalued at each balance sheet date subsequent to the initial issuance using the Black-Scholes pricing model. The Black-Scholes pricing model, which is based, in part, upon unobservable inputs for which there is little or no market data, requires the Company to develop its own assumptions. Changes in the fair value of the warrants are reflected in the accompanying unaudited consolidated statements of operations as change in fair value of common stock warrant liability.

 

Joint Venture

 

We are party to a joint venture with Axane, under the name HyPulsion (the JV). The principal purpose of the JV is to develop and sell hydrogen fuel cell systems for the European material handling market. In exchange for initial ownership of the JV, Axane contributed cash and we contributed the right to use our technology, including design and technology know-how on GenDrive systems. We are not obligated to contribute any cash.

 

We currently own 20% and Axane owns 80% of the JV. We have the right to purchase an additional 60% of the JV from Axane at any time between January 4, 2018 and January 29, 2018 at a market-based price. If we exercise our purchase right, Axane will have the right, at any time between February 1, 2018 and December 31, 2021, to require the Company to buy the remaining 20% interest at a market-based price.  See note 9 regarding our agreement to acquire the remaining ownership of HyPulsion.

 

In accordance with the equity method of accounting, we will increase our investment in the JV by our share of any earnings, and decrease our investment in the JV by our share of any losses. Losses in excess of the investment are not recognized and must be restored from future profits before our proportionate share of profits can be recognized. As of June 30, 2015, we had a zero basis for our investment in the JV.

 

Use of Estimates

 

The unaudited interim consolidated financial statements have been prepared in conformity with GAAP, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Reclassifications

 

Reclassifications are made, whenever necessary, to prior period financial statements to conform to the current period presentation.  These reclassifications did not impact the results of operations or net cash flows in the periods presented.

 

Recent Accounting Pronouncements

 

In August 2014, an accounting update was issued relating to how management assesses conditions and events that could raise substantial doubt about an entity’s ability to continue as a going concern. This accounting update is effective for reporting periods beginning after December 31, 2016. We do not expect the adoption of this update to have a significant effect on our consolidated financial statements.

 

In June 2014, an accounting update was issued that replaces the existing revenue recognition framework regarding contracts with customers. In July 2015, the Financial Accounting Standards Board (FASB) announced a one year delay in the required adoption date from January 1, 2017 to January 1, 2018.  We are evaluating the effect this update will have on our consolidated financial statements and have not yet selected a transition method.

XML 18 R29.htm IDEA: XBRL DOCUMENT v3.2.0.727
Income Taxes (Details) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2015
Dec. 31, 2014
Income Taxes.    
Federal and state net operating loss carryforwards amount not subject to IRC Section 382 limitations $ 54.0  
Amount of net operating loss carryforwards which will not expire prior to utilization $ 13.0  
Recognition period for net unrealized built in losses 5 years  
Unfavorable book to tax add backs in U.S. corporate income tax return amount $ 17.7  
Gross deferred tax liability 6.8  
Accrued interest and penalties $ 0.4 $ 0.4
XML 19 R28.htm IDEA: XBRL DOCUMENT v3.2.0.727
Inventory (Details) - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Inventory.    
Raw materials and supplies $ 23,299 $ 18,502
Work-in-process 2,764 237
Finished goods 6,826 5,997
Total inventory $ 32,889 $ 24,736
XML 20 R30.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value Measurements (Details) - Recurring basis - Warrants - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Significant Other Unobservable Inputs (Level 3)    
Fair Value    
Financial liabilities $ 6,982 $ 9,418
Total.    
Fair Value    
Financial liabilities $ 6,982 $ 9,418
XML 21 R31.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value Measurements (Details 2)
6 Months Ended
Mar. 31, 2015
Dec. 31, 2014
Jun. 30, 2015
Valuation technique for assets measured and recorded at fair value      
Expected dividend yield (as a percent)     0.00%
Minimum      
Valuation technique for assets measured and recorded at fair value      
Risk-free interest rate (as a percent) 0.28% 0.21%  
Volatility (as a percent) 52.92% 119.16%  
Expected average term 11 months 1 day 1 year 5 months 1 day  
Maximum      
Valuation technique for assets measured and recorded at fair value      
Risk-free interest rate (as a percent) 1.375% 1.35%  
Volatility (as a percent) 134.40% 136.62%  
Expected average term 3 years 6 months 18 days 4 years 15 days  
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.2.0.727
Nature of Operations
6 Months Ended
Jun. 30, 2015
Nature Of Operations.  
Nature of Operations

 

1.  Nature of Operations

 

Description of Business

 

Plug Power Inc., (the “Company” or “Plug Power”), is a leading provider of alternative energy technology focused on the design, development, commercialization and manufacture of hydrogen fuel cell systems used primarily for the material handling and stationary power market.

 

We are focused on proton exchange membrane, or PEM, fuel cell and fuel processing technologies, fuel cell/battery hybrid technologies, and associated hydrogen storage and dispensing infrastructure from which multiple products are available. A fuel cell is an electrochemical device that combines hydrogen and oxygen to produce electricity and heat without combustion. Hydrogen is derived from hydrocarbon fuels such as liquid petroleum gas, or LPG, natural gas, propane, methanol, ethanol, gasoline or biofuels. Hydrogen can also be obtained from the electrolysis of water, or produced on-site at consumer locations through a process known as reformation. Plug Power develops complete hydrogen delivery, storage and refueling solutions for customer locations.

 

We sell and continue to develop fuel cell product solutions to replace lead-acid batteries in material handling vehicles and industrial trucks for some of North America’s largest distribution and manufacturing businesses. We are focusing our efforts on material handling applications (forklifts) at multi-shift high volume manufacturing and high throughput distribution sites where our products and services provide a unique combination of productivity, flexibility and environmental benefits. Our current product line includes: GenDrive, our hydrogen fueled PEM fuel cell system providing power to material handling vehicles; GenFuel, our hydrogen fueling delivery system; GenCare, our ongoing maintenance program for both the GenDrive fuel cells and GenFuel products; ReliOn, our stationary fuel cell solution providing scalable, modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors; and GenKey, our turn-key solution coupling together GenDrive or ReliOn, GenFuel and GenCare, offering complete simplicity to customers transitioning to fuel cell power.

 

We sell our products worldwide, with a primary focus on North America, through our direct product sales force, leveraging relationships with original equipment manufacturers, or OEMs, and their dealer networks. We are party to a joint venture based in France with Axane, S.A. (Axane), a subsidiary of Air Liquide, under the name HyPulsion, to develop and sell hydrogen fuel cell systems for the European material handling market.  See note 9 regarding our agreement to acquire the remaining ownership of HyPulsion.  Also, we sell to businesses and government agencies.

 

We were organized in the State of Delaware on June 27, 1997.

 

Unless the context indicates otherwise, the terms “Company,” “Plug Power,” “we,” “our” or “us” as used herein refers to Plug Power Inc. and its subsidiaries.

 

Liquidity

 

Our cash requirements relate primarily to working capital needed to operate and grow our business, including funding operating expenses, growth in inventory to support both shipments of new units and servicing the installed base, funding the growth in our GenKey “turn-key” solution which also includes the installation of our customer’s hydrogen infrastructure as well as delivery of the hydrogen molecule, and continued development and expansion of our products. Our ability to achieve profitability and meet future liquidity needs and capital requirements will depend upon numerous factors, including the timing and quantity of product orders and shipments; attaining positive gross margins; the timing and amount of our operating expenses; the timing and costs of working capital needs; the timing and costs of building a sales base; the ability of our customers to obtain financing to support commercial transactions; our ability to obtain financing arrangements to support the sale or leasing of our products and services to customers; the timing and costs of developing marketing and distribution channels; the timing and costs of product service requirements; the timing and costs of hiring and training product staff; the extent to which our products gain market acceptance; the timing and costs of product development and introductions; the extent of our ongoing and new research and development programs; and changes in our strategy or our planned activities. If we are unable to fund our operations with positive cash flows and cannot obtain external financing, we may not be able to sustain future operations.  As a result, we may be required to delay, reduce and/or cease our operations and/or seek bankruptcy protection.

 

We have experienced and continue to experience negative cash flows from operations and net losses.  The Company incurred net losses attributable to common shareholders of $9.3 million and $20.3 million for the three and six months ended June 30, 2015, respectively, and $88.6 million, $62.8 million and $31.9 million for the years ended December 31, 2014, 2013 and 2012, respectively, and has an accumulated deficit of $958.4 million at June 30, 2015.

 

Net cash used in operating activities for the six months ended June 30, 2015 was $24.3 million. Additionally, on June 30, 2015, we had cash and cash equivalents of $109.1 million and net working capital of $135.8 million. By comparison, net working capital at December 31, 2014 was $167.0 million.

 

During 2015, we had an increase in restricted cash of $11.1 million primarily related to sale/leaseback transactions, as described in note 8.  During 2014, we received gross proceeds of $176.7 million from three underwritten public offerings.  Net proceeds after underwriting discounts and commissions and other estimated fees and expenses were $165.7 million.  In addition, during 2014 we received $18.3 million from the exercise of previously issued common stock warrants.

 

To date, we have funded our operations primarily through public and private offerings of common and preferred stock, a sale-leaseback of our building, and our previous line of credit. The Company believes that its current cash, cash equivalents, cash anticipated to be generated from future sales and, to the extent exercised, cash generated from the exercise of outstanding warrants will provide sufficient liquidity to fund operations for at least the next twelve months. This projection is based on our current expectations regarding product sales, cost structure, cash burn rate and other operating assumptions.

XML 23 R32.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value Measurements (Details 3) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Reconciliations of the beginning and ending balances for liabilities measured at fair value on a recurring basis using significant unobservable inputs (i.e. Level 3)        
Balance at the beginning of the period $ 7,649 $ 25,742 $ 9,418 $ 28,830
Change in fair value of common stock warrants (667) (9,577) (2,436) 58,856
Issuance of common stock warrants       11,773
Exercise of common stock warrants   (36)   (83,330)
Balance at the end of the period $ 6,982 $ 16,129 $ 6,982 $ 16,129
XML 24 R2.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 109,139 $ 146,205
Accounts receivable 12,524 16,095
Inventory 32,889 24,736
Prepaid expenses and other current assets 5,950 5,710
Total current assets 160,502 192,746
Restricted cash 11,634 500
Property, plant, and equipment, net of accumulated depreciation of $27,218 and $26,539 respectively 5,989 5,312
Leased property under capital lease, net of accumulated depreciation of $1,420 and $1,162 respectively 1,679 1,937
Note receivable 415 447
Intangible assets, net 768 1,490
Other assets 1,967 1,719
Total assets 182,954 204,151
Current liabilities:    
Accounts payable 12,188 10,185
Accrued expenses 5,655 8,750
Product warranty reserve 1,006 1,311
Deferred revenue 3,494 3,319
Obligations under capital lease 200 587
Other current liabilities 2,199 1,555
Total current liabilities 24,742 25,707
Deferred revenue 6,114 6,772
Common stock warrant liability 6,982 9,418
Finance obligation 2,391 2,426
Other liabilities   392
Total liabilities 40,229 44,715
Redeemable preferred stock    
Series C redeemable convertible preferred stock, $0.01 par value per share (aggregate involuntary liquidation preference $16,664) 10,431 shares authorized; Issued and outstanding: 5,231 at June 30, 2015 and December 31, 2014 1,153 1,153
Stockholders' equity:    
Common stock, $0.01 par value per share; 450,000,000 shares authorized; Issued (including shares in treasury): 173,827,314 at June 30, 2015 and 173,644,532 at December 31, 2014 1,738 1,736
Additional paid-in capital 1,100,009 1,096,392
Accumulated other comprehensive income 898 898
Accumulated deficit (958,411) (938,081)
Less common stock in treasury: 378,116 at June 30, 2015 and at December 31, 2014 (2,662) (2,662)
Total stockholders' equity 141,572 158,283
Total liabilities, redeemable preferred stock, and stockholders' equity $ 182,954 $ 204,151
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Increase (Decrease) in Stockholders' Equity        
Balance     $ 158,283  
Balance (in shares)     173,644,532  
Net loss attributable to the Company $ (9,226) $ 3,877 $ (20,277) $ (71,980)
Stock based compensation     3,435  
Stock option exercises     131  
Balance $ 141,572   $ 141,572  
Balance (in shares) 173,827,314   173,827,314  
Common Stock        
Increase (Decrease) in Stockholders' Equity        
Balance     $ 1,736  
Balance (in shares)     173,644,532  
Stock based compensation     $ 1  
Stock based compensation (in shares)     47,337  
Stock option exercises     $ 1  
Stock option exercises (in shares)     116,667  
Stock dividend (in shares)     18,778  
Balance $ 1,738   $ 1,738  
Balance (in shares) 173,827,314   173,827,314  
Additional Paid-in-Capital        
Increase (Decrease) in Stockholders' Equity        
Balance     $ 1,096,392  
Stock based compensation     3,434  
Stock option exercises     130  
Stock dividend     53  
Balance $ 1,100,009   1,100,009  
Accumulated Other Comprehensive Income        
Increase (Decrease) in Stockholders' Equity        
Balance     898  
Balance 898   898  
Treasury Stock        
Increase (Decrease) in Stockholders' Equity        
Balance     $ (2,662)  
Balance (in shares)     378,116  
Balance $ (2,662)   $ (2,662)  
Balance (in shares) 378,116   378,116  
Accumulated Deficit        
Increase (Decrease) in Stockholders' Equity        
Balance     $ (938,081)  
Net loss attributable to the Company     (20,277)  
Stock dividend     (53)  
Balance $ (958,411)   $ (958,411)  
XML 26 R22.htm IDEA: XBRL DOCUMENT v3.2.0.727
Nature of Operations (Details 2) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
Nature Of Operation      
Increase in restricted cash related to sale/leaseback transactions $ 11,100    
Net proceeds from public offering     $ 165,700
Gross proceeds from shares of common stock sold in an underwritten public offering     176,700
Net proceeds from shares of common stock sold in an underwritten public offering   $ 176,700 $ 18,300
Minimum period for which we believe that our current cash, cash equivalents, cash generated from future sales, and cash generated from the exercise of outstanding warrants will provide sufficient liquidity to fund operations 12 months    
XML 27 R24.htm IDEA: XBRL DOCUMENT v3.2.0.727
Summary of Siginificant Accounting Policies (Details 2) - Jun. 30, 2015 - HyPulsion
Total
Joint Venture  
Ownership interest percentage 20.00%
Axane, S.A.  
Joint Venture  
Ownership interest percentage 80.00%
Additional ownership interest that can be purchased by entity from counterparty at any time between January 4, 2018 and January 29, 2018 at a formula price 60.00%
XML 28 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 29 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash Flows From Operating Activities:    
Net loss attributable to the Company $ (20,277) $ (71,980)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of property, plant and equipment, and investment in leased property 969 939
Amortization of intangible assets 722 1,174
Stock-based compensation 3,435 1,255
Gain on bargain purchase   (1,014)
Gain on disposal of property, plant and equipment (2) (27)
Change in fair value of common stock warrant liability (2,436) 58,856
Changes in operating assets and liabilities that provide (use) cash:    
Accounts receivable 3,571 (9,716)
Inventory (8,153) (4,195)
Prepaid expenses and other assets (488) (3,170)
Note receivable 32 31
Accounts payable, accrued expenses, product warranty reserve and other liabilities (1,145) 4,188
Deferred revenue (483) 3,725
Net cash used in operating activities (24,255) (19,934)
Cash Flows From Investing Activities:    
Purchase of property, plant and equipment (1,388) (524)
Purchase of ReliOn, net of cash acquired   414
Proceeds from disposal of property, plant and equipment 2 27
Net cash used in investing activities (1,386) (83)
Cash Flows From Financing Activities:    
Change in restricted cash (11,134)  
Proceeds from exercise of warrants   18,317
Purchase of treasury stock   (64)
Proceeds from issuance of common stock and warrants   176,700
Stock issuance costs   (10,977)
Proceeds from exercise of stock options 131  
Principal payments on obligations under capital lease and finance obligation (422) (379)
Net cash (used in) provided by financing activities (11,425) 183,597
Effect of exchange rate changes on cash   2
(Decrease) increase in cash and cash equivalents (37,066) 163,582
Cash and cash equivalents, beginning of period 146,205 5,027
Cash and cash equivalents, end of period 109,139 168,609
Cash paid for interest $ 176 $ 221
XML 30 R3.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Consolidated Balance Sheets    
Series C redeemable convertible Preferred Stock, par value (in dollars per share) $ 0.01 $ 0.01
Series C redeemable convertible Preferred Stock, shares authorized 10,431 10,431
Series C redeemable convertible Preferred Stock, shares issued 5,231 5,231
Series C redeemable convertible Preferred Stock, shares outstanding 5,231 5,231
Series C redeemable convertible Preferred Stock, aggregate involuntary liquidation preference (in dollars) $ 16,664 $ 16,664
Common Stock, par value (in dollars per share) $ 0.01 $ 0.01
Common Stock, shares authorized 450,000,000 450,000,000
Common Stock, shares issued 173,827,314 173,644,532
Common stock in treasury, shares 378,116 378,116
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.2.0.727
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2015
Summary of Significant Accounting Policies  
Principles of Consolidation

 

Principles of Consolidation

 

The accompanying unaudited interim consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Interim Financial Statements

 

Interim Financial Statements

 

The accompanying unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). In the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly, in accordance with U.S. generally accepted accounting principles (GAAP), the financial position, results of operations and cash flows for all periods presented, have been made. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the full year.

 

Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. These unaudited interim consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K, filed for the fiscal year ended December 31, 2014.

 

The information presented in the accompanying consolidated balance sheet as of December 31, 2014 has been derived from the Company’s December 31, 2014 audited consolidated financial statements.  All other information has been derived from the unaudited interim consolidated financial statements of the Company.

Cash Equivalents

 

Cash Equivalents

 

Cash equivalents consist of money market accounts with an initial term of less than three months. For purposes of the unaudited consolidated statements of cash flows, the Company considers all highly-liquid debt instruments with original maturities of three months or less to be cash equivalents.  The Company’s cash and cash equivalents are deposited with financial institutions located in the U.S. and may at times exceed insured limits.

Revenue Recognition

 

Revenue Recognition

 

The Company recognizes revenue under arrangements for products and services, which may include the sale of products and related services, including revenue from installation, service and maintenance, spare parts, hydrogen fueling services (which may include hydrogen supply as well as hydrogen fueling infrastructure) and leased units. The Company also recognizes revenue under research and development contracts, which are primarily cost reimbursement contracts associated with the development of PEM fuel cell technology.

 

Products and Services

 

The Company enters into revenue arrangements that may contain a combination of fuel cell systems and equipment, installation, service, maintenance, spare parts, hydrogen fueling and other support services. Revenue arrangements containing fuel cell systems and equipment may be sold, or under a limited number of arrangements, leased to customers. For the above multiple deliverable arrangements, the Company accounts for each separate deliverable as a separate unit of accounting if the delivered item or items have value to the customer on a standalone basis. The Company considers a deliverable to have standalone value if the item is sold separately by us or another entity or if the item could be resold by the customer. The Company allocates revenue to each separate deliverable based on its relative selling price. For a majority of our deliverables, the Company determines relative selling prices using its best estimate of the selling price as vendor-specific objective evidence and third-party evidence is generally not available for the deliverables involved in its revenue arrangements due to a lack of a competitive environment in selling fuel cell technology. When determining estimated selling prices, the Company may consider the cost to produce the deliverable, the anticipated margin on that deliverable, the selling price and profit margin for similar products and services, the Company’s ongoing pricing strategy and policies, the value of any enhancements that have been built into the deliverable and the characteristics of the varying markets in which the deliverable is sold, as applicable. The Company determines estimated selling prices for deliverables in its arrangements based on the specific facts and circumstances of each arrangement and analyzes the estimated selling prices used for its allocation of consideration of each arrangement.

 

Once relative selling prices are determined, the Company proportionately allocates the sale consideration to each element of the arrangement. The allocated sales consideration related to fuel cell systems and equipment, spare parts, and hydrogen infrastructure is recognized as revenue at shipment if title and risk of loss have passed to the customer, there is persuasive evidence of an arrangement, the sales price is fixed or determinable, collection of the related receivable is reasonably assured, and customer acceptance criteria, if any, have been successfully demonstrated. The allocated sales consideration related to installation, service, maintenance, and hydrogen molecule delivery is generally recognized as revenue when completed or on a straight-line basis over the term of the contract, as appropriate.

 

The Company does not include a right of return on its products other than rights related to standard warranty provisions that permit repair or replacement of defective goods. The Company accrues for anticipated standard warranty costs at the same time that revenue is recognized for the related product.

 

The Company has also sold extended warranty contracts that generally provide for a five to ten year warranty from the date of product installation. These types of contracts are accounted for as a separate deliverable, and accordingly, revenue generated from these transactions is deferred and recognized in income over the warranty period, generally on a straight-line basis. Additionally, the Company may enter into annual service and maintenance contracts that are billed monthly. Revenue generated from these transactions is recognized in income on a straight-line basis over the term of the contract. Costs are recognized as incurred over the term of the contract.

 

Research and Development Contracts

 

Contract accounting is used for research and development contract revenue. The Company generally shares in the cost of these programs with cost sharing percentages ranging from 30% to 50% of total project costs. Revenue from time and material contracts is recognized on the basis of labor hours expended plus other reimbursable contract costs incurred during the period. All allowable work performed through the end of each calendar quarter is billed, subject to limitations in the respective contracts. We expect to continue research and development contract work that is directly related to our current product development efforts. At June 30, 2015 and December 31, 2014, the Company had unbilled amounts from research and development contract revenue in the amount of approximately $0.5 million and $1.0 million, respectively, which is included in other current assets in the accompanying unaudited consolidated balance sheets. Unbilled amounts are expected to be billed during the following quarter.

Common Stock Warrant Accounting

 

Common Stock Warrant Accounting

 

The Company accounts for common stock warrants in accordance with applicable accounting guidance provided in Accounting Standards Codification (ASC) Subtopic 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity, as either derivative liabilities or as equity instruments depending on the specific terms of the warrant agreement. In compliance with applicable securities law, registered common stock warrants that require the issuance of registered shares upon exercise and do not sufficiently preclude an implied right to cash settlement are accounted for as derivative liabilities. We currently classify these derivative warrant liabilities on the accompanying unaudited consolidated balance sheets as a long-term liability, which is revalued at each balance sheet date subsequent to the initial issuance using the Black-Scholes pricing model. The Black-Scholes pricing model, which is based, in part, upon unobservable inputs for which there is little or no market data, requires the Company to develop its own assumptions. Changes in the fair value of the warrants are reflected in the accompanying unaudited consolidated statements of operations as change in fair value of common stock warrant liability.

Joint Venture

 

Joint Venture

 

We are party to a joint venture with Axane, under the name HyPulsion (the JV). The principal purpose of the JV is to develop and sell hydrogen fuel cell systems for the European material handling market. In exchange for initial ownership of the JV, Axane contributed cash and we contributed the right to use our technology, including design and technology know-how on GenDrive systems. We are not obligated to contribute any cash.

 

We currently own 20% and Axane owns 80% of the JV. We have the right to purchase an additional 60% of the JV from Axane at any time between January 4, 2018 and January 29, 2018 at a market-based price. If we exercise our purchase right, Axane will have the right, at any time between February 1, 2018 and December 31, 2021, to require the Company to buy the remaining 20% interest at a market-based price.  See note 9 regarding our agreement to acquire the remaining ownership of HyPulsion.

 

In accordance with the equity method of accounting, we will increase our investment in the JV by our share of any earnings, and decrease our investment in the JV by our share of any losses. Losses in excess of the investment are not recognized and must be restored from future profits before our proportionate share of profits can be recognized. As of June 30, 2015, we had a zero basis for our investment in the JV.

Use of Estimates

 

Use of Estimates

 

The unaudited interim consolidated financial statements have been prepared in conformity with GAAP, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Reclassifications

 

Reclassifications

 

Reclassifications are made, whenever necessary, to prior period financial statements to conform to the current period presentation.  These reclassifications did not impact the results of operations or net cash flows in the periods presented.

Recent Accounting Pronouncements

 

Recent Accounting Pronouncements

 

In August 2014, an accounting update was issued relating to how management assesses conditions and events that could raise substantial doubt about an entity’s ability to continue as a going concern. This accounting update is effective for reporting periods beginning after December 31, 2016. We do not expect the adoption of this update to have a significant effect on our consolidated financial statements.

 

In June 2014, an accounting update was issued that replaces the existing revenue recognition framework regarding contracts with customers. In July 2015, the Financial Accounting Standards Board (FASB) announced a one year delay in the required adoption date from January 1, 2017 to January 1, 2018.  We are evaluating the effect this update will have on our consolidated financial statements and have not yet selected a transition method.

XML 32 R1.htm IDEA: XBRL DOCUMENT v3.2.0.727
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2015
Aug. 06, 2015
Document and Entity Information:    
Entity Registrant Name PLUG POWER INC  
Document Type 10-Q  
Document Period End Date Jun. 30, 2015  
Amendment Flag false  
Entity Central Index Key 0001093691  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   173,523,949
Entity Filer Category Large Accelerated Filer  
Entity Current Reporting Status Yes  
Document Fiscal Year Focus 2015  
Document Fiscal Period Focus Q2  
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.2.0.727
Earnings Per Share (Tables)
6 Months Ended
Jun. 30, 2015
Earnings Per Share.  
Schedule of components of the calculations of basic and diluted earnings per share:

 

 

The following table provides the components of the calculations of basic and diluted earnings per share (in thousands, except share amounts):

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 2015

 

June 30, 2014

 

June 30, 2015

 

June 30, 2014

 

Numerator:

 

 

 

 

 

 

 

 

 

Net loss attributable to common shareholders

 

$

(9,253

)

$

3,825

 

$

(20,330

)

$

(72,084

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding - basic

 

173,439,391

 

159,916,449

 

173,402,611

 

146,905,767

 

 

 

 

 

 

 

 

 

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

Options and restricted stock awards

 

 

4,120,364

 

 

 

Common stock warrants

 

 

1,054,486

 

 

 

Preferred stock

 

 

11,065,880

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding - diluted

 

173,439,391

 

176,157,179

 

173,402,611

 

146,905,767

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of potential dilutive common shares

 

 

At June 30,

 

 

 

2015

 

2014

 

Stock options outstanding (1)

 

8,576,278 

 

5,200,768 

 

Restricted stock outstanding

 

395,558 

 

650,002 

 

Common stock warrants (2)

 

4,219,442 

 

4,244,442 

 

Preferred stock (3)

 

5,554,594 

 

11,076,271 

 

 

 

 

 

 

 

Number of dilutive potential common shares

 

18,745,872 

 

21,171,483 

 

 

 

 

 

 

 

 

 

(1)

During the three months ended June 30, 2015 and 2014, the Company granted 440,000 and 435,500 stock options, respectively. During the six months ended June 30, 2015 and 2014, the Company granted 650,000 and 686,000 stock options, respectively.

(2)

In May 2011, the Company issued 7,128,563 warrants as part of an underwritten public offering. As a result of additional public offerings, and pursuant to the effect of the anti-dilution provisions of these warrants, the number of warrants increased to 22,995,365. Of these warrants, 219,342 and 244,342 were unexercised as of June 30, 2015 and 2014, respectively. In February 2013, the Company issued 23,637,500 warrants as part of an underwritten public offering. Of these warrants, 100 were unexercised as of June 30, 2015 and 2014. In January 2014, the Company issued 4,000,000 warrants as part of an underwritten public offering. Of these warrants, all are unexercised as of June 30, 2015 and 2014. As of June 30, 2015, the remaining warrants have a weighted average exercise price of $3.84.

(3)

The preferred stock amount represents the dilutive potential common shares of the Series C redeemable convertible preferred stock issued on May 16, 2013 based on the conversion price of the preferred stock as of June 30, 2015. Of the 10,431 preferred shares issued in May 2013, 5,200 had been converted to common stock as of June 30, 2015.

XML 34 R4.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Revenue        
Product revenue $ 15,324 $ 12,579 $ 19,391 $ 15,741
Service revenue 8,428 4,415 13,731 6,481
Research and development contract revenue 257 327 303 674
Total revenue 24,009 17,321 33,425 22,896
Cost of product revenue 11,653 10,448 15,491 13,892
Cost of service revenue 10,483 5,908 18,121 9,926
Cost of research and development contract revenue 311 770 362 1,188
Research and development expense 3,425 1,398 6,326 2,652
Selling, general and administrative expenses 8,002 5,439 15,751 9,258
Operating loss (9,865) (6,642) (22,626) (14,020)
Interest and other income 32 49 63 94
Gain on bargain purchase   1,014   1,014
Change in fair value of common stock warrant liability 667 9,577 2,436 (58,856)
Interest and other expense (60) (121) (150) (212)
Net (loss) income attributable to the Company (9,226) 3,877 (20,277) (71,980)
Preferred stock dividends declared (27) (52) (53) (104)
Net (loss) income attributable to common shareholders $ (9,253) $ 3,825 $ (20,330) $ (72,084)
Net (loss) income per share:        
Basic (in dollars per share) $ (0.05) $ 0.02 $ (0.12) $ (0.49)
Diluted (in dollars per share) $ (0.05) $ 0.02 $ (0.12) $ (0.49)
Basic weighted average number of common shares outstanding 173,439,391 159,916,449 173,402,611 146,905,767
Diluted weighted average number of common shares outstanding 173,439,391 176,157,179 173,402,611 146,905,767
XML 35 R12.htm IDEA: XBRL DOCUMENT v3.2.0.727
Inventory
6 Months Ended
Jun. 30, 2015
Inventory.  
Inventory

 

5.  Inventory

 

Inventory as of June 30, 2015 and December 31, 2014 consisted of the following (in thousands):

 

 

 

June 30, 2015

 

December 31, 2014

 

Raw materials and supplies

 

$

23,299 

 

$

18,502 

 

Work-in-process

 

2,764 

 

237 

 

Finished goods

 

6,826 

 

5,997 

 

 

 

 

 

 

 

 

 

$

32,889 

 

$

24,736 

 

 

 

 

 

 

 

 

 

 

XML 36 R11.htm IDEA: XBRL DOCUMENT v3.2.0.727
Earnings Per Share
6 Months Ended
Jun. 30, 2015
Earnings Per Share.  
Earnings Per Share

 

4. Earnings Per Share

 

The following table provides the components of the calculations of basic and diluted earnings per share (in thousands, except share amounts):

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 2015

 

June 30, 2014

 

June 30, 2015

 

June 30, 2014

 

Numerator:

 

 

 

 

 

 

 

 

 

Net loss attributable to common shareholders

 

$

(9,253

)

$

3,825

 

$

(20,330

)

$

(72,084

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding - basic

 

173,439,391

 

159,916,449

 

173,402,611

 

146,905,767

 

 

 

 

 

 

 

 

 

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

Options and restricted stock awards

 

 

4,120,364

 

 

 

Common stock warrants

 

 

1,054,486

 

 

 

Preferred stock

 

 

11,065,880

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding - diluted

 

173,439,391

 

176,157,179

 

173,402,611

 

146,905,767

 

 

 

 

 

 

 

 

 

 

 

 

When the Company is in a net loss position, all common stock equivalents would be considered to be anti-dilutive and are, therefore, not included in the determination of diluted earnings per share.

 

The potential dilutive common shares are summarized as follows:

 

 

 

At June 30,

 

 

 

2015

 

2014

 

Stock options outstanding (1)

 

8,576,278 

 

5,200,768 

 

Restricted stock outstanding

 

395,558 

 

650,002 

 

Common stock warrants (2)

 

4,219,442 

 

4,244,442 

 

Preferred stock (3)

 

5,554,594 

 

11,076,271 

 

 

 

 

 

 

 

Number of dilutive potential common shares

 

18,745,872 

 

21,171,483 

 

 

 

 

 

 

 

 

 

(1)

During the three months ended June 30, 2015 and 2014, the Company granted 440,000 and 435,500 stock options, respectively. During the six months ended June 30, 2015 and 2014, the Company granted 650,000 and 686,000 stock options, respectively.

(2)

In May 2011, the Company issued 7,128,563 warrants as part of an underwritten public offering. As a result of additional public offerings, and pursuant to the effect of the anti-dilution provisions of these warrants, the number of warrants increased to 22,995,365. Of these warrants, 219,342 and 244,342 were unexercised as of June 30, 2015 and 2014, respectively. In February 2013, the Company issued 23,637,500 warrants as part of an underwritten public offering. Of these warrants, 100 were unexercised as of June 30, 2015 and 2014. In January 2014, the Company issued 4,000,000 warrants as part of an underwritten public offering. Of these warrants, all are unexercised as of June 30, 2015 and 2014. As of June 30, 2015, the remaining warrants have a weighted average exercise price of $3.84.

(3)

The preferred stock amount represents the dilutive potential common shares of the Series C redeemable convertible preferred stock issued on May 16, 2013 based on the conversion price of the preferred stock as of June 30, 2015. Of the 10,431 preferred shares issued in May 2013, 5,200 had been converted to common stock as of June 30, 2015.

XML 37 R23.htm IDEA: XBRL DOCUMENT v3.2.0.727
Summary of Siginificant Accounting Policies (Details)
6 Months Ended
Jun. 30, 2015
USD ($)
Dec. 31, 2014
USD ($)
Basis of Presentation    
Minimum term of extended warranty contracts sold 5 years  
Maximum term of extended warranty contracts sold 10 years  
Unbilled amounts $ 500,000 $ 1,000,000
HyPulsion    
Joint Venture    
Ownership interest percentage 20.00%  
Minimum    
Research and Development.    
Cost Sharing Percentages of research and development contracts $ 30  
Maximum    
Research and Development.    
Cost Sharing Percentages of research and development contracts $ 50  
Axane, S.A. | HyPulsion    
Joint Venture    
Ownership interest percentage 80.00%  
Additional ownership interest that can be purchased by entity from counterparty at any time between January 4, 2018 and January 29, 2018 at a formula price 60.00%  
Remaining ownership interest to be acquired by Company upon exercise of its purchase right 20  
XML 38 R19.htm IDEA: XBRL DOCUMENT v3.2.0.727
Inventory (Tables)
6 Months Ended
Jun. 30, 2015
Inventory.  
Schedule of Inventory

 

Inventory as of June 30, 2015 and December 31, 2014 consisted of the following (in thousands):

 

 

June 30, 2015

 

December 31, 2014

 

Raw materials and supplies

 

$

23,299 

 

$

18,502 

 

Work-in-process

 

2,764 

 

237 

 

Finished goods

 

6,826 

 

5,997 

 

 

 

 

 

 

 

 

 

$

32,889 

 

$

24,736 

 

 

 

 

 

 

 

 

 

 

XML 39 R15.htm IDEA: XBRL DOCUMENT v3.2.0.727
Commitment and Contingencies
6 Months Ended
Jun. 30, 2015
Commitments and Contingencies.  
Commitments and Contingencies

 

8. Commitments and Contingencies

 

Litigation

 

Legal matters are defended and handled in the ordinary course of business.  We have established accruals for matters for which management considers a loss to be probable and reasonably estimable. It is the opinion of management that facts known at the present time do not indicate that such litigation, after taking into account insurance coverage and the aforementioned accruals, will have a material adverse impact on our results of operations, financial position, or cash flows.

 

Concentrations of credit risk

 

Concentrations of credit risk with respect to receivables exist due to the limited number of select customers with whom the Company has initial commercial sales arrangements. To mitigate credit risk, the Company performs appropriate evaluation of a prospective customer’s financial condition.

 

At June 30, 2015, two customers comprise approximately 42.6% of the total accounts receivable balance, with each customer individually representing 23.4% and 19.2% of total accounts receivable, respectively.  At December 31, 2014, four customers comprise approximately 69.9% of the total accounts receivable balance, with each customer individually representing 30.2%, 16.0%, 13.4% and 10.3% of total accounts receivable, respectively.

 

For the six months ended June 30, 2015, 95.1% of total consolidated revenues were associated with three customers, with each representing 68.8%, 16.1%, and 10.2% of total consolidated revenues, respectively.  For the six months ended June 30, 2014, 35.9% of total consolidated revenues were associated with two customers, with each representing 20.7% and 15.2% of total consolidated revenues, respectively.

 

Restricted Cash

 

The Company has entered into sales/leaseback agreements associated with its products and services.  In connection with these agreements, cash of $10.6 million is required to be held in escrow, which will be released over the lease term.

 

The Company also has letters of credit in the aggregate amount of $1.0 million associated with an agreement to provide hydrogen infrastructure and hydrogen to a customer at its distribution center and with a finance obligation from the sale/leaseback of its building.  Cash collateralizing these letters of credit is considered restricted cash.

XML 40 R13.htm IDEA: XBRL DOCUMENT v3.2.0.727
Income Taxes
6 Months Ended
Jun. 30, 2015
Income Taxes.  
Income Taxes

 

6. Income Taxes

 

Under Internal Revenue Code (IRC) Section 382, the use of loss carryforwards may be limited if a change in ownership of a company occurs. If it is determined that, due to transactions involving the Company’s shares owned by its 5 percent or greater shareholders, a change of ownership has occurred under the provisions of IRC Section 382, the Company’s federal and state net operating loss carryforwards could be subject to significant IRC Section 382 limitations.

 

Based upon recent IRC Section 382 studies, Section 382 ownership changes occurred that resulted in all but $54 million of the Company’s federal and state net operating loss carryforwards generated through June 30, 2015 to be subject to IRC Section 382 limitations. Of the net operating loss carryforwards subject to IRC Section 382 limitations, $13 million will not expire prior to utilization and are reflected in the Company’s gross deferred tax asset at June 30, 2015.

 

The ownership changes also resulted in net unrealized built in losses per IRS Notice 2003-65 which should result in recognized built in losses during the five year recognition period. These recognized built in losses will translate into unfavorable book to tax add backs in the Company’s 2015 to 2018 U.S. corporate income tax returns of approximately $17.7 million that resulted in a gross deferred tax liability of $6.8 million at June 30, 2015 with a corresponding reduction to the valuation allowance. This gross deferred tax liability will offset certain existing gross deferred tax assets (i.e. capitalized research expense). This has no impact on the Company’s current financial position, results of operations, or cash flows because of the full valuation allowance.

 

The Company’s remaining deferred tax assets have been offset by a full valuation allowance because it is more likely than not that the tax benefits of the net operating loss carryforwards and other tax assets may not be realized.

 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense. The Company had $0.4 million of interest and penalties accrued at June 30, 2015 and December 31, 2014, respectively.

XML 41 R14.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value Measurements
6 Months Ended
Jun. 30, 2015
Fair Value Measurements.  
Fair Value Measurements

 

7. Fair Value Measurements

 

The following table summarizes the financial instruments measured at fair value on a recurring basis in the consolidated balance sheets (in thousands):

 

Balance at June 30, 2015

 

Total

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

 

 

 

 

 

 

 

 

Common stock warrant liability

 

$

6,982 

 

$

 

$

 

$

6,982 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock warrant liability

 

$

9,418 

 

$

 

$

 

$

9,418 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The common stock warrant liability is measured at fair value using Level 3 inputs.  Level 3 inputs are unobservable inputs and should be used to determine fair value only when observable inputs are not available. Unobservable inputs should be developed based on the best information available in the circumstances, which might include internally generated data and assumptions being used to price the asset or liability.  When possible, the Company looks to active and observable markets to price identical assets, however when identical assets are not traded in active markets, the Company looks to market observable data for similar assets. Nevertheless, certain assets are not actively traded in observable markets and the Company must use alternative valuation techniques to derive a fair value measurement.

 

For our common stock warrants, fair value is based on the Black-Scholes pricing model which is based, in part, upon unobservable inputs for which there is little or no market data, requiring the Company to develop its own assumptions. The Company used the following assumptions for its common stock warrants:

 

 

 

At June 30, 2015

 

At December 31, 2014

 

 

 

 

 

 

 

Risk-free interest rate

 

0.28%-1.375%

 

0.21%-1.35%

 

Volatility

 

52.92%-134.4%

 

119.16%-136.62%

 

Expected average term

 

0.92-3.55

 

1.42-4.04

 

 

There was no expected dividend yield for the warrants granted. If factors change and different assumptions are used, the warrant liability and the change in estimated fair value could be materially different. Generally, as the market price of our common stock increases, the fair value of the warrant increases, and conversely, as the market price of our common stock decreases, the fair value of the warrant decreases. Also, a significant increase in the volatility of the market price of the Company’s common stock, in isolation, would result in a significantly higher fair value measurement; and a significant decrease in volatility would result in a significantly lower fair value measurement.

 

The following table shows reconciliations of the beginning and ending balances for financial instruments measured at fair value on a recurring basis using significant unobservable inputs (in thousands):

 

 

 

Fair Value

 

 

 

Measurement Using

 

 

 

Significant

 

 

 

Unobservable Inputs

 

 

 

Three months ended

 

Six months ended

 

Common stock warrant liability

 

June 30, 2015

 

June 30, 2014

 

June 30, 2015

 

June 30, 2014

 

 

 

 

 

 

 

 

 

 

 

Beginning of period

 

$

7,649

 

$

25,742

 

$

9,418

 

$

28,830

 

Change in fair value of common stock warrants

 

(667

)

(9,577

)

(2,436

)

58,856

 

Issuance of common stock warrants

 

 

 

 

11,773

 

Exercise of common stock warrants

 

 

(36

)

 

(83,330

)

 

 

 

 

 

 

 

 

 

 

End of period

 

$

6,982

 

$

16,129

 

$

6,982

 

$

16,129

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

XML 42 R16.htm IDEA: XBRL DOCUMENT v3.2.0.727
Subsequent Events
6 Months Ended
Jun. 30, 2015
Subsequent Events  
Subsequent Event

 

9. Subsequent Event

 

On July 24, 2015, we entered into a Share Purchase Agreement with Axane, pursuant to which on July 31, 2015 we (through a wholly-owned subsidiary) acquired Axane’s 80% equity interest in HyPulsion for $11.5 million, payable in shares of our common stock. In connection with the agreement, we issued 4,781,250 shares of our common stock and agreed to the issuance of up to 3,105,348 additional shares of our common stock in certain circumstances. The purchase price is also subject to certain other post-closing adjustments payable in cash.

XML 43 R34.htm IDEA: XBRL DOCUMENT v3.2.0.727
Subsequent Event (Details) - Jul. 24, 2015 - Subsequent event - Axane, S.A. - HyPulsion - USD ($)
$ in Millions
Total
Subsequent Event [Line Items]  
Percentage of voting interest acquired 80.00%
Value of shares of common stock issued $ 11.5
Number of shares of common stock issued 4,781,250
Additional shares issuable in certain circumstances 3,105,348
XML 44 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727
Nature of Operations (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 02, 2014
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Description of Business                
Net loss attributable to common shareholders   $ 9,253 $ (3,825) $ 20,330 $ 72,084 $ 88,600 $ 62,800 $ 31,900
Accumulated deficit   958,411   958,411   938,081    
Net cash used in operating activities       24,255 19,934      
Cash and cash equivalents   109,139 $ 168,609 109,139 $ 168,609 146,205 $ 5,027  
Net working capital   $ 135,800   $ 135,800   $ 167,000    
ReliOn                
Description of Business                
Number of shares of common stock issued 530,504              
Share price (in dollars per share) $ 7.54              
XML 45 R26.htm IDEA: XBRL DOCUMENT v3.2.0.727
Earnings Per Share (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Numerator:              
Net loss attributable to common shareholders $ (9,253) $ 3,825 $ (20,330) $ (72,084) $ (88,600) $ (62,800) $ (31,900)
Denominator:              
Weighted Average Number of Shares Outstanding, Basic 173,439,391 159,916,449 173,402,611 146,905,767      
Options and restricted stock awards (in shares)   4,120,364          
Common stock warrants (in shares)   1,054,486          
Preferred stock (in shares)   11,065,880          
Weighted Average Number of Shares Outstanding, Diluted 173,439,391 176,157,179 173,402,611 146,905,767      
XML 46 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Consolidated Statements of Comprehensive Loss        
Net (loss) income attributable to the Company $ (9,226) $ 3,877 $ (20,277) $ (71,980)
Comprehensive (Loss) Income $ (9,226) $ 3,877 $ (20,277) $ (71,980)
XML 47 R10.htm IDEA: XBRL DOCUMENT v3.2.0.727
Acquisition of ReliOn Inc
6 Months Ended
Jun. 30, 2015
Acquisition of ReliOn Inc.  
Acquisition of ReliOn Inc.

 

3. Acquisition of ReliOn, Inc.

 

On April 2, 2014, the Company completed the acquisition of ReliOn, Inc. (“ReliOn”) for an aggregate purchase price of $4.0 million. The Company acquired substantially all of the assets of ReliOn, including patents, technology and other intangible assets, equipment and other tangible assets. ReliOn is a developer of hydrogen fuel cell stack technology based in Spokane, Washington. As consideration, the Company issued 530,504 shares of common stock, and assumed certain specified liabilities of ReliOn. The total purchase price is based on the issuance of 530,504 shares of Plug Power common stock at the closing price of the Company’s stock on April 1, 2014 of $7.54. Results of operations of ReliOn have been consolidated since acquisition.  The fair value of the acquired net assets of approximately $5.0 million exceeded the purchase consideration, and therefore a gain on bargain purchase of $1.0 million was recognized during the six months ended June 30, 2014.

XML 48 R27.htm IDEA: XBRL DOCUMENT v3.2.0.727
Earnings Per Share (Details 2) - $ / shares
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2015
Mar. 31, 2015
Jun. 30, 2014
Jan. 31, 2014
Feb. 28, 2013
May. 31, 2011
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
May. 31, 2014
Dilutive potential common shares                      
Stock options outstanding (1) 8,576,278   5,200,768       8,576,278 5,200,768 8,576,278 5,200,768  
Restricted stock outstanding 395,558   650,002       395,558 650,002 395,558 650,002  
Common stock warrants (2) 4,219,442   4,244,442       4,219,442 4,244,442 4,219,442 4,244,442  
Preferred stock (3) 5,554,594   11,076,271       5,554,594 11,076,271 5,554,594 11,076,271  
Number of dilutive potential common shares 18,745,872   21,171,483       18,745,872 21,171,483 18,745,872 21,171,483  
Earnings Per Share                      
Weighted average exercise price   $ 3.84                  
Preferred stock (3) 5,554,594   11,076,271       5,554,594 11,076,271 5,554,594 11,076,271  
Stock options                      
Earnings Per Share                      
Stock options granted             440,000 435,500 650,000 686,000  
Warrants issued in May, 2011                      
Earnings Per Share                      
Number of warrants issued (in shares)           7,128,563          
Antidilutive shares excluded from calculation of diluted earnings per share           22,995,365          
Number of warrants unexercised (in shares)                 219,342 244,342  
Warrants issued in February, 2013                      
Earnings Per Share                      
Number of warrants issued (in shares)         23,637,500            
Number of warrants unexercised (in shares) 100   100                
Warrants issued in January, 2014                      
Earnings Per Share                      
Number of warrants issued (in shares)       4,000,000              
Series C redeemable convertible preferred stock                      
Dilutive potential common shares                      
Preferred stock (3)                     10,431
Earnings Per Share                      
Preferred stock (3)                     10,431
Number of preferred shares that had been converted to common stock 5,200                    
XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.2.0.727 html 78 185 1 false 28 0 false 5 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.plugpoweinc.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.plugpoweinc.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.plugpoweinc.com/role/StatementConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 00200 - Statement - Consolidated Statements of Operations Sheet http://www.plugpoweinc.com/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://www.plugpoweinc.com/role/StatementConsolidatedStatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 00400 - Disclosure - Consolidated Statements of Stockholders' Equity Sheet http://www.plugpoweinc.com/role/DisclosureConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Notes 6 false false R7.htm 00500 - Statement - Consolidated Statements of Cash Flows Sheet http://www.plugpoweinc.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Uncategorized 7 false false R8.htm 10101 - Disclosure - Nature of Operations Sheet http://www.plugpoweinc.com/role/DisclosureNatureOfOperations Nature of Operations Uncategorized 8 false false R9.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.plugpoweinc.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Uncategorized 9 false false R10.htm 10301 - Disclosure - Acquisition of ReliOn Inc Sheet http://www.plugpoweinc.com/role/DisclosureAcquisitionOfRelionInc Acquisition of ReliOn Inc Uncategorized 10 false false R11.htm 10401 - Disclosure - Earnings Per Share Sheet http://www.plugpoweinc.com/role/DisclosureEarningsPerShare Earnings Per Share Uncategorized 11 false false R12.htm 10501 - Disclosure - Inventory Sheet http://www.plugpoweinc.com/role/DisclosureInventory Inventory Uncategorized 12 false false R13.htm 10601 - Disclosure - Income Taxes Sheet http://www.plugpoweinc.com/role/DisclosureIncomeTaxes Income Taxes Uncategorized 13 false false R14.htm 10701 - Disclosure - Fair Value Measurements Sheet http://www.plugpoweinc.com/role/DisclosureFairValueMeasurements Fair Value Measurements Uncategorized 14 false false R15.htm 10801 - Disclosure - Commitment and Contingencies Sheet http://www.plugpoweinc.com/role/DisclosureCommitmentAndContingencies Commitment and Contingencies Uncategorized 15 false false R16.htm 10901 - Disclosure - Subsequent Events Sheet http://www.plugpoweinc.com/role/DisclosureSubsequentEvents Subsequent Events Uncategorized 16 false false R17.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.plugpoweinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Uncategorized 17 false false R18.htm 30403 - Disclosure - Earnings Per Share (Tables) Sheet http://www.plugpoweinc.com/role/DisclosureEarningsPerShareTables Earnings Per Share (Tables) Uncategorized 18 false false R19.htm 30503 - Disclosure - Inventory (Tables) Sheet http://www.plugpoweinc.com/role/DisclosureInventoryTables Inventory (Tables) Uncategorized 19 false false R20.htm 30703 - Disclosure - Fair Value Measurments (Tables) Sheet http://www.plugpoweinc.com/role/DisclosureFairValueMeasurmentsTables Fair Value Measurments (Tables) Uncategorized 20 false false R21.htm 40101 - Disclosure - Nature of Operations (Details) Sheet http://www.plugpoweinc.com/role/DisclosureNatureOfOperationsDetails Nature of Operations (Details) Uncategorized 21 false false R22.htm 40102 - Disclosure - Nature of Operations (Details 2) Sheet http://www.plugpoweinc.com/role/DisclosureNatureOfOperationsDetails2 Nature of Operations (Details 2) Uncategorized 22 false false R23.htm 40201 - Disclosure - Summary of Siginificant Accounting Policies (Details) Sheet http://www.plugpoweinc.com/role/DisclosureSummaryOfSiginificantAccountingPoliciesDetails Summary of Siginificant Accounting Policies (Details) Uncategorized 23 false false R24.htm 40202 - Disclosure - Summary of Siginificant Accounting Policies (Details 2) Sheet http://www.plugpoweinc.com/role/DisclosureSummaryOfSiginificantAccountingPoliciesDetails2 Summary of Siginificant Accounting Policies (Details 2) Uncategorized 24 false false R25.htm 40301 - Disclosure - Acquisition of ReliOn Inc (Details) Sheet http://www.plugpoweinc.com/role/DisclosureAcquisitionOfRelionIncDetails Acquisition of ReliOn Inc (Details) Uncategorized 25 false false R26.htm 40401 - Disclosure - Earnings Per Share (Details) Sheet http://www.plugpoweinc.com/role/DisclosureEarningsPerShareDetails Earnings Per Share (Details) Uncategorized 26 false false R27.htm 40402 - Disclosure - Earnings Per Share (Details 2) Sheet http://www.plugpoweinc.com/role/DisclosureEarningsPerShareDetails2 Earnings Per Share (Details 2) Uncategorized 27 false false R28.htm 40501 - Disclosure - Inventory (Details) Sheet http://www.plugpoweinc.com/role/DisclosureInventoryDetails Inventory (Details) Uncategorized 28 false false R29.htm 40601 - Disclosure - Income Taxes (Details) Sheet http://www.plugpoweinc.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Uncategorized 29 false false R30.htm 40701 - Disclosure - Fair Value Measurements (Details) Sheet http://www.plugpoweinc.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Uncategorized 30 false false R31.htm 40702 - Disclosure - Fair Value Measurements (Details 2) Sheet http://www.plugpoweinc.com/role/DisclosureFairValueMeasurementsDetails2 Fair Value Measurements (Details 2) Uncategorized 31 false false R32.htm 40703 - Disclosure - Fair Value Measurements (Details 3) Sheet http://www.plugpoweinc.com/role/DisclosureFairValueMeasurementsDetails3 Fair Value Measurements (Details 3) Uncategorized 32 false false R33.htm 40801 - Disclosure - Commitment and Contingencies (Details) Sheet http://www.plugpoweinc.com/role/DisclosureCommitmentAndContingenciesDetails Commitment and Contingencies (Details) Uncategorized 33 false false R34.htm 40901 - Disclosure - Subsequent Event (Details) Sheet http://www.plugpoweinc.com/role/DisclosureSubsequentEventDetails Subsequent Event (Details) Uncategorized 34 false false All Reports Book All Reports In ''Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Consolidated Statements of Operations'', column(s) 13, 14, 15 are contained in other reports, so were removed by flow through suppression. In ''Consolidated Statements of Cash Flows'', column(s) 1, 2, 5 are contained in other reports, so were removed by flow through suppression. plug-20150630.xml plug-20150630_cal.xml plug-20150630_def.xml plug-20150630_lab.xml plug-20150630_pre.xml plug-20150630.xsd true true XML 50 R20.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value Measurments (Tables)
6 Months Ended
Jun. 30, 2015
Fair Value Measurements.  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

 

The following table summarizes the financial instruments measured at fair value on a recurring basis in the consolidated balance sheets (in thousands):

 

Balance at June 30, 2015

 

Total

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

 

 

 

 

 

 

 

 

Common stock warrant liability

 

$

6,982 

 

$

 

$

 

$

6,982 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock warrant liability

 

$

9,418 

 

$

 

$

 

$

9,418 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assumptions used to calculate common stock warrants

 

 

At June 30, 2015

 

At December 31, 2014

 

 

 

 

 

 

 

Risk-free interest rate

 

0.28%-1.375%

 

0.21%-1.35%

 

Volatility

 

52.92%-134.4%

 

119.16%-136.62%

 

Expected average term

 

0.92-3.55

 

1.42-4.04

 

 

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation

 

The following table shows reconciliations of the beginning and ending balances for financial instruments measured at fair value on a recurring basis using significant unobservable inputs (in thousands):

 

 

 

Fair Value

 

 

 

Measurement Using

 

 

 

Significant

 

 

 

Unobservable Inputs

 

 

 

Three months ended

 

Six months ended

 

Common stock warrant liability

 

June 30, 2015

 

June 30, 2014

 

June 30, 2015

 

June 30, 2014

 

 

 

 

 

 

 

 

 

 

 

Beginning of period

 

$

7,649

 

$

25,742

 

$

9,418

 

$

28,830

 

Change in fair value of common stock warrants

 

(667

)

(9,577

)

(2,436

)

58,856

 

Issuance of common stock warrants

 

 

 

 

11,773

 

Exercise of common stock warrants

 

 

(36

)

 

(83,330

)

 

 

 

 

 

 

 

 

 

 

End of period

 

$

6,982

 

$

16,129

 

$

6,982

 

$

16,129